data_2m2j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m2j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 138.21 51.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.398 0.279 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.1 m -78.66 138.82 38.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.343 0.657 . . . . 0.0 110.537 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.08 118.12 11.58 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.0 tp -99.18 129.88 45.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.9 p -71.51 154.03 93.49 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.484 0.714 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.27 -18.35 51.83 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.831 2.354 . . . . 0.0 113.498 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.42 -53.63 11.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.211 0.605 . . . . 0.0 109.991 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.19 -33.73 74.96 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.272 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.35 80.8 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.827 0.851 . . . . 0.0 110.772 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.48 -23.29 64.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.244 0.618 . . . . 0.0 111.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.42 3.99 54.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.386 0.674 . . . . 0.0 112.13 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.413 HD13 HD23 ' A' ' 26' ' ' LEU . 93.0 mt -130.2 152.24 49.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.623 0.769 . . . . 0.0 110.245 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -108.18 125.01 32.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 58.1 Cg_endo -68.86 138.99 42.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.234 1.956 . . . . 0.0 111.555 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -79.31 -24.38 42.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.231 0.538 . . . . 0.0 110.459 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -156.24 172.47 18.41 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.592 1.157 . . . . 0.0 108.545 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -143.47 119.87 10.95 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 56' ' ' VAL . 36.5 pt -94.71 138.15 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 122.777 0.431 . . . . 0.0 110.371 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.543 HG23 HG21 ' A' ' 85' ' ' VAL . 38.5 t -121.62 131.99 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 pt -123.54 166.13 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.041 0.936 . . . . 0.0 108.948 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -116.5 145.11 43.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 171.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.1 108.78 0.47 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -80.7 79.06 7.41 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.2 t80 44.07 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.478 1.511 . . . . 0.0 113.675 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -122.44 -65.3 1.12 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.08 148.96 5.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 108.824 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.95 -39.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.07 77.47 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.434 0.459 . . . . 0.0 113.148 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.76 -44.51 77.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.828 0.851 . . . . 0.0 109.444 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.2 -44.78 78.73 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.042 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.48 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.795 0.838 . . . . 0.0 111.016 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 t -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.94 0.496 . . . . 0.0 110.217 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.88 69.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.952 0.501 . . . . 0.0 110.977 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.48 HG13 HD11 ' A' ' 40' ' ' ILE . 97.6 t -70.38 -37.49 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.293 0.637 . . . . 0.0 109.926 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.4 t -64.89 -41.86 95.27 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.769 0.827 . . . . 0.0 110.684 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.34 -59.45 4.35 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.159 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 15.6 tpp180 -63.89 -38.33 90.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.67 0.788 . . . . 0.0 111.837 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.35 98.31 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.04 0.448 . . . . 0.0 110.537 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.19 -36.7 85.01 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.774 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.81 -20.6 61.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.256 0.622 . . . . 0.0 111.279 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 34.4 mm-40 -90.97 -4.62 56.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.991 0.516 . . . . 0.0 111.383 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.13 7.93 76.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.067 0.23 . . . . 0.0 113.672 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 137.66 47.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.559 0.743 . . . . 0.0 110.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -71.0 -40.92 71.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.804 0.841 . . . . 0.0 110.525 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 32.7 m -137.32 172.6 12.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.959 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -143.09 165.05 28.45 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.127 0.971 . . . . 0.0 109.365 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.66 112.19 6.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.042 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.34 113.28 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 86' ' ' ALA . 61.7 t -82.67 -48.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -164.6 143.56 7.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.79 -168.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.484 HG21 HG22 ' A' ' 84' ' ' VAL . 68.8 p -120.84 104.82 10.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 p -129.12 144.88 51.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.329 0.652 . . . . 0.0 111.23 -171.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 27.8 mt-10 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.071 0.948 . . . . 0.0 110.369 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 6.1 p-10 . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 29.6 p-90 -95.83 172.91 7.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.722 172.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.438 ' NH1' ' HB ' ' A' ' 85' ' ' VAL . 2.7 ppt_? -142.56 154.76 44.74 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.319 1.048 . . . . 0.0 108.624 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 73' ' ' THR . 57.5 t -119.22 111.76 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 0.0 109.363 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG21 HG23 ' A' ' 41' ' ' VAL . 7.3 p -90.34 128.82 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 71' ' ' VAL . . . -145.6 131.85 19.5 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.218 0.607 . . . . 0.0 111.167 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 68.7 m-20 -70.12 158.03 36.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 110.6 173.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.9 139.32 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.462 0.705 . . . . 0.0 109.431 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -127.82 136.52 51.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.939 0.896 . . . . 0.0 110.194 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -80.76 167.66 19.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.667 0.787 . . . . 0.0 111.585 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.275 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.83 145.71 42.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.637 0.375 . . . . 0.0 110.328 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.6 m -69.96 140.09 52.94 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.29 0.636 . . . . 0.0 111.107 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.64 126.46 30.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.507 HD21 HD13 ' A' ' 34' ' ' LEU . 12.7 tp -98.93 126.06 44.52 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 p -74.03 143.61 80.99 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.985 0.514 . . . . 0.0 109.996 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.82 -34.84 6.29 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.551 3.5 . . . . 0.0 115.667 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -69.62 -44.22 71.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.576 0.751 . . . . 0.0 110.695 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -68.9 -39.19 79.87 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.141 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.06 63.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.198 0.999 . . . . 0.0 112.099 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.45 77.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.163 0.585 . . . . 0.0 110.164 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.12 36.83 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.507 HD13 HD21 ' A' ' 26' ' ' LEU . 90.2 mt -89.02 157.4 18.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.333 0.653 . . . . 0.0 111.269 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -110.44 128.6 25.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.25 159.69 48.99 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.201 1.934 . . . . 0.0 111.532 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -96.52 -14.73 22.09 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -158.86 154.84 26.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.979 0.912 . . . . 0.0 109.951 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.586 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 86.3 mtm180 -124.49 127.14 47.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.553 1.141 . . . . 0.0 108.764 171.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 HD13 HG12 ' A' ' 56' ' ' VAL . 32.1 pt -103.5 161.7 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.04 0.936 . . . . 0.0 110.63 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.54 129.67 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.984 0.914 . . . . 0.0 109.825 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.66 166.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.407 1.083 . . . . 0.0 108.76 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 29.4 m -149.82 130.47 14.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.38 133.42 6.96 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 23.9 ttm-85 -100.6 123.66 45.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.183 0.593 . . . . 0.0 110.003 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 63.16 11.74 5.51 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.939 1.296 . . . . 0.0 113.049 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 36.1 m-80 -79.79 148.94 31.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.371 0.668 . . . . 0.0 110.287 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.64 168.23 17.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.299 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.1 tp -57.5 -31.9 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.541 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.12 93.59 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.758 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 12.7 m-20 -67.19 -37.51 83.81 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.624 0.77 . . . . 0.0 110.789 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -64.93 -53.4 47.09 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.913 0.758 . . . . 0.0 110.71 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.46 -36.21 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 0.0 110.853 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 t -64.86 -42.85 94.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.918 0.887 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.44 -37.39 65.86 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.52 0.728 . . . . 0.0 111.451 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.528 HG12 HD13 ' A' ' 40' ' ' ILE . 76.6 t -65.19 -45.36 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.132 0.573 . . . . 0.0 110.485 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -68.73 -32.28 71.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.821 0.848 . . . . 0.0 110.744 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -65.79 -55.04 19.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.515 0.726 . . . . 0.0 109.8 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -62.28 -44.67 95.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.994 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.47 -49.13 78.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.751 0.82 . . . . 0.0 111.182 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.64 -38.66 91.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.404 0.682 . . . . 0.0 111.088 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -76.16 -21.04 57.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.151 0.581 . . . . 0.0 112.202 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -76.82 -22.59 53.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.992 0.517 . . . . 0.0 110.277 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.02 11.41 60.15 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.902 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.9 129.16 38.82 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.661 0.784 . . . . 0.0 110.141 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.65 84.67 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 123.874 0.734 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 26' ' ' LEU . 13.8 t -141.4 174.99 10.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.019 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.78 163.94 35.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.299 1.04 . . . . 0.0 108.86 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -151.49 118.4 5.83 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -71.24 114.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.28 -23.35 5.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -163.53 129.61 3.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.981 0.419 . . . . 0.0 111.18 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 p -111.33 141.59 44.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 165.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.494 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 23.0 t -159.19 139.88 12.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.101 0.56 . . . . 0.0 110.663 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 56.6 t30 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -150.22 131.0 14.12 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.368 0.604 . . . . 0.0 111.287 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HD2' ' HB3' ' A' ' 74' ' ' SER . 0.0 OUTLIER -91.66 156.37 17.65 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 110.171 178.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 52' ' ' ALA . 61.0 t -139.7 116.58 9.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 124.14 0.976 . . . . 0.0 108.431 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 132.45 40.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.43 138.07 29.06 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.113 0.965 . . . . 0.0 109.048 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.586 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -101.79 141.76 34.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.637 0.775 . . . . 0.0 109.353 176.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.02 142.6 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.038 0.935 . . . . 0.0 110.045 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -124.52 155.94 38.15 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.338 1.055 . . . . 0.0 111.746 -165.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -110.57 145.46 37.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.494 1.118 . . . . 0.0 108.94 169.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.585 0.754 . . . . 0.0 108.983 -178.079 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.71 129.37 39.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -66.17 135.39 54.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.435 0.694 . . . . 0.0 110.663 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.98 115.83 11.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -89.7 134.6 34.08 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.4 p -68.25 142.49 94.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.778 0.674 . . . . 0.0 109.943 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.47 -34.13 7.27 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 124.08 3.187 . . . . 0.0 113.881 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.28 -57.57 9.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 0.0 110.879 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.7 -33.93 77.11 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.82 -24.98 61.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.082 0.953 . . . . 0.0 112.092 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 -18.31 49.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.982 0.513 . . . . 0.0 111.407 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.89 -39.57 8.92 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.346 0.659 . . . . 0.0 111.0 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.33 142.0 28.22 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.985 0.914 . . . . 0.0 109.35 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -103.08 128.78 26.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.75 161.13 30.79 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.887 2.391 . . . . 0.0 112.138 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -98.41 -21.06 16.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.868 0.467 . . . . 0.0 110.502 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -155.83 161.28 40.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.048 0.939 . . . . 0.0 109.558 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.6 mtm180 -123.09 119.03 29.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 56' ' ' VAL . 43.2 pt -90.98 131.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.59 120.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -118.93 179.4 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.158 0.983 . . . . 0.0 109.119 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 23.7 p -119.06 119.47 34.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.648 0.779 . . . . 0.0 109.539 169.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.65 135.06 12.61 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -97.51 171.36 8.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 117.967 0.883 . . . . 0.0 111.122 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.35 3.38 3.77 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 0.0 112.297 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -52.23 -51.56 57.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.399 1.08 . . . . 0.0 111.578 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.48 164.17 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.742 0.817 . . . . 0.0 110.981 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.96 -43.01 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.08 -16.02 70.3 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.671 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.08 -51.99 61.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.965 0.906 . . . . 0.0 109.651 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -68.91 -46.98 66.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.075 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.19 -35.53 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.761 0.825 . . . . 0.0 111.582 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 t -64.23 -44.57 91.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.568 0.747 . . . . 0.0 110.504 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.78 66.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.054 0.542 . . . . 0.0 111.71 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG11 HD13 ' A' ' 40' ' ' ILE . 49.8 t -72.17 -45.94 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.912 0.485 . . . . 0.0 109.717 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -63.35 -45.32 91.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.064 0.946 . . . . 0.0 110.945 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 31.7 mmt180 -72.3 -37.01 69.08 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.994 0.809 . . . . 0.0 111.427 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 tpt180 -66.7 -48.92 67.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.15 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -34.42 76.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.053 0.941 . . . . 0.0 110.905 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.3 -39.13 92.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.79 0.836 . . . . 0.0 110.806 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 51.5 mt-10 -64.74 -34.68 78.9 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.359 0.663 . . . . 0.0 110.925 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.0 mm-40 -78.64 -8.11 58.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.517 0.727 . . . . 0.0 111.374 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.92 17.45 79.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.269 0.356 . . . . 0.0 112.996 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . . . -73.62 128.52 35.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.978 0.911 . . . . 0.0 109.996 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.26 69.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.67 0.788 . . . . 0.0 111.506 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 56.5 m -144.99 171.21 14.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.379 0.672 . . . . 0.0 111.482 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.7 166.62 28.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.447 1.099 . . . . 0.0 108.698 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -155.29 129.12 8.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -77.09 113.16 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.86 0.464 . . . . 0.0 110.094 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.73 -25.93 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.279 0.632 . . . . 0.0 111.539 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 19.7 t70 -148.29 138.44 22.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.012 0.525 . . . . 0.0 110.849 -174.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.45 HG21 HG22 ' A' ' 84' ' ' VAL . 23.4 p -136.53 106.09 6.14 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.571 1.149 . . . . 0.0 108.033 170.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -121.03 138.44 54.17 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.121 0.968 . . . . 0.0 109.416 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 11.8 pt-20 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.984 0.421 . . . . 0.0 110.985 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.1 p-90 -109.25 108.18 18.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 108.992 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -64.78 149.64 48.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.434 0.694 . . . . 0.0 109.197 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.495 HG23 ' HB1' ' A' ' 52' ' ' ALA . 64.3 t -126.6 114.39 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.537 . . . . 0.0 109.948 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 34.4 t -88.96 124.32 41.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 165.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.69 121.58 14.51 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.426 0.691 . . . . 0.0 109.338 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 46.8 p-10 -81.28 140.41 34.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.733 0.413 . . . . 0.0 110.133 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.18 137.8 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.144 0.978 . . . . 0.0 110.379 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 35.9 m-85 -118.55 139.28 51.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.568 1.147 . . . . 0.0 110.393 -168.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 65' ' ' ALA . 32.7 mmtp -95.36 159.07 15.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 109.839 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.28 149.14 48.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.58 0.752 . . . . 0.0 111.612 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.7 m -74.02 142.35 45.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.559 0.744 . . . . 0.0 110.545 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.27 118.73 14.43 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.1 tp -85.21 119.25 25.38 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -64.73 141.75 98.38 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.59 -39.4 1.92 Allowed 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 125.044 3.83 . . . . 0.0 116.083 -173.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.93 -40.29 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.281 0.632 . . . . 0.0 110.332 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.94 -38.32 76.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.371 0.669 . . . . 0.0 110.213 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.15 -29.78 70.65 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.335 1.054 . . . . 0.0 111.171 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.91 -29.51 55.74 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.856 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.07 26.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.326 0.651 . . . . 0.0 112.36 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD13 HD23 ' A' ' 26' ' ' LEU . 96.9 mt -115.51 143.73 44.89 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.711 0.805 . . . . 0.0 110.171 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -92.7 133.05 29.96 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 0.0 110.137 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.26 153.42 24.4 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -99.12 -32.49 11.22 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.247 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -143.76 174.73 10.56 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -139.26 125.95 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.477 1.111 . . . . 0.0 108.661 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.502 HD12 HG13 ' A' ' 56' ' ' VAL . 32.7 pt -103.06 152.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.977 0.511 . . . . 0.0 110.427 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.99 133.15 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -116.23 157.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.279 1.032 . . . . 0.0 109.076 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.5 m -134.65 139.46 45.3 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.33 142.96 11.52 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.49 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -68.55 -40.71 80.54 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.225 0.61 . . . . 0.0 110.788 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -166.25 135.84 3.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.34 0.656 . . . . 0.0 109.613 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.6 -116.55 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.0 168.17 19.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 0.0 108.323 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.28 -37.59 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.6 88.3 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.457 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.02 -34.34 77.78 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.743 0.817 . . . . 0.0 111.541 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -72.21 -46.19 57.18 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.843 0.857 . . . . 0.0 110.259 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.05 -33.68 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.568 0.747 . . . . 0.0 110.598 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -72.66 -35.01 67.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.91 0.884 . . . . 0.0 110.927 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.82 78.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.244 0.617 . . . . 0.0 109.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.502 HG13 HD12 ' A' ' 40' ' ' ILE . 53.9 t -64.53 -37.05 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.217 1.007 . . . . 0.0 110.852 174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -61.38 -52.73 63.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.888 0.875 . . . . 0.0 110.711 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -69.45 -37.76 77.49 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.79 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -66.85 -37.35 84.29 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.323 0.649 . . . . 0.0 111.256 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.25 83.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.499 0.72 . . . . 0.0 110.343 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.21 -35.1 73.67 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.481 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 12.6 mm-40 -63.19 -34.49 77.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.741 0.816 . . . . 0.0 110.606 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -70.63 -29.02 65.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.506 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.33 4.28 53.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.071 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 141.77 49.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.693 0.797 . . . . 0.0 110.557 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.21 64.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 110.632 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.1 m -141.14 173.57 11.35 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.719 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.48 173.99 12.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.33 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -160.5 120.24 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 109.944 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.22 113.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.868 0.867 . . . . 0.0 109.67 173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.7 -20.76 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 0.0 111.501 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 22.9 t70 -154.29 145.22 22.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.123 0.569 . . . . 0.0 110.904 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 84' ' ' VAL . 26.0 p -137.55 111.49 8.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.915 1.286 . . . . 0.0 107.978 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -118.43 135.19 54.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.227 0.611 . . . . 0.0 109.551 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.114 0.566 . . . . 0.0 110.788 179.4 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 121.251 0.548 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -157.32 177.45 11.43 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.318 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.73 156.01 44.38 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.333 0.653 . . . . 0.0 109.677 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 52' ' ' ALA . 98.9 t -130.92 115.83 31.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.009 0.924 . . . . 0.0 109.564 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 56.5 t -92.39 129.89 42.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 108.766 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.57 125.69 13.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.583 0.753 . . . . 0.0 110.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.33 143.02 35.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.01 139.64 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.414 0.686 . . . . 0.0 110.428 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -121.03 139.59 53.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.484 1.113 . . . . 0.0 109.993 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.08 165.56 13.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.567 0.747 . . . . 0.0 110.49 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.425 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.38 138.09 33.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.315 1.046 . . . . 0.0 112.48 -169.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -63.37 147.6 50.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.079 0.952 . . . . 0.0 110.817 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.39 122.64 20.71 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -81.92 138.07 35.07 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.7 p -74.47 152.07 87.56 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.303 0.641 . . . . 0.0 109.916 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.96 -23.19 75.57 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.335 2.023 . . . . 0.0 112.683 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.39 -56.24 24.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.074 0.95 . . . . 0.0 110.278 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -76.07 -24.99 55.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.112 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.633 0.773 . . . . 0.0 111.156 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.42 -28.75 26.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.141 0.576 . . . . 0.0 110.187 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.03 3.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.413 0.685 . . . . 0.0 110.849 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.7 148.21 25.54 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.72 0.808 . . . . 0.0 110.193 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.3 143.17 26.24 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.09 144.29 37.49 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.394 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -77.08 -20.56 55.63 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.838 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -159.45 161.97 35.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.524 1.13 . . . . 0.0 108.85 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.0 ttm180 -132.88 120.84 22.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.641 0.777 . . . . 0.0 108.917 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.498 HG21 ' HD2' ' A' ' 59' ' ' ARG . 27.9 pt -91.91 163.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.698 0.799 . . . . 0.0 111.451 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.429 HG21 ' NE ' ' A' ' 83' ' ' ARG . 2.2 p -142.22 130.5 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 110.387 -173.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.513 HG13 ' HB ' ' A' ' 84' ' ' VAL . 41.4 pt -144.89 174.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.696 1.198 . . . . 0.0 109.109 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 p -136.56 125.01 23.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.369 1.068 . . . . 0.0 108.819 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.16 73.43 1.51 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 62.6 ttt180 -68.5 96.34 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.845 0.458 . . . . 0.0 111.002 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.4 t80 65.33 19.77 11.71 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.13 1.372 . . . . 0.0 111.118 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.44 150.67 21.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.649 0.779 . . . . 0.0 110.069 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.43 161.06 23.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.368 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.4 -46.83 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.549 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.87 -29.08 69.65 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.664 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.09 -48.54 65.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.462 0.705 . . . . 0.0 110.676 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 84' ' ' VAL . . . -69.74 -32.49 71.05 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.402 ' HA ' HG11 ' A' ' 56' ' ' VAL . 42.6 t -67.85 -38.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.846 0.458 . . . . 0.0 110.625 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -65.98 -35.73 81.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.773 0.429 . . . . 0.0 110.479 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.46 64.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.537 0.735 . . . . 0.0 111.485 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 53' ' ' VAL . 11.6 p -74.36 -31.63 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.284 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.0 t -69.97 -43.12 72.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.683 0.793 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 ttt180 -61.84 -49.12 77.55 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.466 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HD2' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.48 -46.07 87.38 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 109.684 -176.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.53 83.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.085 0.866 . . . . 0.0 111.066 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.04 -34.83 79.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.63 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 58.5 mt-10 -70.62 -23.11 62.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.84 0.456 . . . . 0.0 110.916 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -89.72 2.15 55.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.379 0.672 . . . . 0.0 111.58 175.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 24.08 67.32 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.448 -0.342 . . . . 0.0 113.324 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.43 134.13 35.5 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.376 0.671 . . . . 0.0 110.178 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.33 75.96 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.549 0.69 . . . . 0.0 110.174 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 m -148.98 169.66 20.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.792 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -145.13 149.88 35.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.087 0.955 . . . . 0.0 108.521 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -128.5 131.23 48.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -78.28 123.53 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HB ' ' OD1' ' A' ' 87' ' ' ASP . 7.7 p -86.85 -33.5 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.696 0.399 . . . . 0.0 110.139 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -160.72 144.2 13.41 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.795 0.438 . . . . 0.0 110.839 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 21.1 p -133.38 112.98 12.05 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 t -126.74 120.39 29.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.391 0.676 . . . . 0.0 110.523 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 33.9 mt-10 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.691 0.796 . . . . 0.0 110.474 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 52.3 t30 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 120.692 0.282 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 3.0 p-90 -142.68 124.74 15.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.054 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.561 ' HE ' ' HB ' ' A' ' 85' ' ' VAL . 12.0 tpt180 -64.44 116.58 6.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.03 1.332 . . . . 0.0 109.747 174.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 42' ' ' ILE . 26.6 t -106.43 107.99 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.561 ' HB ' ' HE ' ' A' ' 83' ' ' ARG . 5.8 p -118.91 126.84 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.25 142.75 35.75 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.568 0.747 . . . . 0.0 110.214 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.49 143.53 26.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 124.624 1.17 . . . . 0.0 110.38 178.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.29 141.4 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.086 0.954 . . . . 0.0 110.551 -171.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -125.04 167.58 14.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.01 0.924 . . . . 0.0 112.293 -167.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 10.3 mmpt? -101.56 164.46 11.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.796 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.062 173.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.19 115.49 6.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.586 0.354 . . . . 0.0 110.983 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.9 m -67.73 137.33 55.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.7 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -72.83 118.25 15.53 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.9 tp -85.45 144.85 27.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.994 0.918 . . . . 0.0 109.032 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 p -84.92 157.3 60.33 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.042 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.38 -28.42 80.16 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.813 2.342 . . . . 0.0 113.561 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.84 -44.96 75.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.869 0.468 . . . . 0.0 110.586 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.506 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 51.9 mt-30 -72.22 -28.35 63.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.917 0.487 . . . . 0.0 110.98 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 -23.08 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.31 0.644 . . . . 0.0 110.739 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.33 25.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.461 0.704 . . . . 0.0 110.568 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.53 36.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.663 0.785 . . . . 0.0 110.788 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.6 166.2 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.269 1.027 . . . . 0.0 110.236 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -118.86 149.2 46.14 Favored Pre-proline 0 C--O 1.244 0.795 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.48 165.67 22.8 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.603 2.202 . . . . 0.0 111.871 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -96.61 -45.3 6.77 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.23 -173.84 3.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 109.854 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -123.87 171.55 9.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.304 0.642 . . . . 0.0 109.305 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 pt -138.89 138.35 41.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.1 124.73 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 pt -118.45 175.7 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.968 0.907 . . . . 0.0 108.777 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 19.7 p -130.49 113.87 14.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 64.91 3.72 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 53.7 ttt180 -63.77 95.69 0.12 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.93 0.892 . . . . 0.0 111.089 -172.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.8 t80 63.55 16.4 9.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.727 1.211 . . . . 0.0 111.436 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.69 155.94 19.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.813 0.845 . . . . 0.0 109.739 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.91 161.03 30.56 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.261 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 tp -60.16 -37.39 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.338 0.655 . . . . 0.0 110.875 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.66 90.97 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.344 0.402 . . . . 0.0 112.887 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.19 -36.42 77.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.556 0.742 . . . . 0.0 110.767 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.6 82.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.63 0.581 . . . . 0.0 110.15 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.95 -36.64 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.005 0.522 . . . . 0.0 110.295 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.7 t -68.79 -41.42 78.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.964 0.506 . . . . 0.0 110.691 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.54 -35.08 67.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.165 0.586 . . . . 0.0 111.749 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 p -77.0 -31.01 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -72.44 -35.49 68.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.928 0.491 . . . . 0.0 110.407 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -61.06 -56.91 15.43 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.467 1.105 . . . . 0.0 109.797 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -59.44 -45.68 90.89 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.118 0.886 . . . . 0.0 111.403 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.24 94.45 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.611 0.569 . . . . 0.0 111.317 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.03 -37.49 87.61 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.116 0.567 . . . . 0.0 110.665 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.42 -19.31 60.45 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.547 0.739 . . . . 0.0 111.416 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.11 -7.3 59.41 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.914 0.886 . . . . 0.0 111.133 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 13.95 81.28 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.627 -0.26 . . . . 0.0 112.912 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.05 134.9 38.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.702 0.801 . . . . 0.0 110.318 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.76 -38.79 46.08 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.073 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -134.45 169.82 16.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.664 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -149.53 158.41 44.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.641 0.776 . . . . 0.0 109.0 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -143.78 119.05 10.18 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.386 0.674 . . . . 0.0 109.277 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.47 112.12 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.386 0.675 . . . . 0.0 109.702 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.51 -26.71 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.4 t70 -143.17 133.43 24.57 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.064 0.546 . . . . 0.0 110.281 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.2 p -132.07 112.63 12.51 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -115.88 173.74 6.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.877 0.871 . . . . 0.0 108.98 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.43 0.692 . . . . 0.0 109.993 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 3.6 p-10 . . . . . 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 43.3 p-90 -99.66 127.58 45.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.674 171.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -95.05 153.97 17.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.534 0.733 . . . . 0.0 110.758 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.88 112.78 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.704 1.202 . . . . 0.0 108.863 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 39.9 t -98.08 115.11 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.57 30.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.497 0.719 . . . . 0.0 109.937 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.3 146.12 50.79 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.979 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.35 136.86 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.032 0.533 . . . . 0.0 110.186 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.04 170.17 12.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.638 1.175 . . . . 0.0 110.744 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.99 178.57 5.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.023 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.733 0.813 . . . . 0.0 108.827 172.676 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.87 136.23 56.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.312 0.645 . . . . 0.0 111.583 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 m -68.24 130.63 43.49 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.048 0.539 . . . . 0.0 110.755 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.1 118.26 12.71 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 27.1 tp -93.16 139.78 30.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.473 1.109 . . . . 0.0 109.717 -172.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -71.38 147.95 93.14 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.545 0.738 . . . . 0.0 110.16 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.48 -33.62 86.76 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.421 2.747 . . . . 0.0 113.991 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.0 -46.8 64.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.999 0.52 . . . . 0.0 111.012 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -73.25 -23.44 60.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.201 0.6 . . . . 0.0 111.463 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.13 -36.06 61.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 0.0 110.352 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.36 61.86 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.25 -48.93 38.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.511 0.725 . . . . 0.0 110.392 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.37 170.5 15.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.441 0.696 . . . . 0.0 111.355 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -121.32 123.33 27.73 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.556 0.742 . . . . 0.0 109.694 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.81 133.26 12.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.936 2.424 . . . . 0.0 112.254 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.68 -34.67 30.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.157 0.583 . . . . 0.0 110.194 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.26 171.86 13.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.471 1.108 . . . . 0.0 108.468 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 5.7 ttp180 -140.71 128.5 21.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.372 1.069 . . . . 0.0 108.116 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.7 pt -103.32 161.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.079 0.552 . . . . 0.0 110.531 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.469 HG23 ' HD3' ' A' ' 83' ' ' ARG . 2.0 p -148.76 132.34 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.985 0.914 . . . . 0.0 109.438 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -132.32 166.72 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.608 1.163 . . . . 0.0 109.528 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.7 p -134.08 118.82 18.17 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.382 1.073 . . . . 0.0 109.637 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.86 115.06 5.14 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.653 -0.526 . . . . 0.0 111.811 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -76.11 91.43 3.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.282 0.633 . . . . 0.0 110.165 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 t80 65.79 12.29 8.22 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.309 1.444 . . . . 0.0 112.003 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -72.65 154.78 40.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.9 162.36 29.16 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.592 0.357 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.7 tp -60.31 -31.78 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.053 0.541 . . . . 0.0 110.676 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.88 -42.9 98.24 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.912 -0.382 . . . . 0.0 112.897 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -62.92 -43.18 99.5 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.372 0.669 . . . . 0.0 110.074 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -63.2 -51.2 67.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.021 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.69 -37.4 79.56 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 123.693 0.797 . . . . 0.0 110.395 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.0 t -69.06 -36.44 77.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.364 0.666 . . . . 0.0 111.198 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.01 -40.25 60.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.39 0.676 . . . . 0.0 111.252 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.03 -27.89 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 123.269 0.628 . . . . 0.0 110.19 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.8 t -70.26 -42.97 71.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.851 0.861 . . . . 0.0 110.104 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 18.7 ttt180 -57.47 -57.61 11.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.64 175.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.3 tpp85 -61.03 -40.97 95.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.08 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.78 96.31 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.173 0.589 . . . . 0.0 111.283 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.89 -35.6 80.39 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.25 0.62 . . . . 0.0 110.335 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 55.2 mt-10 -71.12 -29.25 65.02 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.97 0.908 . . . . 0.0 110.849 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 23.8 mm-40 -73.82 -14.36 61.08 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.235 0.614 . . . . 0.0 110.754 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.12 2.74 64.04 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.98 138.76 42.47 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.753 0.821 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.45 -32.37 64.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.176 0.99 . . . . 0.0 110.887 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 66.0 m -143.44 171.07 14.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.21 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.36 162.38 38.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.328 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -141.56 117.51 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.26 113.67 3.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.64 -20.81 6.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.22 137.84 4.4 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 123.321 0.388 . . . . 0.0 110.905 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.5 p -122.43 106.42 11.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 t -123.6 126.26 46.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.044 0.538 . . . . 0.0 109.984 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 31.0 mt-10 . . . . . 0 CA--C 1.541 0.632 0 O-C-N 123.552 0.532 . . . . 0.0 110.236 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.9 t30 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.2 p-90 -109.27 126.78 53.7 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.572 0.749 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.3 tmm_? -83.8 129.19 34.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.782 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 52' ' ' ALA . 62.6 t -113.3 109.31 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.299 1.04 . . . . 0.0 108.248 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.42 134.81 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.14 129.16 18.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.595 0.758 . . . . 0.0 111.079 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 2.6 m-20 -77.51 141.0 39.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.69 145.69 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.285 0.634 . . . . 0.0 111.095 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -127.74 133.6 49.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.488 1.115 . . . . 0.0 110.432 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -84.46 165.55 18.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.978 0.911 . . . . 0.0 111.247 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.39 46.78 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.732 0.645 . . . . 0.0 112.327 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -75.78 145.36 40.79 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.566 0.747 . . . . 0.0 110.311 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.1 118.87 15.51 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 34' ' ' LEU . 19.7 tp -82.16 138.43 34.72 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -64.3 141.62 98.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.219 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -42.21 -30.1 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.985 3.123 . . . . 0.0 115.162 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.59 -54.52 7.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.248 0.619 . . . . 0.0 111.249 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.58 -31.26 71.86 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.74 0.416 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -31.7 65.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.699 0.8 . . . . 0.0 111.048 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.76 62.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.998 0.519 . . . . 0.0 110.875 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -42.9 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.18 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD12 HD21 ' A' ' 26' ' ' LEU . 95.7 mt -86.79 167.23 14.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 110.162 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -120.35 125.0 27.43 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' HD3' ' HH ' ' A' ' 89' ' ' TYR . 96.1 Cg_endo -74.96 146.38 32.73 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.548 2.165 . . . . 0.0 111.923 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.531 ' HH ' ' HB2' ' A' ' 65' ' ' ALA . 34.8 p90 -82.58 -22.87 34.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -158.52 168.58 26.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 110.455 -173.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 18.5 mtm180 -126.91 124.01 38.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.928 1.291 . . . . 0.0 108.507 169.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.88 138.7 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.825 0.45 . . . . 0.0 110.317 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.24 123.97 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 pt -109.39 160.44 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.766 0.826 . . . . 0.0 109.826 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.8 p -132.05 131.86 42.85 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.072 0.949 . . . . 0.0 108.664 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.07 154.79 21.15 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtm105 -110.25 118.96 37.74 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.838 0.819 . . . . 0.0 109.969 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 t80 55.94 82.78 0.1 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.994 1.317 . . . . 0.0 110.98 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -132.75 164.77 26.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.702 0.801 . . . . 0.0 110.01 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.2 178.82 4.79 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.433 ' O ' HG22 ' A' ' 53' ' ' VAL . 9.0 tp -65.66 -37.07 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.21 -38.56 96.7 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 123.191 0.307 . . . . 0.0 113.351 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.18 -39.9 78.42 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.412 0.685 . . . . 0.0 110.2 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -63.1 -40.98 99.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.316 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 49' ' ' ILE . 83.0 t -70.36 -40.2 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.413 0.685 . . . . 0.0 110.467 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -65.89 -34.89 79.17 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 0.0 111.059 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.58 -34.99 58.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.227 0.611 . . . . 0.0 111.222 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.0 p -83.27 -27.01 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.761 0.424 . . . . 0.0 110.685 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -73.32 -36.34 66.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.0 ttt180 -66.36 -45.28 80.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.979 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -64.28 -41.32 96.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.132 0.573 . . . . 0.0 110.883 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.05 -32.54 74.13 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 120.665 0.269 . . . . 0.0 110.889 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 19.8 t70 -67.79 -36.91 81.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.43 0.692 . . . . 0.0 110.872 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.8 mm-40 -63.13 -35.88 81.73 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.378 0.671 . . . . 0.0 110.719 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 29.7 mm-40 -83.79 -11.19 57.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.687 0.795 . . . . 0.0 112.161 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.64 47.8 8.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-O 121.137 0.298 . . . . 0.0 112.554 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.531 ' HB2' ' HH ' ' A' ' 37' ' ' TYR . . . -114.55 131.4 56.68 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 0.0 109.134 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -35.1 74.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.21 0.604 . . . . 0.0 111.507 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -140.92 175.32 9.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.579 0.751 . . . . 0.0 110.613 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 38.5 p90 -149.52 -179.94 7.48 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 173.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -159.11 122.81 3.82 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.7 115.49 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 85' ' ' VAL . 2.5 p -88.56 -31.54 5.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.264 0.626 . . . . 0.0 109.669 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -162.07 142.08 10.03 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.871 0.367 . . . . 0.0 110.982 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.5 p -117.99 147.05 43.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.58 1.152 . . . . 0.0 108.334 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -150.16 169.81 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.69 0.796 . . . . 0.0 110.23 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 171.63 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -66.93 96.82 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.645 1.178 . . . . 0.0 112.556 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.64 111.67 19.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' A' ' 52' ' ' ALA . 57.9 t -123.06 121.2 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.93 0.492 . . . . 0.0 109.955 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 71' ' ' VAL . 5.1 p -109.86 134.19 52.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.297 0.639 . . . . 0.0 109.53 173.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.79 124.72 18.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 109.958 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 5.3 p-10 -72.53 130.83 41.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.428 0.691 . . . . 0.0 110.171 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 13.4 m -112.97 151.84 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.103 0.961 . . . . 0.0 111.301 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.445 ' HH ' ' HD3' ' A' ' 36' ' ' PRO . 88.7 m-85 -130.37 147.42 52.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.782 1.233 . . . . 0.0 110.43 -167.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.3 173.58 9.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.745 0.818 . . . . 0.0 110.268 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.628 174.28 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.37 137.05 58.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.809 0.443 . . . . 0.0 109.951 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 m -62.09 135.44 57.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.44 0.696 . . . . 0.0 110.651 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.01 117.61 13.84 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.7 tp -90.95 142.28 27.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -95.94 153.29 39.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.196 0.599 . . . . 0.0 110.47 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -44.63 -38.62 12.52 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.213 3.276 . . . . 0.0 115.625 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.37 -50.7 72.97 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.358 0.663 . . . . 0.0 111.186 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 44.9 mt-30 -66.31 -46.23 77.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.817 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.67 68.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.889 0.875 . . . . 0.0 112.492 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.22 -24.45 47.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.6 0.76 . . . . 0.0 110.818 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.14 -33.32 14.08 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.759 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -99.45 153.21 19.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.343 0.657 . . . . 0.0 111.191 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -104.76 128.39 26.93 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 109.401 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.34 148.1 23.53 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.677 2.251 . . . . 0.0 111.697 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -80.12 -24.02 40.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.674 0.389 . . . . 0.0 110.47 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -160.74 175.17 12.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.148 0.979 . . . . 0.0 108.923 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.613 HH21 HG11 ' A' ' 71' ' ' VAL . 43.7 mtp180 -132.47 121.15 22.93 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 HD13 HG12 ' A' ' 56' ' ' VAL . 44.9 pt -89.55 149.15 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.012 0.369 . . . . 0.0 110.132 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.98 122.57 49.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -109.65 170.56 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.2 p -125.48 106.02 9.48 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.658 0.783 . . . . 0.0 109.136 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.43 88.73 1.59 Allowed Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.51 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.574 ' HG3' ' HB3' ' A' ' 81' ' ' ASN . 10.0 ttm180 -84.06 96.09 8.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 110.221 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.8 t80 60.79 90.65 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.47 1.106 . . . . 0.0 110.033 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.09 162.96 13.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.693 0.797 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.02 161.89 24.04 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 123.547 0.529 . . . . 0.0 110.018 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.477 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.2 tp -64.87 -29.18 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.9 97.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.072 0.232 . . . . 0.0 113.113 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.16 -43.41 82.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.533 0.733 . . . . 0.0 110.459 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -61.81 -50.11 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.086 0.954 . . . . 0.0 111.623 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.6 -35.84 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.064 0.946 . . . . 0.0 111.031 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 t -67.32 -34.93 78.38 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.043 0.537 . . . . 0.0 110.6 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.88 -33.91 64.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.042 0.537 . . . . 0.0 111.009 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.528 HG12 HD13 ' A' ' 40' ' ' ILE . 79.7 t -69.54 -41.71 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.262 0.625 . . . . 0.0 110.96 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -66.0 -34.18 77.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.938 0.495 . . . . 0.0 111.124 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 15.1 tpt180 -65.93 -57.44 7.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.76 0.824 . . . . 0.0 109.67 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -60.46 -40.36 90.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.04 1.336 . . . . 0.0 112.387 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.12 79.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.851 0.86 . . . . 0.0 110.246 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.75 -31.25 72.36 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.66 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 24.5 mm-40 -69.32 -29.44 67.27 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.046 0.538 . . . . 0.0 111.248 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -83.84 -1.93 55.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.989 0.516 . . . . 0.0 111.129 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.26 16.32 71.98 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.345 -0.388 . . . . 0.0 113.304 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -69.81 124.49 24.14 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.687 . . . . 0.0 110.852 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.95 69.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.859 0.724 . . . . 0.0 110.336 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.98 155.64 44.1 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.41 160.7 27.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -149.69 105.2 3.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.38 107.9 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.613 HG11 HH21 ' A' ' 39' ' ' ARG . 11.4 p -93.49 -36.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.291 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.47 145.28 21.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.875 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.3 p -131.28 134.5 46.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.818 1.247 . . . . 0.0 107.814 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m -139.07 126.57 21.71 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.139 0.576 . . . . 0.0 110.146 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 122.994 0.518 . . . . 0.0 110.83 179.836 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 33.8 p-10 . . . . . 0 C--O 1.24 0.573 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.477 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 7.5 p-90 -146.2 127.21 14.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.853 0.861 . . . . 0.0 109.198 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.93 149.18 50.11 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.979 0.799 . . . . 0.0 108.944 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HB1' ' A' ' 52' ' ' ALA . 32.3 t -127.2 105.28 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.69 131.26 41.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.32 112.22 6.56 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.195 -171.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.05 133.89 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.404 ' HB ' ' HB1' ' A' ' 65' ' ' ALA . 15.6 m -113.99 126.15 71.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.513 0.673 . . . . 0.0 109.859 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -115.11 162.51 16.92 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.868 1.267 . . . . 0.0 110.245 -168.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -107.22 170.2 8.11 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.316 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.848 178.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . . . . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.54 140.14 41.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.259 1.024 . . . . 0.0 112.125 -176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.5 m -66.97 134.04 51.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.977 0.911 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -68.71 116.54 9.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -72.99 137.5 45.48 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.9 p -72.03 147.69 91.22 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.443 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.6 -36.44 18.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.963 3.108 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.01 -37.89 69.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.864 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -74.43 -49.47 22.3 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.138 0.494 . . . . 0.0 110.122 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.06 -22.17 66.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.455 1.102 . . . . 0.0 112.348 -175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.14 -53.86 50.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.34 1.056 . . . . 0.0 112.328 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.13 -22.89 17.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.947 0.499 . . . . 0.0 111.852 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.968 0.413 . . . . 0.0 110.339 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -86.91 125.6 66.08 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.7 166.41 23.71 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.973 2.448 . . . . 0.0 111.374 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -93.5 -26.27 17.24 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.465 -0.147 . . . . 0.0 111.232 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -165.21 -170.94 2.03 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.698 0.399 . . . . 0.0 110.251 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -137.94 138.03 38.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.885 1.274 . . . . 0.0 109.983 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -102.77 144.14 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.914 0.886 . . . . 0.0 109.398 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.418 HG23 HG23 ' A' ' 85' ' ' VAL . 46.1 t -130.83 115.43 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 pt -102.7 156.68 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.1 m -147.1 146.2 29.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 0.0 109.351 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.92 156.57 25.05 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -92.52 132.64 36.66 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.381 1.072 . . . . 0.0 110.003 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 t80 60.46 23.13 12.75 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 124.685 1.194 . . . . 0.0 112.091 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.76 116.93 16.02 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.28 158.98 35.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 tp -57.49 -33.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.284 0.365 . . . . 0.0 111.058 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.28 -45.03 96.82 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.245 0.341 . . . . 0.0 112.936 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.49 -39.67 92.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.711 0.804 . . . . 0.0 110.774 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.36 -47.65 78.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.337 1.055 . . . . 0.0 110.47 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.458 ' HA ' HG13 ' A' ' 56' ' ' VAL . 92.8 t -67.35 -37.57 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.795 0.438 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 t -64.04 -41.81 97.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.732 0.413 . . . . 0.0 110.941 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -44.4 66.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.041 0.536 . . . . 0.0 110.882 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 53' ' ' VAL . 5.8 p -74.98 -28.86 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.084 0.554 . . . . 0.0 111.145 -174.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.8 p -70.74 -49.94 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.634 0.373 . . . . 0.0 110.211 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 79.2 ttt180 -63.52 -44.18 94.99 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 110.173 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -57.57 -41.85 81.91 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.713 0.805 . . . . 0.0 111.474 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.64 86.11 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.33 -31.09 71.66 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.269 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 74.7 mm-40 -69.53 -31.31 69.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.347 0.659 . . . . 0.0 109.896 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 15.0 mm-40 -82.48 0.48 42.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.85 0.46 . . . . 0.0 111.221 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.85 5.05 71.65 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.167 0.413 . . . . 0.0 113.473 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.1 135.31 38.58 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 110.88 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 -26.64 54.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.367 1.067 . . . . 0.0 110.902 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.3 m -145.81 170.32 16.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 111.422 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -149.6 170.49 18.54 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -153.89 117.79 4.74 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.202 0.601 . . . . 0.0 109.505 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.01 107.93 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.716 0.806 . . . . 0.0 110.369 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.17 -43.55 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.265 0.626 . . . . 0.0 110.246 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.1 t70 -133.97 127.56 32.62 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 110.254 -167.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.3 p -122.56 117.23 25.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.4 t -139.48 162.42 35.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 123.362 0.665 . . . . 0.0 111.015 -170.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 5.9 p-90 -144.51 179.83 7.02 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.375 0.67 . . . . 0.0 110.363 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.21 153.16 41.04 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.198 -171.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' HB1' ' A' ' 52' ' ' ALA . 85.2 t -124.11 110.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 0.0 108.915 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 26.4 t -94.65 123.87 46.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.7 123.56 23.88 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.5 0.72 . . . . 0.0 110.728 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.16 136.21 57.03 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.897 0.879 . . . . 0.0 110.067 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.66 138.65 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.347 0.594 . . . . 0.0 110.373 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -126.24 133.58 51.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.756 1.222 . . . . 0.0 109.735 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.24 176.65 9.57 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.205 0.602 . . . . 0.0 110.818 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.529 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.45 142.78 53.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.111 0.564 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' SER . 59.1 m -68.14 124.77 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.0 0.52 . . . . 0.0 110.12 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.92 128.01 34.72 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.52 HD23 HD11 ' A' ' 34' ' ' LEU . 17.5 tp -101.75 140.13 36.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.902 0.881 . . . . 0.0 108.999 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 p -79.96 153.26 74.98 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.332 0.653 . . . . 0.0 110.861 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.23 -39.04 52.55 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.132 3.221 . . . . 0.0 114.155 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.54 -52.58 64.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.779 0.832 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.71 -36.42 75.91 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.539 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.69 92.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.993 0.917 . . . . 0.0 111.312 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.3 63.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.996 0.519 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.07 45.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.205 0.602 . . . . 0.0 111.583 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.52 HD11 HD23 ' A' ' 26' ' ' LEU . 82.5 mt -89.46 163.33 15.3 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.673 0.789 . . . . 0.0 110.101 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.28 124.7 27.6 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.607 0.763 . . . . 0.0 109.083 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.77 153.13 48.15 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.634 2.223 . . . . 0.0 111.952 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -93.08 -25.31 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.841 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.35 168.15 27.01 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.876 0.87 . . . . 0.0 108.879 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.543 HH21 HG11 ' A' ' 71' ' ' VAL . 34.0 mtp-105 -133.29 126.14 30.79 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -104.59 159.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.33 0.652 . . . . 0.0 110.365 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.25 139.29 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 pt -125.9 168.65 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.1 0.96 . . . . 0.0 108.985 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -132.79 129.71 38.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.876 . . . . 0.0 109.142 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.18 92.35 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 54.9 ttp180 -60.07 112.24 1.81 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.654 0.782 . . . . 0.0 111.955 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.9 t80 66.75 11.45 8.23 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.389 1.076 . . . . 0.0 111.706 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -77.94 155.8 30.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.067 0.547 . . . . 0.0 110.066 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.99 43.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -61.75 -43.91 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 123.617 0.573 . . . . 0.0 110.688 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.73 88.38 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.053 0.22 . . . . 0.0 112.949 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.05 -42.85 88.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.118 0.967 . . . . 0.0 110.398 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 84' ' ' VAL . . . -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.216 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.457 ' HA ' HG13 ' A' ' 56' ' ' VAL . 69.1 t -67.68 -33.96 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 122.801 0.441 . . . . 0.0 110.448 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -68.68 -39.35 80.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.797 0.439 . . . . 0.0 110.534 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.87 80.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.433 0.693 . . . . 0.0 111.223 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 53' ' ' VAL . 3.7 p -78.44 -27.05 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.103 0.561 . . . . 0.0 110.663 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 t -69.01 -43.74 74.2 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.883 0.873 . . . . 0.0 110.146 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 14.4 tpt180 -63.82 -45.54 89.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.027 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -60.83 -44.94 96.28 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.84 0.713 . . . . 0.0 109.272 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.02 82.62 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.574 0.75 . . . . 0.0 110.592 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.59 -39.08 93.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.31 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 54.5 mm-40 -62.04 -34.92 77.13 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.391 0.676 . . . . 0.0 110.818 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.1 mm-40 -78.81 -11.63 60.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.851 0.46 . . . . 0.0 111.351 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.42 16.31 34.98 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.088 0.242 . . . . 0.0 113.519 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -77.98 135.04 37.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.269 0.628 . . . . 0.0 111.624 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.24 -31.2 49.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.291 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' THR . 51.1 m -143.63 172.01 13.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -162.29 158.86 24.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -130.79 121.0 24.57 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.68 96.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.543 HG11 HH21 ' A' ' 39' ' ' ARG . 7.2 p -88.9 -34.51 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.215 -172.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -133.39 129.04 36.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.982 0.513 . . . . 0.0 109.718 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.416 HG23 HG22 ' A' ' 84' ' ' VAL . 7.1 p -135.35 104.15 5.76 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 166.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -148.74 168.54 22.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.916 1.286 . . . . 0.0 108.528 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.0 pt-20 . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 14.8 t30 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 16.9 p-90 -108.55 150.36 27.59 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.499 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.11 157.12 19.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.44 1.096 . . . . 0.0 110.601 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 52' ' ' ALA . 64.9 t -126.98 109.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.567 1.147 . . . . 0.0 108.618 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.1 129.91 42.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.66 117.77 10.64 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 10.6 p-10 -84.86 142.33 29.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HB ' ' HB1' ' A' ' 65' ' ' ALA . 26.8 m -113.18 142.36 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.714 0.805 . . . . 0.0 111.245 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.38 167.25 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.107 1.363 . . . . 0.0 111.326 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -108.75 162.97 13.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.83 1.252 . . . . 0.0 109.415 168.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.147 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.64 135.12 29.63 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -66.46 136.18 55.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.789 . . . . 0.0 109.922 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -69.0 125.01 25.31 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 12.8 tp -96.27 105.32 17.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.4 m -56.44 141.86 70.44 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.541 1.136 . . . . 0.0 110.509 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -43.51 -35.09 5.67 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.855 3.037 . . . . 0.0 114.2 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -63.02 -44.62 95.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.979 0.912 . . . . 0.0 111.642 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.85 -41.51 64.73 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.11 -19.52 61.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.382 1.073 . . . . 0.0 111.961 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.66 81.77 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.081 0.552 . . . . 0.0 110.182 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.56 -42.83 11.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.784 0.834 . . . . 0.0 111.352 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.94 134.02 33.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.255 0.622 . . . . 0.0 110.971 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -97.37 134.59 22.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.225 1.01 . . . . 0.0 109.713 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.32 163.65 34.24 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.98 2.453 . . . . 0.0 113.086 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 25.0 p90 -94.96 -25.66 16.43 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.991 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -155.94 177.4 11.45 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.789 0.835 . . . . 0.0 108.853 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 40.4 ttm180 -134.52 124.24 25.22 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.118 0.967 . . . . 0.0 108.781 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.4 pt -89.52 163.67 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.629 0.772 . . . . 0.0 111.265 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 83' ' ' ARG . 7.6 p -141.65 139.78 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.039 0.936 . . . . 0.0 109.164 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.6 pt -137.39 148.57 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -133.46 133.85 42.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.51 174.84 20.81 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 27.9 ttm180 -149.6 111.72 4.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.4 t80 81.75 -3.71 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.947 1.299 . . . . 0.0 111.165 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -71.24 152.35 43.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.484 1.513 . . . . 0.0 110.861 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.63 172.12 9.52 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.309 0.644 . . . . 0.0 110.923 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.68 -32.64 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.27 -35.52 91.67 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-O 120.899 0.166 . . . . 0.0 112.995 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.07 -35.29 69.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.632 0.773 . . . . 0.0 110.445 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -65.78 -43.52 88.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.63 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.59 -43.26 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.328 0.651 . . . . 0.0 111.231 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 p -66.34 -40.97 90.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.377 0.271 . . . . 0.0 111.19 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.99 80.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.949 0.499 . . . . 0.0 111.794 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.33 -29.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 122.813 0.445 . . . . 0.0 110.889 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.8 t -74.09 -41.43 61.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.122 0.569 . . . . 0.0 110.152 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -70.17 -41.5 73.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 tpp180 -60.44 -47.16 87.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.296 0.638 . . . . 0.0 110.231 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.55 83.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.759 0.662 . . . . 0.0 111.436 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.24 -40.53 94.37 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.024 0.929 . . . . 0.0 110.936 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.65 -12.09 60.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.395 0.678 . . . . 0.0 112.364 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.7 mm-40 -89.49 -12.64 39.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.457 0.303 . . . . 0.0 110.786 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.23 61.22 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.722 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -75.26 129.34 37.28 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.345 0.658 . . . . 0.0 111.45 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.22 77.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.943 0.897 . . . . 0.0 111.043 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.3 m -137.29 164.56 28.26 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.994 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -144.57 152.49 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.871 0.868 . . . . 0.0 108.927 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -131.54 118.22 19.82 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.86 107.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.57 -28.44 5.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.211 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 129.72 6.05 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.191 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -113.39 115.59 28.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.9 m -129.74 145.57 51.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.943 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.1 143.88 46.86 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.165 0.507 . . . . 0.0 110.916 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.465 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.4 tmm_? -107.99 130.87 55.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.738 1.215 . . . . 0.0 109.715 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.493 HG23 ' HB1' ' A' ' 52' ' ' ALA . 73.5 t -112.32 125.78 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.36 140.31 45.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.99 143.53 31.26 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.025 0.53 . . . . 0.0 111.021 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 18.0 m-20 -77.76 156.12 30.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.905 0.482 . . . . 0.0 109.94 168.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 4.5 m -127.1 141.85 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.279 0.632 . . . . 0.0 110.526 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -131.09 141.84 50.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.352 1.061 . . . . 0.0 109.676 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 3.3 mmmp? -99.92 145.61 27.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 0.0 110.572 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 166.25 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.123 0.487 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.35 123.97 17.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 m -68.94 124.05 22.67 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.718 0.807 . . . . 0.0 110.028 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.76 116.42 10.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 HD12 ' A' ' 34' ' ' LEU . 14.5 tp -74.43 144.74 44.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.289 . . . . 0.0 109.189 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.9 p -73.48 152.4 89.76 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.963 0.505 . . . . 0.0 110.071 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.64 -32.71 45.85 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.67 2.913 . . . . 0.0 113.54 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -66.65 -52.93 39.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.249 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.16 -32.21 70.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.173 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.38 -29.47 66.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.961 0.904 . . . . 0.0 111.157 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.12 -31.17 65.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.282 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.55 -48.2 9.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.173 0.589 . . . . 0.0 111.068 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.469 HD12 HD21 ' A' ' 26' ' ' LEU . 94.3 mt -81.11 172.97 13.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.751 0.821 . . . . 0.0 110.932 -177.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HD3' ' HD2' ' A' ' 36' ' ' PRO . 10.8 tppt? -132.64 131.93 22.4 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.787 0.835 . . . . 0.0 108.944 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' HD3' ' A' ' 35' ' ' LYS . 73.5 Cg_endo -68.99 150.98 73.49 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.587 2.191 . . . . 0.0 111.471 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -86.11 -19.69 29.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.923 0.392 . . . . 0.0 110.358 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -162.03 169.2 21.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.476 1.11 . . . . 0.0 109.111 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 88.6 mtm180 -131.79 121.98 25.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.674 1.19 . . . . 0.0 108.754 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.3 pt -96.51 144.08 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.292 0.637 . . . . 0.0 110.177 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.35 133.78 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.641 0.777 . . . . 0.0 109.322 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 pt -126.52 153.86 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.792 0.837 . . . . 0.0 108.942 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 83' ' ' ARG . 39.2 p -121.55 149.93 42.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 0.0 109.074 174.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.06 116.29 0.71 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 40.7 ttp-105 -88.82 120.08 29.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.675 0.79 . . . . 0.0 109.627 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 59.05 81.65 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.733 1.213 . . . . 0.0 111.099 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.91 156.15 36.98 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.595 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.32 154.02 39.08 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 124.025 0.828 . . . . 0.0 110.162 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' O ' HG21 ' A' ' 53' ' ' VAL . 5.5 tp -59.92 -41.63 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.597 0.359 . . . . 0.0 110.041 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.37 -31.26 80.27 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.317 0.386 . . . . 0.0 113.34 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.07 -36.09 66.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.728 0.811 . . . . 0.0 110.255 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.9 77.82 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.865 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' HA ' HG11 ' A' ' 56' ' ' VAL . 87.7 t -66.9 -34.01 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.3 t -65.53 -39.43 91.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.466 0.706 . . . . 0.0 110.694 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.23 76.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.22 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 53' ' ' VAL . 8.3 p -82.4 -27.18 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.232 0.613 . . . . 0.0 111.675 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -69.49 -42.72 74.41 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.2 0.524 . . . . 0.0 109.787 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 7.6 tpt180 -65.78 -42.72 90.47 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.3 tpp180 -62.47 -35.99 81.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.147 0.579 . . . . 0.0 110.404 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.29 66.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 0.0 110.477 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.79 -34.89 77.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.837 0.455 . . . . 0.0 110.648 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 26.7 mm-40 -60.51 -37.01 79.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.787 0.835 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 50.1 mm-40 -77.72 -15.02 59.43 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.18 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.97 38.5 48.34 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.562 0.539 . . . . 0.0 111.761 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.84 126.66 40.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.236 1.014 . . . . 0.0 110.092 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.65 83.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.561 0.696 . . . . 0.0 110.739 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 37.2 m -139.95 168.99 18.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.659 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -148.75 169.95 19.3 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -150.2 127.1 11.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.55 97.55 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -86.33 -16.91 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.751 0.82 . . . . 0.0 110.52 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 21.8 t70 -163.51 150.27 12.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.237 0.615 . . . . 0.0 111.029 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 p -141.61 114.28 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.185 1.394 . . . . 0.0 107.834 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.7 m -137.25 152.35 49.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 108.806 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.9 pt-20 . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 122.497 0.319 . . . . 0.0 110.896 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.0 p-90 -121.75 159.3 26.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.576 0.703 . . . . 0.0 110.571 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HB2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -133.71 132.02 40.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.654 -165.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.98 125.84 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.866 0.866 . . . . 0.0 109.759 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 21.6 t -100.88 120.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 166.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.98 121.92 27.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 13.6 p-10 -85.36 136.04 33.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.6 m -112.32 131.64 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.692 0.797 . . . . 0.0 111.349 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 74.0 m-85 -109.76 163.86 13.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 111.54 -171.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -110.15 165.57 11.64 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 108.709 169.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.698 178.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 133.73 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.377 0.671 . . . . 0.0 110.551 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -67.35 134.09 50.86 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.139 0.576 . . . . 0.0 110.557 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.02 116.57 9.63 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.5 tp -84.0 126.65 33.24 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.3 p -66.22 145.23 98.98 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 123.736 0.647 . . . . 0.0 110.208 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -45.65 -31.37 7.3 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.607 2.872 . . . . 0.0 114.25 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.89 -55.66 21.08 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.337 1.055 . . . . 0.0 110.449 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.19 -34.1 75.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.14 69.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.037 0.935 . . . . 0.0 111.423 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.57 -26.05 59.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 0.0 111.174 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.81 19.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.299 0.64 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.41 HD12 HD23 ' A' ' 26' ' ' LEU . 95.2 mt -101.21 160.89 14.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.731 0.812 . . . . 0.0 111.222 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -111.31 123.88 34.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 108.371 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.31 159.08 36.84 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.081 1.854 . . . . 0.0 111.185 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -100.86 -39.19 7.91 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.771 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.58 -170.61 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 109.469 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.724 ' HB3' ' HA ' ' A' ' 87' ' ' ASP . 4.5 ptt180 -149.8 168.08 24.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.79 0.836 . . . . 0.0 111.459 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.545 HD13 HG21 ' A' ' 56' ' ' VAL . 37.7 pt -118.55 151.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.954 0.902 . . . . 0.0 110.33 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.54 HG12 ' HD3' ' A' ' 83' ' ' ARG . 85.5 t -121.3 114.17 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.638 1.175 . . . . 0.0 109.545 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.469 HG13 ' HB ' ' A' ' 84' ' ' VAL . 43.2 pt -133.9 178.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.483 1.113 . . . . 0.0 108.963 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 3.0 p -126.97 105.11 8.39 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.632 0.773 . . . . 0.0 109.475 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.23 149.48 20.75 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -110.49 151.76 27.16 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.828 0.814 . . . . 0.0 111.166 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -72.07 -4.62 29.91 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.188 0.995 . . . . 0.0 112.817 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.507 0.723 . . . . 0.0 110.657 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.4 143.03 4.07 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.932 0.893 . . . . 0.0 110.216 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 tp -62.67 -37.44 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 167.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.47 -26.77 68.54 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.624 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.62 -49.2 78.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.301 0.64 . . . . 0.0 110.263 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -65.24 -42.11 93.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.956 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 56' ' ' VAL . 88.9 t -66.75 -36.18 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.848 0.718 . . . . 0.0 111.338 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.5 m -66.21 -41.77 89.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.782 0.433 . . . . 0.0 110.546 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.17 79.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.69 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 40' ' ' ILE . 12.7 p -77.11 -34.15 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.724 0.41 . . . . 0.0 111.469 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -67.84 -39.99 83.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.796 0.438 . . . . 0.0 110.277 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 29.7 ttt180 -65.03 -56.63 11.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.852 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -66.54 -39.31 88.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.102 0.561 . . . . 0.0 112.3 -172.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.35 93.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.33 -35.92 80.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.708 0.803 . . . . 0.0 111.167 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 47.8 mt-10 -66.46 -33.27 75.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.337 0.655 . . . . 0.0 110.736 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 18.9 mm-40 -82.75 -5.17 58.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.717 0.807 . . . . 0.0 111.469 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.01 14.63 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.21 0.319 . . . . 0.0 113.137 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.105 0.962 . . . . 0.0 109.584 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -28.57 62.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.596 0.759 . . . . 0.0 111.067 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.3 m -143.09 169.4 17.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -147.28 168.11 22.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.959 0.903 . . . . 0.0 109.766 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -160.21 122.27 3.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.206 1.002 . . . . 0.0 108.623 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.45 120.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.601 0.563 . . . . 0.0 109.985 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.25 -30.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.257 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -160.2 149.28 17.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.018 0.527 . . . . 0.0 111.243 -172.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 33.7 p -132.89 104.63 6.67 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.612 1.165 . . . . 0.0 108.857 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.3 m -100.97 109.27 21.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.717 0.807 . . . . 0.0 110.33 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 122.674 0.39 . . . . 0.0 111.439 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -101.0 124.85 47.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.331 1.052 . . . . 0.0 109.144 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 41' ' ' VAL . 2.8 tmm_? -63.88 106.43 1.01 Allowed 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.676 1.19 . . . . 0.0 109.586 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' HG13 ' A' ' 42' ' ' ILE . 43.7 t -88.68 108.34 18.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.81 129.02 58.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.81 120.75 16.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.962 0.505 . . . . 0.0 110.966 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.724 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 5.0 m-20 -63.86 135.85 56.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.131 0.894 . . . . 0.0 110.846 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.84 142.88 22.88 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.498 0.719 . . . . 0.0 109.419 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.566 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 57.3 m-85 -125.1 152.47 44.33 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.177 0.991 . . . . 0.0 109.863 -169.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.68 174.21 7.47 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.289 0.635 . . . . 0.0 109.639 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 C-N-CA 123.307 0.643 . . . . 0.0 110.149 -179.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.97 118.33 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.678 0.672 . . . . 0.0 110.104 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -80.24 149.76 30.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.485 1.114 . . . . 0.0 110.617 -174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.53 134.2 51.9 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.522 0.601 . . . . 0.0 109.438 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.8 tp -94.82 134.92 36.93 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -73.96 144.91 83.07 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.732 0.813 . . . . 0.0 110.362 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.61 -38.19 75.53 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 124.125 3.217 . . . . 0.0 115.687 -165.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -69.83 -41.46 74.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.768 0.427 . . . . 0.0 110.455 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.8 -34.81 76.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.333 0.653 . . . . 0.0 110.63 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.95 -24.12 55.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.051 0.94 . . . . 0.0 111.261 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.03 -35.75 21.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.393 0.677 . . . . 0.0 110.432 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.26 65.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.306 0.643 . . . . 0.0 110.794 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.8 mt -88.17 148.24 24.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -102.54 139.69 20.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 73.9 Cg_endo -72.73 139.29 30.5 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.924 1.749 . . . . 0.0 111.451 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.53 ' HH ' ' HB3' ' A' ' 65' ' ' ALA . 53.4 p90 -78.06 -19.53 54.1 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -166.45 174.3 9.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 108.671 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 87' ' ' ASP . 51.0 mtm180 -135.01 122.76 22.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.084 0.954 . . . . 0.0 108.945 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 pt -87.85 151.88 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.956 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG13 ' HE ' ' A' ' 83' ' ' ARG . 78.7 t -135.53 125.31 42.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.926 0.89 . . . . 0.0 109.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.1 152.42 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.066 0.946 . . . . 0.0 109.132 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.67 164.76 12.96 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.552 0.741 . . . . 0.0 109.747 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.41 178.79 41.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.06 139.9 4.33 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.543 0.671 . . . . 0.0 111.085 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 t80 61.47 29.59 18.47 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 124.254 0.971 . . . . 0.0 111.014 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -123.33 168.35 12.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 0.0 110.774 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.38 166.4 13.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.923 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 6.4 tp -66.08 -31.58 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.953 0.501 . . . . 0.0 110.407 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.97 -33.62 74.9 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.213 0.321 . . . . 0.0 112.914 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.71 -46.73 68.19 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.326 0.65 . . . . 0.0 110.551 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.49 80.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.614 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.457 ' HA ' HG13 ' A' ' 56' ' ' VAL . 77.3 t -68.71 -40.36 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 0.0 110.105 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 58' ' ' ARG . 40.2 m -63.14 -36.65 84.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.879 0.471 . . . . 0.0 111.052 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.32 59.69 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.342 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 53' ' ' VAL . 10.0 p -74.76 -29.69 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.271 0.628 . . . . 0.0 112.203 -172.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.9 p -69.81 -40.92 75.63 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.746 0.419 . . . . 0.0 110.677 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 54' ' ' SER . 8.6 mpt_? -72.95 -36.93 67.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.321 0.648 . . . . 0.0 110.04 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -64.48 -43.55 93.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.613 0.765 . . . . 0.0 110.887 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.33 73.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 0.0 110.99 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.55 -35.12 79.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.658 0.783 . . . . 0.0 110.483 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -64.12 -38.95 92.9 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.532 0.733 . . . . 0.0 110.666 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -74.8 -2.19 25.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.802 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.53 23.98 75.85 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.754 -0.138 . . . . 0.0 112.754 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.53 ' HB3' ' HH ' ' A' ' 37' ' ' TYR . . . -82.82 128.58 34.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.522 0.729 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -33.81 76.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.5 m -147.42 158.97 44.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.634 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -122.18 174.11 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.295 1.038 . . . . 0.0 108.852 170.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -159.62 113.96 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.506 0.722 . . . . 0.0 109.134 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.57 118.82 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.28 0.632 . . . . 0.0 110.442 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.46 -36.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.12 141.24 17.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.367 -168.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -119.69 104.09 9.95 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 14.7 m -84.83 177.72 7.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.809 0.844 . . . . 0.0 110.344 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 124.015 0.926 . . . . 0.0 110.542 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.454 0.169 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 p-90 -143.5 173.76 11.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.366 1.067 . . . . 0.0 110.667 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 1.2 tmt_? -152.2 120.2 6.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.826 0.85 . . . . 0.0 109.076 -165.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.48 131.69 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.247 0.619 . . . . 0.0 110.376 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 127.54 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.184 0.994 . . . . 0.0 108.684 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.63 21.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 m-20 -62.42 136.98 58.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.259 1.424 . . . . 0.0 110.06 171.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.49 138.16 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 118.37 0.532 . . . . 0.0 110.996 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.32 135.98 46.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.768 1.227 . . . . 0.0 109.527 -170.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 37' ' ' TYR . 67.5 mttm -98.04 136.47 38.26 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.299 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.76 177.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.496 0.189 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.47 156.8 22.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.586 0.754 . . . . 0.0 109.681 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 m -64.88 135.85 56.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.727 0.811 . . . . 0.0 111.424 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.05 118.07 17.59 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 19.4 tp -93.11 127.22 38.57 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.5 p -72.74 146.85 88.63 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.487 0.715 . . . . 0.0 110.84 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -43.34 -48.21 8.42 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 125.085 3.857 . . . . 0.0 116.517 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -67.94 -41.63 82.21 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.516 0.598 . . . . 0.0 111.263 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.81 -28.17 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.793 0.437 . . . . 0.0 111.16 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.72 70.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.728 0.811 . . . . 0.0 110.644 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.91 -15.14 61.14 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.605 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.01 -40.61 15.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.639 0.776 . . . . 0.0 110.909 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.01 154.59 17.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.072 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -96.23 126.9 42.36 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.554 0.742 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.89 140.22 22.86 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.292 1.995 . . . . 0.0 111.098 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -83.63 -20.13 34.21 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -158.33 175.04 14.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -140.23 121.72 15.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.7 0.8 . . . . 0.0 109.558 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 59' ' ' ARG . 29.2 pt -95.34 165.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.051 0.941 . . . . 0.0 110.64 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.77 133.97 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 123.23 0.612 . . . . 0.0 110.445 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 pt -122.26 157.25 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.166 0.987 . . . . 0.0 108.351 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -149.45 150.5 32.46 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.82 154.0 6.79 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -97.06 3.08 52.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.962 0.505 . . . . 0.0 111.152 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -106.94 76.22 1.09 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.807 0.843 . . . . 0.0 108.746 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -169.81 163.75 9.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.17 0.988 . . . . 0.0 110.173 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.95 175.25 6.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.266 1.026 . . . . 0.0 108.422 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.413 ' HA ' ' CH2' ' A' ' 82' ' ' TRP . 7.3 tp -60.07 -44.35 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 118.145 0.429 . . . . 0.0 110.515 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.7 -40.71 65.34 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.107 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.12 -25.4 58.43 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.606 0.762 . . . . 0.0 112.179 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -72.73 -43.43 62.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 56' ' ' VAL . 94.8 t -64.38 -33.16 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -67.9 -40.91 83.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.435 0.694 . . . . 0.0 111.279 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.21 -36.69 61.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.122 0.569 . . . . 0.0 111.324 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 53' ' ' VAL . 4.1 p -80.36 -28.65 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.673 0.389 . . . . 0.0 110.307 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.0 p -70.22 -41.16 73.97 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -56.07 -47.87 77.15 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.435 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.3 tpt180 -63.53 -41.1 98.48 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.738 0.649 . . . . 0.0 110.782 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.63 -34.8 76.31 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.188 0.518 . . . . 0.0 111.186 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -70.92 -33.67 70.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.746 0.818 . . . . 0.0 110.574 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -77.55 -18.53 56.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 110.619 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 36.2 mm-40 -80.66 -25.46 38.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.804 170.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.64 3.74 59.47 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.533 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.11 139.92 57.54 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.976 0.91 . . . . 0.0 111.315 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 91' ' ' ALA . . . -68.67 -38.81 80.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 110.409 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 42.0 m -143.45 174.3 10.87 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.883 -175.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -151.22 164.17 37.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -146.26 124.37 12.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.141 0.576 . . . . 0.0 109.465 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.87 117.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.781 0.676 . . . . 0.0 109.211 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.1 -31.7 4.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.233 0.613 . . . . 0.0 110.618 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.05 139.47 21.43 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.072 0.463 . . . . 0.0 110.931 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.9 p -131.15 111.09 11.64 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 168.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -144.81 135.91 25.01 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.285 0.634 . . . . 0.0 109.427 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.3 pt-20 . . . . . 0 C--O 1.242 0.67 0 CA-C-O 121.801 0.81 . . . . 0.0 112.096 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.5 p-90 -87.62 111.59 21.41 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.002 0.906 . . . . 0.0 111.419 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.56 114.25 6.05 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.848 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' A' ' 52' ' ' ALA . 34.4 t -102.94 106.76 20.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.49 133.56 55.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.57 136.2 35.77 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.429 0.692 . . . . 0.0 110.81 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.61 144.59 41.69 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.253 0.621 . . . . 0.0 109.64 170.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.62 128.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -109.03 137.5 46.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 109.881 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 91' ' ' ALA . 1.5 tmmm? -89.4 149.58 22.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.048 0.939 . . . . 0.0 108.892 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.384 0.673 . . . . 0.0 110.888 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.316 0.103 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.446 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -63.45 130.91 46.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.986 0.514 . . . . 0.0 110.419 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 149.97 25.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.717 0.807 . . . . 0.0 110.963 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.05 122.1 15.24 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 34' ' ' LEU . 17.1 tp -92.56 124.32 36.5 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.7 p -69.83 146.9 95.92 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.598 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.48 -33.27 4.18 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 124.493 3.462 . . . . 0.0 115.088 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.45 -48.28 64.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.621 0.768 . . . . 0.0 111.276 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -71.27 -36.39 71.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.148 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.9 61.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.243 1.017 . . . . 0.0 111.744 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.27 81.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.332 0.653 . . . . 0.0 110.793 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 -39.57 30.93 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.359 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.488 HD11 HD23 ' A' ' 26' ' ' LEU . 93.4 mt -85.11 169.35 13.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.074 0.549 . . . . 0.0 111.297 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -130.85 134.54 26.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.097 0.959 . . . . 0.0 109.442 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.63 147.48 22.19 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.452 2.101 . . . . 0.0 111.955 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -96.35 -16.8 21.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.231 0.612 . . . . 0.0 110.372 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -158.56 174.47 15.02 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.487 1.115 . . . . 0.0 108.625 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -145.08 121.63 11.07 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.514 HD13 HG13 ' A' ' 56' ' ' VAL . 23.6 pt -90.22 150.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 175.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' HD3' ' A' ' 83' ' ' ARG . 5.3 p -145.81 117.78 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.49 0.716 . . . . 0.0 109.647 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.6 pt -127.69 154.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.546 0.738 . . . . 0.0 110.678 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 p -118.67 111.37 18.44 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.774 1.23 . . . . 0.0 108.859 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.33 101.8 2.38 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.16 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.52 98.28 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.255 0.622 . . . . 0.0 109.816 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 66.13 92.28 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.668 1.187 . . . . 0.0 111.788 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -164.49 164.92 21.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 0.0 110.938 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.71 168.79 12.2 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.801 0.84 . . . . 0.0 110.522 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.413 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.8 tp -61.51 -34.14 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.925 0.49 . . . . 0.0 111.079 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.18 -37.04 93.86 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.12 0.263 . . . . 0.0 113.232 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.07 -44.5 65.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.74 0.816 . . . . 0.0 110.504 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -58.72 -53.14 61.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.772 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.14 -32.9 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.661 1.184 . . . . 0.0 111.296 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.1 t -65.16 -42.28 93.9 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.207 0.603 . . . . 0.0 110.583 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 HD13 ' A' ' 40' ' ' ILE . 76.7 t -68.22 -40.73 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.109 0.964 . . . . 0.0 110.995 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -69.45 -46.88 65.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.403 0.681 . . . . 0.0 110.938 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -61.73 -50.35 72.78 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.152 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 2.7 tpp180 -64.72 -42.83 94.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.806 0.691 . . . . 0.0 111.182 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.35 82.0 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.607 0.567 . . . . 0.0 110.376 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 23' ' ' ALA . 18.7 t70 -64.93 -34.16 77.75 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.782 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.69 -30.46 69.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.257 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 3.3 mm-40 -76.35 -16.97 59.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.928 0.491 . . . . 0.0 110.562 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.08 20.38 14.14 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.53 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.9 151.2 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.572 0.749 . . . . 0.0 111.508 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' A' ' 90' ' ' LYS . . . -89.23 -29.14 19.47 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.606 1.162 . . . . 0.0 110.527 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 73.3 m -147.7 165.76 29.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.931 0.893 . . . . 0.0 110.74 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -127.88 178.05 6.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.2 1.0 . . . . 0.0 109.178 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.57 99.6 1.59 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.08 101.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.32 -34.17 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.183 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.12 146.38 27.66 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.305 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.7 m -143.02 118.4 10.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.5 m -130.7 124.25 31.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.852 0.861 . . . . 0.0 109.447 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 40.9 tt0 . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 123.426 0.691 . . . . 0.0 111.047 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.9 t30 . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.6 p-90 -113.56 123.52 50.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.126 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.526 ' HD3' HG23 ' A' ' 41' ' ' VAL . 5.6 tmm_? -86.8 115.91 24.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.555 1.142 . . . . 0.0 109.111 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' HB1' ' A' ' 52' ' ' ALA . 46.9 t -104.18 113.85 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.02 137.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.69 127.82 17.59 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 110.851 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.91 137.0 45.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.147 0.579 . . . . 0.0 109.533 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -114.37 132.71 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.469 0.652 . . . . 0.0 110.722 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.53 120.01 35.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.985 1.314 . . . . 0.0 107.9 -171.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HA ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -85.44 169.72 13.38 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.242 0.474 . . . . 0.0 109.798 175.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.489 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 138.9 57.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.863 0.465 . . . . 0.0 110.747 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 m -61.82 124.27 20.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.16 0.984 . . . . 0.0 111.411 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -66.03 116.61 7.33 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.402 HD22 HD12 ' A' ' 34' ' ' LEU . 15.8 tp -105.67 121.82 44.78 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.9 p -65.81 151.83 94.24 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.58 0.752 . . . . 0.0 110.771 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.47 -31.54 39.41 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.505 2.803 . . . . 0.0 113.099 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.93 -53.27 52.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.986 0.914 . . . . 0.0 110.799 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -75.79 -25.34 56.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.602 0.761 . . . . 0.0 111.421 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.09 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.119 0.968 . . . . 0.0 110.341 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.46 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.6 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.1 -7.27 55.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.526 0.73 . . . . 0.0 112.431 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD12 HD22 ' A' ' 26' ' ' LEU . 96.2 mt -125.03 163.47 22.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.723 0.809 . . . . 0.0 110.477 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.9 117.07 51.04 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.001 0.921 . . . . 0.0 108.838 175.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 151.39 46.41 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.539 2.159 . . . . 0.0 111.849 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -96.78 -29.55 13.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.004 0.522 . . . . 0.0 111.471 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -147.76 178.49 8.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.689 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.639 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 66.4 mtt180 -131.36 146.63 52.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 109.204 169.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.03 142.63 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.63 0.772 . . . . 0.0 108.965 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.34 119.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.73 160.04 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 m -148.52 126.23 11.82 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 153.59 24.94 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.709 -0.281 . . . . 0.0 112.88 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 81' ' ' ASN . 3.6 mpt_? -87.28 135.55 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.76 0.824 . . . . 0.0 109.934 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.4 t80 65.01 24.99 12.65 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.8 1.24 . . . . 0.0 111.931 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.427 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 13.1 m120 -70.07 136.39 50.22 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.891 -0.506 . . . . 0.0 109.945 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 170.56 15.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HG21 ' A' ' 53' ' ' VAL . 6.5 tp -61.59 -50.45 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.39 69.55 Favored Glycine 0 C--N 1.348 1.223 0 O-C-N 123.272 0.357 . . . . 0.0 113.151 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.9 -36.27 77.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 110.388 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 84' ' ' VAL . . . -74.25 -34.76 63.72 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.624 0.77 . . . . 0.0 110.67 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 49' ' ' ILE . 70.1 t -66.96 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.781 0.433 . . . . 0.0 110.203 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -65.4 -36.6 84.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.28 0.632 . . . . 0.0 110.522 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.83 -48.67 65.56 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.99 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.6 p -77.45 -27.81 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.226 0.61 . . . . 0.0 111.962 -174.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.8 p -69.66 -48.09 61.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.613 0.365 . . . . 0.0 110.188 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.502 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 42.6 ttt-85 -63.83 -46.98 82.62 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 176.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.8 tpp180 -54.06 -49.17 69.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.973 0.909 . . . . 0.0 111.066 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.83 -43.99 86.18 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.869 0.731 . . . . 0.0 110.516 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.55 -34.63 78.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.632 0.773 . . . . 0.0 110.723 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 10.0 mm-40 -70.19 -29.98 66.99 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.17 0.588 . . . . 0.0 110.538 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 14.7 mm-40 -77.89 -9.77 59.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.835 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.74 10.5 61.54 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 113.101 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.93 143.25 37.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.786 0.834 . . . . 0.0 110.755 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.22 -36.82 17.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.669 0.788 . . . . 0.0 111.099 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.583 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.0 m -140.12 170.92 14.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 110.298 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -154.81 162.66 41.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.241 0.616 . . . . 0.0 109.74 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -147.18 117.89 7.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.595 0.758 . . . . 0.0 109.894 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.84 114.08 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 110.135 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.75 -25.55 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.952 0.501 . . . . 0.0 111.146 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -158.29 145.48 17.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.188 0.518 . . . . 0.0 111.328 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.1 p -134.96 106.8 7.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.21 1.404 . . . . 0.0 108.362 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 46.9 m -105.02 130.75 53.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 123.204 0.601 . . . . 0.0 111.299 -177.873 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 11.3 t30 . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.572 0.225 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.427 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 1.5 p-90 -161.59 158.11 25.75 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.17 0.988 . . . . 0.0 110.136 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -108.65 153.24 23.7 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.01 0.924 . . . . 0.0 110.085 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 52' ' ' ALA . 83.6 t -136.83 111.98 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.335 1.054 . . . . 0.0 108.258 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.8 134.82 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.78 126.21 18.81 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.211 1.004 . . . . 0.0 109.167 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 2.5 p30 -76.92 144.17 39.05 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.44 142.17 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.909 0.883 . . . . 0.0 110.255 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 64.3 m-85 -124.86 161.18 27.12 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.438 1.095 . . . . 0.0 110.802 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -92.23 165.06 13.31 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.704 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.491 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 137.4 47.78 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.023 0.529 . . . . 0.0 110.722 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -68.98 139.93 55.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.412 0.685 . . . . 0.0 110.436 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.53 129.38 34.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.48 HD23 HD12 ' A' ' 34' ' ' LEU . 13.9 tp -90.58 140.16 30.01 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -174.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 p -68.8 147.63 97.91 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.67 -10.6 12.02 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.641 2.228 . . . . 0.0 113.844 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -82.22 -52.95 6.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.308 0.643 . . . . 0.0 110.236 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.428 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 53.0 mt-30 -62.36 -46.0 90.61 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.877 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.85 -36.93 84.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 112.083 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.37 64.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.126 0.57 . . . . 0.0 111.633 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.29 -29.3 12.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.625 0.77 . . . . 0.0 112.151 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.48 HD12 HD23 ' A' ' 26' ' ' LEU . 95.9 mt -98.24 150.74 21.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -96.03 127.83 39.38 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.99 0.916 . . . . 0.0 109.077 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.4 157.46 32.91 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 111.069 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 37.3 p90 -90.35 -32.54 16.43 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.924 0.392 . . . . 0.0 110.567 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.8 -174.95 4.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.03 0.932 . . . . 0.0 110.22 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -149.37 128.9 13.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.11 0.964 . . . . 0.0 108.703 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -109.31 148.28 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 110.972 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.76 121.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.096 0.958 . . . . 0.0 108.446 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 pt -113.95 154.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.053 0.941 . . . . 0.0 109.439 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 83' ' ' ARG . 21.1 p -113.17 153.35 28.43 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.372 0.669 . . . . 0.0 110.167 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.37 97.02 0.15 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-N 116.856 -0.157 . . . . 0.0 112.881 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -96.98 46.39 1.04 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.546 1.165 . . . . 0.0 109.636 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -177.11 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.776 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -56.03 127.03 28.53 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.885 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 -175.78 5.99 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.237 168.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.15 -34.56 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 118.201 0.455 . . . . 0.0 110.49 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.38 -45.87 66.69 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.257 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.26 -31.35 71.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.685 0.794 . . . . 0.0 110.979 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -70.52 -46.15 64.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.992 0.917 . . . . 0.0 109.686 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 55.0 t -64.35 -32.58 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.745 0.653 . . . . 0.0 110.728 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -69.88 -42.7 73.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.216 0.606 . . . . 0.0 110.723 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.35 75.83 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.213 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 53' ' ' VAL . 11.9 p -80.19 -27.97 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 122.701 0.4 . . . . 0.0 110.844 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -63.32 -47.53 81.85 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 28.3 tpt180 -64.54 -56.29 14.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 13.7 tpp180 -57.56 -46.18 84.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.793 0.837 . . . . 0.0 111.25 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.45 81.32 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.63 0.582 . . . . 0.0 110.962 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.76 -39.06 92.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.319 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.1 mm-40 -70.96 -25.57 62.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.939 0.496 . . . . 0.0 110.901 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 12.6 mm-40 -76.87 -11.47 59.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.299 0.639 . . . . 0.0 111.258 173.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.01 29.04 19.1 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.519 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.28 132.03 42.18 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.784 0.834 . . . . 0.0 110.3 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.49 82.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.637 0.775 . . . . 0.0 109.88 173.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . 10.2 t -139.74 172.38 12.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.277 -173.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -148.71 171.11 16.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -152.24 118.62 5.61 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.67 102.9 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 123.77 0.669 . . . . 0.0 109.415 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.17 -31.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.841 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.8 t70 -153.26 148.34 26.72 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.368 -171.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.421 HG23 HG21 ' A' ' 84' ' ' VAL . 12.8 p -142.28 112.84 7.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.458 1.503 . . . . 0.0 107.044 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.423 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . 62.0 m -142.85 147.23 35.06 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.569 0.347 . . . . 0.0 111.031 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 4.5 mm-40 . . . . . 0 N--CA 1.47 0.53 0 C-N-CA 124.677 1.191 . . . . 0.0 110.929 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.291 0.567 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.6 p-90 -60.92 133.42 56.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.325 1.05 . . . . 0.0 111.665 -173.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' HB3' HG23 ' A' ' 43' ' ' THR . 3.5 ppt_? -105.07 155.24 19.18 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.167 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.58 HG22 ' HB1' ' A' ' 52' ' ' ALA . 86.4 t -116.14 123.54 71.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.053 0.941 . . . . 0.0 109.898 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 28.3 t -101.07 124.07 54.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.95 126.47 15.92 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.941 0.496 . . . . 0.0 111.299 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.632 0.773 . . . . 0.0 110.23 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.25 135.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.136 0.493 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 51.9 m-85 -115.39 129.1 56.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.6 1.16 . . . . 0.0 110.306 -170.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' HZ3' ' HB3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -94.62 138.33 32.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.67 1.188 . . . . 0.0 108.878 179.039 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.34 142.31 48.79 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -81.04 144.12 31.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.709 0.804 . . . . 0.0 110.419 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.11 130.96 44.52 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.2 tp -111.65 122.72 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.5 p -67.89 148.96 98.41 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.706 0.803 . . . . 0.0 111.083 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -41.06 -43.21 4.9 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 124.84 3.694 . . . . 0.0 115.601 -177.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.72 -39.77 66.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.061 0.544 . . . . 0.0 111.221 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.2 -25.02 60.6 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.251 0.62 . . . . 0.0 111.025 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.04 -31.8 56.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.276 1.03 . . . . 0.0 110.631 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.53 -23.32 56.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.919 0.888 . . . . 0.0 110.381 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.24 -47.09 16.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.753 0.821 . . . . 0.0 111.243 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -91.59 145.89 24.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.005 0.522 . . . . 0.0 110.613 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -95.39 118.98 66.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.53 0.732 . . . . 0.0 109.248 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.15 153.22 31.79 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.309 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -94.08 -14.91 25.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.148 0.579 . . . . 0.0 111.701 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -166.83 164.73 16.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.318 0.647 . . . . 0.0 110.164 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 129.21 54.74 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.702 1.201 . . . . 0.0 108.777 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 HG11 ' A' ' 56' ' ' VAL . 31.7 pt -95.72 156.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.485 0.714 . . . . 0.0 110.664 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.0 t -129.58 121.42 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 109.21 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.6 166.15 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 p -123.91 114.77 20.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.094 0.558 . . . . 0.0 110.982 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.28 1.05 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 60.7 mtp180 -92.73 94.66 9.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.177 0.591 . . . . 0.0 110.45 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 59.37 41.6 19.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.479 1.111 . . . . 0.0 109.841 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 14.8 m120 -115.38 166.78 11.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.528 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.44 168.53 16.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.859 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.9 tp -63.08 -32.83 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.11 79.61 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.447 0.467 . . . . 0.0 113.083 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 33.9 m-20 -75.05 -35.53 61.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.631 0.772 . . . . 0.0 110.531 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.94 70.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.934 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.34 -33.01 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.324 1.05 . . . . 0.0 110.759 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 t -63.68 -51.85 63.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.765 0.826 . . . . 0.0 110.832 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.81 95.3 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.264 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 40' ' ' ILE . 48.4 t -66.16 -40.11 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.924 0.89 . . . . 0.0 111.725 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -63.62 -43.35 97.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.311 0.645 . . . . 0.0 110.742 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 32.0 ttt180 -65.3 -54.34 30.51 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.969 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 27.4 tpt180 -61.9 -38.13 87.21 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.063 0.852 . . . . 0.0 111.469 -169.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.36 90.39 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.643 0.777 . . . . 0.0 110.619 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.44 -31.61 72.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.685 0.794 . . . . 0.0 110.881 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 4.8 mm-40 -67.04 -33.29 75.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.193 0.597 . . . . 0.0 110.357 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.9 mm-40 -79.74 -12.96 59.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.287 0.635 . . . . 0.0 111.125 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.12 28.05 14.45 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.218 0.324 . . . . 0.0 112.622 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.82 142.16 27.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 0.0 110.705 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.98 -27.72 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.819 0.847 . . . . 0.0 110.253 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 50.4 m -142.88 167.75 21.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.91 0.884 . . . . 0.0 111.137 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 161.8 39.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 109.629 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -155.48 125.11 6.42 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.971 0.508 . . . . 0.0 109.822 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.33 112.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 -41.67 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.456 0.703 . . . . 0.0 110.088 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.0 t70 -131.53 141.0 49.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.728 0.411 . . . . 0.0 110.66 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.0 p -135.41 106.14 6.54 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -121.88 111.09 16.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.904 0.482 . . . . 0.0 109.86 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 10.9 pt-20 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 122.962 0.505 . . . . 0.0 111.414 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 5.2 p-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.6 p-90 -134.24 136.47 43.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.195 0.998 . . . . 0.0 111.688 -175.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -65.07 136.49 56.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.597 1.159 . . . . 0.0 110.198 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.89 106.65 18.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 59.8 t -96.68 124.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.015 0.926 . . . . 0.0 108.968 174.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.55 125.53 22.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.173 0.589 . . . . 0.0 110.952 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.87 144.28 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.704 0.802 . . . . 0.0 109.518 173.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -115.81 134.39 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.297 0.639 . . . . 0.0 110.196 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 68.5 m-85 -124.17 151.11 44.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.757 0.823 . . . . 0.0 110.54 -166.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.23 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.586 0.755 . . . . 0.0 110.755 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.819 0.848 . . . . 0.0 109.338 175.666 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.53 142.59 15.58 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.246 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 138.21 51.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.398 0.279 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.1 m -78.66 138.82 38.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.343 0.657 . . . . 0.0 110.537 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.08 118.12 11.58 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.0 tp -99.18 129.88 45.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.9 p -71.51 154.03 93.49 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.484 0.714 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.27 -18.35 51.83 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.831 2.354 . . . . 0.0 113.498 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.42 -53.63 11.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.211 0.605 . . . . 0.0 109.991 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.19 -33.73 74.96 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.272 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.35 80.8 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.827 0.851 . . . . 0.0 110.772 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.48 -23.29 64.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.244 0.618 . . . . 0.0 111.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.42 3.99 54.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.386 0.674 . . . . 0.0 112.13 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.413 HD13 HD23 ' A' ' 26' ' ' LEU . 93.0 mt -130.2 152.24 49.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.623 0.769 . . . . 0.0 110.245 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -108.18 125.01 32.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 58.1 Cg_endo -68.86 138.99 42.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.234 1.956 . . . . 0.0 111.555 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -79.31 -24.38 42.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.231 0.538 . . . . 0.0 110.459 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -156.24 172.47 18.41 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.592 1.157 . . . . 0.0 108.545 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -143.47 119.87 10.95 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 56' ' ' VAL . 36.5 pt -94.71 138.15 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 122.777 0.431 . . . . 0.0 110.371 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.543 HG23 HG21 ' A' ' 85' ' ' VAL . 38.5 t -121.62 131.99 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 pt -123.54 166.13 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.041 0.936 . . . . 0.0 108.948 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -116.5 145.11 43.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 171.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.1 108.78 0.47 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -80.7 79.06 7.41 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.2 t80 44.07 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.478 1.511 . . . . 0.0 113.675 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -122.44 -65.3 1.12 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.08 148.96 5.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 108.824 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.95 -39.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.07 77.47 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.434 0.459 . . . . 0.0 113.148 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.76 -44.51 77.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.828 0.851 . . . . 0.0 109.444 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.2 -44.78 78.73 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.042 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.48 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.795 0.838 . . . . 0.0 111.016 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 t -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.94 0.496 . . . . 0.0 110.217 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.88 69.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.952 0.501 . . . . 0.0 110.977 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG13 HD11 ' A' ' 40' ' ' ILE . 97.6 t -70.38 -37.49 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.293 0.637 . . . . 0.0 109.926 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.4 t -64.89 -41.86 95.27 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.769 0.827 . . . . 0.0 110.684 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.34 -59.45 4.35 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.159 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 15.6 tpp180 -63.89 -38.33 90.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.67 0.788 . . . . 0.0 111.837 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.35 98.31 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.04 0.448 . . . . 0.0 110.537 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.19 -36.7 85.01 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.774 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.81 -20.6 61.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.256 0.622 . . . . 0.0 111.279 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 34.4 mm-40 -90.97 -4.62 56.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.991 0.516 . . . . 0.0 111.383 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.13 7.93 76.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.067 0.23 . . . . 0.0 113.672 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 137.66 47.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.559 0.743 . . . . 0.0 110.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 91' ' ' ALA . . . -71.0 -40.92 71.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.804 0.841 . . . . 0.0 110.525 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 32.7 m -137.32 172.6 12.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.959 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -143.09 165.05 28.45 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.127 0.971 . . . . 0.0 109.365 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.66 112.19 6.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.042 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.34 113.28 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 86' ' ' ALA . 61.7 t -82.67 -48.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -164.6 143.56 7.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.79 -168.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.484 HG21 HG22 ' A' ' 84' ' ' VAL . 68.8 p -120.84 104.82 10.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 p -129.12 144.88 51.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.329 0.652 . . . . 0.0 111.23 -171.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 27.8 mt-10 -63.77 119.85 10.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.071 0.948 . . . . 0.0 110.369 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' HB3' HD21 ' A' ' 81' ' ' ASN . 77.2 t80 -71.29 77.27 0.73 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.019 1.328 . . . . 0.0 110.296 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.47 -55.97 4.42 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.885 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -118.96 167.94 11.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 110.156 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -77.93 159.38 28.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.52 0.728 . . . . 0.0 110.73 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.97 -55.52 4.62 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 112.046 -0.421 . . . . 0.0 112.046 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.434 HD21 ' HB3' ' A' ' 76' ' ' PHE . 6.1 p-10 -87.43 91.7 8.82 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 29.6 p-90 -95.83 172.91 7.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.722 172.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.438 ' NH1' ' HB ' ' A' ' 85' ' ' VAL . 2.7 ppt_? -142.56 154.76 44.74 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.319 1.048 . . . . 0.0 108.624 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 73' ' ' THR . 57.5 t -119.22 111.76 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 0.0 109.363 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG21 HG23 ' A' ' 41' ' ' VAL . 7.3 p -90.34 128.82 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 71' ' ' VAL . . . -145.6 131.85 19.5 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.218 0.607 . . . . 0.0 111.167 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 68.7 m-20 -70.12 158.03 36.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 110.6 173.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.9 139.32 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.462 0.705 . . . . 0.0 109.431 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -127.82 136.52 51.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.939 0.896 . . . . 0.0 110.194 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -80.76 167.66 19.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.667 0.787 . . . . 0.0 111.585 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.275 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.1 m80 . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 173.71 106.88 0.01 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 124.837 1.255 . . . . 0.0 108.8 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.83 145.71 42.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.637 0.375 . . . . 0.0 110.328 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.6 m -69.96 140.09 52.94 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.29 0.636 . . . . 0.0 111.107 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.64 126.46 30.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.507 HD21 HD13 ' A' ' 34' ' ' LEU . 12.7 tp -98.93 126.06 44.52 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 p -74.03 143.61 80.99 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.985 0.514 . . . . 0.0 109.996 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.82 -34.84 6.29 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.551 3.5 . . . . 0.0 115.667 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -69.62 -44.22 71.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.576 0.751 . . . . 0.0 110.695 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -68.9 -39.19 79.87 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.141 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.06 63.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.198 0.999 . . . . 0.0 112.099 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.45 77.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.163 0.585 . . . . 0.0 110.164 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.12 36.83 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.507 HD13 HD21 ' A' ' 26' ' ' LEU . 90.2 mt -89.02 157.4 18.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.333 0.653 . . . . 0.0 111.269 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -110.44 128.6 25.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.25 159.69 48.99 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.201 1.934 . . . . 0.0 111.532 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -96.52 -14.73 22.09 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -158.86 154.84 26.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.979 0.912 . . . . 0.0 109.951 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.586 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 86.3 mtm180 -124.49 127.14 47.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.553 1.141 . . . . 0.0 108.764 171.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 HD13 HG12 ' A' ' 56' ' ' VAL . 32.1 pt -103.5 161.7 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.04 0.936 . . . . 0.0 110.63 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.54 129.67 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.984 0.914 . . . . 0.0 109.825 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.66 166.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.407 1.083 . . . . 0.0 108.76 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 29.4 m -149.82 130.47 14.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.38 133.42 6.96 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 23.9 ttm-85 -100.6 123.66 45.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.183 0.593 . . . . 0.0 110.003 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 63.16 11.74 5.51 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.939 1.296 . . . . 0.0 113.049 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 36.1 m-80 -79.79 148.94 31.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.371 0.668 . . . . 0.0 110.287 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.64 168.23 17.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.299 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.1 tp -57.5 -31.9 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.541 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.12 93.59 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.758 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 12.7 m-20 -67.19 -37.51 83.81 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.624 0.77 . . . . 0.0 110.789 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -64.93 -53.4 47.09 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.913 0.758 . . . . 0.0 110.71 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.46 -36.21 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 0.0 110.853 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 t -64.86 -42.85 94.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.918 0.887 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.44 -37.39 65.86 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.52 0.728 . . . . 0.0 111.451 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.528 HG12 HD13 ' A' ' 40' ' ' ILE . 76.6 t -65.19 -45.36 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.132 0.573 . . . . 0.0 110.485 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -68.73 -32.28 71.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.821 0.848 . . . . 0.0 110.744 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -65.79 -55.04 19.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.515 0.726 . . . . 0.0 109.8 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -62.28 -44.67 95.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.994 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.47 -49.13 78.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.751 0.82 . . . . 0.0 111.182 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.64 -38.66 91.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.404 0.682 . . . . 0.0 111.088 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -76.16 -21.04 57.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.151 0.581 . . . . 0.0 112.202 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -76.82 -22.59 53.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.992 0.517 . . . . 0.0 110.277 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.02 11.41 60.15 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.902 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.9 129.16 38.82 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.661 0.784 . . . . 0.0 110.141 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.65 84.67 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 123.874 0.734 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 26' ' ' LEU . 13.8 t -141.4 174.99 10.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.019 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.78 163.94 35.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.299 1.04 . . . . 0.0 108.86 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -151.49 118.4 5.83 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -71.24 114.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.28 -23.35 5.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -163.53 129.61 3.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.981 0.419 . . . . 0.0 111.18 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 p -111.33 141.59 44.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 165.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.494 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 23.0 t -159.19 139.88 12.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 79' ' ' SER . 46.8 mt-10 -77.92 119.72 21.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.101 0.56 . . . . 0.0 110.663 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' H ' ' HA ' ' A' ' 82' ' ' TRP . 69.9 t80 -75.92 132.67 40.41 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.634 1.174 . . . . 0.0 109.92 -174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.48 -76.46 1.51 Allowed Glycine 0 C--N 1.343 0.922 0 O-C-N 124.019 0.825 . . . . 0.0 112.155 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -137.05 -77.63 0.4 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.107 0.963 . . . . 0.0 108.635 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 74.7 m -154.78 176.59 12.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.992 0.917 . . . . 0.0 110.201 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.73 -66.28 3.95 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 56.6 t30 -80.17 135.28 36.25 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.407 ' HA ' ' H ' ' A' ' 76' ' ' PHE . 4.6 p-90 -150.22 131.0 14.12 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.368 0.604 . . . . 0.0 111.287 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HD2' ' HB3' ' A' ' 74' ' ' SER . 0.0 OUTLIER -91.66 156.37 17.65 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 110.171 178.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 52' ' ' ALA . 61.0 t -139.7 116.58 9.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 124.14 0.976 . . . . 0.0 108.431 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 132.45 40.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.43 138.07 29.06 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.113 0.965 . . . . 0.0 109.048 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.586 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -101.79 141.76 34.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.637 0.775 . . . . 0.0 109.353 176.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.02 142.6 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.038 0.935 . . . . 0.0 110.045 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -124.52 155.94 38.15 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.338 1.055 . . . . 0.0 111.746 -165.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -110.57 145.46 37.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.494 1.118 . . . . 0.0 108.94 169.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.585 0.754 . . . . 0.0 108.983 -178.079 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 146.51 31.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.547 1.139 . . . . 0.0 108.805 176.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.71 129.37 39.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -66.17 135.39 54.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.435 0.694 . . . . 0.0 110.663 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.98 115.83 11.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -89.7 134.6 34.08 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.4 p -68.25 142.49 94.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.778 0.674 . . . . 0.0 109.943 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.47 -34.13 7.27 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 124.08 3.187 . . . . 0.0 113.881 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.28 -57.57 9.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 0.0 110.879 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.7 -33.93 77.11 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.82 -24.98 61.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.082 0.953 . . . . 0.0 112.092 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 -18.31 49.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.982 0.513 . . . . 0.0 111.407 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.89 -39.57 8.92 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.346 0.659 . . . . 0.0 111.0 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.33 142.0 28.22 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.985 0.914 . . . . 0.0 109.35 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -103.08 128.78 26.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.75 161.13 30.79 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.887 2.391 . . . . 0.0 112.138 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -98.41 -21.06 16.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.868 0.467 . . . . 0.0 110.502 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -155.83 161.28 40.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.048 0.939 . . . . 0.0 109.558 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.6 mtm180 -123.09 119.03 29.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.439 HD13 HG11 ' A' ' 56' ' ' VAL . 43.2 pt -90.98 131.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.59 120.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -118.93 179.4 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.158 0.983 . . . . 0.0 109.119 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 23.7 p -119.06 119.47 34.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.648 0.779 . . . . 0.0 109.539 169.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.65 135.06 12.61 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -97.51 171.36 8.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 117.967 0.883 . . . . 0.0 111.122 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.35 3.38 3.77 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 0.0 112.297 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -52.23 -51.56 57.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.399 1.08 . . . . 0.0 111.578 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.48 164.17 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.742 0.817 . . . . 0.0 110.981 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.96 -43.01 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.08 -16.02 70.3 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.671 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.08 -51.99 61.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.965 0.906 . . . . 0.0 109.651 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -68.91 -46.98 66.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.075 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.19 -35.53 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.761 0.825 . . . . 0.0 111.582 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 t -64.23 -44.57 91.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.568 0.747 . . . . 0.0 110.504 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.78 66.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.054 0.542 . . . . 0.0 111.71 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG11 HD13 ' A' ' 40' ' ' ILE . 49.8 t -72.17 -45.94 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.912 0.485 . . . . 0.0 109.717 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -63.35 -45.32 91.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.064 0.946 . . . . 0.0 110.945 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 31.7 mmt180 -72.3 -37.01 69.08 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.994 0.809 . . . . 0.0 111.427 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 tpt180 -66.7 -48.92 67.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.15 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -34.42 76.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.053 0.941 . . . . 0.0 110.905 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.3 -39.13 92.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.79 0.836 . . . . 0.0 110.806 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 51.5 mt-10 -64.74 -34.68 78.9 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.359 0.663 . . . . 0.0 110.925 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.0 mm-40 -78.64 -8.11 58.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.517 0.727 . . . . 0.0 111.374 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.92 17.45 79.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.269 0.356 . . . . 0.0 112.996 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . . . -73.62 128.52 35.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.978 0.911 . . . . 0.0 109.996 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.26 69.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.67 0.788 . . . . 0.0 111.506 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 56.5 m -144.99 171.21 14.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.379 0.672 . . . . 0.0 111.482 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.7 166.62 28.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.447 1.099 . . . . 0.0 108.698 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -155.29 129.12 8.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -77.09 113.16 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.86 0.464 . . . . 0.0 110.094 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.73 -25.93 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.279 0.632 . . . . 0.0 111.539 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 19.7 t70 -148.29 138.44 22.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.012 0.525 . . . . 0.0 110.849 -174.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.45 HG21 HG22 ' A' ' 84' ' ' VAL . 23.4 p -136.53 106.09 6.14 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.571 1.149 . . . . 0.0 108.033 170.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -121.03 138.44 54.17 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.121 0.968 . . . . 0.0 109.416 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 11.8 pt-20 -69.23 160.03 31.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.984 0.421 . . . . 0.0 110.985 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -77.53 -35.72 53.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 142.35 -95.85 0.19 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -86.09 -21.19 27.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.841 0.856 . . . . 0.0 110.859 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m -76.96 151.95 35.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.373 0.669 . . . . 0.0 111.181 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.32 47.7 3.88 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.03 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -130.73 119.4 22.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.044 1.338 . . . . 0.0 108.604 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.1 p-90 -109.25 108.18 18.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 108.992 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -64.78 149.64 48.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.434 0.694 . . . . 0.0 109.197 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.495 HG23 ' HB1' ' A' ' 52' ' ' ALA . 64.3 t -126.6 114.39 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.537 . . . . 0.0 109.948 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 34.4 t -88.96 124.32 41.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 165.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.69 121.58 14.51 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.426 0.691 . . . . 0.0 109.338 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 46.8 p-10 -81.28 140.41 34.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.733 0.413 . . . . 0.0 110.133 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.18 137.8 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.144 0.978 . . . . 0.0 110.379 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 35.9 m-85 -118.55 139.28 51.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.568 1.147 . . . . 0.0 110.393 -168.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 65' ' ' ALA . 32.7 mmtp -95.36 159.07 15.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 109.839 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.6 t60 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.86 130.72 4.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.4 1.08 . . . . 0.0 108.652 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.28 149.14 48.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.58 0.752 . . . . 0.0 111.612 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.7 m -74.02 142.35 45.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.559 0.744 . . . . 0.0 110.545 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.27 118.73 14.43 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.1 tp -85.21 119.25 25.38 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -64.73 141.75 98.38 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.59 -39.4 1.92 Allowed 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 125.044 3.83 . . . . 0.0 116.083 -173.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.93 -40.29 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.281 0.632 . . . . 0.0 110.332 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.94 -38.32 76.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.371 0.669 . . . . 0.0 110.213 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.15 -29.78 70.65 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.335 1.054 . . . . 0.0 111.171 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.91 -29.51 55.74 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.856 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.07 26.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.326 0.651 . . . . 0.0 112.36 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 HD13 HD23 ' A' ' 26' ' ' LEU . 96.9 mt -115.51 143.73 44.89 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.711 0.805 . . . . 0.0 110.171 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -92.7 133.05 29.96 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 0.0 110.137 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.26 153.42 24.4 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -99.12 -32.49 11.22 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.247 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -143.76 174.73 10.56 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -139.26 125.95 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.477 1.111 . . . . 0.0 108.661 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.502 HD12 HG13 ' A' ' 56' ' ' VAL . 32.7 pt -103.06 152.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.977 0.511 . . . . 0.0 110.427 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.99 133.15 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -116.23 157.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.279 1.032 . . . . 0.0 109.076 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.5 m -134.65 139.46 45.3 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.33 142.96 11.52 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.49 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -68.55 -40.71 80.54 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.225 0.61 . . . . 0.0 110.788 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -166.25 135.84 3.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.34 0.656 . . . . 0.0 109.613 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.6 -116.55 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.0 168.17 19.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 0.0 108.323 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.28 -37.59 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.6 88.3 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.457 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.02 -34.34 77.78 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.743 0.817 . . . . 0.0 111.541 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -72.21 -46.19 57.18 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.843 0.857 . . . . 0.0 110.259 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.05 -33.68 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.568 0.747 . . . . 0.0 110.598 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -72.66 -35.01 67.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.91 0.884 . . . . 0.0 110.927 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.82 78.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.244 0.617 . . . . 0.0 109.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.502 HG13 HD12 ' A' ' 40' ' ' ILE . 53.9 t -64.53 -37.05 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.217 1.007 . . . . 0.0 110.852 174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -61.38 -52.73 63.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.888 0.875 . . . . 0.0 110.711 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -69.45 -37.76 77.49 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.79 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -66.85 -37.35 84.29 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.323 0.649 . . . . 0.0 111.256 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.25 83.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.499 0.72 . . . . 0.0 110.343 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.21 -35.1 73.67 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.481 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 12.6 mm-40 -63.19 -34.49 77.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.741 0.816 . . . . 0.0 110.606 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -70.63 -29.02 65.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.506 175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.33 4.28 53.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.071 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 141.77 49.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.693 0.797 . . . . 0.0 110.557 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.21 64.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 110.632 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.1 m -141.14 173.57 11.35 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.719 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.48 173.99 12.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.33 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -160.5 120.24 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 109.944 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.22 113.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.868 0.867 . . . . 0.0 109.67 173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.7 -20.76 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 0.0 111.501 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 22.9 t70 -154.29 145.22 22.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.123 0.569 . . . . 0.0 110.904 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.453 HG22 HG23 ' A' ' 84' ' ' VAL . 26.0 p -137.55 111.49 8.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.915 1.286 . . . . 0.0 107.978 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -118.43 135.19 54.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.227 0.611 . . . . 0.0 109.551 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -108.39 170.01 8.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.114 0.566 . . . . 0.0 110.788 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -71.97 -34.71 69.17 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.011 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.79 79.88 0.76 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.518 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 67.16 8.85 6.5 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.005 1.322 . . . . 0.0 113.544 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -90.83 4.12 52.6 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.194 0.597 . . . . 0.0 111.234 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.28 -49.3 3.92 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -70.62 141.1 51.75 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 121.251 0.548 . . . . 0.0 110.596 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -157.32 177.45 11.43 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.318 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.73 156.01 44.38 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.333 0.653 . . . . 0.0 109.677 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 52' ' ' ALA . 98.9 t -130.92 115.83 31.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.009 0.924 . . . . 0.0 109.564 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 56.5 t -92.39 129.89 42.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 108.766 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.57 125.69 13.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.583 0.753 . . . . 0.0 110.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.33 143.02 35.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.01 139.64 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.414 0.686 . . . . 0.0 110.428 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -121.03 139.59 53.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.484 1.113 . . . . 0.0 109.993 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.08 165.56 13.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.567 0.747 . . . . 0.0 110.49 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.425 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.71 107.01 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 0.0 109.317 -168.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.38 138.09 33.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.315 1.046 . . . . 0.0 112.48 -169.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -63.37 147.6 50.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.079 0.952 . . . . 0.0 110.817 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.39 122.64 20.71 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -81.92 138.07 35.07 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.7 p -74.47 152.07 87.56 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.303 0.641 . . . . 0.0 109.916 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.96 -23.19 75.57 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.335 2.023 . . . . 0.0 112.683 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.39 -56.24 24.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.074 0.95 . . . . 0.0 110.278 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -76.07 -24.99 55.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.112 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.633 0.773 . . . . 0.0 111.156 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.42 -28.75 26.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.141 0.576 . . . . 0.0 110.187 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.03 3.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.413 0.685 . . . . 0.0 110.849 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.7 148.21 25.54 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.72 0.808 . . . . 0.0 110.193 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.3 143.17 26.24 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.09 144.29 37.49 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.394 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -77.08 -20.56 55.63 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.838 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -159.45 161.97 35.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.524 1.13 . . . . 0.0 108.85 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.0 ttm180 -132.88 120.84 22.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.641 0.777 . . . . 0.0 108.917 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.498 HG21 ' HD2' ' A' ' 59' ' ' ARG . 27.9 pt -91.91 163.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.698 0.799 . . . . 0.0 111.451 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.429 HG21 ' NE ' ' A' ' 83' ' ' ARG . 2.2 p -142.22 130.5 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 110.387 -173.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.513 HG13 ' HB ' ' A' ' 84' ' ' VAL . 41.4 pt -144.89 174.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.696 1.198 . . . . 0.0 109.109 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 p -136.56 125.01 23.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.369 1.068 . . . . 0.0 108.819 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.16 73.43 1.51 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 62.6 ttt180 -68.5 96.34 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.845 0.458 . . . . 0.0 111.002 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.4 t80 65.33 19.77 11.71 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.13 1.372 . . . . 0.0 111.118 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.44 150.67 21.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.649 0.779 . . . . 0.0 110.069 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.43 161.06 23.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.368 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.4 -46.83 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.549 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.87 -29.08 69.65 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.664 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.09 -48.54 65.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.462 0.705 . . . . 0.0 110.676 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.409 ' HB2' HG22 ' A' ' 84' ' ' VAL . . . -69.74 -32.49 71.05 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.402 ' HA ' HG11 ' A' ' 56' ' ' VAL . 42.6 t -67.85 -38.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.846 0.458 . . . . 0.0 110.625 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -65.98 -35.73 81.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.773 0.429 . . . . 0.0 110.479 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.46 64.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.537 0.735 . . . . 0.0 111.485 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG11 ' HA ' ' A' ' 53' ' ' VAL . 11.6 p -74.36 -31.63 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.284 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.0 t -69.97 -43.12 72.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.683 0.793 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 ttt180 -61.84 -49.12 77.55 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.466 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.498 ' HD2' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.48 -46.07 87.38 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 109.684 -176.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.53 83.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.085 0.866 . . . . 0.0 111.066 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.04 -34.83 79.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.63 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 58.5 mt-10 -70.62 -23.11 62.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.84 0.456 . . . . 0.0 110.916 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -89.72 2.15 55.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.379 0.672 . . . . 0.0 111.58 175.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 24.08 67.32 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.448 -0.342 . . . . 0.0 113.324 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.43 134.13 35.5 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.376 0.671 . . . . 0.0 110.178 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.33 75.96 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.549 0.69 . . . . 0.0 110.174 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 m -148.98 169.66 20.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.792 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -145.13 149.88 35.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.087 0.955 . . . . 0.0 108.521 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -128.5 131.23 48.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -78.28 123.53 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HB ' ' OD1' ' A' ' 87' ' ' ASP . 7.7 p -86.85 -33.5 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.696 0.399 . . . . 0.0 110.139 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -160.72 144.2 13.41 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.795 0.438 . . . . 0.0 110.839 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 21.1 p -133.38 112.98 12.05 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 t -126.74 120.39 29.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.391 0.676 . . . . 0.0 110.523 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 33.9 mt-10 -66.62 122.24 17.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.691 0.796 . . . . 0.0 110.474 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -59.71 -44.83 93.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.233 1.013 . . . . 0.0 111.297 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.29 -164.25 13.17 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.446 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.54 -11.65 61.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.491 0.716 . . . . 0.0 111.626 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 t -72.6 177.27 4.81 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.881 0.872 . . . . 0.0 110.513 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.39 11.42 44.73 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.922 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 52.3 t30 -82.54 129.84 35.0 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.484 0.642 . . . . 0.0 110.356 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 3.0 p-90 -142.68 124.74 15.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.054 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.561 ' HE ' ' HB ' ' A' ' 85' ' ' VAL . 12.0 tpt180 -64.44 116.58 6.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.03 1.332 . . . . 0.0 109.747 174.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 42' ' ' ILE . 26.6 t -106.43 107.99 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.561 ' HB ' ' HE ' ' A' ' 83' ' ' ARG . 5.8 p -118.91 126.84 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.25 142.75 35.75 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.568 0.747 . . . . 0.0 110.214 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.49 143.53 26.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 124.624 1.17 . . . . 0.0 110.38 178.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.29 141.4 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.086 0.954 . . . . 0.0 110.551 -171.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -125.04 167.58 14.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.01 0.924 . . . . 0.0 112.293 -167.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 10.3 mmpt? -101.56 164.46 11.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.796 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.062 173.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.53 136.81 0.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.482 1.513 . . . . 0.0 108.178 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.19 115.49 6.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.586 0.354 . . . . 0.0 110.983 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.9 m -67.73 137.33 55.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.7 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -72.83 118.25 15.53 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.9 tp -85.45 144.85 27.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.994 0.918 . . . . 0.0 109.032 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 p -84.92 157.3 60.33 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.042 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.38 -28.42 80.16 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.813 2.342 . . . . 0.0 113.561 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.84 -44.96 75.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.869 0.468 . . . . 0.0 110.586 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.506 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 51.9 mt-30 -72.22 -28.35 63.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.917 0.487 . . . . 0.0 110.98 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 -23.08 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.31 0.644 . . . . 0.0 110.739 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.33 25.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.461 0.704 . . . . 0.0 110.568 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.53 36.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.663 0.785 . . . . 0.0 110.788 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.6 166.2 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.269 1.027 . . . . 0.0 110.236 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -118.86 149.2 46.14 Favored Pre-proline 0 C--O 1.244 0.795 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.48 165.67 22.8 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.603 2.202 . . . . 0.0 111.871 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -96.61 -45.3 6.77 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.23 -173.84 3.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 109.854 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -123.87 171.55 9.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.304 0.642 . . . . 0.0 109.305 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 pt -138.89 138.35 41.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.1 124.73 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 pt -118.45 175.7 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.968 0.907 . . . . 0.0 108.777 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 19.7 p -130.49 113.87 14.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 64.91 3.72 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 53.7 ttt180 -63.77 95.69 0.12 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.93 0.892 . . . . 0.0 111.089 -172.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.8 t80 63.55 16.4 9.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.727 1.211 . . . . 0.0 111.436 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.69 155.94 19.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.813 0.845 . . . . 0.0 109.739 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.91 161.03 30.56 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.261 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 tp -60.16 -37.39 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.338 0.655 . . . . 0.0 110.875 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.66 90.97 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.344 0.402 . . . . 0.0 112.887 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.19 -36.42 77.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.556 0.742 . . . . 0.0 110.767 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.6 82.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.63 0.581 . . . . 0.0 110.15 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.95 -36.64 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.005 0.522 . . . . 0.0 110.295 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.7 t -68.79 -41.42 78.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.964 0.506 . . . . 0.0 110.691 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.54 -35.08 67.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.165 0.586 . . . . 0.0 111.749 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 p -77.0 -31.01 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -72.44 -35.49 68.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.928 0.491 . . . . 0.0 110.407 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -61.06 -56.91 15.43 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.467 1.105 . . . . 0.0 109.797 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -59.44 -45.68 90.89 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.118 0.886 . . . . 0.0 111.403 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.24 94.45 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.611 0.569 . . . . 0.0 111.317 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.03 -37.49 87.61 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.116 0.567 . . . . 0.0 110.665 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.42 -19.31 60.45 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.547 0.739 . . . . 0.0 111.416 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.11 -7.3 59.41 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.914 0.886 . . . . 0.0 111.133 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 13.95 81.28 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.627 -0.26 . . . . 0.0 112.912 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.05 134.9 38.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.702 0.801 . . . . 0.0 110.318 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.76 -38.79 46.08 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.073 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -134.45 169.82 16.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.664 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -149.53 158.41 44.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.641 0.776 . . . . 0.0 109.0 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -143.78 119.05 10.18 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.386 0.674 . . . . 0.0 109.277 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.8 t -71.47 112.12 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.386 0.675 . . . . 0.0 109.702 176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.51 -26.71 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.4 t70 -143.17 133.43 24.57 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.064 0.546 . . . . 0.0 110.281 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.2 p -132.07 112.63 12.51 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -115.88 173.74 6.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.877 0.871 . . . . 0.0 108.98 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -142.1 154.21 44.73 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.43 0.692 . . . . 0.0 109.993 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -100.44 82.5 2.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.1 -118.27 12.78 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.351 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -127.66 41.93 3.42 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.277 1.037 . . . . 0.0 108.295 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.1 t -88.22 -2.82 58.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.46 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.81 -35.43 3.88 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 122.704 0.192 . . . . 0.0 113.363 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 3.6 p-10 -78.31 92.22 4.5 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 0.0 110.926 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 43.3 p-90 -99.66 127.58 45.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.674 171.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -95.05 153.97 17.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.534 0.733 . . . . 0.0 110.758 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.88 112.78 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.704 1.202 . . . . 0.0 108.863 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 39.9 t -98.08 115.11 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -126.15 120.57 30.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.497 0.719 . . . . 0.0 109.937 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.3 146.12 50.79 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.979 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.35 136.86 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.032 0.533 . . . . 0.0 110.186 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -126.04 170.17 12.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.638 1.175 . . . . 0.0 110.744 -168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.99 178.57 5.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.023 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.733 0.813 . . . . 0.0 108.827 172.676 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.829 0.347 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.41 130.53 6.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.966 0.906 . . . . 0.0 108.967 -175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.87 136.23 56.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.312 0.645 . . . . 0.0 111.583 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 m -68.24 130.63 43.49 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.048 0.539 . . . . 0.0 110.755 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.1 118.26 12.71 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 27.1 tp -93.16 139.78 30.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.473 1.109 . . . . 0.0 109.717 -172.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -71.38 147.95 93.14 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.545 0.738 . . . . 0.0 110.16 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.48 -33.62 86.76 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.421 2.747 . . . . 0.0 113.991 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.0 -46.8 64.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.999 0.52 . . . . 0.0 111.012 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -73.25 -23.44 60.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.201 0.6 . . . . 0.0 111.463 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.13 -36.06 61.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 0.0 110.352 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.36 61.86 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.25 -48.93 38.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.511 0.725 . . . . 0.0 110.392 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.37 170.5 15.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.441 0.696 . . . . 0.0 111.355 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -121.32 123.33 27.73 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.556 0.742 . . . . 0.0 109.694 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.81 133.26 12.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.936 2.424 . . . . 0.0 112.254 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.68 -34.67 30.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.157 0.583 . . . . 0.0 110.194 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.26 171.86 13.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.471 1.108 . . . . 0.0 108.468 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 5.7 ttp180 -140.71 128.5 21.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.372 1.069 . . . . 0.0 108.116 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.7 pt -103.32 161.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.079 0.552 . . . . 0.0 110.531 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.469 HG23 ' HD3' ' A' ' 83' ' ' ARG . 2.0 p -148.76 132.34 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.985 0.914 . . . . 0.0 109.438 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -132.32 166.72 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.608 1.163 . . . . 0.0 109.528 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.7 p -134.08 118.82 18.17 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.382 1.073 . . . . 0.0 109.637 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.86 115.06 5.14 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.653 -0.526 . . . . 0.0 111.811 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -76.11 91.43 3.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.282 0.633 . . . . 0.0 110.165 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 t80 65.79 12.29 8.22 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.309 1.444 . . . . 0.0 112.003 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -72.65 154.78 40.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.9 162.36 29.16 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.592 0.357 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.7 tp -60.31 -31.78 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.053 0.541 . . . . 0.0 110.676 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.88 -42.9 98.24 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.912 -0.382 . . . . 0.0 112.897 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -62.92 -43.18 99.5 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.372 0.669 . . . . 0.0 110.074 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.532 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -63.2 -51.2 67.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.021 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.69 -37.4 79.56 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 123.693 0.797 . . . . 0.0 110.395 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.0 t -69.06 -36.44 77.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.364 0.666 . . . . 0.0 111.198 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.01 -40.25 60.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.39 0.676 . . . . 0.0 111.252 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.03 -27.89 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 123.269 0.628 . . . . 0.0 110.19 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.8 t -70.26 -42.97 71.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.851 0.861 . . . . 0.0 110.104 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 18.7 ttt180 -57.47 -57.61 11.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.64 175.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.3 tpp85 -61.03 -40.97 95.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.08 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.78 96.31 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.173 0.589 . . . . 0.0 111.283 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.89 -35.6 80.39 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.25 0.62 . . . . 0.0 110.335 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 55.2 mt-10 -71.12 -29.25 65.02 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.97 0.908 . . . . 0.0 110.849 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 23.8 mm-40 -73.82 -14.36 61.08 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.235 0.614 . . . . 0.0 110.754 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.12 2.74 64.04 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.98 138.76 42.47 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.753 0.821 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.45 -32.37 64.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.176 0.99 . . . . 0.0 110.887 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 66.0 m -143.44 171.07 14.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.21 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.36 162.38 38.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.328 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -141.56 117.51 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.26 113.67 3.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.64 -20.81 6.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.22 137.84 4.4 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 123.321 0.388 . . . . 0.0 110.905 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.5 p -122.43 106.42 11.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 t -123.6 126.26 46.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.044 0.538 . . . . 0.0 109.984 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 31.0 mt-10 -73.22 124.92 26.59 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.552 0.532 . . . . 0.0 110.236 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -72.94 128.55 35.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.463 0.705 . . . . 0.0 110.037 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.83 -80.81 1.31 Allowed Glycine 0 C--N 1.346 1.124 0 O-C-N 123.876 0.735 . . . . 0.0 111.884 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.45 -72.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.327 1.051 . . . . 0.0 108.899 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 74.6 m -154.51 -173.97 4.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.408 0.683 . . . . 0.0 110.975 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -87.95 1.44 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -71.81 100.16 2.33 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.2 p-90 -109.27 126.78 53.7 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.572 0.749 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.3 tmm_? -83.8 129.19 34.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.782 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 52' ' ' ALA . 62.6 t -113.3 109.31 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.299 1.04 . . . . 0.0 108.248 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.42 134.81 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.14 129.16 18.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.595 0.758 . . . . 0.0 111.079 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 2.6 m-20 -77.51 141.0 39.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.69 145.69 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.285 0.634 . . . . 0.0 111.095 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -127.74 133.6 49.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.488 1.115 . . . . 0.0 110.432 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -84.46 165.55 18.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.978 0.911 . . . . 0.0 111.247 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.9 m80 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . . . -64.87 134.65 54.49 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 171.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.39 46.78 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.732 0.645 . . . . 0.0 112.327 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -75.78 145.36 40.79 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.566 0.747 . . . . 0.0 110.311 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.1 118.87 15.51 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 34' ' ' LEU . 19.7 tp -82.16 138.43 34.72 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -64.3 141.62 98.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.219 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -42.21 -30.1 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.985 3.123 . . . . 0.0 115.162 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.59 -54.52 7.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.248 0.619 . . . . 0.0 111.249 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.58 -31.26 71.86 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.74 0.416 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -31.7 65.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.699 0.8 . . . . 0.0 111.048 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.76 62.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.998 0.519 . . . . 0.0 110.875 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -42.9 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.18 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD12 HD21 ' A' ' 26' ' ' LEU . 95.7 mt -86.79 167.23 14.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 110.162 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -120.35 125.0 27.43 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' HD3' ' HH ' ' A' ' 89' ' ' TYR . 96.1 Cg_endo -74.96 146.38 32.73 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.548 2.165 . . . . 0.0 111.923 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.531 ' HH ' ' HB2' ' A' ' 65' ' ' ALA . 34.8 p90 -82.58 -22.87 34.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -158.52 168.58 26.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 110.455 -173.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 18.5 mtm180 -126.91 124.01 38.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.928 1.291 . . . . 0.0 108.507 169.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.88 138.7 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.825 0.45 . . . . 0.0 110.317 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.24 123.97 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 pt -109.39 160.44 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.766 0.826 . . . . 0.0 109.826 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.8 p -132.05 131.86 42.85 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.072 0.949 . . . . 0.0 108.664 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.07 154.79 21.15 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtm105 -110.25 118.96 37.74 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.838 0.819 . . . . 0.0 109.969 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 t80 55.94 82.78 0.1 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.994 1.317 . . . . 0.0 110.98 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -132.75 164.77 26.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.702 0.801 . . . . 0.0 110.01 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.2 178.82 4.79 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.433 ' O ' HG22 ' A' ' 53' ' ' VAL . 9.0 tp -65.66 -37.07 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.21 -38.56 96.7 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 123.191 0.307 . . . . 0.0 113.351 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.18 -39.9 78.42 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.412 0.685 . . . . 0.0 110.2 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -63.1 -40.98 99.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.316 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 49' ' ' ILE . 83.0 t -70.36 -40.2 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.413 0.685 . . . . 0.0 110.467 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -65.89 -34.89 79.17 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 0.0 111.059 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.58 -34.99 58.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.227 0.611 . . . . 0.0 111.222 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.0 p -83.27 -27.01 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.761 0.424 . . . . 0.0 110.685 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -73.32 -36.34 66.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.0 ttt180 -66.36 -45.28 80.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.979 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -64.28 -41.32 96.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.132 0.573 . . . . 0.0 110.883 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.05 -32.54 74.13 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 120.665 0.269 . . . . 0.0 110.889 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 19.8 t70 -67.79 -36.91 81.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.43 0.692 . . . . 0.0 110.872 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.8 mm-40 -63.13 -35.88 81.73 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.378 0.671 . . . . 0.0 110.719 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 29.7 mm-40 -83.79 -11.19 57.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.687 0.795 . . . . 0.0 112.161 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.64 47.8 8.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-O 121.137 0.298 . . . . 0.0 112.554 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.531 ' HB2' ' HH ' ' A' ' 37' ' ' TYR . . . -114.55 131.4 56.68 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 0.0 109.134 177.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -35.1 74.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.21 0.604 . . . . 0.0 111.507 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -140.92 175.32 9.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.579 0.751 . . . . 0.0 110.613 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 38.5 p90 -149.52 -179.94 7.48 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 173.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -159.11 122.81 3.82 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.7 115.49 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 85' ' ' VAL . 2.5 p -88.56 -31.54 5.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.264 0.626 . . . . 0.0 109.669 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -162.07 142.08 10.03 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.871 0.367 . . . . 0.0 110.982 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.5 p -117.99 147.05 43.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.58 1.152 . . . . 0.0 108.334 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -150.16 169.81 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.69 0.796 . . . . 0.0 110.23 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.9 149.02 50.23 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -71.53 98.32 1.84 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.02 -107.87 2.09 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -120.13 1.52 10.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.375 0.67 . . . . 0.0 111.113 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -84.54 154.87 22.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.732 0.413 . . . . 0.0 110.197 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.41 25.17 2.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.06 90.65 2.01 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 117.665 0.733 . . . . 0.0 109.44 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -66.93 96.82 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.645 1.178 . . . . 0.0 112.556 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.64 111.67 19.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' A' ' 52' ' ' ALA . 57.9 t -123.06 121.2 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.93 0.492 . . . . 0.0 109.955 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 71' ' ' VAL . 5.1 p -109.86 134.19 52.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.297 0.639 . . . . 0.0 109.53 173.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.79 124.72 18.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 109.958 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 5.3 p-10 -72.53 130.83 41.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.428 0.691 . . . . 0.0 110.171 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 13.4 m -112.97 151.84 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.103 0.961 . . . . 0.0 111.301 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.445 ' HH ' ' HD3' ' A' ' 36' ' ' PRO . 88.7 m-85 -130.37 147.42 52.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.782 1.233 . . . . 0.0 110.43 -167.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.3 173.58 9.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.745 0.818 . . . . 0.0 110.268 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.628 174.28 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m170 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -169.52 132.36 1.22 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.928 1.291 . . . . 0.0 107.873 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.37 137.05 58.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.809 0.443 . . . . 0.0 109.951 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 m -62.09 135.44 57.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.44 0.696 . . . . 0.0 110.651 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.01 117.61 13.84 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.7 tp -90.95 142.28 27.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -95.94 153.29 39.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.196 0.599 . . . . 0.0 110.47 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -44.63 -38.62 12.52 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.213 3.276 . . . . 0.0 115.625 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.37 -50.7 72.97 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.358 0.663 . . . . 0.0 111.186 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 44.9 mt-30 -66.31 -46.23 77.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.817 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.67 68.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.889 0.875 . . . . 0.0 112.492 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.22 -24.45 47.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.6 0.76 . . . . 0.0 110.818 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.14 -33.32 14.08 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.759 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -99.45 153.21 19.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.343 0.657 . . . . 0.0 111.191 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -104.76 128.39 26.93 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 109.401 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.34 148.1 23.53 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.677 2.251 . . . . 0.0 111.697 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -80.12 -24.02 40.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.674 0.389 . . . . 0.0 110.47 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -160.74 175.17 12.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.148 0.979 . . . . 0.0 108.923 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.613 HH21 HG11 ' A' ' 71' ' ' VAL . 43.7 mtp180 -132.47 121.15 22.93 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 HD13 HG12 ' A' ' 56' ' ' VAL . 44.9 pt -89.55 149.15 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.012 0.369 . . . . 0.0 110.132 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.98 122.57 49.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -109.65 170.56 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.2 p -125.48 106.02 9.48 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.658 0.783 . . . . 0.0 109.136 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.43 88.73 1.59 Allowed Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.51 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.574 ' HG3' ' HB3' ' A' ' 81' ' ' ASN . 10.0 ttm180 -84.06 96.09 8.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 110.221 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.8 t80 60.79 90.65 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.47 1.106 . . . . 0.0 110.033 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.09 162.96 13.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.693 0.797 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.02 161.89 24.04 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 123.547 0.529 . . . . 0.0 110.018 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.477 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.2 tp -64.87 -29.18 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.9 97.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.072 0.232 . . . . 0.0 113.113 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.16 -43.41 82.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.533 0.733 . . . . 0.0 110.459 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -61.81 -50.11 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.086 0.954 . . . . 0.0 111.623 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.6 -35.84 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.064 0.946 . . . . 0.0 111.031 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 t -67.32 -34.93 78.38 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.043 0.537 . . . . 0.0 110.6 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.88 -33.91 64.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.042 0.537 . . . . 0.0 111.009 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.528 HG12 HD13 ' A' ' 40' ' ' ILE . 79.7 t -69.54 -41.71 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.262 0.625 . . . . 0.0 110.96 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -66.0 -34.18 77.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.938 0.495 . . . . 0.0 111.124 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 15.1 tpt180 -65.93 -57.44 7.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.76 0.824 . . . . 0.0 109.67 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -60.46 -40.36 90.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.04 1.336 . . . . 0.0 112.387 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.12 79.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.851 0.86 . . . . 0.0 110.246 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.75 -31.25 72.36 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.66 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 24.5 mm-40 -69.32 -29.44 67.27 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.046 0.538 . . . . 0.0 111.248 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -83.84 -1.93 55.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.989 0.516 . . . . 0.0 111.129 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.26 16.32 71.98 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.345 -0.388 . . . . 0.0 113.304 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -69.81 124.49 24.14 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.687 . . . . 0.0 110.852 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.95 69.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.859 0.724 . . . . 0.0 110.336 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.98 155.64 44.1 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.41 160.7 27.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -149.69 105.2 3.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.38 107.9 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.613 HG11 HH21 ' A' ' 39' ' ' ARG . 11.4 p -93.49 -36.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.291 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.47 145.28 21.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.875 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.3 p -131.28 134.5 46.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.818 1.247 . . . . 0.0 107.814 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m -139.07 126.57 21.71 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.139 0.576 . . . . 0.0 110.146 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.26 128.56 36.02 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.994 0.518 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -86.5 -52.28 5.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.333 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.4 -50.93 0.64 Allowed Glycine 0 C--N 1.349 1.275 0 N-CA-C 114.209 0.444 . . . . 0.0 114.209 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -56.83 107.87 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.6 m 62.62 22.75 13.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.992 0.917 . . . . 0.0 112.148 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.47 38.8 69.49 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.212 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 33.8 p-10 -78.84 146.41 33.69 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.477 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 7.5 p-90 -146.2 127.21 14.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.853 0.861 . . . . 0.0 109.198 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.93 149.18 50.11 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.979 0.799 . . . . 0.0 108.944 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HB1' ' A' ' 52' ' ' ALA . 32.3 t -127.2 105.28 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.69 131.26 41.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.32 112.22 6.56 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.195 -171.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.05 133.89 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.404 ' HB ' ' HB1' ' A' ' 65' ' ' ALA . 15.6 m -113.99 126.15 71.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.513 0.673 . . . . 0.0 109.859 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -115.11 162.51 16.92 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.868 1.267 . . . . 0.0 110.245 -168.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -107.22 170.2 8.11 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.316 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.848 178.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.2 m170 . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . . . 58.71 96.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.044 1.337 . . . . 0.0 111.404 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.54 140.14 41.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.259 1.024 . . . . 0.0 112.125 -176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.5 m -66.97 134.04 51.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.977 0.911 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -68.71 116.54 9.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -72.99 137.5 45.48 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.9 p -72.03 147.69 91.22 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.443 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.6 -36.44 18.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.963 3.108 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.01 -37.89 69.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.864 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -74.43 -49.47 22.3 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.138 0.494 . . . . 0.0 110.122 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.06 -22.17 66.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.455 1.102 . . . . 0.0 112.348 -175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.14 -53.86 50.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.34 1.056 . . . . 0.0 112.328 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.13 -22.89 17.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.947 0.499 . . . . 0.0 111.852 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.968 0.413 . . . . 0.0 110.339 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -86.91 125.6 66.08 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.7 166.41 23.71 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.973 2.448 . . . . 0.0 111.374 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -93.5 -26.27 17.24 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.465 -0.147 . . . . 0.0 111.232 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -165.21 -170.94 2.03 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.698 0.399 . . . . 0.0 110.251 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -137.94 138.03 38.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.885 1.274 . . . . 0.0 109.983 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -102.77 144.14 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.914 0.886 . . . . 0.0 109.398 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.418 HG23 HG23 ' A' ' 85' ' ' VAL . 46.1 t -130.83 115.43 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 pt -102.7 156.68 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.1 m -147.1 146.2 29.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 0.0 109.351 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.92 156.57 25.05 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -92.52 132.64 36.66 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.381 1.072 . . . . 0.0 110.003 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 t80 60.46 23.13 12.75 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 124.685 1.194 . . . . 0.0 112.091 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.76 116.93 16.02 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.28 158.98 35.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 tp -57.49 -33.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.284 0.365 . . . . 0.0 111.058 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.28 -45.03 96.82 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.245 0.341 . . . . 0.0 112.936 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.49 -39.67 92.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.711 0.804 . . . . 0.0 110.774 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.36 -47.65 78.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.337 1.055 . . . . 0.0 110.47 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.458 ' HA ' HG13 ' A' ' 56' ' ' VAL . 92.8 t -67.35 -37.57 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.795 0.438 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 t -64.04 -41.81 97.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.732 0.413 . . . . 0.0 110.941 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -44.4 66.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.041 0.536 . . . . 0.0 110.882 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 53' ' ' VAL . 5.8 p -74.98 -28.86 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.084 0.554 . . . . 0.0 111.145 -174.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.8 p -70.74 -49.94 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.634 0.373 . . . . 0.0 110.211 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 79.2 ttt180 -63.52 -44.18 94.99 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 110.173 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -57.57 -41.85 81.91 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.713 0.805 . . . . 0.0 111.474 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.64 86.11 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.33 -31.09 71.66 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.269 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 74.7 mm-40 -69.53 -31.31 69.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.347 0.659 . . . . 0.0 109.896 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 15.0 mm-40 -82.48 0.48 42.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.85 0.46 . . . . 0.0 111.221 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.85 5.05 71.65 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.167 0.413 . . . . 0.0 113.473 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.1 135.31 38.58 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 110.88 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 -26.64 54.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.367 1.067 . . . . 0.0 110.902 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.3 m -145.81 170.32 16.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 111.422 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -149.6 170.49 18.54 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -153.89 117.79 4.74 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.202 0.601 . . . . 0.0 109.505 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.01 107.93 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.716 0.806 . . . . 0.0 110.369 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.17 -43.55 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.265 0.626 . . . . 0.0 110.246 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.1 t70 -133.97 127.56 32.62 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 110.254 -167.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.3 p -122.56 117.23 25.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.4 t -139.48 162.42 35.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -138.0 174.27 10.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.362 0.665 . . . . 0.0 111.015 -170.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -77.69 175.04 10.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.69 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.76 -23.06 49.31 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 120.851 0.139 . . . . 0.0 113.056 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -102.65 129.21 49.17 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.66 1.184 . . . . 0.0 109.316 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.8 m -74.45 133.26 42.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.23 0.612 . . . . 0.0 110.343 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.35 -47.5 1.02 Allowed Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -90.01 109.95 20.96 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 5.9 p-90 -144.51 179.83 7.02 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.375 0.67 . . . . 0.0 110.363 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.21 153.16 41.04 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.198 -171.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' HB1' ' A' ' 52' ' ' ALA . 85.2 t -124.11 110.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 0.0 108.915 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 26.4 t -94.65 123.87 46.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.7 123.56 23.88 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.5 0.72 . . . . 0.0 110.728 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.16 136.21 57.03 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.897 0.879 . . . . 0.0 110.067 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.66 138.65 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.347 0.594 . . . . 0.0 110.373 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -126.24 133.58 51.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.756 1.222 . . . . 0.0 109.735 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.24 176.65 9.57 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.205 0.602 . . . . 0.0 110.818 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.529 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.63 157.4 42.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.843 0.857 . . . . 0.0 110.137 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.45 142.78 53.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.111 0.564 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' SER . 59.1 m -68.14 124.77 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.0 0.52 . . . . 0.0 110.12 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.92 128.01 34.72 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.52 HD23 HD11 ' A' ' 34' ' ' LEU . 17.5 tp -101.75 140.13 36.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.902 0.881 . . . . 0.0 108.999 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 p -79.96 153.26 74.98 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.332 0.653 . . . . 0.0 110.861 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.23 -39.04 52.55 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.132 3.221 . . . . 0.0 114.155 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.54 -52.58 64.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.779 0.832 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.71 -36.42 75.91 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.539 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.69 92.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.993 0.917 . . . . 0.0 111.312 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.3 63.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.996 0.519 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.07 45.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.205 0.602 . . . . 0.0 111.583 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.52 HD11 HD23 ' A' ' 26' ' ' LEU . 82.5 mt -89.46 163.33 15.3 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.673 0.789 . . . . 0.0 110.101 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.28 124.7 27.6 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.607 0.763 . . . . 0.0 109.083 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.77 153.13 48.15 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.634 2.223 . . . . 0.0 111.952 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -93.08 -25.31 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.841 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.35 168.15 27.01 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.876 0.87 . . . . 0.0 108.879 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.543 HH21 HG11 ' A' ' 71' ' ' VAL . 34.0 mtp-105 -133.29 126.14 30.79 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.6 pt -104.59 159.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.33 0.652 . . . . 0.0 110.365 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.25 139.29 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 pt -125.9 168.65 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.1 0.96 . . . . 0.0 108.985 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -132.79 129.71 38.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.876 . . . . 0.0 109.142 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.18 92.35 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 54.9 ttp180 -60.07 112.24 1.81 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.654 0.782 . . . . 0.0 111.955 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.9 t80 66.75 11.45 8.23 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.389 1.076 . . . . 0.0 111.706 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -77.94 155.8 30.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.067 0.547 . . . . 0.0 110.066 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.99 43.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -61.75 -43.91 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 123.617 0.573 . . . . 0.0 110.688 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.73 88.38 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.053 0.22 . . . . 0.0 112.949 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.05 -42.85 88.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.118 0.967 . . . . 0.0 110.398 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 84' ' ' VAL . . . -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.216 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 ' HA ' HG13 ' A' ' 56' ' ' VAL . 69.1 t -67.68 -33.96 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 122.801 0.441 . . . . 0.0 110.448 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -68.68 -39.35 80.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.797 0.439 . . . . 0.0 110.534 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.87 80.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.433 0.693 . . . . 0.0 111.223 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 53' ' ' VAL . 3.7 p -78.44 -27.05 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.103 0.561 . . . . 0.0 110.663 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 t -69.01 -43.74 74.2 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.883 0.873 . . . . 0.0 110.146 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 14.4 tpt180 -63.82 -45.54 89.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.027 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -60.83 -44.94 96.28 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.84 0.713 . . . . 0.0 109.272 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.02 82.62 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.574 0.75 . . . . 0.0 110.592 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.59 -39.08 93.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.31 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 54.5 mm-40 -62.04 -34.92 77.13 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.391 0.676 . . . . 0.0 110.818 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.1 mm-40 -78.81 -11.63 60.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.851 0.46 . . . . 0.0 111.351 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.42 16.31 34.98 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.088 0.242 . . . . 0.0 113.519 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -77.98 135.04 37.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.269 0.628 . . . . 0.0 111.624 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.24 -31.2 49.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.291 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' THR . 51.1 m -143.63 172.01 13.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -162.29 158.86 24.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -130.79 121.0 24.57 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.68 96.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.543 HG11 HH21 ' A' ' 39' ' ' ARG . 7.2 p -88.9 -34.51 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.215 -172.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -133.39 129.04 36.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.982 0.513 . . . . 0.0 109.718 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.416 HG23 HG22 ' A' ' 84' ' ' VAL . 7.1 p -135.35 104.15 5.76 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 166.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -148.74 168.54 22.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.916 1.286 . . . . 0.0 108.528 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.0 pt-20 -68.23 149.45 49.5 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -84.04 48.49 1.48 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 109.346 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.73 45.93 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.508 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -138.29 120.73 16.02 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.769 0.828 . . . . 0.0 109.1 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.2 m -65.26 115.25 5.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.883 0.873 . . . . 0.0 110.226 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.72 -55.04 0.6 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 14.8 t30 -86.54 96.76 10.18 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 16.9 p-90 -108.55 150.36 27.59 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.499 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.11 157.12 19.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.44 1.096 . . . . 0.0 110.601 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 52' ' ' ALA . 64.9 t -126.98 109.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.567 1.147 . . . . 0.0 108.618 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.1 129.91 42.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.66 117.77 10.64 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 10.6 p-10 -84.86 142.33 29.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HB ' ' HB1' ' A' ' 65' ' ' ALA . 26.8 m -113.18 142.36 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.714 0.805 . . . . 0.0 111.245 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -126.38 167.25 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.107 1.363 . . . . 0.0 111.326 -165.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -108.75 162.97 13.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.83 1.252 . . . . 0.0 109.415 168.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.147 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 37.3 m80 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 -60.72 3.36 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.64 135.12 29.63 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -66.46 136.18 55.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.789 . . . . 0.0 109.922 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -69.0 125.01 25.31 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 12.8 tp -96.27 105.32 17.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.4 m -56.44 141.86 70.44 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.541 1.136 . . . . 0.0 110.509 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -43.51 -35.09 5.67 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.855 3.037 . . . . 0.0 114.2 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -63.02 -44.62 95.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.979 0.912 . . . . 0.0 111.642 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.85 -41.51 64.73 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.11 -19.52 61.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.382 1.073 . . . . 0.0 111.961 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.66 81.77 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.081 0.552 . . . . 0.0 110.182 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.56 -42.83 11.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.784 0.834 . . . . 0.0 111.352 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.94 134.02 33.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.255 0.622 . . . . 0.0 110.971 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -97.37 134.59 22.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.225 1.01 . . . . 0.0 109.713 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.32 163.65 34.24 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.98 2.453 . . . . 0.0 113.086 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 25.0 p90 -94.96 -25.66 16.43 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.991 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -155.94 177.4 11.45 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.789 0.835 . . . . 0.0 108.853 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 40.4 ttm180 -134.52 124.24 25.22 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.118 0.967 . . . . 0.0 108.781 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.4 pt -89.52 163.67 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.629 0.772 . . . . 0.0 111.265 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 83' ' ' ARG . 7.6 p -141.65 139.78 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.039 0.936 . . . . 0.0 109.164 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.6 pt -137.39 148.57 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -133.46 133.85 42.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.51 174.84 20.81 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 27.9 ttm180 -149.6 111.72 4.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.4 t80 81.75 -3.71 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.947 1.299 . . . . 0.0 111.165 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -71.24 152.35 43.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.484 1.513 . . . . 0.0 110.861 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.63 172.12 9.52 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.309 0.644 . . . . 0.0 110.923 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.68 -32.64 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.27 -35.52 91.67 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-O 120.899 0.166 . . . . 0.0 112.995 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.07 -35.29 69.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.632 0.773 . . . . 0.0 110.445 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -65.78 -43.52 88.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.63 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.59 -43.26 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.328 0.651 . . . . 0.0 111.231 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 p -66.34 -40.97 90.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.377 0.271 . . . . 0.0 111.19 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.99 80.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.949 0.499 . . . . 0.0 111.794 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.33 -29.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 122.813 0.445 . . . . 0.0 110.889 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.8 t -74.09 -41.43 61.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.122 0.569 . . . . 0.0 110.152 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -70.17 -41.5 73.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 tpp180 -60.44 -47.16 87.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.296 0.638 . . . . 0.0 110.231 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.55 83.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.759 0.662 . . . . 0.0 111.436 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.24 -40.53 94.37 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.024 0.929 . . . . 0.0 110.936 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.65 -12.09 60.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.395 0.678 . . . . 0.0 112.364 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.7 mm-40 -89.49 -12.64 39.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.457 0.303 . . . . 0.0 110.786 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.23 61.22 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.722 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -75.26 129.34 37.28 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.345 0.658 . . . . 0.0 111.45 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.22 77.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.943 0.897 . . . . 0.0 111.043 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.3 m -137.29 164.56 28.26 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.994 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -144.57 152.49 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.871 0.868 . . . . 0.0 108.927 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -131.54 118.22 19.82 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.86 107.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.57 -28.44 5.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.211 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 129.72 6.05 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.191 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -113.39 115.59 28.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.9 m -129.74 145.57 51.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 8.7 pt-20 -69.37 152.18 45.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -92.49 57.68 3.0 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.5 27.5 66.01 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.443 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 81' ' ' ASN . 50.5 t-20 -161.24 137.13 8.03 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -169.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.8 t -68.93 -32.27 71.75 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.001 0.52 . . . . 0.0 111.391 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.36 -43.56 5.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.678 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -83.72 113.4 20.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.1 143.88 46.86 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.165 0.507 . . . . 0.0 110.916 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.465 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.4 tmm_? -107.99 130.87 55.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.738 1.215 . . . . 0.0 109.715 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.493 HG23 ' HB1' ' A' ' 52' ' ' ALA . 73.5 t -112.32 125.78 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.36 140.31 45.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.99 143.53 31.26 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.025 0.53 . . . . 0.0 111.021 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 18.0 m-20 -77.76 156.12 30.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.905 0.482 . . . . 0.0 109.94 168.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 4.5 m -127.1 141.85 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.279 0.632 . . . . 0.0 110.526 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -131.09 141.84 50.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.352 1.061 . . . . 0.0 109.676 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 3.3 mmmp? -99.92 145.61 27.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 0.0 110.572 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 166.25 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.48 -68.12 0.43 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.448 0.699 . . . . 0.0 110.141 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.35 123.97 17.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.1 m -68.94 124.05 22.67 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.718 0.807 . . . . 0.0 110.028 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.76 116.42 10.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 HD12 ' A' ' 34' ' ' LEU . 14.5 tp -74.43 144.74 44.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.289 . . . . 0.0 109.189 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.9 p -73.48 152.4 89.76 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.963 0.505 . . . . 0.0 110.071 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.64 -32.71 45.85 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.67 2.913 . . . . 0.0 113.54 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -66.65 -52.93 39.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.249 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.16 -32.21 70.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.173 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.38 -29.47 66.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.961 0.904 . . . . 0.0 111.157 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.12 -31.17 65.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.282 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.55 -48.2 9.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.173 0.589 . . . . 0.0 111.068 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD12 HD21 ' A' ' 26' ' ' LEU . 94.3 mt -81.11 172.97 13.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.751 0.821 . . . . 0.0 110.932 -177.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HD3' ' HD2' ' A' ' 36' ' ' PRO . 10.8 tppt? -132.64 131.93 22.4 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.787 0.835 . . . . 0.0 108.944 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' HD3' ' A' ' 35' ' ' LYS . 73.5 Cg_endo -68.99 150.98 73.49 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.587 2.191 . . . . 0.0 111.471 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -86.11 -19.69 29.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.923 0.392 . . . . 0.0 110.358 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -162.03 169.2 21.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.476 1.11 . . . . 0.0 109.111 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 88.6 mtm180 -131.79 121.98 25.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.674 1.19 . . . . 0.0 108.754 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.3 pt -96.51 144.08 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.292 0.637 . . . . 0.0 110.177 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.35 133.78 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.641 0.777 . . . . 0.0 109.322 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 pt -126.52 153.86 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.792 0.837 . . . . 0.0 108.942 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 83' ' ' ARG . 39.2 p -121.55 149.93 42.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 0.0 109.074 174.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.06 116.29 0.71 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 40.7 ttp-105 -88.82 120.08 29.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.675 0.79 . . . . 0.0 109.627 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 59.05 81.65 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.733 1.213 . . . . 0.0 111.099 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.91 156.15 36.98 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.595 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.32 154.02 39.08 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 124.025 0.828 . . . . 0.0 110.162 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' O ' HG21 ' A' ' 53' ' ' VAL . 5.5 tp -59.92 -41.63 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.597 0.359 . . . . 0.0 110.041 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.37 -31.26 80.27 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.317 0.386 . . . . 0.0 113.34 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.07 -36.09 66.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.728 0.811 . . . . 0.0 110.255 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.9 77.82 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.865 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' HA ' HG11 ' A' ' 56' ' ' VAL . 87.7 t -66.9 -34.01 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.3 t -65.53 -39.43 91.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.466 0.706 . . . . 0.0 110.694 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.23 76.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.22 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 53' ' ' VAL . 8.3 p -82.4 -27.18 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.232 0.613 . . . . 0.0 111.675 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -69.49 -42.72 74.41 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.2 0.524 . . . . 0.0 109.787 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 7.6 tpt180 -65.78 -42.72 90.47 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.3 tpp180 -62.47 -35.99 81.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.147 0.579 . . . . 0.0 110.404 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.29 66.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 0.0 110.477 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.79 -34.89 77.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.837 0.455 . . . . 0.0 110.648 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 26.7 mm-40 -60.51 -37.01 79.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.787 0.835 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 50.1 mm-40 -77.72 -15.02 59.43 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.18 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.97 38.5 48.34 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.562 0.539 . . . . 0.0 111.761 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.84 126.66 40.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.236 1.014 . . . . 0.0 110.092 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.65 83.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.561 0.696 . . . . 0.0 110.739 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 37.2 m -139.95 168.99 18.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.659 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -148.75 169.95 19.3 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -150.2 127.1 11.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.55 97.55 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -86.33 -16.91 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.751 0.82 . . . . 0.0 110.52 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 21.8 t70 -163.51 150.27 12.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.237 0.615 . . . . 0.0 111.029 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 p -141.61 114.28 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.185 1.394 . . . . 0.0 107.834 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.7 m -137.25 152.35 49.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 108.806 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.9 pt-20 -64.48 148.9 49.65 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.497 0.319 . . . . 0.0 110.896 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.31 -34.63 76.98 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.661 0.384 . . . . 0.0 111.081 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.72 -7.11 0.08 OUTLIER Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.88 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -140.07 148.19 41.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.3 p -69.94 104.39 2.5 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.985 0.514 . . . . 0.0 109.853 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.79 -39.16 1.43 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -102.55 113.02 26.03 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.0 p-90 -121.75 159.3 26.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.576 0.703 . . . . 0.0 110.571 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HB2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -133.71 132.02 40.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.654 -165.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.98 125.84 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.866 0.866 . . . . 0.0 109.759 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 21.6 t -100.88 120.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 166.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.98 121.92 27.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 13.6 p-10 -85.36 136.04 33.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.6 m -112.32 131.64 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.692 0.797 . . . . 0.0 111.349 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 74.0 m-85 -109.76 163.86 13.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 111.54 -171.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -110.15 165.57 11.64 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 108.709 169.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.698 178.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.81 108.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.099 1.36 . . . . 0.0 111.879 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 133.73 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.377 0.671 . . . . 0.0 110.551 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -67.35 134.09 50.86 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.139 0.576 . . . . 0.0 110.557 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.02 116.57 9.63 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.5 tp -84.0 126.65 33.24 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.3 p -66.22 145.23 98.98 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 123.736 0.647 . . . . 0.0 110.208 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -45.65 -31.37 7.3 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.607 2.872 . . . . 0.0 114.25 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.89 -55.66 21.08 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.337 1.055 . . . . 0.0 110.449 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.19 -34.1 75.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.14 69.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.037 0.935 . . . . 0.0 111.423 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.57 -26.05 59.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 0.0 111.174 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.81 19.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.299 0.64 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.41 HD12 HD23 ' A' ' 26' ' ' LEU . 95.2 mt -101.21 160.89 14.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.731 0.812 . . . . 0.0 111.222 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -111.31 123.88 34.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 108.371 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.31 159.08 36.84 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.081 1.854 . . . . 0.0 111.185 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -100.86 -39.19 7.91 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.771 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.58 -170.61 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 109.469 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.724 ' HB3' ' HA ' ' A' ' 87' ' ' ASP . 4.5 ptt180 -149.8 168.08 24.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.79 0.836 . . . . 0.0 111.459 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.545 HD13 HG21 ' A' ' 56' ' ' VAL . 37.7 pt -118.55 151.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.954 0.902 . . . . 0.0 110.33 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.54 HG12 ' HD3' ' A' ' 83' ' ' ARG . 85.5 t -121.3 114.17 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.638 1.175 . . . . 0.0 109.545 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.469 HG13 ' HB ' ' A' ' 84' ' ' VAL . 43.2 pt -133.9 178.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.483 1.113 . . . . 0.0 108.963 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 3.0 p -126.97 105.11 8.39 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.632 0.773 . . . . 0.0 109.475 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.23 149.48 20.75 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -110.49 151.76 27.16 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.828 0.814 . . . . 0.0 111.166 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -72.07 -4.62 29.91 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.188 0.995 . . . . 0.0 112.817 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.507 0.723 . . . . 0.0 110.657 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.4 143.03 4.07 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.932 0.893 . . . . 0.0 110.216 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 tp -62.67 -37.44 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 167.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.47 -26.77 68.54 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.624 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.62 -49.2 78.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.301 0.64 . . . . 0.0 110.263 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 84' ' ' VAL . . . -65.24 -42.11 93.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.956 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 56' ' ' VAL . 88.9 t -66.75 -36.18 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.848 0.718 . . . . 0.0 111.338 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.5 m -66.21 -41.77 89.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.782 0.433 . . . . 0.0 110.546 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.17 79.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.69 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 40' ' ' ILE . 12.7 p -77.11 -34.15 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.724 0.41 . . . . 0.0 111.469 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -67.84 -39.99 83.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.796 0.438 . . . . 0.0 110.277 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 29.7 ttt180 -65.03 -56.63 11.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.852 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -66.54 -39.31 88.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.102 0.561 . . . . 0.0 112.3 -172.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.35 93.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.33 -35.92 80.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.708 0.803 . . . . 0.0 111.167 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 47.8 mt-10 -66.46 -33.27 75.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.337 0.655 . . . . 0.0 110.736 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 18.9 mm-40 -82.75 -5.17 58.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.717 0.807 . . . . 0.0 111.469 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.01 14.63 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.21 0.319 . . . . 0.0 113.137 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.105 0.962 . . . . 0.0 109.584 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -28.57 62.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.596 0.759 . . . . 0.0 111.067 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.3 m -143.09 169.4 17.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -147.28 168.11 22.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.959 0.903 . . . . 0.0 109.766 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -160.21 122.27 3.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.206 1.002 . . . . 0.0 108.623 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.45 120.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.601 0.563 . . . . 0.0 109.985 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.25 -30.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.257 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -160.2 149.28 17.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.018 0.527 . . . . 0.0 111.243 -172.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 33.7 p -132.89 104.63 6.67 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.612 1.165 . . . . 0.0 108.857 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.3 m -100.97 109.27 21.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.717 0.807 . . . . 0.0 110.33 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -51.93 127.9 22.57 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.674 0.39 . . . . 0.0 111.439 177.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.53 168.73 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.123 0.969 . . . . 0.0 109.503 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.26 67.39 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.162 0.425 . . . . 0.0 114.162 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -80.81 162.07 24.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.938 0.495 . . . . 0.0 109.795 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 m -72.9 106.23 4.74 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.29 0.636 . . . . 0.0 112.433 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.0 88.76 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 165.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -95.85 111.29 23.31 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -101.0 124.85 47.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.331 1.052 . . . . 0.0 109.144 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HD3' HG12 ' A' ' 41' ' ' VAL . 2.8 tmm_? -63.88 106.43 1.01 Allowed 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.676 1.19 . . . . 0.0 109.586 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' HG13 ' A' ' 42' ' ' ILE . 43.7 t -88.68 108.34 18.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.81 129.02 58.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.81 120.75 16.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.962 0.505 . . . . 0.0 110.966 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.724 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 5.0 m-20 -63.86 135.85 56.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.131 0.894 . . . . 0.0 110.846 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.84 142.88 22.88 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.498 0.719 . . . . 0.0 109.419 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.566 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 57.3 m-85 -125.1 152.47 44.33 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.177 0.991 . . . . 0.0 109.863 -169.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.68 174.21 7.47 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.289 0.635 . . . . 0.0 109.639 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 C-N-CA 123.307 0.643 . . . . 0.0 110.149 -179.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.478 0.656 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.23 -146.67 0.32 Allowed 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.97 118.33 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.678 0.672 . . . . 0.0 110.104 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -80.24 149.76 30.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.485 1.114 . . . . 0.0 110.617 -174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.53 134.2 51.9 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.522 0.601 . . . . 0.0 109.438 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.8 tp -94.82 134.92 36.93 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -73.96 144.91 83.07 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.732 0.813 . . . . 0.0 110.362 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.61 -38.19 75.53 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 124.125 3.217 . . . . 0.0 115.687 -165.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -69.83 -41.46 74.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.768 0.427 . . . . 0.0 110.455 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.8 -34.81 76.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.333 0.653 . . . . 0.0 110.63 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.95 -24.12 55.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.051 0.94 . . . . 0.0 111.261 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.03 -35.75 21.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.393 0.677 . . . . 0.0 110.432 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.26 65.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.306 0.643 . . . . 0.0 110.794 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.8 mt -88.17 148.24 24.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -102.54 139.69 20.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 73.9 Cg_endo -72.73 139.29 30.5 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.924 1.749 . . . . 0.0 111.451 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.53 ' HH ' ' HB3' ' A' ' 65' ' ' ALA . 53.4 p90 -78.06 -19.53 54.1 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -166.45 174.3 9.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 108.671 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 87' ' ' ASP . 51.0 mtm180 -135.01 122.76 22.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.084 0.954 . . . . 0.0 108.945 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 pt -87.85 151.88 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.956 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG13 ' HE ' ' A' ' 83' ' ' ARG . 78.7 t -135.53 125.31 42.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.926 0.89 . . . . 0.0 109.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.1 152.42 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.066 0.946 . . . . 0.0 109.132 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.67 164.76 12.96 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.552 0.741 . . . . 0.0 109.747 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.41 178.79 41.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.06 139.9 4.33 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.543 0.671 . . . . 0.0 111.085 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 t80 61.47 29.59 18.47 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 124.254 0.971 . . . . 0.0 111.014 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -123.33 168.35 12.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 0.0 110.774 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.38 166.4 13.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.923 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 6.4 tp -66.08 -31.58 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.953 0.501 . . . . 0.0 110.407 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.97 -33.62 74.9 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.213 0.321 . . . . 0.0 112.914 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.71 -46.73 68.19 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.326 0.65 . . . . 0.0 110.551 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.49 80.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.614 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 ' HA ' HG13 ' A' ' 56' ' ' VAL . 77.3 t -68.71 -40.36 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 0.0 110.105 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 58' ' ' ARG . 40.2 m -63.14 -36.65 84.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.879 0.471 . . . . 0.0 111.052 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.32 59.69 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.342 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 53' ' ' VAL . 10.0 p -74.76 -29.69 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.271 0.628 . . . . 0.0 112.203 -172.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.9 p -69.81 -40.92 75.63 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.746 0.419 . . . . 0.0 110.677 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 54' ' ' SER . 8.6 mpt_? -72.95 -36.93 67.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.321 0.648 . . . . 0.0 110.04 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -64.48 -43.55 93.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.613 0.765 . . . . 0.0 110.887 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.33 73.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 0.0 110.99 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.55 -35.12 79.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.658 0.783 . . . . 0.0 110.483 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -64.12 -38.95 92.9 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.532 0.733 . . . . 0.0 110.666 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -74.8 -2.19 25.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.802 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.53 23.98 75.85 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.754 -0.138 . . . . 0.0 112.754 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.53 ' HB3' ' HH ' ' A' ' 37' ' ' TYR . . . -82.82 128.58 34.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.522 0.729 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -33.81 76.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.5 m -147.42 158.97 44.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.634 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -122.18 174.11 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.295 1.038 . . . . 0.0 108.852 170.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -159.62 113.96 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.506 0.722 . . . . 0.0 109.134 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.57 118.82 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.28 0.632 . . . . 0.0 110.442 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.46 -36.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.12 141.24 17.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.367 -168.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -119.69 104.09 9.95 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 14.7 m -84.83 177.72 7.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.809 0.844 . . . . 0.0 110.344 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER -160.54 168.07 25.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.015 0.926 . . . . 0.0 110.542 177.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.6 ' HB3' ' HB3' ' A' ' 79' ' ' SER . 44.8 t80 -77.23 -8.01 56.87 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.476 0.71 . . . . 0.0 112.41 -168.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.23 85.68 1.86 Allowed Glycine 0 C--N 1.353 1.472 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.11 35.85 23.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.937 1.295 . . . . 0.0 111.582 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 33.6 t -127.79 164.82 21.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.578 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.77 76.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.581 0.551 . . . . 0.0 113.34 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -69.97 137.39 51.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.219 0.608 . . . . 0.0 110.711 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 p-90 -143.5 173.76 11.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.366 1.067 . . . . 0.0 110.667 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 1.2 tmt_? -152.2 120.2 6.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.826 0.85 . . . . 0.0 109.076 -165.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.48 131.69 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.247 0.619 . . . . 0.0 110.376 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 127.54 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.184 0.994 . . . . 0.0 108.684 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.63 21.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 m-20 -62.42 136.98 58.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.259 1.424 . . . . 0.0 110.06 171.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.49 138.16 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 118.37 0.532 . . . . 0.0 110.996 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.32 135.98 46.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.768 1.227 . . . . 0.0 109.527 -170.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 37' ' ' TYR . 67.5 mttm -98.04 136.47 38.26 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.299 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.76 177.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 139.71 15.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.47 156.8 22.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.586 0.754 . . . . 0.0 109.681 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 m -64.88 135.85 56.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.727 0.811 . . . . 0.0 111.424 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.05 118.07 17.59 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 19.4 tp -93.11 127.22 38.57 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.5 p -72.74 146.85 88.63 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.487 0.715 . . . . 0.0 110.84 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -43.34 -48.21 8.42 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 125.085 3.857 . . . . 0.0 116.517 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -67.94 -41.63 82.21 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.516 0.598 . . . . 0.0 111.263 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.81 -28.17 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.793 0.437 . . . . 0.0 111.16 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.72 70.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.728 0.811 . . . . 0.0 110.644 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.91 -15.14 61.14 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.605 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.01 -40.61 15.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.639 0.776 . . . . 0.0 110.909 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.01 154.59 17.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.072 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -96.23 126.9 42.36 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.554 0.742 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.89 140.22 22.86 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.292 1.995 . . . . 0.0 111.098 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -83.63 -20.13 34.21 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -158.33 175.04 14.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -140.23 121.72 15.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.7 0.8 . . . . 0.0 109.558 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 59' ' ' ARG . 29.2 pt -95.34 165.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.051 0.941 . . . . 0.0 110.64 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.77 133.97 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 123.23 0.612 . . . . 0.0 110.445 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 pt -122.26 157.25 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.166 0.987 . . . . 0.0 108.351 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -149.45 150.5 32.46 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.82 154.0 6.79 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 32.1 ptt-85 -97.06 3.08 52.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.962 0.505 . . . . 0.0 111.152 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -106.94 76.22 1.09 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.807 0.843 . . . . 0.0 108.746 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -169.81 163.75 9.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.17 0.988 . . . . 0.0 110.173 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.95 175.25 6.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.266 1.026 . . . . 0.0 108.422 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.413 ' HA ' ' CH2' ' A' ' 82' ' ' TRP . 7.3 tp -60.07 -44.35 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 118.145 0.429 . . . . 0.0 110.515 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.7 -40.71 65.34 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.107 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -75.12 -25.4 58.43 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.606 0.762 . . . . 0.0 112.179 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -72.73 -43.43 62.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 56' ' ' VAL . 94.8 t -64.38 -33.16 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -67.9 -40.91 83.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.435 0.694 . . . . 0.0 111.279 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.21 -36.69 61.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.122 0.569 . . . . 0.0 111.324 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 53' ' ' VAL . 4.1 p -80.36 -28.65 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.673 0.389 . . . . 0.0 110.307 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.0 p -70.22 -41.16 73.97 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -56.07 -47.87 77.15 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.435 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.3 tpt180 -63.53 -41.1 98.48 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.738 0.649 . . . . 0.0 110.782 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.63 -34.8 76.31 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.188 0.518 . . . . 0.0 111.186 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -70.92 -33.67 70.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.746 0.818 . . . . 0.0 110.574 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -77.55 -18.53 56.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 110.619 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 36.2 mm-40 -80.66 -25.46 38.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.804 170.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.64 3.74 59.47 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.533 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.11 139.92 57.54 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.976 0.91 . . . . 0.0 111.315 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 91' ' ' ALA . . . -68.67 -38.81 80.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 110.409 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 42.0 m -143.45 174.3 10.87 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.883 -175.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -151.22 164.17 37.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -146.26 124.37 12.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.141 0.576 . . . . 0.0 109.465 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.87 117.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.781 0.676 . . . . 0.0 109.211 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.1 -31.7 4.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.233 0.613 . . . . 0.0 110.618 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.05 139.47 21.43 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.072 0.463 . . . . 0.0 110.931 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.9 p -131.15 111.09 11.64 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 168.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -144.81 135.91 25.01 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.285 0.634 . . . . 0.0 109.427 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.3 pt-20 -88.14 157.58 18.79 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.801 0.81 . . . . 0.0 112.096 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' A' ' 81' ' ' ASN . 74.1 m-85 -140.3 -174.51 3.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.711 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 59.53 -95.9 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 O-C-N 123.72 0.638 . . . . 0.0 111.806 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -173.22 127.01 0.44 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.232 1.013 . . . . 0.0 109.365 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 m 64.89 85.78 0.14 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 112.953 169.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 83.54 4.77 89.0 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 165.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 52.5 t30 -77.49 63.05 2.57 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.81 1.305 . . . . 0.0 110.245 174.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.5 p-90 -87.62 111.59 21.41 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.002 0.906 . . . . 0.0 111.419 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.56 114.25 6.05 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.848 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' A' ' 52' ' ' ALA . 34.4 t -102.94 106.76 20.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.49 133.56 55.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.57 136.2 35.77 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.429 0.692 . . . . 0.0 110.81 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.61 144.59 41.69 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.253 0.621 . . . . 0.0 109.64 170.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.62 128.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -109.03 137.5 46.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 109.881 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 91' ' ' ALA . 1.5 tmmm? -89.4 149.58 22.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.048 0.939 . . . . 0.0 108.892 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.384 0.673 . . . . 0.0 110.888 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.63 -167.79 1.98 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.398 0.679 . . . . 0.0 110.728 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.446 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -63.45 130.91 46.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.986 0.514 . . . . 0.0 110.419 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 149.97 25.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.717 0.807 . . . . 0.0 110.963 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.05 122.1 15.24 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 34' ' ' LEU . 17.1 tp -92.56 124.32 36.5 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.7 p -69.83 146.9 95.92 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.598 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.48 -33.27 4.18 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 124.493 3.462 . . . . 0.0 115.088 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.45 -48.28 64.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.621 0.768 . . . . 0.0 111.276 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -71.27 -36.39 71.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.148 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.9 61.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.243 1.017 . . . . 0.0 111.744 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.27 81.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.332 0.653 . . . . 0.0 110.793 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 -39.57 30.93 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.359 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 HD11 HD23 ' A' ' 26' ' ' LEU . 93.4 mt -85.11 169.35 13.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.074 0.549 . . . . 0.0 111.297 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -130.85 134.54 26.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.097 0.959 . . . . 0.0 109.442 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.63 147.48 22.19 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.452 2.101 . . . . 0.0 111.955 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -96.35 -16.8 21.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.231 0.612 . . . . 0.0 110.372 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -158.56 174.47 15.02 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.487 1.115 . . . . 0.0 108.625 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -145.08 121.63 11.07 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.514 HD13 HG13 ' A' ' 56' ' ' VAL . 23.6 pt -90.22 150.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 175.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' HD3' ' A' ' 83' ' ' ARG . 5.3 p -145.81 117.78 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.49 0.716 . . . . 0.0 109.647 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.6 pt -127.69 154.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.546 0.738 . . . . 0.0 110.678 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 p -118.67 111.37 18.44 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.774 1.23 . . . . 0.0 108.859 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.33 101.8 2.38 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.16 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.52 98.28 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.255 0.622 . . . . 0.0 109.816 177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 66.13 92.28 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.668 1.187 . . . . 0.0 111.788 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -164.49 164.92 21.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 0.0 110.938 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.71 168.79 12.2 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.801 0.84 . . . . 0.0 110.522 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.413 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.8 tp -61.51 -34.14 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.925 0.49 . . . . 0.0 111.079 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.18 -37.04 93.86 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.12 0.263 . . . . 0.0 113.232 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.07 -44.5 65.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.74 0.816 . . . . 0.0 110.504 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB1' HG23 ' A' ' 84' ' ' VAL . . . -58.72 -53.14 61.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.772 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.14 -32.9 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.661 1.184 . . . . 0.0 111.296 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.1 t -65.16 -42.28 93.9 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.207 0.603 . . . . 0.0 110.583 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG13 HD13 ' A' ' 40' ' ' ILE . 76.7 t -68.22 -40.73 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.109 0.964 . . . . 0.0 110.995 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -69.45 -46.88 65.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.403 0.681 . . . . 0.0 110.938 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -61.73 -50.35 72.78 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.152 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 2.7 tpp180 -64.72 -42.83 94.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.806 0.691 . . . . 0.0 111.182 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.35 82.0 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.607 0.567 . . . . 0.0 110.376 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 23' ' ' ALA . 18.7 t70 -64.93 -34.16 77.75 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.782 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.69 -30.46 69.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.257 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 3.3 mm-40 -76.35 -16.97 59.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.928 0.491 . . . . 0.0 110.562 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.08 20.38 14.14 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.53 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.9 151.2 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.572 0.749 . . . . 0.0 111.508 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' A' ' 90' ' ' LYS . . . -89.23 -29.14 19.47 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.606 1.162 . . . . 0.0 110.527 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 73.3 m -147.7 165.76 29.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.931 0.893 . . . . 0.0 110.74 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -127.88 178.05 6.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.2 1.0 . . . . 0.0 109.178 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.57 99.6 1.59 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.08 101.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.32 -34.17 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.183 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.12 146.38 27.66 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.305 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.7 m -143.02 118.4 10.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.5 m -130.7 124.25 31.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.852 0.861 . . . . 0.0 109.447 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.564 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 40.9 tt0 -95.58 157.24 15.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.426 0.691 . . . . 0.0 111.047 -176.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.62 -29.39 69.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.294 1.037 . . . . 0.0 110.739 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.564 ' H ' ' HG2' ' A' ' 75' ' ' GLU . . . 85.72 -55.2 4.84 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 123.196 0.427 . . . . 0.0 112.167 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -70.4 -13.08 61.99 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.306 1.043 . . . . 0.0 110.734 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 t -146.55 167.94 22.46 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.717 0.807 . . . . 0.0 110.253 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.19 13.23 40.23 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.766 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -75.32 102.19 4.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.6 p-90 -113.56 123.52 50.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.126 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.526 ' HD3' HG23 ' A' ' 41' ' ' VAL . 5.6 tmm_? -86.8 115.91 24.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.555 1.142 . . . . 0.0 109.111 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' HB1' ' A' ' 52' ' ' ALA . 46.9 t -104.18 113.85 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.02 137.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.69 127.82 17.59 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 110.851 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.91 137.0 45.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.147 0.579 . . . . 0.0 109.533 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -114.37 132.71 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.469 0.652 . . . . 0.0 110.722 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.53 120.01 35.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.985 1.314 . . . . 0.0 107.9 -171.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HA ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -85.44 169.72 13.38 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.242 0.474 . . . . 0.0 109.798 175.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.489 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.9 m80 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.821 0.343 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 176.57 113.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.667 1.587 . . . . 0.0 107.275 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 138.9 57.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.863 0.465 . . . . 0.0 110.747 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 m -61.82 124.27 20.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.16 0.984 . . . . 0.0 111.411 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -66.03 116.61 7.33 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD22 HD12 ' A' ' 34' ' ' LEU . 15.8 tp -105.67 121.82 44.78 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.9 p -65.81 151.83 94.24 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.58 0.752 . . . . 0.0 110.771 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.47 -31.54 39.41 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.505 2.803 . . . . 0.0 113.099 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.93 -53.27 52.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.986 0.914 . . . . 0.0 110.799 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -75.79 -25.34 56.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.602 0.761 . . . . 0.0 111.421 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.09 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.119 0.968 . . . . 0.0 110.341 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.46 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.6 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.1 -7.27 55.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.526 0.73 . . . . 0.0 112.431 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD12 HD22 ' A' ' 26' ' ' LEU . 96.2 mt -125.03 163.47 22.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.723 0.809 . . . . 0.0 110.477 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.9 117.07 51.04 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.001 0.921 . . . . 0.0 108.838 175.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 151.39 46.41 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.539 2.159 . . . . 0.0 111.849 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -96.78 -29.55 13.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.004 0.522 . . . . 0.0 111.471 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -147.76 178.49 8.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.689 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.639 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 66.4 mtt180 -131.36 146.63 52.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 109.204 169.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.03 142.63 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.63 0.772 . . . . 0.0 108.965 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.34 119.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.73 160.04 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 m -148.52 126.23 11.82 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 153.59 24.94 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.709 -0.281 . . . . 0.0 112.88 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 81' ' ' ASN . 3.6 mpt_? -87.28 135.55 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.76 0.824 . . . . 0.0 109.934 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.4 t80 65.01 24.99 12.65 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.8 1.24 . . . . 0.0 111.931 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.427 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 13.1 m120 -70.07 136.39 50.22 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.891 -0.506 . . . . 0.0 109.945 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 170.56 15.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' O ' HG21 ' A' ' 53' ' ' VAL . 6.5 tp -61.59 -50.45 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.39 69.55 Favored Glycine 0 C--N 1.348 1.223 0 O-C-N 123.272 0.357 . . . . 0.0 113.151 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.9 -36.27 77.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 110.388 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 84' ' ' VAL . . . -74.25 -34.76 63.72 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.624 0.77 . . . . 0.0 110.67 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 49' ' ' ILE . 70.1 t -66.96 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.781 0.433 . . . . 0.0 110.203 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -65.4 -36.6 84.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.28 0.632 . . . . 0.0 110.522 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.83 -48.67 65.56 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.99 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.6 p -77.45 -27.81 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.226 0.61 . . . . 0.0 111.962 -174.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.8 p -69.66 -48.09 61.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.613 0.365 . . . . 0.0 110.188 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.502 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 42.6 ttt-85 -63.83 -46.98 82.62 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 176.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.8 tpp180 -54.06 -49.17 69.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.973 0.909 . . . . 0.0 111.066 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.83 -43.99 86.18 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.869 0.731 . . . . 0.0 110.516 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.55 -34.63 78.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.632 0.773 . . . . 0.0 110.723 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 10.0 mm-40 -70.19 -29.98 66.99 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.17 0.588 . . . . 0.0 110.538 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 14.7 mm-40 -77.89 -9.77 59.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.835 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.74 10.5 61.54 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 113.101 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.93 143.25 37.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.786 0.834 . . . . 0.0 110.755 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.22 -36.82 17.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.669 0.788 . . . . 0.0 111.099 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.583 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.0 m -140.12 170.92 14.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 110.298 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -154.81 162.66 41.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.241 0.616 . . . . 0.0 109.74 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -147.18 117.89 7.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.595 0.758 . . . . 0.0 109.894 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.84 114.08 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 110.135 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.75 -25.55 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.952 0.501 . . . . 0.0 111.146 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -158.29 145.48 17.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.188 0.518 . . . . 0.0 111.328 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.1 p -134.96 106.8 7.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.21 1.404 . . . . 0.0 108.362 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 46.9 m -105.02 130.75 53.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.6 145.87 24.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.204 0.601 . . . . 0.0 111.299 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -103.3 -33.75 9.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.438 1.095 . . . . 0.0 109.195 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.21 -64.8 0.3 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.991 173.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.81 128.54 37.17 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.905 0.882 . . . . 0.0 111.165 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m 65.14 17.16 10.93 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.29 1.036 . . . . 0.0 112.162 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.61 28.61 72.78 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.471 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 11.3 t30 -80.9 140.98 35.02 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.427 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 1.5 p-90 -161.59 158.11 25.75 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.17 0.988 . . . . 0.0 110.136 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -108.65 153.24 23.7 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.01 0.924 . . . . 0.0 110.085 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.481 HG23 ' HB2' ' A' ' 52' ' ' ALA . 83.6 t -136.83 111.98 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.335 1.054 . . . . 0.0 108.258 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.8 134.82 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.78 126.21 18.81 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.211 1.004 . . . . 0.0 109.167 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.639 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 2.5 p30 -76.92 144.17 39.05 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.44 142.17 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.909 0.883 . . . . 0.0 110.255 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 64.3 m-85 -124.86 161.18 27.12 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.438 1.095 . . . . 0.0 110.802 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -92.23 165.06 13.31 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.704 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.491 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 m80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.611 0.243 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.31 117.53 1.89 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.17 0.988 . . . . 0.0 109.109 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 137.4 47.78 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.023 0.529 . . . . 0.0 110.722 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -68.98 139.93 55.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.412 0.685 . . . . 0.0 110.436 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.53 129.38 34.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.48 HD23 HD12 ' A' ' 34' ' ' LEU . 13.9 tp -90.58 140.16 30.01 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -174.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 p -68.8 147.63 97.91 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.67 -10.6 12.02 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.641 2.228 . . . . 0.0 113.844 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -82.22 -52.95 6.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.308 0.643 . . . . 0.0 110.236 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.428 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 53.0 mt-30 -62.36 -46.0 90.61 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.877 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.85 -36.93 84.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 112.083 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.37 64.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.126 0.57 . . . . 0.0 111.633 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.29 -29.3 12.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.625 0.77 . . . . 0.0 112.151 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.48 HD12 HD23 ' A' ' 26' ' ' LEU . 95.9 mt -98.24 150.74 21.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -96.03 127.83 39.38 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.99 0.916 . . . . 0.0 109.077 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.4 157.46 32.91 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 111.069 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 37.3 p90 -90.35 -32.54 16.43 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.924 0.392 . . . . 0.0 110.567 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.8 -174.95 4.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.03 0.932 . . . . 0.0 110.22 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -149.37 128.9 13.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.11 0.964 . . . . 0.0 108.703 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -109.31 148.28 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 110.972 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.76 121.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.096 0.958 . . . . 0.0 108.446 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 pt -113.95 154.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.053 0.941 . . . . 0.0 109.439 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 83' ' ' ARG . 21.1 p -113.17 153.35 28.43 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.372 0.669 . . . . 0.0 110.167 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.37 97.02 0.15 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-N 116.856 -0.157 . . . . 0.0 112.881 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -96.98 46.39 1.04 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.546 1.165 . . . . 0.0 109.636 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -177.11 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.776 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -56.03 127.03 28.53 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.885 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 -175.78 5.99 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.237 168.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.15 -34.56 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 118.201 0.455 . . . . 0.0 110.49 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.38 -45.87 66.69 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.257 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.26 -31.35 71.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.685 0.794 . . . . 0.0 110.979 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -70.52 -46.15 64.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.992 0.917 . . . . 0.0 109.686 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 55.0 t -64.35 -32.58 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.745 0.653 . . . . 0.0 110.728 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -69.88 -42.7 73.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.216 0.606 . . . . 0.0 110.723 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.35 75.83 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.213 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 53' ' ' VAL . 11.9 p -80.19 -27.97 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 122.701 0.4 . . . . 0.0 110.844 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -63.32 -47.53 81.85 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 28.3 tpt180 -64.54 -56.29 14.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 13.7 tpp180 -57.56 -46.18 84.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.793 0.837 . . . . 0.0 111.25 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.45 81.32 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.63 0.582 . . . . 0.0 110.962 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.76 -39.06 92.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.319 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.1 mm-40 -70.96 -25.57 62.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.939 0.496 . . . . 0.0 110.901 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 12.6 mm-40 -76.87 -11.47 59.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.299 0.639 . . . . 0.0 111.258 173.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.01 29.04 19.1 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.519 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.28 132.03 42.18 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.784 0.834 . . . . 0.0 110.3 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.49 82.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.637 0.775 . . . . 0.0 109.88 173.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . 10.2 t -139.74 172.38 12.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.277 -173.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -148.71 171.11 16.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -152.24 118.62 5.61 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.67 102.9 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 123.77 0.669 . . . . 0.0 109.415 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.17 -31.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.841 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.8 t70 -153.26 148.34 26.72 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.368 -171.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.421 HG23 HG21 ' A' ' 84' ' ' VAL . 12.8 p -142.28 112.84 7.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.458 1.503 . . . . 0.0 107.044 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.423 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . 62.0 m -142.85 147.23 35.06 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.569 0.347 . . . . 0.0 111.031 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 4.5 mm-40 -61.46 136.0 57.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.677 1.191 . . . . 0.0 110.929 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -95.65 27.97 3.22 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.523 0.729 . . . . 0.0 110.362 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.88 3.0 0.7 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.045 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 60.25 82.17 0.16 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.705 1.202 . . . . 0.0 111.37 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.9 t -168.92 21.01 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.833 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.12 23.04 78.57 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -171.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -105.44 25.9 10.12 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.804 1.242 . . . . 0.0 110.158 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.6 p-90 -60.92 133.42 56.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.325 1.05 . . . . 0.0 111.665 -173.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' HB3' HG23 ' A' ' 43' ' ' THR . 3.5 ppt_? -105.07 155.24 19.18 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.167 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.58 HG22 ' HB1' ' A' ' 52' ' ' ALA . 86.4 t -116.14 123.54 71.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.053 0.941 . . . . 0.0 109.898 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 28.3 t -101.07 124.07 54.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.95 126.47 15.92 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.941 0.496 . . . . 0.0 111.299 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.632 0.773 . . . . 0.0 110.23 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.25 135.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.136 0.493 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.403 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 51.9 m-85 -115.39 129.1 56.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.6 1.16 . . . . 0.0 110.306 -170.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' HZ3' ' HB3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -94.62 138.33 32.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.67 1.188 . . . . 0.0 108.878 179.039 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.06 147.77 9.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.246 1.018 . . . . 0.0 109.132 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.34 142.31 48.79 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -81.04 144.12 31.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.709 0.804 . . . . 0.0 110.419 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.11 130.96 44.52 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.2 tp -111.65 122.72 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.5 p -67.89 148.96 98.41 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.706 0.803 . . . . 0.0 111.083 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -41.06 -43.21 4.9 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 124.84 3.694 . . . . 0.0 115.601 -177.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.72 -39.77 66.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.061 0.544 . . . . 0.0 111.221 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.2 -25.02 60.6 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.251 0.62 . . . . 0.0 111.025 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.04 -31.8 56.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.276 1.03 . . . . 0.0 110.631 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.53 -23.32 56.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.919 0.888 . . . . 0.0 110.381 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.24 -47.09 16.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.753 0.821 . . . . 0.0 111.243 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -91.59 145.89 24.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.005 0.522 . . . . 0.0 110.613 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -95.39 118.98 66.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.53 0.732 . . . . 0.0 109.248 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.15 153.22 31.79 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.309 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -94.08 -14.91 25.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.148 0.579 . . . . 0.0 111.701 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -166.83 164.73 16.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.318 0.647 . . . . 0.0 110.164 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 129.21 54.74 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.702 1.201 . . . . 0.0 108.777 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 HG11 ' A' ' 56' ' ' VAL . 31.7 pt -95.72 156.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.485 0.714 . . . . 0.0 110.664 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.0 t -129.58 121.42 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 109.21 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.6 166.15 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 p -123.91 114.77 20.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.094 0.558 . . . . 0.0 110.982 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.28 1.05 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 60.7 mtp180 -92.73 94.66 9.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.177 0.591 . . . . 0.0 110.45 -174.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 59.37 41.6 19.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.479 1.111 . . . . 0.0 109.841 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 14.8 m120 -115.38 166.78 11.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.528 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.44 168.53 16.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.859 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.9 tp -63.08 -32.83 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.11 79.61 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.447 0.467 . . . . 0.0 113.083 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.496 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 33.9 m-20 -75.05 -35.53 61.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.631 0.772 . . . . 0.0 110.531 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.94 70.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.934 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.34 -33.01 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.324 1.05 . . . . 0.0 110.759 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 t -63.68 -51.85 63.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.765 0.826 . . . . 0.0 110.832 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.81 95.3 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.264 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.522 HG11 HD12 ' A' ' 40' ' ' ILE . 48.4 t -66.16 -40.11 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.924 0.89 . . . . 0.0 111.725 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -63.62 -43.35 97.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.311 0.645 . . . . 0.0 110.742 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 32.0 ttt180 -65.3 -54.34 30.51 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.969 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 27.4 tpt180 -61.9 -38.13 87.21 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.063 0.852 . . . . 0.0 111.469 -169.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.36 90.39 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.643 0.777 . . . . 0.0 110.619 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.44 -31.61 72.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.685 0.794 . . . . 0.0 110.881 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 4.8 mm-40 -67.04 -33.29 75.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.193 0.597 . . . . 0.0 110.357 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.9 mm-40 -79.74 -12.96 59.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.287 0.635 . . . . 0.0 111.125 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.12 28.05 14.45 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.218 0.324 . . . . 0.0 112.622 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.82 142.16 27.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 0.0 110.705 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.98 -27.72 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.819 0.847 . . . . 0.0 110.253 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 50.4 m -142.88 167.75 21.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.91 0.884 . . . . 0.0 111.137 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 161.8 39.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 109.629 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -155.48 125.11 6.42 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.971 0.508 . . . . 0.0 109.822 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.33 112.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 -41.67 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.456 0.703 . . . . 0.0 110.088 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.0 t70 -131.53 141.0 49.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.728 0.411 . . . . 0.0 110.66 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.0 p -135.41 106.14 6.54 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -121.88 111.09 16.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.904 0.482 . . . . 0.0 109.86 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 10.9 pt-20 -70.66 158.01 36.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.962 0.505 . . . . 0.0 111.414 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -59.34 -41.33 88.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.295 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.69 90.75 0.09 OUTLIER Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.65 -19.82 0.36 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 125.451 1.5 . . . . 0.0 113.028 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.3 p -77.92 156.68 30.14 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.174 0.99 . . . . 0.0 111.13 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.37 -7.82 83.0 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.745 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 5.2 p-10 -89.79 122.49 32.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.761 0.781 . . . . 0.0 109.462 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.6 p-90 -134.24 136.47 43.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.195 0.998 . . . . 0.0 111.688 -175.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -65.07 136.49 56.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.597 1.159 . . . . 0.0 110.198 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.89 106.65 18.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 59.8 t -96.68 124.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.015 0.926 . . . . 0.0 108.968 174.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.55 125.53 22.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.173 0.589 . . . . 0.0 110.952 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.87 144.28 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.704 0.802 . . . . 0.0 109.518 173.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -115.81 134.39 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.297 0.639 . . . . 0.0 110.196 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 68.5 m-85 -124.17 151.11 44.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.757 0.823 . . . . 0.0 110.54 -166.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.23 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.586 0.755 . . . . 0.0 110.755 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.819 0.848 . . . . 0.0 109.338 175.666 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 138.21 51.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.398 0.279 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.1 m -78.66 138.82 38.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.343 0.657 . . . . 0.0 110.537 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.08 118.12 11.58 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.0 tp -99.18 129.88 45.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.9 p -71.51 154.03 93.49 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.484 0.714 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.27 -18.35 51.83 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.831 2.354 . . . . 0.0 113.498 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.42 -53.63 11.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.211 0.605 . . . . 0.0 109.991 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.19 -33.73 74.96 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.272 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.35 80.8 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.827 0.851 . . . . 0.0 110.772 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.48 -23.29 64.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.244 0.618 . . . . 0.0 111.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.42 3.99 54.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.386 0.674 . . . . 0.0 112.13 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.438 HD12 HD21 ' A' ' 26' ' ' LEU . 93.0 mt -130.2 152.24 49.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.623 0.769 . . . . 0.0 110.245 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -108.18 125.01 32.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 58.1 Cg_endo -68.86 138.99 42.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.234 1.956 . . . . 0.0 111.555 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -79.31 -24.38 42.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.231 0.538 . . . . 0.0 110.459 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -156.24 172.47 18.41 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.592 1.157 . . . . 0.0 108.545 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -143.47 119.87 10.95 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HG13 ' A' ' 56' ' ' VAL . 36.5 pt -94.71 138.15 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 122.777 0.431 . . . . 0.0 110.371 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 85' ' ' VAL . 38.5 t -121.62 131.99 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 pt -123.54 166.13 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.041 0.936 . . . . 0.0 108.948 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -116.5 145.11 43.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 171.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.1 108.78 0.47 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -80.7 79.06 7.41 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.2 t80 44.07 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.478 1.511 . . . . 0.0 113.675 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -122.44 -65.3 1.12 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.08 148.96 5.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 108.824 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.95 -39.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.07 77.47 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.434 0.459 . . . . 0.0 113.148 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.76 -44.51 77.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.828 0.851 . . . . 0.0 109.444 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -67.2 -44.78 78.73 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.042 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.48 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.795 0.838 . . . . 0.0 111.016 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 t -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.94 0.496 . . . . 0.0 110.217 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.88 69.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.952 0.501 . . . . 0.0 110.977 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 40' ' ' ILE . 97.6 t -70.38 -37.49 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.293 0.637 . . . . 0.0 109.926 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.4 t -64.89 -41.86 95.27 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.769 0.827 . . . . 0.0 110.684 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.34 -59.45 4.35 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.159 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 15.6 tpp180 -63.89 -38.33 90.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.67 0.788 . . . . 0.0 111.837 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.35 98.31 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.04 0.448 . . . . 0.0 110.537 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.19 -36.7 85.01 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.774 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.81 -20.6 61.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.256 0.622 . . . . 0.0 111.279 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 34.4 mm-40 -90.97 -4.62 56.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.991 0.516 . . . . 0.0 111.383 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.13 7.93 76.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.067 0.23 . . . . 0.0 113.672 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 137.66 47.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.559 0.743 . . . . 0.0 110.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -71.0 -40.92 71.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.804 0.841 . . . . 0.0 110.525 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 32.7 m -137.32 172.6 12.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.959 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -143.09 165.05 28.45 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.127 0.971 . . . . 0.0 109.365 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.66 112.19 6.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.042 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.34 113.28 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 86' ' ' ALA . 61.7 t -82.67 -48.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -164.6 143.56 7.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.79 -168.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 84' ' ' VAL . 68.8 p -120.84 104.82 10.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 p -129.12 144.88 51.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.329 0.652 . . . . 0.0 111.23 -171.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 27.8 mt-10 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.071 0.948 . . . . 0.0 110.369 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 6.1 p-10 . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 29.6 p-90 -95.83 172.91 7.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.722 172.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' NH1' ' HB ' ' A' ' 85' ' ' VAL . 2.7 ppt_? -142.56 154.76 44.74 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.319 1.048 . . . . 0.0 108.624 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 73' ' ' THR . 57.5 t -119.22 111.76 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 0.0 109.363 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 41' ' ' VAL . 7.3 p -90.34 128.82 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' A' ' 71' ' ' VAL . . . -145.6 131.85 19.5 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.218 0.607 . . . . 0.0 111.167 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 68.7 m-20 -70.12 158.03 36.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 110.6 173.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.9 139.32 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.462 0.705 . . . . 0.0 109.431 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -127.82 136.52 51.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.939 0.896 . . . . 0.0 110.194 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -80.76 167.66 19.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.667 0.787 . . . . 0.0 111.585 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.275 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.83 145.71 42.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.637 0.375 . . . . 0.0 110.328 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.6 m -69.96 140.09 52.94 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.29 0.636 . . . . 0.0 111.107 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.64 126.46 30.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 34' ' ' LEU . 12.7 tp -98.93 126.06 44.52 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 p -74.03 143.61 80.99 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.985 0.514 . . . . 0.0 109.996 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.82 -34.84 6.29 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.551 3.5 . . . . 0.0 115.667 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -69.62 -44.22 71.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.576 0.751 . . . . 0.0 110.695 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -68.9 -39.19 79.87 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.141 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.06 63.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.198 0.999 . . . . 0.0 112.099 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.45 77.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.163 0.585 . . . . 0.0 110.164 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.12 36.83 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.534 HD12 HD21 ' A' ' 26' ' ' LEU . 90.2 mt -89.02 157.4 18.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.333 0.653 . . . . 0.0 111.269 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -110.44 128.6 25.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.25 159.69 48.99 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.201 1.934 . . . . 0.0 111.532 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -96.52 -14.73 22.09 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -158.86 154.84 26.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.979 0.912 . . . . 0.0 109.951 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 86.3 mtm180 -124.49 127.14 47.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.553 1.141 . . . . 0.0 108.764 171.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 56' ' ' VAL . 32.1 pt -103.5 161.7 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.04 0.936 . . . . 0.0 110.63 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.54 129.67 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.984 0.914 . . . . 0.0 109.825 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.66 166.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.407 1.083 . . . . 0.0 108.76 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 29.4 m -149.82 130.47 14.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.38 133.42 6.96 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 23.9 ttm-85 -100.6 123.66 45.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.183 0.593 . . . . 0.0 110.003 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 63.16 11.74 5.51 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.939 1.296 . . . . 0.0 113.049 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 13.8 m120 -79.79 148.94 31.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.371 0.668 . . . . 0.0 110.287 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.64 168.23 17.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.299 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.1 tp -57.5 -31.9 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.541 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.12 93.59 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.758 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 12.7 m-20 -67.19 -37.51 83.81 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.624 0.77 . . . . 0.0 110.789 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.93 -53.4 47.09 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.913 0.758 . . . . 0.0 110.71 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.46 -36.21 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 0.0 110.853 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 t -64.86 -42.85 94.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.918 0.887 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.44 -37.39 65.86 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.52 0.728 . . . . 0.0 111.451 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 40' ' ' ILE . 76.6 t -65.19 -45.36 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.132 0.573 . . . . 0.0 110.485 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -68.73 -32.28 71.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.821 0.848 . . . . 0.0 110.744 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -65.79 -55.04 19.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.515 0.726 . . . . 0.0 109.8 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -62.28 -44.67 95.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.994 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.47 -49.13 78.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.751 0.82 . . . . 0.0 111.182 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.64 -38.66 91.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.404 0.682 . . . . 0.0 111.088 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -76.16 -21.04 57.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.151 0.581 . . . . 0.0 112.202 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -76.82 -22.59 53.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.992 0.517 . . . . 0.0 110.277 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.02 11.41 60.15 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.902 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.9 129.16 38.82 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.661 0.784 . . . . 0.0 110.141 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.65 84.67 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 123.874 0.734 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 26' ' ' LEU . 13.8 t -141.4 174.99 10.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.019 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.78 163.94 35.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.299 1.04 . . . . 0.0 108.86 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -151.49 118.4 5.83 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -71.24 114.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.28 -23.35 5.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -163.53 129.61 3.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.981 0.419 . . . . 0.0 111.18 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 p -111.33 141.59 44.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 165.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 23.0 t -159.19 139.88 12.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.101 0.56 . . . . 0.0 110.663 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 56.6 t30 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -150.22 131.0 14.12 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.368 0.604 . . . . 0.0 111.287 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HD2' ' HB3' ' A' ' 74' ' ' SER . 0.0 OUTLIER -91.66 156.37 17.65 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 110.171 178.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' A' ' 52' ' ' ALA . 61.0 t -139.7 116.58 9.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 124.14 0.976 . . . . 0.0 108.431 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 132.45 40.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.43 138.07 29.06 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.113 0.965 . . . . 0.0 109.048 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.597 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -101.79 141.76 34.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.637 0.775 . . . . 0.0 109.353 176.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.02 142.6 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.038 0.935 . . . . 0.0 110.045 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -124.52 155.94 38.15 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.338 1.055 . . . . 0.0 111.746 -165.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -110.57 145.46 37.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.494 1.118 . . . . 0.0 108.94 169.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.585 0.754 . . . . 0.0 108.983 -178.079 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.71 129.37 39.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -66.17 135.39 54.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.435 0.694 . . . . 0.0 110.663 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.98 115.83 11.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -89.7 134.6 34.08 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.4 p -68.25 142.49 94.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.778 0.674 . . . . 0.0 109.943 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.47 -34.13 7.27 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 124.08 3.187 . . . . 0.0 113.881 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.28 -57.57 9.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 0.0 110.879 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.7 -33.93 77.11 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.82 -24.98 61.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.082 0.953 . . . . 0.0 112.092 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 -18.31 49.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.982 0.513 . . . . 0.0 111.407 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.89 -39.57 8.92 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.346 0.659 . . . . 0.0 111.0 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.33 142.0 28.22 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.985 0.914 . . . . 0.0 109.35 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -103.08 128.78 26.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.75 161.13 30.79 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.887 2.391 . . . . 0.0 112.138 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -98.41 -21.06 16.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.868 0.467 . . . . 0.0 110.502 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -155.83 161.28 40.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.048 0.939 . . . . 0.0 109.558 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.6 mtm180 -123.09 119.03 29.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 56' ' ' VAL . 43.2 pt -90.98 131.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.59 120.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -118.93 179.4 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.158 0.983 . . . . 0.0 109.119 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 23.7 p -119.06 119.47 34.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.648 0.779 . . . . 0.0 109.539 169.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.65 135.06 12.61 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -97.51 171.36 8.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 117.967 0.883 . . . . 0.0 111.122 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.35 3.38 3.77 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 0.0 112.297 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -52.23 -51.56 57.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.399 1.08 . . . . 0.0 111.578 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.48 164.17 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.742 0.817 . . . . 0.0 110.981 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.96 -43.01 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.08 -16.02 70.3 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.671 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.08 -51.99 61.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.965 0.906 . . . . 0.0 109.651 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -68.91 -46.98 66.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.075 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.19 -35.53 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.761 0.825 . . . . 0.0 111.582 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 t -64.23 -44.57 91.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.568 0.747 . . . . 0.0 110.504 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.78 66.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.054 0.542 . . . . 0.0 111.71 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG13 HD11 ' A' ' 40' ' ' ILE . 49.8 t -72.17 -45.94 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.912 0.485 . . . . 0.0 109.717 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -63.35 -45.32 91.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.064 0.946 . . . . 0.0 110.945 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 31.7 mmt180 -72.3 -37.01 69.08 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.994 0.809 . . . . 0.0 111.427 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 tpt180 -66.7 -48.92 67.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.15 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -34.42 76.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.053 0.941 . . . . 0.0 110.905 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.3 -39.13 92.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.79 0.836 . . . . 0.0 110.806 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 51.5 mt-10 -64.74 -34.68 78.9 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.359 0.663 . . . . 0.0 110.925 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.0 mm-40 -78.64 -8.11 58.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.517 0.727 . . . . 0.0 111.374 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.92 17.45 79.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.269 0.356 . . . . 0.0 112.996 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . . . -73.62 128.52 35.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.978 0.911 . . . . 0.0 109.996 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.26 69.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.67 0.788 . . . . 0.0 111.506 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 56.5 m -144.99 171.21 14.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.379 0.672 . . . . 0.0 111.482 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.7 166.62 28.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.447 1.099 . . . . 0.0 108.698 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -155.29 129.12 8.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -77.09 113.16 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.86 0.464 . . . . 0.0 110.094 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.73 -25.93 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.279 0.632 . . . . 0.0 111.539 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 19.7 t70 -148.29 138.44 22.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.012 0.525 . . . . 0.0 110.849 -174.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 84' ' ' VAL . 23.4 p -136.53 106.09 6.14 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.571 1.149 . . . . 0.0 108.033 170.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -121.03 138.44 54.17 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.121 0.968 . . . . 0.0 109.416 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 11.8 pt-20 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.984 0.421 . . . . 0.0 110.985 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.1 p-90 -109.25 108.18 18.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 108.992 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -64.78 149.64 48.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.434 0.694 . . . . 0.0 109.197 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.3 t -126.6 114.39 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.537 . . . . 0.0 109.948 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 34.4 t -88.96 124.32 41.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 165.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.69 121.58 14.51 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.426 0.691 . . . . 0.0 109.338 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 46.8 p-10 -81.28 140.41 34.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.733 0.413 . . . . 0.0 110.133 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.18 137.8 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.144 0.978 . . . . 0.0 110.379 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 35.9 m-85 -118.55 139.28 51.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.568 1.147 . . . . 0.0 110.393 -168.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 65' ' ' ALA . 32.7 mmtp -95.36 159.07 15.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 109.839 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.883 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.28 149.14 48.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.58 0.752 . . . . 0.0 111.612 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.7 m -74.02 142.35 45.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.559 0.744 . . . . 0.0 110.545 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.27 118.73 14.43 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.1 tp -85.21 119.25 25.38 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -64.73 141.75 98.38 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.59 -39.4 1.92 Allowed 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 125.044 3.83 . . . . 0.0 116.083 -173.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.93 -40.29 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.281 0.632 . . . . 0.0 110.332 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.94 -38.32 76.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.371 0.669 . . . . 0.0 110.213 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.15 -29.78 70.65 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.335 1.054 . . . . 0.0 111.171 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.91 -29.51 55.74 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.856 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.07 26.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.326 0.651 . . . . 0.0 112.36 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 26' ' ' LEU . 96.9 mt -115.51 143.73 44.89 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.711 0.805 . . . . 0.0 110.171 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -92.7 133.05 29.96 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 0.0 110.137 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.26 153.42 24.4 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 5.7 p90 -99.12 -32.49 11.22 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -143.76 174.73 10.56 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -139.26 125.95 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.477 1.111 . . . . 0.0 108.661 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.58 HD11 HG13 ' A' ' 56' ' ' VAL . 32.7 pt -103.06 152.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.977 0.511 . . . . 0.0 110.427 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.99 133.15 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -116.23 157.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.279 1.032 . . . . 0.0 109.076 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.5 m -134.65 139.46 45.3 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.33 142.96 11.52 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.49 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -68.55 -40.71 80.54 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.225 0.61 . . . . 0.0 110.788 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -166.25 135.84 3.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.34 0.656 . . . . 0.0 109.613 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.6 -116.55 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.0 168.17 19.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 0.0 108.323 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 9.7 tp -63.28 -37.59 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.6 88.3 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.457 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.02 -34.34 77.78 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.743 0.817 . . . . 0.0 111.541 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.21 -46.19 57.18 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.843 0.857 . . . . 0.0 110.259 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.05 -33.68 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.568 0.747 . . . . 0.0 110.598 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -72.66 -35.01 67.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.91 0.884 . . . . 0.0 110.927 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.82 78.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.244 0.617 . . . . 0.0 109.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 40' ' ' ILE . 53.9 t -64.53 -37.05 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.217 1.007 . . . . 0.0 110.852 174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -61.38 -52.73 63.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.888 0.875 . . . . 0.0 110.711 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -69.45 -37.76 77.49 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.79 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 12.5 tpt180 -66.85 -37.35 84.29 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.323 0.649 . . . . 0.0 111.256 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.25 83.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.499 0.72 . . . . 0.0 110.343 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.21 -35.1 73.67 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.481 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 12.6 mm-40 -63.19 -34.49 77.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.741 0.816 . . . . 0.0 110.606 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 37.1 mm-40 -70.63 -29.02 65.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.506 175.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.33 4.28 53.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.071 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 141.77 49.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.693 0.797 . . . . 0.0 110.557 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.21 64.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 110.632 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.1 m -141.14 173.57 11.35 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.719 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.48 173.99 12.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.33 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -160.5 120.24 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 109.944 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.22 113.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.868 0.867 . . . . 0.0 109.67 173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.7 -20.76 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 0.0 111.501 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 22.9 t70 -154.29 145.22 22.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.123 0.569 . . . . 0.0 110.904 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.5 HG22 HG22 ' A' ' 84' ' ' VAL . 26.0 p -137.55 111.49 8.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.915 1.286 . . . . 0.0 107.978 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -118.43 135.19 54.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.227 0.611 . . . . 0.0 109.551 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.114 0.566 . . . . 0.0 110.788 179.4 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 121.251 0.548 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.415 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 1.7 p-90 -157.32 177.45 11.43 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.318 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.73 156.01 44.38 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.333 0.653 . . . . 0.0 109.677 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.603 HG21 ' HB1' ' A' ' 52' ' ' ALA . 98.9 t -130.92 115.83 31.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.009 0.924 . . . . 0.0 109.564 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 56.5 t -92.39 129.89 42.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 108.766 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.57 125.69 13.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.583 0.753 . . . . 0.0 110.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.33 143.02 35.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.01 139.64 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.414 0.686 . . . . 0.0 110.428 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -121.03 139.59 53.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.484 1.113 . . . . 0.0 109.993 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 31.6 mmmt -90.08 165.56 13.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.567 0.747 . . . . 0.0 110.49 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.425 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.38 138.09 33.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.315 1.046 . . . . 0.0 112.48 -169.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -63.37 147.6 50.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.079 0.952 . . . . 0.0 110.817 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.39 122.64 20.71 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -81.92 138.07 35.07 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.7 p -74.47 152.07 87.56 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.303 0.641 . . . . 0.0 109.916 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.96 -23.19 75.57 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.335 2.023 . . . . 0.0 112.683 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.39 -56.24 24.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.074 0.95 . . . . 0.0 110.278 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -76.07 -24.99 55.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.112 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.633 0.773 . . . . 0.0 111.156 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.42 -28.75 26.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.141 0.576 . . . . 0.0 110.187 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.03 3.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.413 0.685 . . . . 0.0 110.849 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.7 148.21 25.54 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.72 0.808 . . . . 0.0 110.193 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.3 143.17 26.24 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.09 144.29 37.49 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.394 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -77.08 -20.56 55.63 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.838 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -159.45 161.97 35.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.524 1.13 . . . . 0.0 108.85 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.0 ttm180 -132.88 120.84 22.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.641 0.777 . . . . 0.0 108.917 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.471 HG21 ' HD2' ' A' ' 59' ' ' ARG . 27.9 pt -91.91 163.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.698 0.799 . . . . 0.0 111.451 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG23 ' NE ' ' A' ' 83' ' ' ARG . 2.2 p -142.22 130.5 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 110.387 -173.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' A' ' 84' ' ' VAL . 41.4 pt -144.89 174.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.696 1.198 . . . . 0.0 109.109 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 p -136.56 125.01 23.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.369 1.068 . . . . 0.0 108.819 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.16 73.43 1.51 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 62.6 ttt180 -68.5 96.34 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.845 0.458 . . . . 0.0 111.002 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.4 t80 65.33 19.77 11.71 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.13 1.372 . . . . 0.0 111.118 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -91.44 150.67 21.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.649 0.779 . . . . 0.0 110.069 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.43 161.06 23.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.368 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.4 -46.83 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.549 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.87 -29.08 69.65 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.664 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.09 -48.54 65.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.462 0.705 . . . . 0.0 110.676 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -69.74 -32.49 71.05 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.85 -38.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.846 0.458 . . . . 0.0 110.625 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -65.98 -35.73 81.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.773 0.429 . . . . 0.0 110.479 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.46 64.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.537 0.735 . . . . 0.0 111.485 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.36 -31.63 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.284 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.0 t -69.97 -43.12 72.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.683 0.793 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 ttt180 -61.84 -49.12 77.55 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.466 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.48 -46.07 87.38 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 109.684 -176.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.53 83.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.085 0.866 . . . . 0.0 111.066 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.04 -34.83 79.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.63 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 58.5 mt-10 -70.62 -23.11 62.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.84 0.456 . . . . 0.0 110.916 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -89.72 2.15 55.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.379 0.672 . . . . 0.0 111.58 175.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 24.08 67.32 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.448 -0.342 . . . . 0.0 113.324 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.43 134.13 35.5 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.376 0.671 . . . . 0.0 110.178 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.33 75.96 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.549 0.69 . . . . 0.0 110.174 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 m -148.98 169.66 20.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.792 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -145.13 149.88 35.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.087 0.955 . . . . 0.0 108.521 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -128.5 131.23 48.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -78.28 123.53 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HB ' ' OD1' ' A' ' 87' ' ' ASP . 7.7 p -86.85 -33.5 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.696 0.399 . . . . 0.0 110.139 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -160.72 144.2 13.41 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.795 0.438 . . . . 0.0 110.839 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 21.1 p -133.38 112.98 12.05 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 t -126.74 120.39 29.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.391 0.676 . . . . 0.0 110.523 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 33.9 mt-10 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.691 0.796 . . . . 0.0 110.474 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 52.3 t30 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 120.692 0.282 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 3.0 p-90 -142.68 124.74 15.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.054 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.614 ' HE ' ' HB ' ' A' ' 85' ' ' VAL . 12.0 tpt180 -64.44 116.58 6.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.03 1.332 . . . . 0.0 109.747 174.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.51 ' HB ' HG13 ' A' ' 42' ' ' ILE . 26.6 t -106.43 107.99 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.614 ' HB ' ' HE ' ' A' ' 83' ' ' ARG . 5.8 p -118.91 126.84 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.25 142.75 35.75 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.568 0.747 . . . . 0.0 110.214 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.49 143.53 26.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 124.624 1.17 . . . . 0.0 110.38 178.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.29 141.4 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.086 0.954 . . . . 0.0 110.551 -171.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -125.04 167.58 14.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.01 0.924 . . . . 0.0 112.293 -167.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 10.3 mmpt? -101.56 164.46 11.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.796 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.062 173.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.19 115.49 6.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.586 0.354 . . . . 0.0 110.983 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.9 m -67.73 137.33 55.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.7 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -72.83 118.25 15.53 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.9 tp -85.45 144.85 27.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.994 0.918 . . . . 0.0 109.032 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 p -84.92 157.3 60.33 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.042 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.38 -28.42 80.16 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.813 2.342 . . . . 0.0 113.561 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.84 -44.96 75.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.869 0.468 . . . . 0.0 110.586 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.516 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 51.9 mt-30 -72.22 -28.35 63.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.917 0.487 . . . . 0.0 110.98 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 -23.08 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.31 0.644 . . . . 0.0 110.739 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.33 25.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.461 0.704 . . . . 0.0 110.568 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.53 36.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.663 0.785 . . . . 0.0 110.788 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.6 166.2 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.269 1.027 . . . . 0.0 110.236 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -118.86 149.2 46.14 Favored Pre-proline 0 C--O 1.244 0.795 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.48 165.67 22.8 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.603 2.202 . . . . 0.0 111.871 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -96.61 -45.3 6.77 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.23 -173.84 3.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 109.854 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 29.8 mtt180 -123.87 171.55 9.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.304 0.642 . . . . 0.0 109.305 170.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 pt -138.89 138.35 41.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.1 124.73 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 pt -118.45 175.7 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.968 0.907 . . . . 0.0 108.777 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 19.7 p -130.49 113.87 14.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 64.91 3.72 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 53.7 ttt180 -63.77 95.69 0.12 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.93 0.892 . . . . 0.0 111.089 -172.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.8 t80 63.55 16.4 9.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.727 1.211 . . . . 0.0 111.436 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -88.69 155.94 19.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.813 0.845 . . . . 0.0 109.739 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.91 161.03 30.56 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.261 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 tp -60.16 -37.39 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.338 0.655 . . . . 0.0 110.875 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.66 90.97 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.344 0.402 . . . . 0.0 112.887 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.19 -36.42 77.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.556 0.742 . . . . 0.0 110.767 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.6 82.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.63 0.581 . . . . 0.0 110.15 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.95 -36.64 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.005 0.522 . . . . 0.0 110.295 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.7 t -68.79 -41.42 78.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.964 0.506 . . . . 0.0 110.691 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.54 -35.08 67.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.165 0.586 . . . . 0.0 111.749 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 p -77.0 -31.01 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -72.44 -35.49 68.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.928 0.491 . . . . 0.0 110.407 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -61.06 -56.91 15.43 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.467 1.105 . . . . 0.0 109.797 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -59.44 -45.68 90.89 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.118 0.886 . . . . 0.0 111.403 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.24 94.45 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.611 0.569 . . . . 0.0 111.317 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.03 -37.49 87.61 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.116 0.567 . . . . 0.0 110.665 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.42 -19.31 60.45 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.547 0.739 . . . . 0.0 111.416 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.11 -7.3 59.41 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.914 0.886 . . . . 0.0 111.133 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 13.95 81.28 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.627 -0.26 . . . . 0.0 112.912 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.05 134.9 38.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.702 0.801 . . . . 0.0 110.318 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.76 -38.79 46.08 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.073 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 22.8 m -134.45 169.82 16.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.664 -176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -149.53 158.41 44.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.641 0.776 . . . . 0.0 109.0 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -143.78 119.05 10.18 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.386 0.674 . . . . 0.0 109.277 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 86' ' ' ALA . 63.8 t -71.47 112.12 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.386 0.675 . . . . 0.0 109.702 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.51 -26.71 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.4 t70 -143.17 133.43 24.57 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.064 0.546 . . . . 0.0 110.281 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.2 p -132.07 112.63 12.51 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -115.88 173.74 6.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.877 0.871 . . . . 0.0 108.98 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.43 0.692 . . . . 0.0 109.993 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 3.6 p-10 . . . . . 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 43.3 p-90 -99.66 127.58 45.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.674 171.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -95.05 153.97 17.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.534 0.733 . . . . 0.0 110.758 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.88 112.78 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.704 1.202 . . . . 0.0 108.863 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 39.9 t -98.08 115.11 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 70' ' ' VAL . . . -126.15 120.57 30.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.497 0.719 . . . . 0.0 109.937 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 1.2 m-20 -70.3 146.12 50.79 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.979 174.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.35 136.86 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.032 0.533 . . . . 0.0 110.186 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 34.5 m-85 -126.04 170.17 12.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.638 1.175 . . . . 0.0 110.744 -168.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.99 178.57 5.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.023 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.733 0.813 . . . . 0.0 108.827 172.676 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.87 136.23 56.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.312 0.645 . . . . 0.0 111.583 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 m -68.24 130.63 43.49 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.048 0.539 . . . . 0.0 110.755 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.1 118.26 12.71 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 27.1 tp -93.16 139.78 30.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.473 1.109 . . . . 0.0 109.717 -172.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -71.38 147.95 93.14 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.545 0.738 . . . . 0.0 110.16 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.48 -33.62 86.76 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.421 2.747 . . . . 0.0 113.991 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.0 -46.8 64.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.999 0.52 . . . . 0.0 111.012 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -73.25 -23.44 60.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.201 0.6 . . . . 0.0 111.463 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.13 -36.06 61.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 0.0 110.352 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.36 61.86 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.25 -48.93 38.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.511 0.725 . . . . 0.0 110.392 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.37 170.5 15.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.441 0.696 . . . . 0.0 111.355 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -121.32 123.33 27.73 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.556 0.742 . . . . 0.0 109.694 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.81 133.26 12.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.936 2.424 . . . . 0.0 112.254 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.68 -34.67 30.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.157 0.583 . . . . 0.0 110.194 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.26 171.86 13.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.471 1.108 . . . . 0.0 108.468 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 5.7 ttp180 -140.71 128.5 21.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.372 1.069 . . . . 0.0 108.116 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.7 pt -103.32 161.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.079 0.552 . . . . 0.0 110.531 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG23 ' HD3' ' A' ' 83' ' ' ARG . 2.0 p -148.76 132.34 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.985 0.914 . . . . 0.0 109.438 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -132.32 166.72 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.608 1.163 . . . . 0.0 109.528 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.7 p -134.08 118.82 18.17 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.382 1.073 . . . . 0.0 109.637 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.86 115.06 5.14 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.653 -0.526 . . . . 0.0 111.811 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -76.11 91.43 3.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.282 0.633 . . . . 0.0 110.165 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 t80 65.79 12.29 8.22 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.309 1.444 . . . . 0.0 112.003 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -72.65 154.78 40.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.9 162.36 29.16 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.592 0.357 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.7 tp -60.31 -31.78 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.053 0.541 . . . . 0.0 110.676 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.88 -42.9 98.24 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.912 -0.382 . . . . 0.0 112.897 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -62.92 -43.18 99.5 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.372 0.669 . . . . 0.0 110.074 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.2 -51.2 67.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.021 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.69 -37.4 79.56 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 123.693 0.797 . . . . 0.0 110.395 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.0 t -69.06 -36.44 77.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.364 0.666 . . . . 0.0 111.198 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.01 -40.25 60.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.39 0.676 . . . . 0.0 111.252 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.03 -27.89 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 123.269 0.628 . . . . 0.0 110.19 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.408 ' OG ' ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -70.26 -42.97 71.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.851 0.861 . . . . 0.0 110.104 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 18.7 ttt180 -57.47 -57.61 11.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.64 175.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.3 tpp85 -61.03 -40.97 95.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.08 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.78 96.31 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.173 0.589 . . . . 0.0 111.283 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.89 -35.6 80.39 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.25 0.62 . . . . 0.0 110.335 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 55.2 mt-10 -71.12 -29.25 65.02 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.97 0.908 . . . . 0.0 110.849 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 23.8 mm-40 -73.82 -14.36 61.08 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.235 0.614 . . . . 0.0 110.754 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.12 2.74 64.04 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.98 138.76 42.47 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.753 0.821 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.45 -32.37 64.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.176 0.99 . . . . 0.0 110.887 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 66.0 m -143.44 171.07 14.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.21 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.36 162.38 38.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.328 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -141.56 117.51 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.26 113.67 3.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.64 -20.81 6.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.22 137.84 4.4 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 123.321 0.388 . . . . 0.0 110.905 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.5 p -122.43 106.42 11.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 t -123.6 126.26 46.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.044 0.538 . . . . 0.0 109.984 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 31.0 mt-10 . . . . . 0 CA--C 1.541 0.632 0 O-C-N 123.552 0.532 . . . . 0.0 110.236 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.9 t30 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.2 p-90 -109.27 126.78 53.7 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.572 0.749 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.3 tmm_? -83.8 129.19 34.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.782 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.543 HG21 ' HB1' ' A' ' 52' ' ' ALA . 62.6 t -113.3 109.31 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.299 1.04 . . . . 0.0 108.248 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.42 134.81 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.14 129.16 18.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.595 0.758 . . . . 0.0 111.079 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 2.6 m-20 -77.51 141.0 39.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.69 145.69 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.285 0.634 . . . . 0.0 111.095 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -127.74 133.6 49.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.488 1.115 . . . . 0.0 110.432 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -84.46 165.55 18.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.978 0.911 . . . . 0.0 111.247 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.628 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.39 46.78 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.732 0.645 . . . . 0.0 112.327 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -75.78 145.36 40.79 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.566 0.747 . . . . 0.0 110.311 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.1 118.87 15.51 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HD12 ' A' ' 34' ' ' LEU . 19.7 tp -82.16 138.43 34.72 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -64.3 141.62 98.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.219 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -42.21 -30.1 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.985 3.123 . . . . 0.0 115.162 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.59 -54.52 7.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.248 0.619 . . . . 0.0 111.249 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.58 -31.26 71.86 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.74 0.416 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -31.7 65.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.699 0.8 . . . . 0.0 111.048 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.76 62.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.998 0.519 . . . . 0.0 110.875 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -42.9 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.18 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 HD21 ' A' ' 26' ' ' LEU . 95.7 mt -86.79 167.23 14.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 110.162 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -120.35 125.0 27.43 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.96 146.38 32.73 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.548 2.165 . . . . 0.0 111.923 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -82.58 -22.87 34.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 111.277 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -158.52 168.58 26.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 110.455 -173.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 18.5 mtm180 -126.91 124.01 38.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.928 1.291 . . . . 0.0 108.507 169.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.88 138.7 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.825 0.45 . . . . 0.0 110.317 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.24 123.97 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 pt -109.39 160.44 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.766 0.826 . . . . 0.0 109.826 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.8 p -132.05 131.86 42.85 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.072 0.949 . . . . 0.0 108.664 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.07 154.79 21.15 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtm105 -110.25 118.96 37.74 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.838 0.819 . . . . 0.0 109.969 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 t80 55.94 82.78 0.1 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.994 1.317 . . . . 0.0 110.98 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -132.75 164.77 26.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.702 0.801 . . . . 0.0 110.01 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.2 178.82 4.79 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 53' ' ' VAL . 9.0 tp -65.66 -37.07 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.21 -38.56 96.7 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 123.191 0.307 . . . . 0.0 113.351 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.18 -39.9 78.42 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.412 0.685 . . . . 0.0 110.2 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.1 -40.98 99.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.316 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 49' ' ' ILE . 83.0 t -70.36 -40.2 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.413 0.685 . . . . 0.0 110.467 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -65.89 -34.89 79.17 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 0.0 111.059 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.58 -34.99 58.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.227 0.611 . . . . 0.0 111.222 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.0 p -83.27 -27.01 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.761 0.424 . . . . 0.0 110.685 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -73.32 -36.34 66.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.0 ttt180 -66.36 -45.28 80.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.979 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -64.28 -41.32 96.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.132 0.573 . . . . 0.0 110.883 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.05 -32.54 74.13 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 120.665 0.269 . . . . 0.0 110.889 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 19.8 t70 -67.79 -36.91 81.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.43 0.692 . . . . 0.0 110.872 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.8 mm-40 -63.13 -35.88 81.73 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.378 0.671 . . . . 0.0 110.719 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 29.7 mm-40 -83.79 -11.19 57.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.687 0.795 . . . . 0.0 112.161 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.64 47.8 8.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-O 121.137 0.298 . . . . 0.0 112.554 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.55 131.4 56.68 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 0.0 109.134 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -35.1 74.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.21 0.604 . . . . 0.0 111.507 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -140.92 175.32 9.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.579 0.751 . . . . 0.0 110.613 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 38.5 p90 -149.52 -179.94 7.48 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 173.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -159.11 122.81 3.82 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.7 115.49 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 85' ' ' VAL . 2.5 p -88.56 -31.54 5.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.264 0.626 . . . . 0.0 109.669 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -162.07 142.08 10.03 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.871 0.367 . . . . 0.0 110.982 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.5 p -117.99 147.05 43.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.58 1.152 . . . . 0.0 108.334 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -150.16 169.81 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.69 0.796 . . . . 0.0 110.23 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 171.63 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -66.93 96.82 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.645 1.178 . . . . 0.0 112.556 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.64 111.67 19.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HB1' ' A' ' 52' ' ' ALA . 57.9 t -123.06 121.2 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.93 0.492 . . . . 0.0 109.955 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 p -109.86 134.19 52.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.297 0.639 . . . . 0.0 109.53 173.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.79 124.72 18.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 109.958 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 5.3 p-10 -72.53 130.83 41.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.428 0.691 . . . . 0.0 110.171 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 13.4 m -112.97 151.84 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.103 0.961 . . . . 0.0 111.301 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -130.37 147.42 52.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.782 1.233 . . . . 0.0 110.43 -167.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.3 173.58 9.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.745 0.818 . . . . 0.0 110.268 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.628 174.28 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.37 137.05 58.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.809 0.443 . . . . 0.0 109.951 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 m -62.09 135.44 57.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.44 0.696 . . . . 0.0 110.651 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.01 117.61 13.84 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.7 tp -90.95 142.28 27.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -95.94 153.29 39.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.196 0.599 . . . . 0.0 110.47 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -44.63 -38.62 12.52 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.213 3.276 . . . . 0.0 115.625 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.37 -50.7 72.97 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.358 0.663 . . . . 0.0 111.186 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 44.9 mt-30 -66.31 -46.23 77.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.817 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.67 68.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.889 0.875 . . . . 0.0 112.492 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.22 -24.45 47.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.6 0.76 . . . . 0.0 110.818 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.14 -33.32 14.08 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.759 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -99.45 153.21 19.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.343 0.657 . . . . 0.0 111.191 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -104.76 128.39 26.93 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 109.401 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.34 148.1 23.53 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.677 2.251 . . . . 0.0 111.697 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -80.12 -24.02 40.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.674 0.389 . . . . 0.0 110.47 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -160.74 175.17 12.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.148 0.979 . . . . 0.0 108.923 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.624 HH21 HG11 ' A' ' 71' ' ' VAL . 43.7 mtp180 -132.47 121.15 22.93 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.606 HD11 HG13 ' A' ' 56' ' ' VAL . 44.9 pt -89.55 149.15 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.012 0.369 . . . . 0.0 110.132 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.98 122.57 49.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -109.65 170.56 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.2 p -125.48 106.02 9.48 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.658 0.783 . . . . 0.0 109.136 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.43 88.73 1.59 Allowed Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.51 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 81' ' ' ASN . 10.0 ttm180 -84.06 96.09 8.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 110.221 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.8 t80 60.79 90.65 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.47 1.106 . . . . 0.0 110.033 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -168.09 162.96 13.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.693 0.797 . . . . 0.0 109.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.02 161.89 24.04 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 123.547 0.529 . . . . 0.0 110.018 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.498 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.2 tp -64.87 -29.18 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.9 97.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.072 0.232 . . . . 0.0 113.113 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.16 -43.41 82.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.533 0.733 . . . . 0.0 110.459 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -61.81 -50.11 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.086 0.954 . . . . 0.0 111.623 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.6 -35.84 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.064 0.946 . . . . 0.0 111.031 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 t -67.32 -34.93 78.38 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.043 0.537 . . . . 0.0 110.6 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.88 -33.91 64.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.042 0.537 . . . . 0.0 111.009 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.606 HG13 HD11 ' A' ' 40' ' ' ILE . 79.7 t -69.54 -41.71 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.262 0.625 . . . . 0.0 110.96 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.0 p -66.0 -34.18 77.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.938 0.495 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 15.1 tpt180 -65.93 -57.44 7.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.76 0.824 . . . . 0.0 109.67 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -60.46 -40.36 90.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.04 1.336 . . . . 0.0 112.387 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.12 79.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.851 0.86 . . . . 0.0 110.246 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.75 -31.25 72.36 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.66 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 24.5 mm-40 -69.32 -29.44 67.27 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.046 0.538 . . . . 0.0 111.248 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -83.84 -1.93 55.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.989 0.516 . . . . 0.0 111.129 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.26 16.32 71.98 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.345 -0.388 . . . . 0.0 113.304 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -69.81 124.49 24.14 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.687 . . . . 0.0 110.852 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.95 69.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.859 0.724 . . . . 0.0 110.336 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.98 155.64 44.1 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 36.3 p90 -124.41 160.7 27.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -149.69 105.2 3.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.38 107.9 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.624 HG11 HH21 ' A' ' 39' ' ' ARG . 11.4 p -93.49 -36.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.291 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.47 145.28 21.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.875 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.3 p -131.28 134.5 46.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.818 1.247 . . . . 0.0 107.814 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m -139.07 126.57 21.71 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.139 0.576 . . . . 0.0 110.146 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 122.994 0.518 . . . . 0.0 110.83 179.836 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 33.8 p-10 . . . . . 0 C--O 1.24 0.573 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.498 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 7.5 p-90 -146.2 127.21 14.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.853 0.861 . . . . 0.0 109.198 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.93 149.18 50.11 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.979 0.799 . . . . 0.0 108.944 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 52' ' ' ALA . 32.3 t -127.2 105.28 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.69 131.26 41.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.32 112.22 6.56 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.195 -171.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.05 133.89 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 15.6 m -113.99 126.15 71.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.513 0.673 . . . . 0.0 109.859 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -115.11 162.51 16.92 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.868 1.267 . . . . 0.0 110.245 -168.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -107.22 170.2 8.11 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.316 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.848 178.917 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . . . . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.54 140.14 41.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.259 1.024 . . . . 0.0 112.125 -176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.5 m -66.97 134.04 51.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.977 0.911 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -68.71 116.54 9.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -72.99 137.5 45.48 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.9 p -72.03 147.69 91.22 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.443 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.6 -36.44 18.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.963 3.108 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.01 -37.89 69.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.864 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -74.43 -49.47 22.3 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.138 0.494 . . . . 0.0 110.122 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.06 -22.17 66.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.455 1.102 . . . . 0.0 112.348 -175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.14 -53.86 50.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.34 1.056 . . . . 0.0 112.328 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.13 -22.89 17.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.947 0.499 . . . . 0.0 111.852 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.968 0.413 . . . . 0.0 110.339 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -86.91 125.6 66.08 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.7 166.41 23.71 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.973 2.448 . . . . 0.0 111.374 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -93.5 -26.27 17.24 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.465 -0.147 . . . . 0.0 111.232 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -165.21 -170.94 2.03 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.698 0.399 . . . . 0.0 110.251 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -137.94 138.03 38.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.885 1.274 . . . . 0.0 109.983 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -102.77 144.14 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.914 0.886 . . . . 0.0 109.398 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 85' ' ' VAL . 46.1 t -130.83 115.43 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 pt -102.7 156.68 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.1 m -147.1 146.2 29.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 0.0 109.351 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.92 156.57 25.05 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -92.52 132.64 36.66 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.381 1.072 . . . . 0.0 110.003 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 t80 60.46 23.13 12.75 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 124.685 1.194 . . . . 0.0 112.091 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -74.76 116.93 16.02 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.28 158.98 35.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 tp -57.49 -33.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.284 0.365 . . . . 0.0 111.058 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.28 -45.03 96.82 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.245 0.341 . . . . 0.0 112.936 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.49 -39.67 92.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.711 0.804 . . . . 0.0 110.774 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.36 -47.65 78.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.337 1.055 . . . . 0.0 110.47 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 56' ' ' VAL . 92.8 t -67.35 -37.57 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.795 0.438 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 t -64.04 -41.81 97.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.732 0.413 . . . . 0.0 110.941 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -44.4 66.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.041 0.536 . . . . 0.0 110.882 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.8 p -74.98 -28.86 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.084 0.554 . . . . 0.0 111.145 -174.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.8 p -70.74 -49.94 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.634 0.373 . . . . 0.0 110.211 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 79.2 ttt180 -63.52 -44.18 94.99 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 110.173 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -57.57 -41.85 81.91 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.713 0.805 . . . . 0.0 111.474 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.64 86.11 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.33 -31.09 71.66 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.269 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 74.7 mm-40 -69.53 -31.31 69.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.347 0.659 . . . . 0.0 109.896 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 15.0 mm-40 -82.48 0.48 42.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.85 0.46 . . . . 0.0 111.221 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.85 5.05 71.65 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.167 0.413 . . . . 0.0 113.473 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.1 135.31 38.58 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 110.88 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 -26.64 54.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.367 1.067 . . . . 0.0 110.902 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.3 m -145.81 170.32 16.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 111.422 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -149.6 170.49 18.54 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -153.89 117.79 4.74 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.202 0.601 . . . . 0.0 109.505 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.01 107.93 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.716 0.806 . . . . 0.0 110.369 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.17 -43.55 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.265 0.626 . . . . 0.0 110.246 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.1 t70 -133.97 127.56 32.62 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 110.254 -167.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.3 p -122.56 117.23 25.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.4 t -139.48 162.42 35.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 123.362 0.665 . . . . 0.0 111.015 -170.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 5.9 p-90 -144.51 179.83 7.02 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.375 0.67 . . . . 0.0 110.363 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.21 153.16 41.04 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.198 -171.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' A' ' 52' ' ' ALA . 85.2 t -124.11 110.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 0.0 108.915 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 26.4 t -94.65 123.87 46.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.7 123.56 23.88 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.5 0.72 . . . . 0.0 110.728 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.16 136.21 57.03 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.897 0.879 . . . . 0.0 110.067 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.66 138.65 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.347 0.594 . . . . 0.0 110.373 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -126.24 133.58 51.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.756 1.222 . . . . 0.0 109.735 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.24 176.65 9.57 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.205 0.602 . . . . 0.0 110.818 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.529 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.45 142.78 53.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.111 0.564 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' SER . 59.1 m -68.14 124.77 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.0 0.52 . . . . 0.0 110.12 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.92 128.01 34.72 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 34' ' ' LEU . 17.5 tp -101.75 140.13 36.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.902 0.881 . . . . 0.0 108.999 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 p -79.96 153.26 74.98 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.332 0.653 . . . . 0.0 110.861 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.23 -39.04 52.55 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.132 3.221 . . . . 0.0 114.155 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.54 -52.58 64.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.779 0.832 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.71 -36.42 75.91 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.539 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.69 92.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.993 0.917 . . . . 0.0 111.312 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.3 63.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.996 0.519 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.07 45.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.205 0.602 . . . . 0.0 111.583 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HD21 ' A' ' 26' ' ' LEU . 82.5 mt -89.46 163.33 15.3 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.673 0.789 . . . . 0.0 110.101 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.28 124.7 27.6 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.607 0.763 . . . . 0.0 109.083 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.77 153.13 48.15 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.634 2.223 . . . . 0.0 111.952 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -93.08 -25.31 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.841 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.35 168.15 27.01 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.876 0.87 . . . . 0.0 108.879 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.562 HH21 HG11 ' A' ' 71' ' ' VAL . 34.0 mtp-105 -133.29 126.14 30.79 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.406 ' HB ' HH11 ' A' ' 59' ' ' ARG . 28.6 pt -104.59 159.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.33 0.652 . . . . 0.0 110.365 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.25 139.29 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 pt -125.9 168.65 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.1 0.96 . . . . 0.0 108.985 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -132.79 129.71 38.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.876 . . . . 0.0 109.142 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.18 92.35 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 54.9 ttp180 -60.07 112.24 1.81 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.654 0.782 . . . . 0.0 111.955 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.9 t80 66.75 11.45 8.23 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.389 1.076 . . . . 0.0 111.706 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -77.94 155.8 30.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.067 0.547 . . . . 0.0 110.066 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.99 43.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -61.75 -43.91 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 123.617 0.573 . . . . 0.0 110.688 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.73 88.38 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.053 0.22 . . . . 0.0 112.949 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.05 -42.85 88.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.118 0.967 . . . . 0.0 110.398 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.216 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.501 ' HA ' HG12 ' A' ' 56' ' ' VAL . 69.1 t -67.68 -33.96 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 122.801 0.441 . . . . 0.0 110.448 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -68.68 -39.35 80.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.797 0.439 . . . . 0.0 110.534 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.87 80.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.433 0.693 . . . . 0.0 111.223 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 53' ' ' VAL . 3.7 p -78.44 -27.05 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.103 0.561 . . . . 0.0 110.663 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 t -69.01 -43.74 74.2 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.883 0.873 . . . . 0.0 110.146 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 14.4 tpt180 -63.82 -45.54 89.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.027 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -60.83 -44.94 96.28 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.84 0.713 . . . . 0.0 109.272 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.02 82.62 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.574 0.75 . . . . 0.0 110.592 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.59 -39.08 93.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.31 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 54.5 mm-40 -62.04 -34.92 77.13 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.391 0.676 . . . . 0.0 110.818 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.1 mm-40 -78.81 -11.63 60.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.851 0.46 . . . . 0.0 111.351 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.42 16.31 34.98 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.088 0.242 . . . . 0.0 113.519 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -77.98 135.04 37.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.269 0.628 . . . . 0.0 111.624 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.24 -31.2 49.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.291 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' THR . 51.1 m -143.63 172.01 13.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -162.29 158.86 24.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -130.79 121.0 24.57 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.68 96.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HH21 ' A' ' 39' ' ' ARG . 7.2 p -88.9 -34.51 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.215 -172.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -133.39 129.04 36.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.982 0.513 . . . . 0.0 109.718 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 84' ' ' VAL . 7.1 p -135.35 104.15 5.76 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 166.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -148.74 168.54 22.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.916 1.286 . . . . 0.0 108.528 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.0 pt-20 . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 14.8 t30 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 16.9 p-90 -108.55 150.36 27.59 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.499 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.11 157.12 19.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.44 1.096 . . . . 0.0 110.601 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.9 t -126.98 109.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.567 1.147 . . . . 0.0 108.618 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.1 129.91 42.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.66 117.77 10.64 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 10.6 p-10 -84.86 142.33 29.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 26.8 m -113.18 142.36 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.714 0.805 . . . . 0.0 111.245 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 88.5 m-85 -126.38 167.25 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.107 1.363 . . . . 0.0 111.326 -165.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -108.75 162.97 13.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.83 1.252 . . . . 0.0 109.415 168.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.147 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.64 135.12 29.63 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -66.46 136.18 55.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.789 . . . . 0.0 109.922 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -69.0 125.01 25.31 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 12.8 tp -96.27 105.32 17.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.4 m -56.44 141.86 70.44 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.541 1.136 . . . . 0.0 110.509 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -43.51 -35.09 5.67 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.855 3.037 . . . . 0.0 114.2 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -63.02 -44.62 95.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.979 0.912 . . . . 0.0 111.642 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.85 -41.51 64.73 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.11 -19.52 61.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.382 1.073 . . . . 0.0 111.961 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.66 81.77 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.081 0.552 . . . . 0.0 110.182 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.56 -42.83 11.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.784 0.834 . . . . 0.0 111.352 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.94 134.02 33.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.255 0.622 . . . . 0.0 110.971 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -97.37 134.59 22.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.225 1.01 . . . . 0.0 109.713 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 83.6 Cg_endo -75.32 163.65 34.24 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.98 2.453 . . . . 0.0 113.086 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 25.0 p90 -94.96 -25.66 16.43 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.991 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -155.94 177.4 11.45 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.789 0.835 . . . . 0.0 108.853 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 40.4 ttm180 -134.52 124.24 25.22 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.118 0.967 . . . . 0.0 108.781 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.4 pt -89.52 163.67 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.629 0.772 . . . . 0.0 111.265 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 83' ' ' ARG . 7.6 p -141.65 139.78 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.039 0.936 . . . . 0.0 109.164 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.6 pt -137.39 148.57 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -133.46 133.85 42.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.51 174.84 20.81 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 27.9 ttm180 -149.6 111.72 4.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.4 t80 81.75 -3.71 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.947 1.299 . . . . 0.0 111.165 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -71.24 152.35 43.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.484 1.513 . . . . 0.0 110.861 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.63 172.12 9.52 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.309 0.644 . . . . 0.0 110.923 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.68 -32.64 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.27 -35.52 91.67 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-O 120.899 0.166 . . . . 0.0 112.995 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.07 -35.29 69.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.632 0.773 . . . . 0.0 110.445 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.78 -43.52 88.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.63 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.59 -43.26 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.328 0.651 . . . . 0.0 111.231 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 p -66.34 -40.97 90.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.377 0.271 . . . . 0.0 111.19 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.99 80.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.949 0.499 . . . . 0.0 111.794 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.33 -29.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 122.813 0.445 . . . . 0.0 110.889 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.8 t -74.09 -41.43 61.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.122 0.569 . . . . 0.0 110.152 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -70.17 -41.5 73.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 tpp180 -60.44 -47.16 87.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.296 0.638 . . . . 0.0 110.231 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.55 83.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.759 0.662 . . . . 0.0 111.436 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.24 -40.53 94.37 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.024 0.929 . . . . 0.0 110.936 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.65 -12.09 60.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.395 0.678 . . . . 0.0 112.364 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.7 mm-40 -89.49 -12.64 39.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.457 0.303 . . . . 0.0 110.786 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.23 61.22 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.722 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -75.26 129.34 37.28 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.345 0.658 . . . . 0.0 111.45 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.22 77.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.943 0.897 . . . . 0.0 111.043 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.3 m -137.29 164.56 28.26 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.994 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -144.57 152.49 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.871 0.868 . . . . 0.0 108.927 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -131.54 118.22 19.82 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.86 107.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.57 -28.44 5.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.211 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 129.72 6.05 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.191 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -113.39 115.59 28.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.9 m -129.74 145.57 51.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.943 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.1 143.88 46.86 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.165 0.507 . . . . 0.0 110.916 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.4 tmm_? -107.99 130.87 55.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.738 1.215 . . . . 0.0 109.715 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 73.5 t -112.32 125.78 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.36 140.31 45.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.99 143.53 31.26 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.025 0.53 . . . . 0.0 111.021 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.0 m-20 -77.76 156.12 30.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.905 0.482 . . . . 0.0 109.94 168.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 4.5 m -127.1 141.85 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.279 0.632 . . . . 0.0 110.526 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -131.09 141.84 50.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.352 1.061 . . . . 0.0 109.676 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 3.3 mmmp? -99.92 145.61 27.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 0.0 110.572 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 166.25 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ASP . . . . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.123 0.487 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.35 123.97 17.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 67' ' ' SER . 73.1 m -68.94 124.05 22.67 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.718 0.807 . . . . 0.0 110.028 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.76 116.42 10.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.504 HD21 HD12 ' A' ' 34' ' ' LEU . 14.5 tp -74.43 144.74 44.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.289 . . . . 0.0 109.189 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.9 p -73.48 152.4 89.76 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.963 0.505 . . . . 0.0 110.071 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.64 -32.71 45.85 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.67 2.913 . . . . 0.0 113.54 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -66.65 -52.93 39.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.249 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.16 -32.21 70.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.173 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.38 -29.47 66.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.961 0.904 . . . . 0.0 111.157 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.12 -31.17 65.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.282 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.55 -48.2 9.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.173 0.589 . . . . 0.0 111.068 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.504 HD12 HD21 ' A' ' 26' ' ' LEU . 94.3 mt -81.11 172.97 13.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.751 0.821 . . . . 0.0 110.932 -177.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 36' ' ' PRO . 10.8 tppt? -132.64 131.93 22.4 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.787 0.835 . . . . 0.0 108.944 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HD2' ' HD3' ' A' ' 35' ' ' LYS . 73.5 Cg_endo -68.99 150.98 73.49 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.587 2.191 . . . . 0.0 111.471 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -86.11 -19.69 29.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.923 0.392 . . . . 0.0 110.358 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -162.03 169.2 21.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.476 1.11 . . . . 0.0 109.111 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 88.6 mtm180 -131.79 121.98 25.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.674 1.19 . . . . 0.0 108.754 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.3 pt -96.51 144.08 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.292 0.637 . . . . 0.0 110.177 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.35 133.78 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.641 0.777 . . . . 0.0 109.322 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 pt -126.52 153.86 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.792 0.837 . . . . 0.0 108.942 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' ARG . 39.2 p -121.55 149.93 42.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 0.0 109.074 174.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.06 116.29 0.71 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 40.7 ttp-105 -88.82 120.08 29.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.675 0.79 . . . . 0.0 109.627 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 59.05 81.65 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.733 1.213 . . . . 0.0 111.099 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.91 156.15 36.98 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.595 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.32 154.02 39.08 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 124.025 0.828 . . . . 0.0 110.162 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 53' ' ' VAL . 5.5 tp -59.92 -41.63 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.597 0.359 . . . . 0.0 110.041 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.37 -31.26 80.27 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.317 0.386 . . . . 0.0 113.34 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.07 -36.09 66.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.728 0.811 . . . . 0.0 110.255 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.9 77.82 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.865 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HA ' HG12 ' A' ' 56' ' ' VAL . 87.7 t -66.9 -34.01 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.3 t -65.53 -39.43 91.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.466 0.706 . . . . 0.0 110.694 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.23 76.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.22 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 53' ' ' VAL . 8.3 p -82.4 -27.18 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.232 0.613 . . . . 0.0 111.675 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -69.49 -42.72 74.41 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.2 0.524 . . . . 0.0 109.787 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 7.6 tpt180 -65.78 -42.72 90.47 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.3 tpp180 -62.47 -35.99 81.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.147 0.579 . . . . 0.0 110.404 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.29 66.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 0.0 110.477 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 27.3 t70 -67.79 -34.89 77.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.837 0.455 . . . . 0.0 110.648 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 26.7 mm-40 -60.51 -37.01 79.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.787 0.835 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 50.1 mm-40 -77.72 -15.02 59.43 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.18 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.97 38.5 48.34 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.562 0.539 . . . . 0.0 111.761 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.84 126.66 40.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.236 1.014 . . . . 0.0 110.092 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.65 83.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.561 0.696 . . . . 0.0 110.739 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 37.2 m -139.95 168.99 18.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.659 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 24.8 p90 -148.75 169.95 19.3 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -150.2 127.1 11.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.55 97.55 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -86.33 -16.91 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.751 0.82 . . . . 0.0 110.52 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 21.8 t70 -163.51 150.27 12.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.237 0.615 . . . . 0.0 111.029 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 p -141.61 114.28 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.185 1.394 . . . . 0.0 107.834 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.7 m -137.25 152.35 49.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 108.806 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.9 pt-20 . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 122.497 0.319 . . . . 0.0 110.896 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.0 p-90 -121.75 159.3 26.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.576 0.703 . . . . 0.0 110.571 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HB2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -133.71 132.02 40.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.654 -165.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.98 125.84 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.866 0.866 . . . . 0.0 109.759 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 21.6 t -100.88 120.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 166.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.98 121.92 27.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 13.6 p-10 -85.36 136.04 33.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 16.6 m -112.32 131.64 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.692 0.797 . . . . 0.0 111.349 -166.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.588 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 74.0 m-85 -109.76 163.86 13.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 111.54 -171.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -110.15 165.57 11.64 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 108.709 169.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.698 178.933 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 133.73 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.377 0.671 . . . . 0.0 110.551 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -67.35 134.09 50.86 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.139 0.576 . . . . 0.0 110.557 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.02 116.57 9.63 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.5 tp -84.0 126.65 33.24 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.3 p -66.22 145.23 98.98 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 123.736 0.647 . . . . 0.0 110.208 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -45.65 -31.37 7.3 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.607 2.872 . . . . 0.0 114.25 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.89 -55.66 21.08 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.337 1.055 . . . . 0.0 110.449 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.19 -34.1 75.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.14 69.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.037 0.935 . . . . 0.0 111.423 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.57 -26.05 59.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 0.0 111.174 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.81 19.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.299 0.64 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 26' ' ' LEU . 95.2 mt -101.21 160.89 14.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.731 0.812 . . . . 0.0 111.222 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -111.31 123.88 34.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 108.371 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.31 159.08 36.84 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.081 1.854 . . . . 0.0 111.185 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -100.86 -39.19 7.91 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.771 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.58 -170.61 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 109.469 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HB3' ' HA ' ' A' ' 87' ' ' ASP . 4.5 ptt180 -149.8 168.08 24.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.79 0.836 . . . . 0.0 111.459 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 56' ' ' VAL . 37.7 pt -118.55 151.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.954 0.902 . . . . 0.0 110.33 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG13 ' HD3' ' A' ' 83' ' ' ARG . 85.5 t -121.3 114.17 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.638 1.175 . . . . 0.0 109.545 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 84' ' ' VAL . 43.2 pt -133.9 178.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.483 1.113 . . . . 0.0 108.963 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 3.0 p -126.97 105.11 8.39 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.632 0.773 . . . . 0.0 109.475 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 84' ' ' VAL . . . -89.23 149.48 20.75 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -110.49 151.76 27.16 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.828 0.814 . . . . 0.0 111.166 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -72.07 -4.62 29.91 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.188 0.995 . . . . 0.0 112.817 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.26 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.507 0.723 . . . . 0.0 110.657 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.4 143.03 4.07 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.932 0.893 . . . . 0.0 110.216 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 tp -62.67 -37.44 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 167.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.47 -26.77 68.54 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.624 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.62 -49.2 78.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.301 0.64 . . . . 0.0 110.263 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.24 -42.11 93.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.956 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 88.9 t -66.75 -36.18 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.848 0.718 . . . . 0.0 111.338 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.5 m -66.21 -41.77 89.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.782 0.433 . . . . 0.0 110.546 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.17 79.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.69 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 HD11 ' A' ' 40' ' ' ILE . 12.7 p -77.11 -34.15 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.724 0.41 . . . . 0.0 111.469 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -67.84 -39.99 83.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.796 0.438 . . . . 0.0 110.277 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 29.7 ttt180 -65.03 -56.63 11.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.852 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -66.54 -39.31 88.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.102 0.561 . . . . 0.0 112.3 -172.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.35 93.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.33 -35.92 80.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.708 0.803 . . . . 0.0 111.167 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 47.8 mt-10 -66.46 -33.27 75.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.337 0.655 . . . . 0.0 110.736 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 18.9 mm-40 -82.75 -5.17 58.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.717 0.807 . . . . 0.0 111.469 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.01 14.63 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.21 0.319 . . . . 0.0 113.137 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.105 0.962 . . . . 0.0 109.584 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -28.57 62.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.596 0.759 . . . . 0.0 111.067 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.3 m -143.09 169.4 17.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -147.28 168.11 22.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.959 0.903 . . . . 0.0 109.766 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -160.21 122.27 3.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.206 1.002 . . . . 0.0 108.623 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.45 120.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.601 0.563 . . . . 0.0 109.985 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.25 -30.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.257 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -160.2 149.28 17.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.018 0.527 . . . . 0.0 111.243 -172.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 33.7 p -132.89 104.63 6.67 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.612 1.165 . . . . 0.0 108.857 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.3 m -100.97 109.27 21.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.717 0.807 . . . . 0.0 110.33 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 122.674 0.39 . . . . 0.0 111.439 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.476 ' N ' HD21 ' A' ' 81' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -101.0 124.85 47.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.331 1.052 . . . . 0.0 109.144 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HD3' HG13 ' A' ' 41' ' ' VAL . 2.8 tmm_? -63.88 106.43 1.01 Allowed 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.676 1.19 . . . . 0.0 109.586 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 42' ' ' ILE . 43.7 t -88.68 108.34 18.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.81 129.02 58.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.81 120.75 16.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.962 0.505 . . . . 0.0 110.966 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.722 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 5.0 m-20 -63.86 135.85 56.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.131 0.894 . . . . 0.0 110.846 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.84 142.88 22.88 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.498 0.719 . . . . 0.0 109.419 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 57.3 m-85 -125.1 152.47 44.33 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.177 0.991 . . . . 0.0 109.863 -169.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.68 174.21 7.47 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.289 0.635 . . . . 0.0 109.639 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 C-N-CA 123.307 0.643 . . . . 0.0 110.149 -179.278 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.97 118.33 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.678 0.672 . . . . 0.0 110.104 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -80.24 149.76 30.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.485 1.114 . . . . 0.0 110.617 -174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.53 134.2 51.9 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.522 0.601 . . . . 0.0 109.438 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.8 tp -94.82 134.92 36.93 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -73.96 144.91 83.07 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.732 0.813 . . . . 0.0 110.362 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.61 -38.19 75.53 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 124.125 3.217 . . . . 0.0 115.687 -165.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -69.83 -41.46 74.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.768 0.427 . . . . 0.0 110.455 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.8 -34.81 76.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.333 0.653 . . . . 0.0 110.63 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.95 -24.12 55.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.051 0.94 . . . . 0.0 111.261 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.03 -35.75 21.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.393 0.677 . . . . 0.0 110.432 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.26 65.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.306 0.643 . . . . 0.0 110.794 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.8 mt -88.17 148.24 24.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -102.54 139.69 20.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 73.9 Cg_endo -72.73 139.29 30.5 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.924 1.749 . . . . 0.0 111.451 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 90' ' ' LYS . 53.4 p90 -78.06 -19.53 54.1 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -166.45 174.3 9.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 108.671 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 87' ' ' ASP . 51.0 mtm180 -135.01 122.76 22.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.084 0.954 . . . . 0.0 108.945 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 pt -87.85 151.88 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.956 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' A' ' 83' ' ' ARG . 78.7 t -135.53 125.31 42.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.926 0.89 . . . . 0.0 109.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.1 152.42 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.066 0.946 . . . . 0.0 109.132 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.67 164.76 12.96 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.552 0.741 . . . . 0.0 109.747 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.41 178.79 41.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.06 139.9 4.33 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.543 0.671 . . . . 0.0 111.085 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 t80 61.47 29.59 18.47 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 124.254 0.971 . . . . 0.0 111.014 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -123.33 168.35 12.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 0.0 110.774 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.38 166.4 13.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.923 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 6.4 tp -66.08 -31.58 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.953 0.501 . . . . 0.0 110.407 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.97 -33.62 74.9 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.213 0.321 . . . . 0.0 112.914 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.71 -46.73 68.19 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.326 0.65 . . . . 0.0 110.551 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.49 80.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.614 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 56' ' ' VAL . 77.3 t -68.71 -40.36 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 0.0 110.105 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' ARG . 40.2 m -63.14 -36.65 84.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.879 0.471 . . . . 0.0 111.052 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.32 59.69 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.342 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.0 p -74.76 -29.69 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.271 0.628 . . . . 0.0 112.203 -172.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.9 p -69.81 -40.92 75.63 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.746 0.419 . . . . 0.0 110.677 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 54' ' ' SER . 8.6 mpt_? -72.95 -36.93 67.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.321 0.648 . . . . 0.0 110.04 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -64.48 -43.55 93.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.613 0.765 . . . . 0.0 110.887 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.33 73.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 0.0 110.99 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.55 -35.12 79.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.658 0.783 . . . . 0.0 110.483 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -64.12 -38.95 92.9 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.532 0.733 . . . . 0.0 110.666 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -74.8 -2.19 25.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.802 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.53 23.98 75.85 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.754 -0.138 . . . . 0.0 112.754 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.82 128.58 34.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.522 0.729 . . . . 0.0 109.688 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -33.81 76.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.5 m -147.42 158.97 44.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.634 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -122.18 174.11 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.295 1.038 . . . . 0.0 108.852 170.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -159.62 113.96 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.506 0.722 . . . . 0.0 109.134 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.57 118.82 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.28 0.632 . . . . 0.0 110.442 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.46 -36.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.12 141.24 17.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.367 -168.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -119.69 104.09 9.95 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 14.7 m -84.83 177.72 7.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.809 0.844 . . . . 0.0 110.344 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 124.015 0.926 . . . . 0.0 110.542 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.454 0.169 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 p-90 -143.5 173.76 11.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.366 1.067 . . . . 0.0 110.667 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 1.2 tmt_? -152.2 120.2 6.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.826 0.85 . . . . 0.0 109.076 -165.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.48 131.69 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.247 0.619 . . . . 0.0 110.376 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 127.54 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.184 0.994 . . . . 0.0 108.684 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.63 21.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 m-20 -62.42 136.98 58.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.259 1.424 . . . . 0.0 110.06 171.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.49 138.16 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 118.37 0.532 . . . . 0.0 110.996 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.32 135.98 46.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.768 1.227 . . . . 0.0 109.527 -170.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 37' ' ' TYR . 67.5 mttm -98.04 136.47 38.26 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.299 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.76 177.68 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.496 0.189 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.47 156.8 22.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.586 0.754 . . . . 0.0 109.681 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 m -64.88 135.85 56.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.727 0.811 . . . . 0.0 111.424 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.05 118.07 17.59 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 19.4 tp -93.11 127.22 38.57 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.5 p -72.74 146.85 88.63 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.487 0.715 . . . . 0.0 110.84 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -43.34 -48.21 8.42 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 125.085 3.857 . . . . 0.0 116.517 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -67.94 -41.63 82.21 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.516 0.598 . . . . 0.0 111.263 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.81 -28.17 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.793 0.437 . . . . 0.0 111.16 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.72 70.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.728 0.811 . . . . 0.0 110.644 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.91 -15.14 61.14 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.605 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.01 -40.61 15.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.639 0.776 . . . . 0.0 110.909 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.01 154.59 17.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.072 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -96.23 126.9 42.36 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.554 0.742 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.89 140.22 22.86 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.292 1.995 . . . . 0.0 111.098 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -83.63 -20.13 34.21 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -158.33 175.04 14.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -140.23 121.72 15.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.7 0.8 . . . . 0.0 109.558 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 59' ' ' ARG . 29.2 pt -95.34 165.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.051 0.941 . . . . 0.0 110.64 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.77 133.97 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 123.23 0.612 . . . . 0.0 110.445 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 pt -122.26 157.25 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.166 0.987 . . . . 0.0 108.351 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -149.45 150.5 32.46 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.82 154.0 6.79 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -97.06 3.08 52.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.962 0.505 . . . . 0.0 111.152 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -106.94 76.22 1.09 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.807 0.843 . . . . 0.0 108.746 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -169.81 163.75 9.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.17 0.988 . . . . 0.0 110.173 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' ' HB2' ' A' ' 51' ' ' ASP . . . -119.95 175.25 6.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.266 1.026 . . . . 0.0 108.422 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HA ' ' CH2' ' A' ' 82' ' ' TRP . 7.3 tp -60.07 -44.35 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 118.145 0.429 . . . . 0.0 110.515 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.7 -40.71 65.34 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.107 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 48' ' ' ALA . 45.9 m-20 -75.12 -25.4 58.43 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.606 0.762 . . . . 0.0 112.179 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.73 -43.43 62.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 56' ' ' VAL . 94.8 t -64.38 -33.16 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -67.9 -40.91 83.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.435 0.694 . . . . 0.0 111.279 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.21 -36.69 61.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.122 0.569 . . . . 0.0 111.324 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 53' ' ' VAL . 4.1 p -80.36 -28.65 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.673 0.389 . . . . 0.0 110.307 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.0 p -70.22 -41.16 73.97 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -56.07 -47.87 77.15 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.435 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.3 tpt180 -63.53 -41.1 98.48 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.738 0.649 . . . . 0.0 110.782 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.63 -34.8 76.31 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.188 0.518 . . . . 0.0 111.186 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -70.92 -33.67 70.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.746 0.818 . . . . 0.0 110.574 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -77.55 -18.53 56.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 110.619 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 36.2 mm-40 -80.66 -25.46 38.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.804 170.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.64 3.74 59.47 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.533 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.11 139.92 57.54 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.976 0.91 . . . . 0.0 111.315 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -68.67 -38.81 80.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 110.409 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 42.0 m -143.45 174.3 10.87 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.883 -175.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -151.22 164.17 37.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -146.26 124.37 12.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.141 0.576 . . . . 0.0 109.465 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.87 117.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.781 0.676 . . . . 0.0 109.211 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.1 -31.7 4.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.233 0.613 . . . . 0.0 110.618 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.05 139.47 21.43 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.072 0.463 . . . . 0.0 110.931 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.9 p -131.15 111.09 11.64 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 168.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -144.81 135.91 25.01 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.285 0.634 . . . . 0.0 109.427 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.3 pt-20 . . . . . 0 C--O 1.242 0.67 0 CA-C-O 121.801 0.81 . . . . 0.0 112.096 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.5 p-90 -87.62 111.59 21.41 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.002 0.906 . . . . 0.0 111.419 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.56 114.25 6.05 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.848 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 52' ' ' ALA . 34.4 t -102.94 106.76 20.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.49 133.56 55.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.57 136.2 35.77 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.429 0.692 . . . . 0.0 110.81 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.61 144.59 41.69 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.253 0.621 . . . . 0.0 109.64 170.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.62 128.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -109.03 137.5 46.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 109.881 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 91' ' ' ALA . 1.5 tmmm? -89.4 149.58 22.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.048 0.939 . . . . 0.0 108.892 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.384 0.673 . . . . 0.0 110.888 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.316 0.103 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -63.45 130.91 46.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.986 0.514 . . . . 0.0 110.419 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 149.97 25.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.717 0.807 . . . . 0.0 110.963 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.05 122.1 15.24 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 34' ' ' LEU . 17.1 tp -92.56 124.32 36.5 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.7 p -69.83 146.9 95.92 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.598 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.48 -33.27 4.18 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 124.493 3.462 . . . . 0.0 115.088 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.45 -48.28 64.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.621 0.768 . . . . 0.0 111.276 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -71.27 -36.39 71.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.148 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.9 61.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.243 1.017 . . . . 0.0 111.744 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.27 81.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.332 0.653 . . . . 0.0 110.793 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 -39.57 30.93 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.359 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 26' ' ' LEU . 93.4 mt -85.11 169.35 13.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.074 0.549 . . . . 0.0 111.297 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -130.85 134.54 26.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.097 0.959 . . . . 0.0 109.442 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.63 147.48 22.19 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.452 2.101 . . . . 0.0 111.955 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -96.35 -16.8 21.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.231 0.612 . . . . 0.0 110.372 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -158.56 174.47 15.02 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.487 1.115 . . . . 0.0 108.625 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' NH2' HG11 ' A' ' 71' ' ' VAL . 17.1 ttt180 -145.08 121.63 11.07 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 56' ' ' VAL . 23.6 pt -90.22 150.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 175.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 83' ' ' ARG . 5.3 p -145.81 117.78 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.49 0.716 . . . . 0.0 109.647 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.6 pt -127.69 154.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.546 0.738 . . . . 0.0 110.678 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 p -118.67 111.37 18.44 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.774 1.23 . . . . 0.0 108.859 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.33 101.8 2.38 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.16 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -76.52 98.28 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.255 0.622 . . . . 0.0 109.816 177.083 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 66.13 92.28 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.668 1.187 . . . . 0.0 111.788 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -164.49 164.92 21.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 0.0 110.938 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.71 168.79 12.2 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.801 0.84 . . . . 0.0 110.522 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.8 tp -61.51 -34.14 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.925 0.49 . . . . 0.0 111.079 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.18 -37.04 93.86 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.12 0.263 . . . . 0.0 113.232 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.07 -44.5 65.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.74 0.816 . . . . 0.0 110.504 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -58.72 -53.14 61.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.772 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.14 -32.9 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.661 1.184 . . . . 0.0 111.296 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.1 t -65.16 -42.28 93.9 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.207 0.603 . . . . 0.0 110.583 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 40' ' ' ILE . 76.7 t -68.22 -40.73 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.109 0.964 . . . . 0.0 110.995 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -69.45 -46.88 65.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.403 0.681 . . . . 0.0 110.938 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -61.73 -50.35 72.78 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.152 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 2.7 tpp180 -64.72 -42.83 94.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.806 0.691 . . . . 0.0 111.182 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.35 82.0 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.607 0.567 . . . . 0.0 110.376 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 23' ' ' ALA . 18.7 t70 -64.93 -34.16 77.75 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.782 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.69 -30.46 69.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.257 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 3.3 mm-40 -76.35 -16.97 59.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.928 0.491 . . . . 0.0 110.562 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.08 20.38 14.14 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.53 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.9 151.2 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.572 0.749 . . . . 0.0 111.508 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.414 ' H ' ' HA ' ' A' ' 90' ' ' LYS . . . -89.23 -29.14 19.47 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.606 1.162 . . . . 0.0 110.527 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 73.3 m -147.7 165.76 29.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.931 0.893 . . . . 0.0 110.74 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -127.88 178.05 6.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.2 1.0 . . . . 0.0 109.178 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.57 99.6 1.59 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.08 101.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG11 ' NH2' ' A' ' 39' ' ' ARG . 5.0 p -89.32 -34.17 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.183 -169.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.12 146.38 27.66 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.305 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.7 m -143.02 118.4 10.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.5 m -130.7 124.25 31.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.852 0.861 . . . . 0.0 109.447 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 40.9 tt0 . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 123.426 0.691 . . . . 0.0 111.047 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 37.9 t30 . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.6 p-90 -113.56 123.52 50.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.126 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 41' ' ' VAL . 5.6 tmm_? -86.8 115.91 24.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.555 1.142 . . . . 0.0 109.111 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' HB1' ' A' ' 52' ' ' ALA . 46.9 t -104.18 113.85 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.02 137.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.69 127.82 17.59 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 110.851 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.91 137.0 45.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.147 0.579 . . . . 0.0 109.533 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -114.37 132.71 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.469 0.652 . . . . 0.0 110.722 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.53 120.01 35.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.985 1.314 . . . . 0.0 107.9 -171.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -85.44 169.72 13.38 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.242 0.474 . . . . 0.0 109.798 175.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.489 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 138.9 57.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.863 0.465 . . . . 0.0 110.747 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 m -61.82 124.27 20.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.16 0.984 . . . . 0.0 111.411 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -66.03 116.61 7.33 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 34' ' ' LEU . 15.8 tp -105.67 121.82 44.78 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.9 p -65.81 151.83 94.24 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.58 0.752 . . . . 0.0 110.771 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.47 -31.54 39.41 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.505 2.803 . . . . 0.0 113.099 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.93 -53.27 52.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.986 0.914 . . . . 0.0 110.799 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -75.79 -25.34 56.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.602 0.761 . . . . 0.0 111.421 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.09 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.119 0.968 . . . . 0.0 110.341 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.46 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.6 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.1 -7.27 55.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.526 0.73 . . . . 0.0 112.431 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD12 HD21 ' A' ' 26' ' ' LEU . 96.2 mt -125.03 163.47 22.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.723 0.809 . . . . 0.0 110.477 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 117.07 51.04 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.001 0.921 . . . . 0.0 108.838 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 151.39 46.41 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.539 2.159 . . . . 0.0 111.849 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -96.78 -29.55 13.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.004 0.522 . . . . 0.0 111.471 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -147.76 178.49 8.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.689 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.652 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 66.4 mtt180 -131.36 146.63 52.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 109.204 169.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.03 142.63 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.63 0.772 . . . . 0.0 108.965 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.34 119.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.73 160.04 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 m -148.52 126.23 11.82 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 153.59 24.94 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.709 -0.281 . . . . 0.0 112.88 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 81' ' ' ASN . 3.6 mpt_? -87.28 135.55 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.76 0.824 . . . . 0.0 109.934 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.4 t80 65.01 24.99 12.65 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.8 1.24 . . . . 0.0 111.931 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 13.1 m120 -70.07 136.39 50.22 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.891 -0.506 . . . . 0.0 109.945 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 170.56 15.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 6.5 tp -61.59 -50.45 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.39 69.55 Favored Glycine 0 C--N 1.348 1.223 0 O-C-N 123.272 0.357 . . . . 0.0 113.151 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.9 -36.27 77.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 110.388 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -74.25 -34.76 63.72 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.624 0.77 . . . . 0.0 110.67 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 70.1 t -66.96 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.781 0.433 . . . . 0.0 110.203 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -65.4 -36.6 84.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.28 0.632 . . . . 0.0 110.522 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.83 -48.67 65.56 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.99 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.6 p -77.45 -27.81 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.226 0.61 . . . . 0.0 111.962 -174.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.8 p -69.66 -48.09 61.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.613 0.365 . . . . 0.0 110.188 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 42.6 ttt-85 -63.83 -46.98 82.62 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 176.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.8 tpp180 -54.06 -49.17 69.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.973 0.909 . . . . 0.0 111.066 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.83 -43.99 86.18 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.869 0.731 . . . . 0.0 110.516 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.55 -34.63 78.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.632 0.773 . . . . 0.0 110.723 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 10.0 mm-40 -70.19 -29.98 66.99 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.17 0.588 . . . . 0.0 110.538 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 14.7 mm-40 -77.89 -9.77 59.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.835 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.74 10.5 61.54 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 113.101 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.93 143.25 37.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.786 0.834 . . . . 0.0 110.755 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.22 -36.82 17.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.669 0.788 . . . . 0.0 111.099 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.0 m -140.12 170.92 14.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 110.298 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -154.81 162.66 41.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.241 0.616 . . . . 0.0 109.74 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -147.18 117.89 7.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.595 0.758 . . . . 0.0 109.894 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.84 114.08 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 110.135 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.75 -25.55 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.952 0.501 . . . . 0.0 111.146 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -158.29 145.48 17.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.188 0.518 . . . . 0.0 111.328 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 84' ' ' VAL . 44.1 p -134.96 106.8 7.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.21 1.404 . . . . 0.0 108.362 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 46.9 m -105.02 130.75 53.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 123.204 0.601 . . . . 0.0 111.299 -177.873 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 11.3 t30 . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.572 0.225 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 1.5 p-90 -161.59 158.11 25.75 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.17 0.988 . . . . 0.0 110.136 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -108.65 153.24 23.7 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.01 0.924 . . . . 0.0 110.085 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 83.6 t -136.83 111.98 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.335 1.054 . . . . 0.0 108.258 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.8 134.82 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.78 126.21 18.81 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.211 1.004 . . . . 0.0 109.167 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 2.5 p30 -76.92 144.17 39.05 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.44 142.17 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.909 0.883 . . . . 0.0 110.255 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.602 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 64.3 m-85 -124.86 161.18 27.12 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.438 1.095 . . . . 0.0 110.802 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -92.23 165.06 13.31 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.704 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.491 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 137.4 47.78 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.023 0.529 . . . . 0.0 110.722 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -68.98 139.93 55.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.412 0.685 . . . . 0.0 110.436 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.53 129.38 34.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 34' ' ' LEU . 13.9 tp -90.58 140.16 30.01 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -174.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 p -68.8 147.63 97.91 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.67 -10.6 12.02 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.641 2.228 . . . . 0.0 113.844 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -82.22 -52.95 6.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.308 0.643 . . . . 0.0 110.236 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 53.0 mt-30 -62.36 -46.0 90.61 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.877 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.85 -36.93 84.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 112.083 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.37 64.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.126 0.57 . . . . 0.0 111.633 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.29 -29.3 12.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.625 0.77 . . . . 0.0 112.151 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 26' ' ' LEU . 95.9 mt -98.24 150.74 21.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -96.03 127.83 39.38 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.99 0.916 . . . . 0.0 109.077 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.4 157.46 32.91 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 111.069 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 37.3 p90 -90.35 -32.54 16.43 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.924 0.392 . . . . 0.0 110.567 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.8 -174.95 4.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.03 0.932 . . . . 0.0 110.22 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -149.37 128.9 13.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.11 0.964 . . . . 0.0 108.703 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -109.31 148.28 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 110.972 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.76 121.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.096 0.958 . . . . 0.0 108.446 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 pt -113.95 154.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.053 0.941 . . . . 0.0 109.439 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 83' ' ' ARG . 21.1 p -113.17 153.35 28.43 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.372 0.669 . . . . 0.0 110.167 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.37 97.02 0.15 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-N 116.856 -0.157 . . . . 0.0 112.881 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -96.98 46.39 1.04 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.546 1.165 . . . . 0.0 109.636 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -177.11 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.776 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -56.03 127.03 28.53 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.885 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 -175.78 5.99 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.237 168.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.15 -34.56 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 118.201 0.455 . . . . 0.0 110.49 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.38 -45.87 66.69 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.257 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.26 -31.35 71.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.685 0.794 . . . . 0.0 110.979 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.52 -46.15 64.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.992 0.917 . . . . 0.0 109.686 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 55.0 t -64.35 -32.58 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.745 0.653 . . . . 0.0 110.728 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -69.88 -42.7 73.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.216 0.606 . . . . 0.0 110.723 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.35 75.83 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.213 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 53' ' ' VAL . 11.9 p -80.19 -27.97 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 122.701 0.4 . . . . 0.0 110.844 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -63.32 -47.53 81.85 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 28.3 tpt180 -64.54 -56.29 14.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 13.7 tpp180 -57.56 -46.18 84.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.793 0.837 . . . . 0.0 111.25 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.45 81.32 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.63 0.582 . . . . 0.0 110.962 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.76 -39.06 92.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.319 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.1 mm-40 -70.96 -25.57 62.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.939 0.496 . . . . 0.0 110.901 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 12.6 mm-40 -76.87 -11.47 59.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.299 0.639 . . . . 0.0 111.258 173.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.01 29.04 19.1 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.519 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.28 132.03 42.18 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.784 0.834 . . . . 0.0 110.3 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.49 82.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.637 0.775 . . . . 0.0 109.88 173.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . 10.2 t -139.74 172.38 12.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.277 -173.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -148.71 171.11 16.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -152.24 118.62 5.61 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.67 102.9 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 123.77 0.669 . . . . 0.0 109.415 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.17 -31.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.841 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.8 t70 -153.26 148.34 26.72 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.368 -171.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 84' ' ' VAL . 12.8 p -142.28 112.84 7.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.458 1.503 . . . . 0.0 107.044 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.419 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . 62.0 m -142.85 147.23 35.06 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.569 0.347 . . . . 0.0 111.031 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 4.5 mm-40 . . . . . 0 N--CA 1.47 0.53 0 C-N-CA 124.677 1.191 . . . . 0.0 110.929 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 81' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.291 0.567 . . . . 0.0 110.158 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.6 p-90 -60.92 133.42 56.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.325 1.05 . . . . 0.0 111.665 -173.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HB3' HG22 ' A' ' 43' ' ' THR . 3.5 ppt_? -105.07 155.24 19.18 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.167 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG21 ' HB1' ' A' ' 52' ' ' ALA . 86.4 t -116.14 123.54 71.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.053 0.941 . . . . 0.0 109.898 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 28.3 t -101.07 124.07 54.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.95 126.47 15.92 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.941 0.496 . . . . 0.0 111.299 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.632 0.773 . . . . 0.0 110.23 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.25 135.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.136 0.493 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 51.9 m-85 -115.39 129.1 56.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.6 1.16 . . . . 0.0 110.306 -170.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HB2' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.62 138.33 32.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.67 1.188 . . . . 0.0 108.878 179.039 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.34 142.31 48.79 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -81.04 144.12 31.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.709 0.804 . . . . 0.0 110.419 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.11 130.96 44.52 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.2 tp -111.65 122.72 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.5 p -67.89 148.96 98.41 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.706 0.803 . . . . 0.0 111.083 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -41.06 -43.21 4.9 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 124.84 3.694 . . . . 0.0 115.601 -177.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.72 -39.77 66.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.061 0.544 . . . . 0.0 111.221 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.2 -25.02 60.6 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.251 0.62 . . . . 0.0 111.025 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.04 -31.8 56.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.276 1.03 . . . . 0.0 110.631 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.53 -23.32 56.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.919 0.888 . . . . 0.0 110.381 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.24 -47.09 16.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.753 0.821 . . . . 0.0 111.243 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -91.59 145.89 24.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.005 0.522 . . . . 0.0 110.613 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -95.39 118.98 66.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.53 0.732 . . . . 0.0 109.248 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.15 153.22 31.79 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.309 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -94.08 -14.91 25.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.148 0.579 . . . . 0.0 111.701 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -166.83 164.73 16.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.318 0.647 . . . . 0.0 110.164 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 129.21 54.74 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.702 1.201 . . . . 0.0 108.777 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 56' ' ' VAL . 31.7 pt -95.72 156.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.485 0.714 . . . . 0.0 110.664 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.0 t -129.58 121.42 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 109.21 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.6 166.15 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 p -123.91 114.77 20.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.094 0.558 . . . . 0.0 110.982 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.28 1.05 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -92.73 94.66 9.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.177 0.591 . . . . 0.0 110.45 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 59.37 41.6 19.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.479 1.111 . . . . 0.0 109.841 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 14.8 m120 -115.38 166.78 11.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.528 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.44 168.53 16.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.859 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.9 tp -63.08 -32.83 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.11 79.61 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.447 0.467 . . . . 0.0 113.083 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 33.9 m-20 -75.05 -35.53 61.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.631 0.772 . . . . 0.0 110.531 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.94 70.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.934 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.34 -33.01 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.324 1.05 . . . . 0.0 110.759 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 t -63.68 -51.85 63.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.765 0.826 . . . . 0.0 110.832 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.81 95.3 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.264 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 40' ' ' ILE . 48.4 t -66.16 -40.11 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.924 0.89 . . . . 0.0 111.725 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -63.62 -43.35 97.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.311 0.645 . . . . 0.0 110.742 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 32.0 ttt180 -65.3 -54.34 30.51 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.969 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 27.4 tpt180 -61.9 -38.13 87.21 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.063 0.852 . . . . 0.0 111.469 -169.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.36 90.39 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.643 0.777 . . . . 0.0 110.619 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.44 -31.61 72.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.685 0.794 . . . . 0.0 110.881 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 4.8 mm-40 -67.04 -33.29 75.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.193 0.597 . . . . 0.0 110.357 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.9 mm-40 -79.74 -12.96 59.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.287 0.635 . . . . 0.0 111.125 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.12 28.05 14.45 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.218 0.324 . . . . 0.0 112.622 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.82 142.16 27.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 0.0 110.705 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.98 -27.72 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.819 0.847 . . . . 0.0 110.253 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 50.4 m -142.88 167.75 21.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.91 0.884 . . . . 0.0 111.137 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 161.8 39.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 109.629 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -155.48 125.11 6.42 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.971 0.508 . . . . 0.0 109.822 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.33 112.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 -41.67 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.456 0.703 . . . . 0.0 110.088 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.0 t70 -131.53 141.0 49.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.728 0.411 . . . . 0.0 110.66 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.0 p -135.41 106.14 6.54 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -121.88 111.09 16.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.904 0.482 . . . . 0.0 109.86 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 10.9 pt-20 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 122.962 0.505 . . . . 0.0 111.414 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.6 p-90 -134.24 136.47 43.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.195 0.998 . . . . 0.0 111.688 -175.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -65.07 136.49 56.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.597 1.159 . . . . 0.0 110.198 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.89 106.65 18.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 59.8 t -96.68 124.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.015 0.926 . . . . 0.0 108.968 174.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.55 125.53 22.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.173 0.589 . . . . 0.0 110.952 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.87 144.28 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.704 0.802 . . . . 0.0 109.518 173.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -115.81 134.39 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.297 0.639 . . . . 0.0 110.196 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 68.5 m-85 -124.17 151.11 44.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.757 0.823 . . . . 0.0 110.54 -166.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.23 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.586 0.755 . . . . 0.0 110.755 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.819 0.848 . . . . 0.0 109.338 175.666 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.53 142.59 15.58 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.246 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 138.21 51.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.398 0.279 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.1 m -78.66 138.82 38.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.343 0.657 . . . . 0.0 110.537 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.08 118.12 11.58 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.0 tp -99.18 129.88 45.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.9 p -71.51 154.03 93.49 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.484 0.714 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.27 -18.35 51.83 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.831 2.354 . . . . 0.0 113.498 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.42 -53.63 11.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.211 0.605 . . . . 0.0 109.991 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.19 -33.73 74.96 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.272 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.35 80.8 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.827 0.851 . . . . 0.0 110.772 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.48 -23.29 64.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.244 0.618 . . . . 0.0 111.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.42 3.99 54.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.386 0.674 . . . . 0.0 112.13 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.438 HD12 HD21 ' A' ' 26' ' ' LEU . 93.0 mt -130.2 152.24 49.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.623 0.769 . . . . 0.0 110.245 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -108.18 125.01 32.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 58.1 Cg_endo -68.86 138.99 42.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.234 1.956 . . . . 0.0 111.555 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -79.31 -24.38 42.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.231 0.538 . . . . 0.0 110.459 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -156.24 172.47 18.41 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.592 1.157 . . . . 0.0 108.545 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -143.47 119.87 10.95 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HG13 ' A' ' 56' ' ' VAL . 36.5 pt -94.71 138.15 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 122.777 0.431 . . . . 0.0 110.371 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 85' ' ' VAL . 38.5 t -121.62 131.99 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 pt -123.54 166.13 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.041 0.936 . . . . 0.0 108.948 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -116.5 145.11 43.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 171.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.1 108.78 0.47 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -80.7 79.06 7.41 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.2 t80 44.07 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.478 1.511 . . . . 0.0 113.675 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -122.44 -65.3 1.12 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.08 148.96 5.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 108.824 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.95 -39.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.07 77.47 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.434 0.459 . . . . 0.0 113.148 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.76 -44.51 77.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.828 0.851 . . . . 0.0 109.444 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -67.2 -44.78 78.73 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.042 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.48 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.795 0.838 . . . . 0.0 111.016 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 t -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.94 0.496 . . . . 0.0 110.217 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.88 69.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.952 0.501 . . . . 0.0 110.977 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 40' ' ' ILE . 97.6 t -70.38 -37.49 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.293 0.637 . . . . 0.0 109.926 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.4 t -64.89 -41.86 95.27 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.769 0.827 . . . . 0.0 110.684 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.34 -59.45 4.35 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.159 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 15.6 tpp180 -63.89 -38.33 90.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.67 0.788 . . . . 0.0 111.837 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.35 98.31 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.04 0.448 . . . . 0.0 110.537 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.19 -36.7 85.01 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.774 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.81 -20.6 61.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.256 0.622 . . . . 0.0 111.279 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 34.4 mm-40 -90.97 -4.62 56.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.991 0.516 . . . . 0.0 111.383 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.13 7.93 76.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.067 0.23 . . . . 0.0 113.672 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 137.66 47.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.559 0.743 . . . . 0.0 110.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -71.0 -40.92 71.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.804 0.841 . . . . 0.0 110.525 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 32.7 m -137.32 172.6 12.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.959 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -143.09 165.05 28.45 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.127 0.971 . . . . 0.0 109.365 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.66 112.19 6.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.042 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.34 113.28 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 86' ' ' ALA . 61.7 t -82.67 -48.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -164.6 143.56 7.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.79 -168.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 84' ' ' VAL . 68.8 p -120.84 104.82 10.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 p -129.12 144.88 51.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.329 0.652 . . . . 0.0 111.23 -171.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 27.8 mt-10 -63.77 119.85 10.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.071 0.948 . . . . 0.0 110.369 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -71.29 77.27 0.73 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.019 1.328 . . . . 0.0 110.296 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.47 -55.97 4.42 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.885 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -118.96 167.94 11.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 110.156 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -77.93 159.38 28.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.52 0.728 . . . . 0.0 110.73 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.97 -55.52 4.62 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 112.046 -0.421 . . . . 0.0 112.046 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 4.4 p30 -87.43 91.7 8.82 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 29.6 p-90 -95.83 172.91 7.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.722 172.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.435 ' NH1' ' HB ' ' A' ' 85' ' ' VAL . 2.7 ppt_? -142.56 154.76 44.74 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.319 1.048 . . . . 0.0 108.624 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 73' ' ' THR . 57.5 t -119.22 111.76 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 0.0 109.363 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 41' ' ' VAL . 7.3 p -90.34 128.82 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' A' ' 71' ' ' VAL . . . -145.6 131.85 19.5 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.218 0.607 . . . . 0.0 111.167 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 68.7 m-20 -70.12 158.03 36.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 110.6 173.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.9 139.32 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.462 0.705 . . . . 0.0 109.431 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -127.82 136.52 51.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.939 0.896 . . . . 0.0 110.194 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -80.76 167.66 19.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.667 0.787 . . . . 0.0 111.585 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.275 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.1 m80 . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 173.71 106.88 0.01 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 124.837 1.255 . . . . 0.0 108.8 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.83 145.71 42.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.637 0.375 . . . . 0.0 110.328 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.6 m -69.96 140.09 52.94 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.29 0.636 . . . . 0.0 111.107 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.64 126.46 30.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 34' ' ' LEU . 12.7 tp -98.93 126.06 44.52 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 p -74.03 143.61 80.99 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.985 0.514 . . . . 0.0 109.996 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.82 -34.84 6.29 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.551 3.5 . . . . 0.0 115.667 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -69.62 -44.22 71.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.576 0.751 . . . . 0.0 110.695 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -68.9 -39.19 79.87 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.141 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.06 63.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.198 0.999 . . . . 0.0 112.099 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.45 77.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.163 0.585 . . . . 0.0 110.164 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.12 36.83 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.534 HD12 HD21 ' A' ' 26' ' ' LEU . 90.2 mt -89.02 157.4 18.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.333 0.653 . . . . 0.0 111.269 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -110.44 128.6 25.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.25 159.69 48.99 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.201 1.934 . . . . 0.0 111.532 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -96.52 -14.73 22.09 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -158.86 154.84 26.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.979 0.912 . . . . 0.0 109.951 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 86.3 mtm180 -124.49 127.14 47.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.553 1.141 . . . . 0.0 108.764 171.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 56' ' ' VAL . 32.1 pt -103.5 161.7 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.04 0.936 . . . . 0.0 110.63 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.54 129.67 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.984 0.914 . . . . 0.0 109.825 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.66 166.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.407 1.083 . . . . 0.0 108.76 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 29.4 m -149.82 130.47 14.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.38 133.42 6.96 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 23.9 ttm-85 -100.6 123.66 45.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.183 0.593 . . . . 0.0 110.003 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 63.16 11.74 5.51 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.939 1.296 . . . . 0.0 113.049 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 13.8 m120 -79.79 148.94 31.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.371 0.668 . . . . 0.0 110.287 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.64 168.23 17.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.299 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.1 tp -57.5 -31.9 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.541 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.12 93.59 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.758 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 12.7 m-20 -67.19 -37.51 83.81 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.624 0.77 . . . . 0.0 110.789 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.93 -53.4 47.09 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.913 0.758 . . . . 0.0 110.71 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.46 -36.21 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 0.0 110.853 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 t -64.86 -42.85 94.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.918 0.887 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.44 -37.39 65.86 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.52 0.728 . . . . 0.0 111.451 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 40' ' ' ILE . 76.6 t -65.19 -45.36 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.132 0.573 . . . . 0.0 110.485 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -68.73 -32.28 71.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.821 0.848 . . . . 0.0 110.744 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -65.79 -55.04 19.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.515 0.726 . . . . 0.0 109.8 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -62.28 -44.67 95.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.994 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.47 -49.13 78.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.751 0.82 . . . . 0.0 111.182 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.64 -38.66 91.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.404 0.682 . . . . 0.0 111.088 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -76.16 -21.04 57.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.151 0.581 . . . . 0.0 112.202 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -76.82 -22.59 53.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.992 0.517 . . . . 0.0 110.277 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.02 11.41 60.15 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.902 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.9 129.16 38.82 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.661 0.784 . . . . 0.0 110.141 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.65 84.67 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 123.874 0.734 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 26' ' ' LEU . 13.8 t -141.4 174.99 10.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.019 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.78 163.94 35.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.299 1.04 . . . . 0.0 108.86 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -151.49 118.4 5.83 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -71.24 114.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.28 -23.35 5.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -163.53 129.61 3.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.981 0.419 . . . . 0.0 111.18 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 p -111.33 141.59 44.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 165.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 23.0 t -159.19 139.88 12.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 79' ' ' SER . 46.8 mt-10 -77.92 119.72 21.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.101 0.56 . . . . 0.0 110.663 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' H ' ' HA ' ' A' ' 82' ' ' TRP . 69.9 t80 -75.92 132.67 40.41 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.634 1.174 . . . . 0.0 109.92 -174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.48 -76.46 1.51 Allowed Glycine 0 C--N 1.343 0.922 0 O-C-N 124.019 0.825 . . . . 0.0 112.155 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -137.05 -77.63 0.4 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.107 0.963 . . . . 0.0 108.635 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 74.7 m -154.78 176.59 12.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.992 0.917 . . . . 0.0 110.201 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.73 -66.28 3.95 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 56.6 t30 -80.17 135.28 36.25 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.434 ' HA ' ' H ' ' A' ' 76' ' ' PHE . 4.6 p-90 -150.22 131.0 14.12 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.368 0.604 . . . . 0.0 111.287 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HD2' ' HB3' ' A' ' 74' ' ' SER . 0.0 OUTLIER -91.66 156.37 17.65 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 110.171 178.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' A' ' 52' ' ' ALA . 61.0 t -139.7 116.58 9.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 124.14 0.976 . . . . 0.0 108.431 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 132.45 40.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.43 138.07 29.06 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.113 0.965 . . . . 0.0 109.048 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.597 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -101.79 141.76 34.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.637 0.775 . . . . 0.0 109.353 176.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.02 142.6 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.038 0.935 . . . . 0.0 110.045 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -124.52 155.94 38.15 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.338 1.055 . . . . 0.0 111.746 -165.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -110.57 145.46 37.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.494 1.118 . . . . 0.0 108.94 169.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.585 0.754 . . . . 0.0 108.983 -178.079 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 146.51 31.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.547 1.139 . . . . 0.0 108.805 176.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.71 129.37 39.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -66.17 135.39 54.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.435 0.694 . . . . 0.0 110.663 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.98 115.83 11.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -89.7 134.6 34.08 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.4 p -68.25 142.49 94.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.778 0.674 . . . . 0.0 109.943 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.47 -34.13 7.27 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 124.08 3.187 . . . . 0.0 113.881 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.28 -57.57 9.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 0.0 110.879 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.7 -33.93 77.11 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.82 -24.98 61.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.082 0.953 . . . . 0.0 112.092 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 -18.31 49.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.982 0.513 . . . . 0.0 111.407 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.89 -39.57 8.92 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.346 0.659 . . . . 0.0 111.0 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.33 142.0 28.22 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.985 0.914 . . . . 0.0 109.35 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -103.08 128.78 26.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.75 161.13 30.79 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.887 2.391 . . . . 0.0 112.138 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -98.41 -21.06 16.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.868 0.467 . . . . 0.0 110.502 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -155.83 161.28 40.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.048 0.939 . . . . 0.0 109.558 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.6 mtm180 -123.09 119.03 29.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 56' ' ' VAL . 43.2 pt -90.98 131.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.59 120.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -118.93 179.4 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.158 0.983 . . . . 0.0 109.119 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 23.7 p -119.06 119.47 34.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.648 0.779 . . . . 0.0 109.539 169.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.65 135.06 12.61 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -97.51 171.36 8.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 117.967 0.883 . . . . 0.0 111.122 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.35 3.38 3.77 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 0.0 112.297 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -52.23 -51.56 57.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.399 1.08 . . . . 0.0 111.578 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.48 164.17 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.742 0.817 . . . . 0.0 110.981 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.96 -43.01 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.08 -16.02 70.3 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.671 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.08 -51.99 61.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.965 0.906 . . . . 0.0 109.651 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -68.91 -46.98 66.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.075 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.19 -35.53 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.761 0.825 . . . . 0.0 111.582 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 t -64.23 -44.57 91.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.568 0.747 . . . . 0.0 110.504 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.78 66.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.054 0.542 . . . . 0.0 111.71 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG13 HD11 ' A' ' 40' ' ' ILE . 49.8 t -72.17 -45.94 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.912 0.485 . . . . 0.0 109.717 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -63.35 -45.32 91.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.064 0.946 . . . . 0.0 110.945 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 31.7 mmt180 -72.3 -37.01 69.08 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.994 0.809 . . . . 0.0 111.427 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 tpt180 -66.7 -48.92 67.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.15 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -34.42 76.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.053 0.941 . . . . 0.0 110.905 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.3 -39.13 92.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.79 0.836 . . . . 0.0 110.806 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 51.5 mt-10 -64.74 -34.68 78.9 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.359 0.663 . . . . 0.0 110.925 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.0 mm-40 -78.64 -8.11 58.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.517 0.727 . . . . 0.0 111.374 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.92 17.45 79.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.269 0.356 . . . . 0.0 112.996 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . . . -73.62 128.52 35.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.978 0.911 . . . . 0.0 109.996 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.26 69.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.67 0.788 . . . . 0.0 111.506 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 56.5 m -144.99 171.21 14.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.379 0.672 . . . . 0.0 111.482 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.7 166.62 28.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.447 1.099 . . . . 0.0 108.698 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -155.29 129.12 8.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -77.09 113.16 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.86 0.464 . . . . 0.0 110.094 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.73 -25.93 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.279 0.632 . . . . 0.0 111.539 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 19.7 t70 -148.29 138.44 22.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.012 0.525 . . . . 0.0 110.849 -174.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 84' ' ' VAL . 23.4 p -136.53 106.09 6.14 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.571 1.149 . . . . 0.0 108.033 170.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -121.03 138.44 54.17 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.121 0.968 . . . . 0.0 109.416 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 11.8 pt-20 -69.23 160.03 31.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.984 0.421 . . . . 0.0 110.985 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -77.53 -35.72 53.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 142.35 -95.85 0.19 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -86.09 -21.19 27.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.841 0.856 . . . . 0.0 110.859 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m -76.96 151.95 35.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.373 0.669 . . . . 0.0 111.181 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.32 47.7 3.88 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.03 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -130.73 119.4 22.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.044 1.338 . . . . 0.0 108.604 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.1 p-90 -109.25 108.18 18.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 108.992 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -64.78 149.64 48.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.434 0.694 . . . . 0.0 109.197 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.3 t -126.6 114.39 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.537 . . . . 0.0 109.948 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 34.4 t -88.96 124.32 41.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 165.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.69 121.58 14.51 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.426 0.691 . . . . 0.0 109.338 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 46.8 p-10 -81.28 140.41 34.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.733 0.413 . . . . 0.0 110.133 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.18 137.8 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.144 0.978 . . . . 0.0 110.379 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 35.9 m-85 -118.55 139.28 51.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.568 1.147 . . . . 0.0 110.393 -168.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 65' ' ' ALA . 32.7 mmtp -95.36 159.07 15.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 109.839 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.883 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.6 t60 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.86 130.72 4.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.4 1.08 . . . . 0.0 108.652 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.28 149.14 48.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.58 0.752 . . . . 0.0 111.612 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.7 m -74.02 142.35 45.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.559 0.744 . . . . 0.0 110.545 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.27 118.73 14.43 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.1 tp -85.21 119.25 25.38 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -64.73 141.75 98.38 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.59 -39.4 1.92 Allowed 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 125.044 3.83 . . . . 0.0 116.083 -173.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.93 -40.29 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.281 0.632 . . . . 0.0 110.332 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.94 -38.32 76.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.371 0.669 . . . . 0.0 110.213 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.15 -29.78 70.65 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.335 1.054 . . . . 0.0 111.171 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.91 -29.51 55.74 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.856 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.07 26.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.326 0.651 . . . . 0.0 112.36 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 26' ' ' LEU . 96.9 mt -115.51 143.73 44.89 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.711 0.805 . . . . 0.0 110.171 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -92.7 133.05 29.96 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 0.0 110.137 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.26 153.42 24.4 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 5.7 p90 -99.12 -32.49 11.22 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -143.76 174.73 10.56 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -139.26 125.95 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.477 1.111 . . . . 0.0 108.661 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.58 HD11 HG13 ' A' ' 56' ' ' VAL . 32.7 pt -103.06 152.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.977 0.511 . . . . 0.0 110.427 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.99 133.15 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -116.23 157.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.279 1.032 . . . . 0.0 109.076 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.5 m -134.65 139.46 45.3 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.33 142.96 11.52 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.49 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -68.55 -40.71 80.54 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.225 0.61 . . . . 0.0 110.788 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -166.25 135.84 3.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.34 0.656 . . . . 0.0 109.613 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.6 -116.55 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.0 168.17 19.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 0.0 108.323 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 9.7 tp -63.28 -37.59 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.6 88.3 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.457 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.02 -34.34 77.78 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.743 0.817 . . . . 0.0 111.541 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.21 -46.19 57.18 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.843 0.857 . . . . 0.0 110.259 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.05 -33.68 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.568 0.747 . . . . 0.0 110.598 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -72.66 -35.01 67.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.91 0.884 . . . . 0.0 110.927 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.82 78.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.244 0.617 . . . . 0.0 109.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 40' ' ' ILE . 53.9 t -64.53 -37.05 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.217 1.007 . . . . 0.0 110.852 174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -61.38 -52.73 63.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.888 0.875 . . . . 0.0 110.711 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -69.45 -37.76 77.49 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.79 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 12.5 tpt180 -66.85 -37.35 84.29 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.323 0.649 . . . . 0.0 111.256 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.25 83.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.499 0.72 . . . . 0.0 110.343 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.21 -35.1 73.67 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.481 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 12.6 mm-40 -63.19 -34.49 77.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.741 0.816 . . . . 0.0 110.606 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 37.1 mm-40 -70.63 -29.02 65.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.506 175.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.33 4.28 53.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.071 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 141.77 49.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.693 0.797 . . . . 0.0 110.557 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.21 64.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 110.632 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.1 m -141.14 173.57 11.35 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.719 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.48 173.99 12.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.33 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -160.5 120.24 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 109.944 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.22 113.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.868 0.867 . . . . 0.0 109.67 173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.7 -20.76 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 0.0 111.501 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 22.9 t70 -154.29 145.22 22.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.123 0.569 . . . . 0.0 110.904 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.5 HG22 HG22 ' A' ' 84' ' ' VAL . 26.0 p -137.55 111.49 8.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.915 1.286 . . . . 0.0 107.978 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -118.43 135.19 54.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.227 0.611 . . . . 0.0 109.551 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -108.39 170.01 8.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.114 0.566 . . . . 0.0 110.788 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -71.97 -34.71 69.17 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.011 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.79 79.88 0.76 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.518 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 67.16 8.85 6.5 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.005 1.322 . . . . 0.0 113.544 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -90.83 4.12 52.6 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.194 0.597 . . . . 0.0 111.234 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.28 -49.3 3.92 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -70.62 141.1 51.75 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 121.251 0.548 . . . . 0.0 110.596 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.415 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 1.7 p-90 -157.32 177.45 11.43 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.318 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.73 156.01 44.38 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.333 0.653 . . . . 0.0 109.677 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.603 HG21 ' HB1' ' A' ' 52' ' ' ALA . 98.9 t -130.92 115.83 31.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.009 0.924 . . . . 0.0 109.564 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 56.5 t -92.39 129.89 42.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 108.766 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.57 125.69 13.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.583 0.753 . . . . 0.0 110.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.33 143.02 35.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.01 139.64 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.414 0.686 . . . . 0.0 110.428 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -121.03 139.59 53.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.484 1.113 . . . . 0.0 109.993 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 31.6 mmmt -90.08 165.56 13.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.567 0.747 . . . . 0.0 110.49 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.425 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.71 107.01 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 0.0 109.317 -168.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.38 138.09 33.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.315 1.046 . . . . 0.0 112.48 -169.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -63.37 147.6 50.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.079 0.952 . . . . 0.0 110.817 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.39 122.64 20.71 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -81.92 138.07 35.07 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.7 p -74.47 152.07 87.56 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.303 0.641 . . . . 0.0 109.916 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.96 -23.19 75.57 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.335 2.023 . . . . 0.0 112.683 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.39 -56.24 24.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.074 0.95 . . . . 0.0 110.278 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -76.07 -24.99 55.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.112 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.633 0.773 . . . . 0.0 111.156 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.42 -28.75 26.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.141 0.576 . . . . 0.0 110.187 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.03 3.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.413 0.685 . . . . 0.0 110.849 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.7 148.21 25.54 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.72 0.808 . . . . 0.0 110.193 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.3 143.17 26.24 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.09 144.29 37.49 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.394 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -77.08 -20.56 55.63 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.838 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -159.45 161.97 35.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.524 1.13 . . . . 0.0 108.85 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.0 ttm180 -132.88 120.84 22.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.641 0.777 . . . . 0.0 108.917 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 HG21 ' HD2' ' A' ' 59' ' ' ARG . 27.9 pt -91.91 163.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.698 0.799 . . . . 0.0 111.451 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG23 ' NE ' ' A' ' 83' ' ' ARG . 2.2 p -142.22 130.5 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 110.387 -173.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' A' ' 84' ' ' VAL . 41.4 pt -144.89 174.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.696 1.198 . . . . 0.0 109.109 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 p -136.56 125.01 23.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.369 1.068 . . . . 0.0 108.819 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.16 73.43 1.51 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 62.6 ttt180 -68.5 96.34 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.845 0.458 . . . . 0.0 111.002 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.4 t80 65.33 19.77 11.71 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.13 1.372 . . . . 0.0 111.118 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -91.44 150.67 21.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.649 0.779 . . . . 0.0 110.069 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.43 161.06 23.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.368 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.4 -46.83 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.549 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.87 -29.08 69.65 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.664 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.09 -48.54 65.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.462 0.705 . . . . 0.0 110.676 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -69.74 -32.49 71.05 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.85 -38.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.846 0.458 . . . . 0.0 110.625 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -65.98 -35.73 81.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.773 0.429 . . . . 0.0 110.479 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.46 64.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.537 0.735 . . . . 0.0 111.485 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.36 -31.63 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.284 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.0 t -69.97 -43.12 72.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.683 0.793 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 ttt180 -61.84 -49.12 77.55 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.466 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.48 -46.07 87.38 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 109.684 -176.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.53 83.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.085 0.866 . . . . 0.0 111.066 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.04 -34.83 79.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.63 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 58.5 mt-10 -70.62 -23.11 62.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.84 0.456 . . . . 0.0 110.916 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -89.72 2.15 55.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.379 0.672 . . . . 0.0 111.58 175.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 24.08 67.32 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.448 -0.342 . . . . 0.0 113.324 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.43 134.13 35.5 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.376 0.671 . . . . 0.0 110.178 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.33 75.96 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.549 0.69 . . . . 0.0 110.174 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 m -148.98 169.66 20.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.792 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -145.13 149.88 35.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.087 0.955 . . . . 0.0 108.521 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -128.5 131.23 48.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -78.28 123.53 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HB ' ' OD1' ' A' ' 87' ' ' ASP . 7.7 p -86.85 -33.5 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.696 0.399 . . . . 0.0 110.139 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -160.72 144.2 13.41 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.795 0.438 . . . . 0.0 110.839 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 21.1 p -133.38 112.98 12.05 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 t -126.74 120.39 29.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.391 0.676 . . . . 0.0 110.523 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 33.9 mt-10 -66.62 122.24 17.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.691 0.796 . . . . 0.0 110.474 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -59.71 -44.83 93.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.233 1.013 . . . . 0.0 111.297 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.29 -164.25 13.17 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.446 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.54 -11.65 61.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.491 0.716 . . . . 0.0 111.626 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 t -72.6 177.27 4.81 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.881 0.872 . . . . 0.0 110.513 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.39 11.42 44.73 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.922 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 52.3 t30 -82.54 129.84 35.0 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.484 0.642 . . . . 0.0 110.356 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 3.0 p-90 -142.68 124.74 15.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.054 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.614 ' HE ' ' HB ' ' A' ' 85' ' ' VAL . 12.0 tpt180 -64.44 116.58 6.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.03 1.332 . . . . 0.0 109.747 174.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.51 ' HB ' HG13 ' A' ' 42' ' ' ILE . 26.6 t -106.43 107.99 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.614 ' HB ' ' HE ' ' A' ' 83' ' ' ARG . 5.8 p -118.91 126.84 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.25 142.75 35.75 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.568 0.747 . . . . 0.0 110.214 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.49 143.53 26.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 124.624 1.17 . . . . 0.0 110.38 178.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.29 141.4 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.086 0.954 . . . . 0.0 110.551 -171.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -125.04 167.58 14.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.01 0.924 . . . . 0.0 112.293 -167.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 10.3 mmpt? -101.56 164.46 11.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.796 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.062 173.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.53 136.81 0.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.482 1.513 . . . . 0.0 108.178 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.19 115.49 6.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.586 0.354 . . . . 0.0 110.983 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.9 m -67.73 137.33 55.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.7 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -72.83 118.25 15.53 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.9 tp -85.45 144.85 27.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.994 0.918 . . . . 0.0 109.032 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 p -84.92 157.3 60.33 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.042 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.38 -28.42 80.16 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.813 2.342 . . . . 0.0 113.561 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.84 -44.96 75.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.869 0.468 . . . . 0.0 110.586 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.516 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 51.9 mt-30 -72.22 -28.35 63.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.917 0.487 . . . . 0.0 110.98 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 -23.08 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.31 0.644 . . . . 0.0 110.739 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.33 25.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.461 0.704 . . . . 0.0 110.568 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.53 36.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.663 0.785 . . . . 0.0 110.788 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.6 166.2 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.269 1.027 . . . . 0.0 110.236 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -118.86 149.2 46.14 Favored Pre-proline 0 C--O 1.244 0.795 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.48 165.67 22.8 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.603 2.202 . . . . 0.0 111.871 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -96.61 -45.3 6.77 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.23 -173.84 3.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 109.854 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 29.8 mtt180 -123.87 171.55 9.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.304 0.642 . . . . 0.0 109.305 170.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 pt -138.89 138.35 41.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.1 124.73 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 pt -118.45 175.7 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.968 0.907 . . . . 0.0 108.777 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 19.7 p -130.49 113.87 14.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 64.91 3.72 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 53.7 ttt180 -63.77 95.69 0.12 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.93 0.892 . . . . 0.0 111.089 -172.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.8 t80 63.55 16.4 9.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.727 1.211 . . . . 0.0 111.436 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -88.69 155.94 19.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.813 0.845 . . . . 0.0 109.739 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.91 161.03 30.56 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.261 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 tp -60.16 -37.39 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.338 0.655 . . . . 0.0 110.875 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.66 90.97 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.344 0.402 . . . . 0.0 112.887 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.19 -36.42 77.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.556 0.742 . . . . 0.0 110.767 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.6 82.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.63 0.581 . . . . 0.0 110.15 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.95 -36.64 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.005 0.522 . . . . 0.0 110.295 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.7 t -68.79 -41.42 78.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.964 0.506 . . . . 0.0 110.691 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.54 -35.08 67.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.165 0.586 . . . . 0.0 111.749 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 p -77.0 -31.01 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -72.44 -35.49 68.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.928 0.491 . . . . 0.0 110.407 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -61.06 -56.91 15.43 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.467 1.105 . . . . 0.0 109.797 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -59.44 -45.68 90.89 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.118 0.886 . . . . 0.0 111.403 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.24 94.45 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.611 0.569 . . . . 0.0 111.317 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.03 -37.49 87.61 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.116 0.567 . . . . 0.0 110.665 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.42 -19.31 60.45 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.547 0.739 . . . . 0.0 111.416 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.11 -7.3 59.41 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.914 0.886 . . . . 0.0 111.133 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 13.95 81.28 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.627 -0.26 . . . . 0.0 112.912 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.05 134.9 38.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.702 0.801 . . . . 0.0 110.318 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.76 -38.79 46.08 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.073 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 22.8 m -134.45 169.82 16.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.664 -176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -149.53 158.41 44.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.641 0.776 . . . . 0.0 109.0 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -143.78 119.05 10.18 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.386 0.674 . . . . 0.0 109.277 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 86' ' ' ALA . 63.8 t -71.47 112.12 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.386 0.675 . . . . 0.0 109.702 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.51 -26.71 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.4 t70 -143.17 133.43 24.57 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.064 0.546 . . . . 0.0 110.281 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.2 p -132.07 112.63 12.51 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -115.88 173.74 6.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.877 0.871 . . . . 0.0 108.98 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -142.1 154.21 44.73 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.43 0.692 . . . . 0.0 109.993 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -100.44 82.5 2.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.1 -118.27 12.78 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.351 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -127.66 41.93 3.42 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.277 1.037 . . . . 0.0 108.295 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.1 t -88.22 -2.82 58.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.46 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.81 -35.43 3.88 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 122.704 0.192 . . . . 0.0 113.363 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 3.6 p-10 -78.31 92.22 4.5 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 0.0 110.926 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 43.3 p-90 -99.66 127.58 45.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.674 171.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -95.05 153.97 17.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.534 0.733 . . . . 0.0 110.758 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.88 112.78 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.704 1.202 . . . . 0.0 108.863 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 39.9 t -98.08 115.11 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 70' ' ' VAL . . . -126.15 120.57 30.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.497 0.719 . . . . 0.0 109.937 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 1.2 m-20 -70.3 146.12 50.79 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.979 174.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.35 136.86 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.032 0.533 . . . . 0.0 110.186 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 34.5 m-85 -126.04 170.17 12.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.638 1.175 . . . . 0.0 110.744 -168.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.99 178.57 5.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.023 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.733 0.813 . . . . 0.0 108.827 172.676 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.829 0.347 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . -159.41 130.53 6.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.966 0.906 . . . . 0.0 108.967 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.87 136.23 56.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.312 0.645 . . . . 0.0 111.583 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 m -68.24 130.63 43.49 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.048 0.539 . . . . 0.0 110.755 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.1 118.26 12.71 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 27.1 tp -93.16 139.78 30.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.473 1.109 . . . . 0.0 109.717 -172.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -71.38 147.95 93.14 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.545 0.738 . . . . 0.0 110.16 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.48 -33.62 86.76 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.421 2.747 . . . . 0.0 113.991 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.0 -46.8 64.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.999 0.52 . . . . 0.0 111.012 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -73.25 -23.44 60.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.201 0.6 . . . . 0.0 111.463 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.13 -36.06 61.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 0.0 110.352 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.36 61.86 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.25 -48.93 38.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.511 0.725 . . . . 0.0 110.392 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.37 170.5 15.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.441 0.696 . . . . 0.0 111.355 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -121.32 123.33 27.73 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.556 0.742 . . . . 0.0 109.694 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.81 133.26 12.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.936 2.424 . . . . 0.0 112.254 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.68 -34.67 30.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.157 0.583 . . . . 0.0 110.194 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.26 171.86 13.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.471 1.108 . . . . 0.0 108.468 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 5.7 ttp180 -140.71 128.5 21.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.372 1.069 . . . . 0.0 108.116 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.7 pt -103.32 161.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.079 0.552 . . . . 0.0 110.531 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG23 ' HD3' ' A' ' 83' ' ' ARG . 2.0 p -148.76 132.34 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.985 0.914 . . . . 0.0 109.438 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -132.32 166.72 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.608 1.163 . . . . 0.0 109.528 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.7 p -134.08 118.82 18.17 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.382 1.073 . . . . 0.0 109.637 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.86 115.06 5.14 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.653 -0.526 . . . . 0.0 111.811 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -76.11 91.43 3.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.282 0.633 . . . . 0.0 110.165 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 t80 65.79 12.29 8.22 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.309 1.444 . . . . 0.0 112.003 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -72.65 154.78 40.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.9 162.36 29.16 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.592 0.357 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.7 tp -60.31 -31.78 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.053 0.541 . . . . 0.0 110.676 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.88 -42.9 98.24 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.912 -0.382 . . . . 0.0 112.897 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -62.92 -43.18 99.5 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.372 0.669 . . . . 0.0 110.074 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.2 -51.2 67.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.021 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.69 -37.4 79.56 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 123.693 0.797 . . . . 0.0 110.395 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.0 t -69.06 -36.44 77.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.364 0.666 . . . . 0.0 111.198 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.01 -40.25 60.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.39 0.676 . . . . 0.0 111.252 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.03 -27.89 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 123.269 0.628 . . . . 0.0 110.19 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.408 ' OG ' ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -70.26 -42.97 71.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.851 0.861 . . . . 0.0 110.104 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 18.7 ttt180 -57.47 -57.61 11.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.64 175.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.3 tpp85 -61.03 -40.97 95.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.08 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.78 96.31 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.173 0.589 . . . . 0.0 111.283 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.89 -35.6 80.39 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.25 0.62 . . . . 0.0 110.335 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 55.2 mt-10 -71.12 -29.25 65.02 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.97 0.908 . . . . 0.0 110.849 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 23.8 mm-40 -73.82 -14.36 61.08 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.235 0.614 . . . . 0.0 110.754 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.12 2.74 64.04 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.98 138.76 42.47 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.753 0.821 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.45 -32.37 64.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.176 0.99 . . . . 0.0 110.887 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 66.0 m -143.44 171.07 14.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.21 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.36 162.38 38.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.328 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -141.56 117.51 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.26 113.67 3.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.64 -20.81 6.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.22 137.84 4.4 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 123.321 0.388 . . . . 0.0 110.905 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.5 p -122.43 106.42 11.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 t -123.6 126.26 46.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.044 0.538 . . . . 0.0 109.984 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 31.0 mt-10 -73.22 124.92 26.59 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.552 0.532 . . . . 0.0 110.236 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.401 ' HB3' HD22 ' A' ' 81' ' ' ASN . 81.2 t80 -72.94 128.55 35.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.463 0.705 . . . . 0.0 110.037 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.83 -80.81 1.31 Allowed Glycine 0 C--N 1.346 1.124 0 O-C-N 123.876 0.735 . . . . 0.0 111.884 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.45 -72.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.327 1.051 . . . . 0.0 108.899 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 74.6 m -154.51 -173.97 4.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.408 0.683 . . . . 0.0 110.975 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -87.95 1.44 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 76' ' ' PHE . 11.9 t30 -71.81 100.16 2.33 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.2 p-90 -109.27 126.78 53.7 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.572 0.749 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.3 tmm_? -83.8 129.19 34.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.782 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.543 HG21 ' HB1' ' A' ' 52' ' ' ALA . 62.6 t -113.3 109.31 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.299 1.04 . . . . 0.0 108.248 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.42 134.81 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.14 129.16 18.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.595 0.758 . . . . 0.0 111.079 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 2.6 m-20 -77.51 141.0 39.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.69 145.69 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.285 0.634 . . . . 0.0 111.095 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -127.74 133.6 49.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.488 1.115 . . . . 0.0 110.432 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -84.46 165.55 18.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.978 0.911 . . . . 0.0 111.247 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.628 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.9 m80 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . . . -64.87 134.65 54.49 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 171.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.39 46.78 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.732 0.645 . . . . 0.0 112.327 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -75.78 145.36 40.79 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.566 0.747 . . . . 0.0 110.311 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.1 118.87 15.51 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HD12 ' A' ' 34' ' ' LEU . 19.7 tp -82.16 138.43 34.72 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -64.3 141.62 98.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.219 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -42.21 -30.1 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.985 3.123 . . . . 0.0 115.162 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.59 -54.52 7.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.248 0.619 . . . . 0.0 111.249 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.58 -31.26 71.86 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.74 0.416 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -31.7 65.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.699 0.8 . . . . 0.0 111.048 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.76 62.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.998 0.519 . . . . 0.0 110.875 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -42.9 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.18 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 HD21 ' A' ' 26' ' ' LEU . 95.7 mt -86.79 167.23 14.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 110.162 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -120.35 125.0 27.43 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.96 146.38 32.73 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.548 2.165 . . . . 0.0 111.923 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -82.58 -22.87 34.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 111.277 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -158.52 168.58 26.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 110.455 -173.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 18.5 mtm180 -126.91 124.01 38.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.928 1.291 . . . . 0.0 108.507 169.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.88 138.7 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.825 0.45 . . . . 0.0 110.317 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.24 123.97 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 pt -109.39 160.44 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.766 0.826 . . . . 0.0 109.826 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.8 p -132.05 131.86 42.85 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.072 0.949 . . . . 0.0 108.664 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.07 154.79 21.15 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtm105 -110.25 118.96 37.74 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.838 0.819 . . . . 0.0 109.969 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 t80 55.94 82.78 0.1 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.994 1.317 . . . . 0.0 110.98 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -132.75 164.77 26.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.702 0.801 . . . . 0.0 110.01 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.2 178.82 4.79 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 53' ' ' VAL . 9.0 tp -65.66 -37.07 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.21 -38.56 96.7 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 123.191 0.307 . . . . 0.0 113.351 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.18 -39.9 78.42 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.412 0.685 . . . . 0.0 110.2 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.1 -40.98 99.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.316 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 49' ' ' ILE . 83.0 t -70.36 -40.2 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.413 0.685 . . . . 0.0 110.467 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -65.89 -34.89 79.17 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 0.0 111.059 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.58 -34.99 58.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.227 0.611 . . . . 0.0 111.222 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.0 p -83.27 -27.01 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.761 0.424 . . . . 0.0 110.685 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -73.32 -36.34 66.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.0 ttt180 -66.36 -45.28 80.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.979 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -64.28 -41.32 96.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.132 0.573 . . . . 0.0 110.883 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.05 -32.54 74.13 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 120.665 0.269 . . . . 0.0 110.889 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 19.8 t70 -67.79 -36.91 81.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.43 0.692 . . . . 0.0 110.872 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.8 mm-40 -63.13 -35.88 81.73 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.378 0.671 . . . . 0.0 110.719 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 29.7 mm-40 -83.79 -11.19 57.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.687 0.795 . . . . 0.0 112.161 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.64 47.8 8.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-O 121.137 0.298 . . . . 0.0 112.554 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.55 131.4 56.68 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 0.0 109.134 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -35.1 74.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.21 0.604 . . . . 0.0 111.507 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -140.92 175.32 9.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.579 0.751 . . . . 0.0 110.613 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 38.5 p90 -149.52 -179.94 7.48 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 173.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -159.11 122.81 3.82 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.7 115.49 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 85' ' ' VAL . 2.5 p -88.56 -31.54 5.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.264 0.626 . . . . 0.0 109.669 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -162.07 142.08 10.03 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.871 0.367 . . . . 0.0 110.982 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.5 p -117.99 147.05 43.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.58 1.152 . . . . 0.0 108.334 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -150.16 169.81 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.69 0.796 . . . . 0.0 110.23 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.9 149.02 50.23 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -71.53 98.32 1.84 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.02 -107.87 2.09 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -120.13 1.52 10.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.375 0.67 . . . . 0.0 111.113 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -84.54 154.87 22.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.732 0.413 . . . . 0.0 110.197 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.41 25.17 2.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.06 90.65 2.01 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 117.665 0.733 . . . . 0.0 109.44 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -66.93 96.82 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.645 1.178 . . . . 0.0 112.556 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.64 111.67 19.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HB1' ' A' ' 52' ' ' ALA . 57.9 t -123.06 121.2 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.93 0.492 . . . . 0.0 109.955 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 p -109.86 134.19 52.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.297 0.639 . . . . 0.0 109.53 173.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.79 124.72 18.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 109.958 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 5.3 p-10 -72.53 130.83 41.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.428 0.691 . . . . 0.0 110.171 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 13.4 m -112.97 151.84 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.103 0.961 . . . . 0.0 111.301 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -130.37 147.42 52.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.782 1.233 . . . . 0.0 110.43 -167.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.3 173.58 9.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.745 0.818 . . . . 0.0 110.268 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.628 174.28 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m170 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -169.52 132.36 1.22 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.928 1.291 . . . . 0.0 107.873 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.37 137.05 58.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.809 0.443 . . . . 0.0 109.951 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 m -62.09 135.44 57.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.44 0.696 . . . . 0.0 110.651 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.01 117.61 13.84 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.7 tp -90.95 142.28 27.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -95.94 153.29 39.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.196 0.599 . . . . 0.0 110.47 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -44.63 -38.62 12.52 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.213 3.276 . . . . 0.0 115.625 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.37 -50.7 72.97 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.358 0.663 . . . . 0.0 111.186 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 44.9 mt-30 -66.31 -46.23 77.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.817 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.67 68.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.889 0.875 . . . . 0.0 112.492 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.22 -24.45 47.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.6 0.76 . . . . 0.0 110.818 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.14 -33.32 14.08 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.759 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -99.45 153.21 19.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.343 0.657 . . . . 0.0 111.191 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -104.76 128.39 26.93 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 109.401 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.34 148.1 23.53 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.677 2.251 . . . . 0.0 111.697 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -80.12 -24.02 40.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.674 0.389 . . . . 0.0 110.47 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -160.74 175.17 12.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.148 0.979 . . . . 0.0 108.923 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.624 HH21 HG11 ' A' ' 71' ' ' VAL . 43.7 mtp180 -132.47 121.15 22.93 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.606 HD11 HG13 ' A' ' 56' ' ' VAL . 44.9 pt -89.55 149.15 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.012 0.369 . . . . 0.0 110.132 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.98 122.57 49.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -109.65 170.56 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.2 p -125.48 106.02 9.48 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.658 0.783 . . . . 0.0 109.136 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.43 88.73 1.59 Allowed Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.51 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 81' ' ' ASN . 10.0 ttm180 -84.06 96.09 8.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 110.221 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.8 t80 60.79 90.65 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.47 1.106 . . . . 0.0 110.033 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -168.09 162.96 13.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.693 0.797 . . . . 0.0 109.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.02 161.89 24.04 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 123.547 0.529 . . . . 0.0 110.018 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.498 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.2 tp -64.87 -29.18 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.9 97.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.072 0.232 . . . . 0.0 113.113 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.16 -43.41 82.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.533 0.733 . . . . 0.0 110.459 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -61.81 -50.11 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.086 0.954 . . . . 0.0 111.623 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.6 -35.84 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.064 0.946 . . . . 0.0 111.031 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 t -67.32 -34.93 78.38 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.043 0.537 . . . . 0.0 110.6 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.88 -33.91 64.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.042 0.537 . . . . 0.0 111.009 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.606 HG13 HD11 ' A' ' 40' ' ' ILE . 79.7 t -69.54 -41.71 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.262 0.625 . . . . 0.0 110.96 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.0 p -66.0 -34.18 77.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.938 0.495 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 15.1 tpt180 -65.93 -57.44 7.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.76 0.824 . . . . 0.0 109.67 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -60.46 -40.36 90.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.04 1.336 . . . . 0.0 112.387 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.12 79.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.851 0.86 . . . . 0.0 110.246 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.75 -31.25 72.36 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.66 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 24.5 mm-40 -69.32 -29.44 67.27 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.046 0.538 . . . . 0.0 111.248 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -83.84 -1.93 55.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.989 0.516 . . . . 0.0 111.129 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.26 16.32 71.98 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.345 -0.388 . . . . 0.0 113.304 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -69.81 124.49 24.14 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.687 . . . . 0.0 110.852 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.95 69.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.859 0.724 . . . . 0.0 110.336 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.98 155.64 44.1 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 36.3 p90 -124.41 160.7 27.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -149.69 105.2 3.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.38 107.9 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.624 HG11 HH21 ' A' ' 39' ' ' ARG . 11.4 p -93.49 -36.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.291 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.47 145.28 21.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.875 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.3 p -131.28 134.5 46.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.818 1.247 . . . . 0.0 107.814 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m -139.07 126.57 21.71 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.139 0.576 . . . . 0.0 110.146 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.26 128.56 36.02 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.994 0.518 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -86.5 -52.28 5.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.333 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.4 -50.93 0.64 Allowed Glycine 0 C--N 1.349 1.275 0 N-CA-C 114.209 0.444 . . . . 0.0 114.209 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -56.83 107.87 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.6 m 62.62 22.75 13.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.992 0.917 . . . . 0.0 112.148 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.47 38.8 69.49 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.212 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 33.8 p-10 -78.84 146.41 33.69 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.498 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 7.5 p-90 -146.2 127.21 14.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.853 0.861 . . . . 0.0 109.198 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.93 149.18 50.11 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.979 0.799 . . . . 0.0 108.944 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 52' ' ' ALA . 32.3 t -127.2 105.28 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.69 131.26 41.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.32 112.22 6.56 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.195 -171.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.05 133.89 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 15.6 m -113.99 126.15 71.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.513 0.673 . . . . 0.0 109.859 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -115.11 162.51 16.92 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.868 1.267 . . . . 0.0 110.245 -168.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -107.22 170.2 8.11 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.316 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.848 178.917 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.2 m170 . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . . . 58.71 96.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.044 1.337 . . . . 0.0 111.404 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.54 140.14 41.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.259 1.024 . . . . 0.0 112.125 -176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.5 m -66.97 134.04 51.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.977 0.911 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -68.71 116.54 9.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -72.99 137.5 45.48 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.9 p -72.03 147.69 91.22 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.443 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.6 -36.44 18.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.963 3.108 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.01 -37.89 69.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.864 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -74.43 -49.47 22.3 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.138 0.494 . . . . 0.0 110.122 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.06 -22.17 66.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.455 1.102 . . . . 0.0 112.348 -175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.14 -53.86 50.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.34 1.056 . . . . 0.0 112.328 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.13 -22.89 17.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.947 0.499 . . . . 0.0 111.852 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.968 0.413 . . . . 0.0 110.339 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -86.91 125.6 66.08 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.7 166.41 23.71 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.973 2.448 . . . . 0.0 111.374 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -93.5 -26.27 17.24 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.465 -0.147 . . . . 0.0 111.232 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -165.21 -170.94 2.03 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.698 0.399 . . . . 0.0 110.251 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -137.94 138.03 38.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.885 1.274 . . . . 0.0 109.983 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -102.77 144.14 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.914 0.886 . . . . 0.0 109.398 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 85' ' ' VAL . 46.1 t -130.83 115.43 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 pt -102.7 156.68 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.1 m -147.1 146.2 29.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 0.0 109.351 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.92 156.57 25.05 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -92.52 132.64 36.66 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.381 1.072 . . . . 0.0 110.003 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 t80 60.46 23.13 12.75 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 124.685 1.194 . . . . 0.0 112.091 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -74.76 116.93 16.02 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.28 158.98 35.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 tp -57.49 -33.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.284 0.365 . . . . 0.0 111.058 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.28 -45.03 96.82 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.245 0.341 . . . . 0.0 112.936 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.49 -39.67 92.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.711 0.804 . . . . 0.0 110.774 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.36 -47.65 78.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.337 1.055 . . . . 0.0 110.47 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 56' ' ' VAL . 92.8 t -67.35 -37.57 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.795 0.438 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 t -64.04 -41.81 97.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.732 0.413 . . . . 0.0 110.941 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -44.4 66.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.041 0.536 . . . . 0.0 110.882 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.8 p -74.98 -28.86 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.084 0.554 . . . . 0.0 111.145 -174.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.8 p -70.74 -49.94 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.634 0.373 . . . . 0.0 110.211 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 79.2 ttt180 -63.52 -44.18 94.99 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 110.173 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -57.57 -41.85 81.91 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.713 0.805 . . . . 0.0 111.474 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.64 86.11 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.33 -31.09 71.66 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.269 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 74.7 mm-40 -69.53 -31.31 69.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.347 0.659 . . . . 0.0 109.896 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 15.0 mm-40 -82.48 0.48 42.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.85 0.46 . . . . 0.0 111.221 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.85 5.05 71.65 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.167 0.413 . . . . 0.0 113.473 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.1 135.31 38.58 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 110.88 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 -26.64 54.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.367 1.067 . . . . 0.0 110.902 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.3 m -145.81 170.32 16.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 111.422 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -149.6 170.49 18.54 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -153.89 117.79 4.74 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.202 0.601 . . . . 0.0 109.505 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.01 107.93 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.716 0.806 . . . . 0.0 110.369 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.17 -43.55 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.265 0.626 . . . . 0.0 110.246 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.1 t70 -133.97 127.56 32.62 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 110.254 -167.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.3 p -122.56 117.23 25.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.4 t -139.48 162.42 35.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -138.0 174.27 10.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.362 0.665 . . . . 0.0 111.015 -170.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HB2' HD22 ' A' ' 81' ' ' ASN . 57.1 t80 -77.69 175.04 10.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.69 172.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.76 -23.06 49.31 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 120.851 0.139 . . . . 0.0 113.056 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -102.65 129.21 49.17 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.66 1.184 . . . . 0.0 109.316 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.8 m -74.45 133.26 42.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.23 0.612 . . . . 0.0 110.343 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.35 -47.5 1.02 Allowed Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.465 HD22 ' HB2' ' A' ' 76' ' ' PHE . 6.6 t30 -90.01 109.95 20.96 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 172.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 5.9 p-90 -144.51 179.83 7.02 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.375 0.67 . . . . 0.0 110.363 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.21 153.16 41.04 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.198 -171.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' A' ' 52' ' ' ALA . 85.2 t -124.11 110.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 0.0 108.915 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 26.4 t -94.65 123.87 46.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.7 123.56 23.88 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.5 0.72 . . . . 0.0 110.728 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.16 136.21 57.03 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.897 0.879 . . . . 0.0 110.067 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.66 138.65 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.347 0.594 . . . . 0.0 110.373 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -126.24 133.58 51.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.756 1.222 . . . . 0.0 109.735 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.24 176.65 9.57 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.205 0.602 . . . . 0.0 110.818 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.529 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.63 157.4 42.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.843 0.857 . . . . 0.0 110.137 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.45 142.78 53.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.111 0.564 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' SER . 59.1 m -68.14 124.77 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.0 0.52 . . . . 0.0 110.12 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.92 128.01 34.72 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 34' ' ' LEU . 17.5 tp -101.75 140.13 36.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.902 0.881 . . . . 0.0 108.999 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 p -79.96 153.26 74.98 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.332 0.653 . . . . 0.0 110.861 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.23 -39.04 52.55 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.132 3.221 . . . . 0.0 114.155 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.54 -52.58 64.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.779 0.832 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.71 -36.42 75.91 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.539 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.69 92.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.993 0.917 . . . . 0.0 111.312 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.3 63.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.996 0.519 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.07 45.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.205 0.602 . . . . 0.0 111.583 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HD21 ' A' ' 26' ' ' LEU . 82.5 mt -89.46 163.33 15.3 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.673 0.789 . . . . 0.0 110.101 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.28 124.7 27.6 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.607 0.763 . . . . 0.0 109.083 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.77 153.13 48.15 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.634 2.223 . . . . 0.0 111.952 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -93.08 -25.31 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.841 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.35 168.15 27.01 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.876 0.87 . . . . 0.0 108.879 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.562 HH21 HG11 ' A' ' 71' ' ' VAL . 34.0 mtp-105 -133.29 126.14 30.79 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.406 ' HB ' HH11 ' A' ' 59' ' ' ARG . 28.6 pt -104.59 159.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.33 0.652 . . . . 0.0 110.365 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.25 139.29 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 pt -125.9 168.65 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.1 0.96 . . . . 0.0 108.985 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -132.79 129.71 38.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.876 . . . . 0.0 109.142 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.18 92.35 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 54.9 ttp180 -60.07 112.24 1.81 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.654 0.782 . . . . 0.0 111.955 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.9 t80 66.75 11.45 8.23 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.389 1.076 . . . . 0.0 111.706 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -77.94 155.8 30.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.067 0.547 . . . . 0.0 110.066 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.99 43.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -61.75 -43.91 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 123.617 0.573 . . . . 0.0 110.688 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.73 88.38 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.053 0.22 . . . . 0.0 112.949 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.05 -42.85 88.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.118 0.967 . . . . 0.0 110.398 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.216 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.501 ' HA ' HG12 ' A' ' 56' ' ' VAL . 69.1 t -67.68 -33.96 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 122.801 0.441 . . . . 0.0 110.448 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -68.68 -39.35 80.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.797 0.439 . . . . 0.0 110.534 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.87 80.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.433 0.693 . . . . 0.0 111.223 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 53' ' ' VAL . 3.7 p -78.44 -27.05 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.103 0.561 . . . . 0.0 110.663 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 t -69.01 -43.74 74.2 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.883 0.873 . . . . 0.0 110.146 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 14.4 tpt180 -63.82 -45.54 89.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.027 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -60.83 -44.94 96.28 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.84 0.713 . . . . 0.0 109.272 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.02 82.62 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.574 0.75 . . . . 0.0 110.592 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.59 -39.08 93.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.31 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 54.5 mm-40 -62.04 -34.92 77.13 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.391 0.676 . . . . 0.0 110.818 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.1 mm-40 -78.81 -11.63 60.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.851 0.46 . . . . 0.0 111.351 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.42 16.31 34.98 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.088 0.242 . . . . 0.0 113.519 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -77.98 135.04 37.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.269 0.628 . . . . 0.0 111.624 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.24 -31.2 49.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.291 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' THR . 51.1 m -143.63 172.01 13.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -162.29 158.86 24.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -130.79 121.0 24.57 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.68 96.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HH21 ' A' ' 39' ' ' ARG . 7.2 p -88.9 -34.51 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.215 -172.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -133.39 129.04 36.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.982 0.513 . . . . 0.0 109.718 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 84' ' ' VAL . 7.1 p -135.35 104.15 5.76 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 166.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -148.74 168.54 22.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.916 1.286 . . . . 0.0 108.528 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.0 pt-20 -68.23 149.45 49.5 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -84.04 48.49 1.48 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 109.346 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.73 45.93 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.508 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -138.29 120.73 16.02 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.769 0.828 . . . . 0.0 109.1 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.2 m -65.26 115.25 5.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.883 0.873 . . . . 0.0 110.226 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.72 -55.04 0.6 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 14.8 t30 -86.54 96.76 10.18 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 16.9 p-90 -108.55 150.36 27.59 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.499 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.11 157.12 19.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.44 1.096 . . . . 0.0 110.601 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.9 t -126.98 109.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.567 1.147 . . . . 0.0 108.618 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.1 129.91 42.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.66 117.77 10.64 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 10.6 p-10 -84.86 142.33 29.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 26.8 m -113.18 142.36 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.714 0.805 . . . . 0.0 111.245 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 88.5 m-85 -126.38 167.25 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.107 1.363 . . . . 0.0 111.326 -165.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -108.75 162.97 13.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.83 1.252 . . . . 0.0 109.415 168.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.147 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 37.3 m80 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 -60.72 3.36 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.64 135.12 29.63 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -66.46 136.18 55.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.789 . . . . 0.0 109.922 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -69.0 125.01 25.31 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 12.8 tp -96.27 105.32 17.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.4 m -56.44 141.86 70.44 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.541 1.136 . . . . 0.0 110.509 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -43.51 -35.09 5.67 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.855 3.037 . . . . 0.0 114.2 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -63.02 -44.62 95.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.979 0.912 . . . . 0.0 111.642 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.85 -41.51 64.73 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.11 -19.52 61.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.382 1.073 . . . . 0.0 111.961 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.66 81.77 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.081 0.552 . . . . 0.0 110.182 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.56 -42.83 11.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.784 0.834 . . . . 0.0 111.352 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.94 134.02 33.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.255 0.622 . . . . 0.0 110.971 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -97.37 134.59 22.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.225 1.01 . . . . 0.0 109.713 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 83.6 Cg_endo -75.32 163.65 34.24 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.98 2.453 . . . . 0.0 113.086 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 25.0 p90 -94.96 -25.66 16.43 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.991 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -155.94 177.4 11.45 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.789 0.835 . . . . 0.0 108.853 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 40.4 ttm180 -134.52 124.24 25.22 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.118 0.967 . . . . 0.0 108.781 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.4 pt -89.52 163.67 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.629 0.772 . . . . 0.0 111.265 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 83' ' ' ARG . 7.6 p -141.65 139.78 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.039 0.936 . . . . 0.0 109.164 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.6 pt -137.39 148.57 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -133.46 133.85 42.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.51 174.84 20.81 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 27.9 ttm180 -149.6 111.72 4.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.4 t80 81.75 -3.71 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.947 1.299 . . . . 0.0 111.165 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -71.24 152.35 43.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.484 1.513 . . . . 0.0 110.861 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.63 172.12 9.52 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.309 0.644 . . . . 0.0 110.923 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.68 -32.64 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.27 -35.52 91.67 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-O 120.899 0.166 . . . . 0.0 112.995 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.07 -35.29 69.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.632 0.773 . . . . 0.0 110.445 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.78 -43.52 88.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.63 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.59 -43.26 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.328 0.651 . . . . 0.0 111.231 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 p -66.34 -40.97 90.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.377 0.271 . . . . 0.0 111.19 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.99 80.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.949 0.499 . . . . 0.0 111.794 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.33 -29.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 122.813 0.445 . . . . 0.0 110.889 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.8 t -74.09 -41.43 61.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.122 0.569 . . . . 0.0 110.152 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -70.17 -41.5 73.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 tpp180 -60.44 -47.16 87.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.296 0.638 . . . . 0.0 110.231 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.55 83.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.759 0.662 . . . . 0.0 111.436 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.24 -40.53 94.37 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.024 0.929 . . . . 0.0 110.936 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.65 -12.09 60.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.395 0.678 . . . . 0.0 112.364 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.7 mm-40 -89.49 -12.64 39.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.457 0.303 . . . . 0.0 110.786 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.23 61.22 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.722 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -75.26 129.34 37.28 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.345 0.658 . . . . 0.0 111.45 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.22 77.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.943 0.897 . . . . 0.0 111.043 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.3 m -137.29 164.56 28.26 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.994 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -144.57 152.49 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.871 0.868 . . . . 0.0 108.927 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -131.54 118.22 19.82 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.86 107.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.57 -28.44 5.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.211 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 129.72 6.05 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.191 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -113.39 115.59 28.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.9 m -129.74 145.57 51.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 8.7 pt-20 -69.37 152.18 45.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -92.49 57.68 3.0 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.5 27.5 66.01 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.443 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 81' ' ' ASN . 50.5 t-20 -161.24 137.13 8.03 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -169.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.8 t -68.93 -32.27 71.75 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.001 0.52 . . . . 0.0 111.391 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.36 -43.56 5.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.678 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -83.72 113.4 20.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.1 143.88 46.86 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.165 0.507 . . . . 0.0 110.916 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.4 tmm_? -107.99 130.87 55.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.738 1.215 . . . . 0.0 109.715 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 73.5 t -112.32 125.78 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.36 140.31 45.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.99 143.53 31.26 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.025 0.53 . . . . 0.0 111.021 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.0 m-20 -77.76 156.12 30.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.905 0.482 . . . . 0.0 109.94 168.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 4.5 m -127.1 141.85 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.279 0.632 . . . . 0.0 110.526 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -131.09 141.84 50.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.352 1.061 . . . . 0.0 109.676 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 3.3 mmmp? -99.92 145.61 27.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 0.0 110.572 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 166.25 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ASP . . . -69.48 -68.12 0.43 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.448 0.699 . . . . 0.0 110.141 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.35 123.97 17.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 67' ' ' SER . 73.1 m -68.94 124.05 22.67 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.718 0.807 . . . . 0.0 110.028 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.76 116.42 10.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.504 HD21 HD12 ' A' ' 34' ' ' LEU . 14.5 tp -74.43 144.74 44.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.289 . . . . 0.0 109.189 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.9 p -73.48 152.4 89.76 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.963 0.505 . . . . 0.0 110.071 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.64 -32.71 45.85 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.67 2.913 . . . . 0.0 113.54 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -66.65 -52.93 39.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.249 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.16 -32.21 70.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.173 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.38 -29.47 66.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.961 0.904 . . . . 0.0 111.157 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.12 -31.17 65.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.282 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.55 -48.2 9.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.173 0.589 . . . . 0.0 111.068 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.504 HD12 HD21 ' A' ' 26' ' ' LEU . 94.3 mt -81.11 172.97 13.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.751 0.821 . . . . 0.0 110.932 -177.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 36' ' ' PRO . 10.8 tppt? -132.64 131.93 22.4 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.787 0.835 . . . . 0.0 108.944 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HD2' ' HD3' ' A' ' 35' ' ' LYS . 73.5 Cg_endo -68.99 150.98 73.49 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.587 2.191 . . . . 0.0 111.471 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -86.11 -19.69 29.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.923 0.392 . . . . 0.0 110.358 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -162.03 169.2 21.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.476 1.11 . . . . 0.0 109.111 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 88.6 mtm180 -131.79 121.98 25.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.674 1.19 . . . . 0.0 108.754 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.3 pt -96.51 144.08 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.292 0.637 . . . . 0.0 110.177 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.35 133.78 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.641 0.777 . . . . 0.0 109.322 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 pt -126.52 153.86 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.792 0.837 . . . . 0.0 108.942 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' ARG . 39.2 p -121.55 149.93 42.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 0.0 109.074 174.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.06 116.29 0.71 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 40.7 ttp-105 -88.82 120.08 29.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.675 0.79 . . . . 0.0 109.627 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 59.05 81.65 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.733 1.213 . . . . 0.0 111.099 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.91 156.15 36.98 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.595 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.32 154.02 39.08 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 124.025 0.828 . . . . 0.0 110.162 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 53' ' ' VAL . 5.5 tp -59.92 -41.63 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.597 0.359 . . . . 0.0 110.041 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.37 -31.26 80.27 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.317 0.386 . . . . 0.0 113.34 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.07 -36.09 66.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.728 0.811 . . . . 0.0 110.255 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.9 77.82 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.865 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HA ' HG12 ' A' ' 56' ' ' VAL . 87.7 t -66.9 -34.01 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.3 t -65.53 -39.43 91.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.466 0.706 . . . . 0.0 110.694 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.23 76.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.22 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 53' ' ' VAL . 8.3 p -82.4 -27.18 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.232 0.613 . . . . 0.0 111.675 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -69.49 -42.72 74.41 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.2 0.524 . . . . 0.0 109.787 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 7.6 tpt180 -65.78 -42.72 90.47 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.3 tpp180 -62.47 -35.99 81.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.147 0.579 . . . . 0.0 110.404 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.29 66.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 0.0 110.477 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 27.3 t70 -67.79 -34.89 77.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.837 0.455 . . . . 0.0 110.648 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 26.7 mm-40 -60.51 -37.01 79.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.787 0.835 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 50.1 mm-40 -77.72 -15.02 59.43 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.18 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.97 38.5 48.34 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.562 0.539 . . . . 0.0 111.761 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.84 126.66 40.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.236 1.014 . . . . 0.0 110.092 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.65 83.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.561 0.696 . . . . 0.0 110.739 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 37.2 m -139.95 168.99 18.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.659 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 24.8 p90 -148.75 169.95 19.3 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -150.2 127.1 11.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.55 97.55 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -86.33 -16.91 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.751 0.82 . . . . 0.0 110.52 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 21.8 t70 -163.51 150.27 12.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.237 0.615 . . . . 0.0 111.029 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 p -141.61 114.28 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.185 1.394 . . . . 0.0 107.834 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.7 m -137.25 152.35 49.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 108.806 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.9 pt-20 -64.48 148.9 49.65 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.497 0.319 . . . . 0.0 110.896 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.31 -34.63 76.98 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.661 0.384 . . . . 0.0 111.081 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.72 -7.11 0.08 OUTLIER Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.88 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -140.07 148.19 41.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.3 p -69.94 104.39 2.5 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.985 0.514 . . . . 0.0 109.853 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.79 -39.16 1.43 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 11.7 p30 -102.55 113.02 26.03 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.0 p-90 -121.75 159.3 26.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.576 0.703 . . . . 0.0 110.571 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HB2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -133.71 132.02 40.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.654 -165.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.98 125.84 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.866 0.866 . . . . 0.0 109.759 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 21.6 t -100.88 120.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 166.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.98 121.92 27.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 13.6 p-10 -85.36 136.04 33.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 16.6 m -112.32 131.64 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.692 0.797 . . . . 0.0 111.349 -166.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.588 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 74.0 m-85 -109.76 163.86 13.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 111.54 -171.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -110.15 165.57 11.64 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 108.709 169.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.698 178.933 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.81 108.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.099 1.36 . . . . 0.0 111.879 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 133.73 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.377 0.671 . . . . 0.0 110.551 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -67.35 134.09 50.86 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.139 0.576 . . . . 0.0 110.557 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.02 116.57 9.63 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.5 tp -84.0 126.65 33.24 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.3 p -66.22 145.23 98.98 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 123.736 0.647 . . . . 0.0 110.208 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -45.65 -31.37 7.3 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.607 2.872 . . . . 0.0 114.25 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.89 -55.66 21.08 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.337 1.055 . . . . 0.0 110.449 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.19 -34.1 75.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.14 69.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.037 0.935 . . . . 0.0 111.423 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.57 -26.05 59.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 0.0 111.174 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.81 19.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.299 0.64 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 26' ' ' LEU . 95.2 mt -101.21 160.89 14.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.731 0.812 . . . . 0.0 111.222 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -111.31 123.88 34.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 108.371 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.31 159.08 36.84 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.081 1.854 . . . . 0.0 111.185 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -100.86 -39.19 7.91 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.771 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.58 -170.61 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 109.469 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HB3' ' HA ' ' A' ' 87' ' ' ASP . 4.5 ptt180 -149.8 168.08 24.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.79 0.836 . . . . 0.0 111.459 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 56' ' ' VAL . 37.7 pt -118.55 151.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.954 0.902 . . . . 0.0 110.33 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG13 ' HD3' ' A' ' 83' ' ' ARG . 85.5 t -121.3 114.17 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.638 1.175 . . . . 0.0 109.545 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 84' ' ' VAL . 43.2 pt -133.9 178.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.483 1.113 . . . . 0.0 108.963 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 3.0 p -126.97 105.11 8.39 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.632 0.773 . . . . 0.0 109.475 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 84' ' ' VAL . . . -89.23 149.48 20.75 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -110.49 151.76 27.16 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.828 0.814 . . . . 0.0 111.166 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -72.07 -4.62 29.91 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.188 0.995 . . . . 0.0 112.817 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -60.26 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.507 0.723 . . . . 0.0 110.657 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.4 143.03 4.07 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.932 0.893 . . . . 0.0 110.216 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 tp -62.67 -37.44 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 167.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.47 -26.77 68.54 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.624 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.62 -49.2 78.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.301 0.64 . . . . 0.0 110.263 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.24 -42.11 93.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.956 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 88.9 t -66.75 -36.18 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.848 0.718 . . . . 0.0 111.338 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.5 m -66.21 -41.77 89.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.782 0.433 . . . . 0.0 110.546 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.17 79.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.69 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 HD11 ' A' ' 40' ' ' ILE . 12.7 p -77.11 -34.15 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.724 0.41 . . . . 0.0 111.469 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -67.84 -39.99 83.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.796 0.438 . . . . 0.0 110.277 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 29.7 ttt180 -65.03 -56.63 11.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.852 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -66.54 -39.31 88.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.102 0.561 . . . . 0.0 112.3 -172.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.35 93.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.33 -35.92 80.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.708 0.803 . . . . 0.0 111.167 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 47.8 mt-10 -66.46 -33.27 75.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.337 0.655 . . . . 0.0 110.736 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 18.9 mm-40 -82.75 -5.17 58.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.717 0.807 . . . . 0.0 111.469 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.01 14.63 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.21 0.319 . . . . 0.0 113.137 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.105 0.962 . . . . 0.0 109.584 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -28.57 62.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.596 0.759 . . . . 0.0 111.067 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.3 m -143.09 169.4 17.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -147.28 168.11 22.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.959 0.903 . . . . 0.0 109.766 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -160.21 122.27 3.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.206 1.002 . . . . 0.0 108.623 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.45 120.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.601 0.563 . . . . 0.0 109.985 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.25 -30.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.257 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -160.2 149.28 17.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.018 0.527 . . . . 0.0 111.243 -172.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 33.7 p -132.89 104.63 6.67 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.612 1.165 . . . . 0.0 108.857 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.3 m -100.97 109.27 21.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.717 0.807 . . . . 0.0 110.33 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -51.93 127.9 22.57 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.674 0.39 . . . . 0.0 111.439 177.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.53 168.73 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.123 0.969 . . . . 0.0 109.503 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.26 67.39 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.162 0.425 . . . . 0.0 114.162 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.405 ' HB2' ' OD1' ' A' ' 81' ' ' ASN . 1.7 m-20 -80.81 162.07 24.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.938 0.495 . . . . 0.0 109.795 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 m -72.9 106.23 4.74 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.29 0.636 . . . . 0.0 112.433 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.0 88.76 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 165.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 27.5 p-10 -95.85 111.29 23.31 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -101.0 124.85 47.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.331 1.052 . . . . 0.0 109.144 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HD3' HG13 ' A' ' 41' ' ' VAL . 2.8 tmm_? -63.88 106.43 1.01 Allowed 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.676 1.19 . . . . 0.0 109.586 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 42' ' ' ILE . 43.7 t -88.68 108.34 18.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.81 129.02 58.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.81 120.75 16.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.962 0.505 . . . . 0.0 110.966 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.722 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 5.0 m-20 -63.86 135.85 56.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.131 0.894 . . . . 0.0 110.846 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.84 142.88 22.88 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.498 0.719 . . . . 0.0 109.419 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 57.3 m-85 -125.1 152.47 44.33 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.177 0.991 . . . . 0.0 109.863 -169.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.68 174.21 7.47 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.289 0.635 . . . . 0.0 109.639 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 C-N-CA 123.307 0.643 . . . . 0.0 110.149 -179.278 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.478 0.656 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.23 -146.67 0.32 Allowed 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.97 118.33 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.678 0.672 . . . . 0.0 110.104 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -80.24 149.76 30.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.485 1.114 . . . . 0.0 110.617 -174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.53 134.2 51.9 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.522 0.601 . . . . 0.0 109.438 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.8 tp -94.82 134.92 36.93 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -73.96 144.91 83.07 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.732 0.813 . . . . 0.0 110.362 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.61 -38.19 75.53 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 124.125 3.217 . . . . 0.0 115.687 -165.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -69.83 -41.46 74.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.768 0.427 . . . . 0.0 110.455 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.8 -34.81 76.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.333 0.653 . . . . 0.0 110.63 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.95 -24.12 55.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.051 0.94 . . . . 0.0 111.261 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.03 -35.75 21.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.393 0.677 . . . . 0.0 110.432 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.26 65.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.306 0.643 . . . . 0.0 110.794 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.8 mt -88.17 148.24 24.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -102.54 139.69 20.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 73.9 Cg_endo -72.73 139.29 30.5 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.924 1.749 . . . . 0.0 111.451 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 90' ' ' LYS . 53.4 p90 -78.06 -19.53 54.1 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -166.45 174.3 9.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 108.671 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 87' ' ' ASP . 51.0 mtm180 -135.01 122.76 22.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.084 0.954 . . . . 0.0 108.945 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 pt -87.85 151.88 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.956 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' A' ' 83' ' ' ARG . 78.7 t -135.53 125.31 42.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.926 0.89 . . . . 0.0 109.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.1 152.42 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.066 0.946 . . . . 0.0 109.132 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.67 164.76 12.96 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.552 0.741 . . . . 0.0 109.747 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.41 178.79 41.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.06 139.9 4.33 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.543 0.671 . . . . 0.0 111.085 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 t80 61.47 29.59 18.47 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 124.254 0.971 . . . . 0.0 111.014 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -123.33 168.35 12.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 0.0 110.774 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.38 166.4 13.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.923 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 6.4 tp -66.08 -31.58 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.953 0.501 . . . . 0.0 110.407 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.97 -33.62 74.9 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.213 0.321 . . . . 0.0 112.914 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.71 -46.73 68.19 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.326 0.65 . . . . 0.0 110.551 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.49 80.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.614 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 56' ' ' VAL . 77.3 t -68.71 -40.36 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 0.0 110.105 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' ARG . 40.2 m -63.14 -36.65 84.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.879 0.471 . . . . 0.0 111.052 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.32 59.69 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.342 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.0 p -74.76 -29.69 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.271 0.628 . . . . 0.0 112.203 -172.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.9 p -69.81 -40.92 75.63 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.746 0.419 . . . . 0.0 110.677 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 54' ' ' SER . 8.6 mpt_? -72.95 -36.93 67.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.321 0.648 . . . . 0.0 110.04 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -64.48 -43.55 93.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.613 0.765 . . . . 0.0 110.887 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.33 73.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 0.0 110.99 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.55 -35.12 79.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.658 0.783 . . . . 0.0 110.483 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -64.12 -38.95 92.9 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.532 0.733 . . . . 0.0 110.666 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -74.8 -2.19 25.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.802 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.53 23.98 75.85 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.754 -0.138 . . . . 0.0 112.754 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.82 128.58 34.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.522 0.729 . . . . 0.0 109.688 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -33.81 76.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.5 m -147.42 158.97 44.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.634 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -122.18 174.11 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.295 1.038 . . . . 0.0 108.852 170.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -159.62 113.96 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.506 0.722 . . . . 0.0 109.134 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.57 118.82 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.28 0.632 . . . . 0.0 110.442 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.46 -36.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.12 141.24 17.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.367 -168.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -119.69 104.09 9.95 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 14.7 m -84.83 177.72 7.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.809 0.844 . . . . 0.0 110.344 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER -160.54 168.07 25.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.015 0.926 . . . . 0.0 110.542 177.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.604 ' HB3' ' HB3' ' A' ' 79' ' ' SER . 44.8 t80 -77.23 -8.01 56.87 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.476 0.71 . . . . 0.0 112.41 -168.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.23 85.68 1.86 Allowed Glycine 0 C--N 1.353 1.472 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.11 35.85 23.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.937 1.295 . . . . 0.0 111.582 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 33.6 t -127.79 164.82 21.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.578 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.77 76.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.581 0.551 . . . . 0.0 113.34 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -69.97 137.39 51.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.219 0.608 . . . . 0.0 110.711 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 p-90 -143.5 173.76 11.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.366 1.067 . . . . 0.0 110.667 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 1.2 tmt_? -152.2 120.2 6.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.826 0.85 . . . . 0.0 109.076 -165.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.48 131.69 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.247 0.619 . . . . 0.0 110.376 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 127.54 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.184 0.994 . . . . 0.0 108.684 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.63 21.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 m-20 -62.42 136.98 58.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.259 1.424 . . . . 0.0 110.06 171.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.49 138.16 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 118.37 0.532 . . . . 0.0 110.996 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.32 135.98 46.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.768 1.227 . . . . 0.0 109.527 -170.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 37' ' ' TYR . 67.5 mttm -98.04 136.47 38.26 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.299 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.76 177.68 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 139.71 15.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.47 156.8 22.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.586 0.754 . . . . 0.0 109.681 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 m -64.88 135.85 56.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.727 0.811 . . . . 0.0 111.424 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.05 118.07 17.59 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 19.4 tp -93.11 127.22 38.57 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.5 p -72.74 146.85 88.63 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.487 0.715 . . . . 0.0 110.84 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -43.34 -48.21 8.42 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 125.085 3.857 . . . . 0.0 116.517 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -67.94 -41.63 82.21 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.516 0.598 . . . . 0.0 111.263 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.81 -28.17 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.793 0.437 . . . . 0.0 111.16 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.72 70.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.728 0.811 . . . . 0.0 110.644 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.91 -15.14 61.14 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.605 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.01 -40.61 15.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.639 0.776 . . . . 0.0 110.909 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.01 154.59 17.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.072 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -96.23 126.9 42.36 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.554 0.742 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.89 140.22 22.86 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.292 1.995 . . . . 0.0 111.098 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -83.63 -20.13 34.21 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -158.33 175.04 14.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -140.23 121.72 15.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.7 0.8 . . . . 0.0 109.558 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 59' ' ' ARG . 29.2 pt -95.34 165.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.051 0.941 . . . . 0.0 110.64 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.77 133.97 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 123.23 0.612 . . . . 0.0 110.445 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 pt -122.26 157.25 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.166 0.987 . . . . 0.0 108.351 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -149.45 150.5 32.46 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.82 154.0 6.79 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 32.1 ptt-85 -97.06 3.08 52.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.962 0.505 . . . . 0.0 111.152 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -106.94 76.22 1.09 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.807 0.843 . . . . 0.0 108.746 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -169.81 163.75 9.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.17 0.988 . . . . 0.0 110.173 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' ' HB2' ' A' ' 51' ' ' ASP . . . -119.95 175.25 6.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.266 1.026 . . . . 0.0 108.422 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HA ' ' CH2' ' A' ' 82' ' ' TRP . 7.3 tp -60.07 -44.35 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 118.145 0.429 . . . . 0.0 110.515 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.7 -40.71 65.34 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.107 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 48' ' ' ALA . 45.9 m-20 -75.12 -25.4 58.43 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.606 0.762 . . . . 0.0 112.179 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.73 -43.43 62.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 56' ' ' VAL . 94.8 t -64.38 -33.16 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -67.9 -40.91 83.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.435 0.694 . . . . 0.0 111.279 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.21 -36.69 61.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.122 0.569 . . . . 0.0 111.324 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 53' ' ' VAL . 4.1 p -80.36 -28.65 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.673 0.389 . . . . 0.0 110.307 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.0 p -70.22 -41.16 73.97 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -56.07 -47.87 77.15 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.435 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.3 tpt180 -63.53 -41.1 98.48 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.738 0.649 . . . . 0.0 110.782 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.63 -34.8 76.31 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.188 0.518 . . . . 0.0 111.186 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -70.92 -33.67 70.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.746 0.818 . . . . 0.0 110.574 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -77.55 -18.53 56.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 110.619 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 36.2 mm-40 -80.66 -25.46 38.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.804 170.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.64 3.74 59.47 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.533 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.11 139.92 57.54 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.976 0.91 . . . . 0.0 111.315 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -68.67 -38.81 80.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 110.409 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 42.0 m -143.45 174.3 10.87 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.883 -175.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -151.22 164.17 37.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -146.26 124.37 12.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.141 0.576 . . . . 0.0 109.465 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.87 117.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.781 0.676 . . . . 0.0 109.211 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.1 -31.7 4.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.233 0.613 . . . . 0.0 110.618 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.05 139.47 21.43 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.072 0.463 . . . . 0.0 110.931 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.9 p -131.15 111.09 11.64 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 168.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -144.81 135.91 25.01 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.285 0.634 . . . . 0.0 109.427 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.3 pt-20 -88.14 157.58 18.79 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.801 0.81 . . . . 0.0 112.096 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 81' ' ' ASN . 74.1 m-85 -140.3 -174.51 3.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.711 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 59.53 -95.9 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 O-C-N 123.72 0.638 . . . . 0.0 111.806 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -173.22 127.01 0.44 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.232 1.013 . . . . 0.0 109.365 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 m 64.89 85.78 0.14 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 112.953 169.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 83.54 4.77 89.0 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 165.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 52.5 t30 -77.49 63.05 2.57 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.81 1.305 . . . . 0.0 110.245 174.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.5 p-90 -87.62 111.59 21.41 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.002 0.906 . . . . 0.0 111.419 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.56 114.25 6.05 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.848 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 52' ' ' ALA . 34.4 t -102.94 106.76 20.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.49 133.56 55.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.57 136.2 35.77 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.429 0.692 . . . . 0.0 110.81 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.61 144.59 41.69 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.253 0.621 . . . . 0.0 109.64 170.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.62 128.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -109.03 137.5 46.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 109.881 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 91' ' ' ALA . 1.5 tmmm? -89.4 149.58 22.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.048 0.939 . . . . 0.0 108.892 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.384 0.673 . . . . 0.0 110.888 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.63 -167.79 1.98 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.398 0.679 . . . . 0.0 110.728 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -63.45 130.91 46.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.986 0.514 . . . . 0.0 110.419 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 149.97 25.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.717 0.807 . . . . 0.0 110.963 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.05 122.1 15.24 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 34' ' ' LEU . 17.1 tp -92.56 124.32 36.5 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.7 p -69.83 146.9 95.92 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.598 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.48 -33.27 4.18 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 124.493 3.462 . . . . 0.0 115.088 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.45 -48.28 64.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.621 0.768 . . . . 0.0 111.276 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -71.27 -36.39 71.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.148 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.9 61.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.243 1.017 . . . . 0.0 111.744 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.27 81.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.332 0.653 . . . . 0.0 110.793 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 -39.57 30.93 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.359 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 26' ' ' LEU . 93.4 mt -85.11 169.35 13.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.074 0.549 . . . . 0.0 111.297 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -130.85 134.54 26.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.097 0.959 . . . . 0.0 109.442 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.63 147.48 22.19 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.452 2.101 . . . . 0.0 111.955 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -96.35 -16.8 21.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.231 0.612 . . . . 0.0 110.372 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -158.56 174.47 15.02 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.487 1.115 . . . . 0.0 108.625 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' NH2' HG11 ' A' ' 71' ' ' VAL . 17.1 ttt180 -145.08 121.63 11.07 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 56' ' ' VAL . 23.6 pt -90.22 150.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 175.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 83' ' ' ARG . 5.3 p -145.81 117.78 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.49 0.716 . . . . 0.0 109.647 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.6 pt -127.69 154.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.546 0.738 . . . . 0.0 110.678 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 p -118.67 111.37 18.44 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.774 1.23 . . . . 0.0 108.859 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.33 101.8 2.38 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.16 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -76.52 98.28 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.255 0.622 . . . . 0.0 109.816 177.083 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 66.13 92.28 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.668 1.187 . . . . 0.0 111.788 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -164.49 164.92 21.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 0.0 110.938 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.71 168.79 12.2 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.801 0.84 . . . . 0.0 110.522 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.8 tp -61.51 -34.14 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.925 0.49 . . . . 0.0 111.079 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.18 -37.04 93.86 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.12 0.263 . . . . 0.0 113.232 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.07 -44.5 65.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.74 0.816 . . . . 0.0 110.504 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -58.72 -53.14 61.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.772 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.14 -32.9 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.661 1.184 . . . . 0.0 111.296 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.1 t -65.16 -42.28 93.9 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.207 0.603 . . . . 0.0 110.583 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 40' ' ' ILE . 76.7 t -68.22 -40.73 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.109 0.964 . . . . 0.0 110.995 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -69.45 -46.88 65.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.403 0.681 . . . . 0.0 110.938 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -61.73 -50.35 72.78 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.152 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 2.7 tpp180 -64.72 -42.83 94.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.806 0.691 . . . . 0.0 111.182 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.35 82.0 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.607 0.567 . . . . 0.0 110.376 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 23' ' ' ALA . 18.7 t70 -64.93 -34.16 77.75 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.782 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.69 -30.46 69.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.257 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 3.3 mm-40 -76.35 -16.97 59.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.928 0.491 . . . . 0.0 110.562 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.08 20.38 14.14 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.53 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.9 151.2 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.572 0.749 . . . . 0.0 111.508 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.414 ' H ' ' HA ' ' A' ' 90' ' ' LYS . . . -89.23 -29.14 19.47 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.606 1.162 . . . . 0.0 110.527 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 73.3 m -147.7 165.76 29.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.931 0.893 . . . . 0.0 110.74 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -127.88 178.05 6.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.2 1.0 . . . . 0.0 109.178 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.57 99.6 1.59 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.08 101.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG11 ' NH2' ' A' ' 39' ' ' ARG . 5.0 p -89.32 -34.17 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.183 -169.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.12 146.38 27.66 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.305 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.7 m -143.02 118.4 10.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.5 m -130.7 124.25 31.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.852 0.861 . . . . 0.0 109.447 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 40.9 tt0 -95.58 157.24 15.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.426 0.691 . . . . 0.0 111.047 -176.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.62 -29.39 69.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.294 1.037 . . . . 0.0 110.739 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.616 ' H ' ' HG2' ' A' ' 75' ' ' GLU . . . 85.72 -55.2 4.84 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 123.196 0.427 . . . . 0.0 112.167 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -70.4 -13.08 61.99 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.306 1.043 . . . . 0.0 110.734 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 t -146.55 167.94 22.46 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.717 0.807 . . . . 0.0 110.253 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.19 13.23 40.23 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.766 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 37.9 t30 -75.32 102.19 4.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.6 p-90 -113.56 123.52 50.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.126 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 41' ' ' VAL . 5.6 tmm_? -86.8 115.91 24.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.555 1.142 . . . . 0.0 109.111 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' HB1' ' A' ' 52' ' ' ALA . 46.9 t -104.18 113.85 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.02 137.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.69 127.82 17.59 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 110.851 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.91 137.0 45.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.147 0.579 . . . . 0.0 109.533 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -114.37 132.71 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.469 0.652 . . . . 0.0 110.722 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.53 120.01 35.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.985 1.314 . . . . 0.0 107.9 -171.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -85.44 169.72 13.38 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.242 0.474 . . . . 0.0 109.798 175.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.489 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.9 m80 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.821 0.343 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 176.57 113.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.667 1.587 . . . . 0.0 107.275 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 138.9 57.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.863 0.465 . . . . 0.0 110.747 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 m -61.82 124.27 20.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.16 0.984 . . . . 0.0 111.411 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -66.03 116.61 7.33 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 34' ' ' LEU . 15.8 tp -105.67 121.82 44.78 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.9 p -65.81 151.83 94.24 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.58 0.752 . . . . 0.0 110.771 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.47 -31.54 39.41 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.505 2.803 . . . . 0.0 113.099 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.93 -53.27 52.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.986 0.914 . . . . 0.0 110.799 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -75.79 -25.34 56.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.602 0.761 . . . . 0.0 111.421 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.09 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.119 0.968 . . . . 0.0 110.341 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.46 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.6 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.1 -7.27 55.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.526 0.73 . . . . 0.0 112.431 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.432 HD12 HD21 ' A' ' 26' ' ' LEU . 96.2 mt -125.03 163.47 22.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.723 0.809 . . . . 0.0 110.477 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 117.07 51.04 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.001 0.921 . . . . 0.0 108.838 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 151.39 46.41 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.539 2.159 . . . . 0.0 111.849 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -96.78 -29.55 13.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.004 0.522 . . . . 0.0 111.471 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -147.76 178.49 8.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.689 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.652 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 66.4 mtt180 -131.36 146.63 52.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 109.204 169.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.03 142.63 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.63 0.772 . . . . 0.0 108.965 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.34 119.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.73 160.04 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 m -148.52 126.23 11.82 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 153.59 24.94 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.709 -0.281 . . . . 0.0 112.88 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 81' ' ' ASN . 3.6 mpt_? -87.28 135.55 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.76 0.824 . . . . 0.0 109.934 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.4 t80 65.01 24.99 12.65 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.8 1.24 . . . . 0.0 111.931 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 13.1 m120 -70.07 136.39 50.22 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.891 -0.506 . . . . 0.0 109.945 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 170.56 15.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 6.5 tp -61.59 -50.45 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.39 69.55 Favored Glycine 0 C--N 1.348 1.223 0 O-C-N 123.272 0.357 . . . . 0.0 113.151 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.9 -36.27 77.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 110.388 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -74.25 -34.76 63.72 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.624 0.77 . . . . 0.0 110.67 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 70.1 t -66.96 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.781 0.433 . . . . 0.0 110.203 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -65.4 -36.6 84.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.28 0.632 . . . . 0.0 110.522 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.83 -48.67 65.56 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.99 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.6 p -77.45 -27.81 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.226 0.61 . . . . 0.0 111.962 -174.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.8 p -69.66 -48.09 61.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.613 0.365 . . . . 0.0 110.188 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 42.6 ttt-85 -63.83 -46.98 82.62 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 176.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.8 tpp180 -54.06 -49.17 69.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.973 0.909 . . . . 0.0 111.066 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.83 -43.99 86.18 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.869 0.731 . . . . 0.0 110.516 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.55 -34.63 78.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.632 0.773 . . . . 0.0 110.723 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 10.0 mm-40 -70.19 -29.98 66.99 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.17 0.588 . . . . 0.0 110.538 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 14.7 mm-40 -77.89 -9.77 59.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.835 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.74 10.5 61.54 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 113.101 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.93 143.25 37.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.786 0.834 . . . . 0.0 110.755 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.22 -36.82 17.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.669 0.788 . . . . 0.0 111.099 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.0 m -140.12 170.92 14.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 110.298 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -154.81 162.66 41.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.241 0.616 . . . . 0.0 109.74 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -147.18 117.89 7.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.595 0.758 . . . . 0.0 109.894 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.84 114.08 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 110.135 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.75 -25.55 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.952 0.501 . . . . 0.0 111.146 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -158.29 145.48 17.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.188 0.518 . . . . 0.0 111.328 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 84' ' ' VAL . 44.1 p -134.96 106.8 7.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.21 1.404 . . . . 0.0 108.362 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 46.9 m -105.02 130.75 53.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.6 145.87 24.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.204 0.601 . . . . 0.0 111.299 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -103.3 -33.75 9.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.438 1.095 . . . . 0.0 109.195 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.21 -64.8 0.3 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.991 173.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.81 128.54 37.17 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.905 0.882 . . . . 0.0 111.165 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m 65.14 17.16 10.93 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.29 1.036 . . . . 0.0 112.162 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.61 28.61 72.78 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.471 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 11.3 t30 -80.9 140.98 35.02 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 1.5 p-90 -161.59 158.11 25.75 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.17 0.988 . . . . 0.0 110.136 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -108.65 153.24 23.7 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.01 0.924 . . . . 0.0 110.085 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 83.6 t -136.83 111.98 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.335 1.054 . . . . 0.0 108.258 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.8 134.82 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.78 126.21 18.81 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.211 1.004 . . . . 0.0 109.167 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 2.5 p30 -76.92 144.17 39.05 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.44 142.17 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.909 0.883 . . . . 0.0 110.255 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.602 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 64.3 m-85 -124.86 161.18 27.12 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.438 1.095 . . . . 0.0 110.802 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -92.23 165.06 13.31 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.704 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.491 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 m80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.611 0.243 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.31 117.53 1.89 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.17 0.988 . . . . 0.0 109.109 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 137.4 47.78 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.023 0.529 . . . . 0.0 110.722 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -68.98 139.93 55.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.412 0.685 . . . . 0.0 110.436 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.53 129.38 34.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 34' ' ' LEU . 13.9 tp -90.58 140.16 30.01 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -174.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 p -68.8 147.63 97.91 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.67 -10.6 12.02 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.641 2.228 . . . . 0.0 113.844 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -82.22 -52.95 6.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.308 0.643 . . . . 0.0 110.236 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 53.0 mt-30 -62.36 -46.0 90.61 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.877 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.85 -36.93 84.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 112.083 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.37 64.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.126 0.57 . . . . 0.0 111.633 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.29 -29.3 12.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.625 0.77 . . . . 0.0 112.151 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 26' ' ' LEU . 95.9 mt -98.24 150.74 21.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -96.03 127.83 39.38 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.99 0.916 . . . . 0.0 109.077 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.4 157.46 32.91 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 111.069 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 37.3 p90 -90.35 -32.54 16.43 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.924 0.392 . . . . 0.0 110.567 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.8 -174.95 4.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.03 0.932 . . . . 0.0 110.22 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -149.37 128.9 13.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.11 0.964 . . . . 0.0 108.703 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -109.31 148.28 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 110.972 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.76 121.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.096 0.958 . . . . 0.0 108.446 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 pt -113.95 154.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.053 0.941 . . . . 0.0 109.439 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 83' ' ' ARG . 21.1 p -113.17 153.35 28.43 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.372 0.669 . . . . 0.0 110.167 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.37 97.02 0.15 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-N 116.856 -0.157 . . . . 0.0 112.881 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -96.98 46.39 1.04 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.546 1.165 . . . . 0.0 109.636 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -177.11 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.776 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -56.03 127.03 28.53 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.885 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 -175.78 5.99 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.237 168.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.15 -34.56 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 118.201 0.455 . . . . 0.0 110.49 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.38 -45.87 66.69 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.257 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.26 -31.35 71.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.685 0.794 . . . . 0.0 110.979 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.52 -46.15 64.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.992 0.917 . . . . 0.0 109.686 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 55.0 t -64.35 -32.58 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.745 0.653 . . . . 0.0 110.728 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -69.88 -42.7 73.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.216 0.606 . . . . 0.0 110.723 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.35 75.83 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.213 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 53' ' ' VAL . 11.9 p -80.19 -27.97 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 122.701 0.4 . . . . 0.0 110.844 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -63.32 -47.53 81.85 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 28.3 tpt180 -64.54 -56.29 14.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 13.7 tpp180 -57.56 -46.18 84.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.793 0.837 . . . . 0.0 111.25 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.45 81.32 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.63 0.582 . . . . 0.0 110.962 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.76 -39.06 92.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.319 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.1 mm-40 -70.96 -25.57 62.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.939 0.496 . . . . 0.0 110.901 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 12.6 mm-40 -76.87 -11.47 59.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.299 0.639 . . . . 0.0 111.258 173.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.01 29.04 19.1 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.519 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.28 132.03 42.18 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.784 0.834 . . . . 0.0 110.3 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.49 82.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.637 0.775 . . . . 0.0 109.88 173.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . 10.2 t -139.74 172.38 12.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.277 -173.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -148.71 171.11 16.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -152.24 118.62 5.61 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.67 102.9 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 123.77 0.669 . . . . 0.0 109.415 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.17 -31.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.841 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.8 t70 -153.26 148.34 26.72 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.368 -171.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 84' ' ' VAL . 12.8 p -142.28 112.84 7.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.458 1.503 . . . . 0.0 107.044 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.419 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . 62.0 m -142.85 147.23 35.06 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.569 0.347 . . . . 0.0 111.031 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 4.5 mm-40 -61.46 136.0 57.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.677 1.191 . . . . 0.0 110.929 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -95.65 27.97 3.22 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.523 0.729 . . . . 0.0 110.362 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.88 3.0 0.7 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.045 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' H ' ' HB3' ' A' ' 75' ' ' GLU . 26.6 t-20 60.25 82.17 0.16 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.705 1.202 . . . . 0.0 111.37 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.9 t -168.92 21.01 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.833 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.12 23.04 78.57 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -171.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -105.44 25.9 10.12 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.804 1.242 . . . . 0.0 110.158 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.6 p-90 -60.92 133.42 56.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.325 1.05 . . . . 0.0 111.665 -173.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HB3' HG22 ' A' ' 43' ' ' THR . 3.5 ppt_? -105.07 155.24 19.18 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.167 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG21 ' HB1' ' A' ' 52' ' ' ALA . 86.4 t -116.14 123.54 71.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.053 0.941 . . . . 0.0 109.898 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 28.3 t -101.07 124.07 54.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.95 126.47 15.92 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.941 0.496 . . . . 0.0 111.299 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.632 0.773 . . . . 0.0 110.23 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.25 135.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.136 0.493 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 51.9 m-85 -115.39 129.1 56.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.6 1.16 . . . . 0.0 110.306 -170.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HB2' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.62 138.33 32.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.67 1.188 . . . . 0.0 108.878 179.039 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.06 147.77 9.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.246 1.018 . . . . 0.0 109.132 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.34 142.31 48.79 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -81.04 144.12 31.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.709 0.804 . . . . 0.0 110.419 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.11 130.96 44.52 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.2 tp -111.65 122.72 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.5 p -67.89 148.96 98.41 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.706 0.803 . . . . 0.0 111.083 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -41.06 -43.21 4.9 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 124.84 3.694 . . . . 0.0 115.601 -177.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.72 -39.77 66.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.061 0.544 . . . . 0.0 111.221 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.2 -25.02 60.6 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.251 0.62 . . . . 0.0 111.025 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.04 -31.8 56.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.276 1.03 . . . . 0.0 110.631 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.53 -23.32 56.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.919 0.888 . . . . 0.0 110.381 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.24 -47.09 16.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.753 0.821 . . . . 0.0 111.243 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -91.59 145.89 24.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.005 0.522 . . . . 0.0 110.613 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -95.39 118.98 66.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.53 0.732 . . . . 0.0 109.248 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.15 153.22 31.79 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.309 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -94.08 -14.91 25.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.148 0.579 . . . . 0.0 111.701 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -166.83 164.73 16.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.318 0.647 . . . . 0.0 110.164 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 129.21 54.74 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.702 1.201 . . . . 0.0 108.777 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 56' ' ' VAL . 31.7 pt -95.72 156.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.485 0.714 . . . . 0.0 110.664 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.0 t -129.58 121.42 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 109.21 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.6 166.15 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 p -123.91 114.77 20.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.094 0.558 . . . . 0.0 110.982 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.28 1.05 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -92.73 94.66 9.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.177 0.591 . . . . 0.0 110.45 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 59.37 41.6 19.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.479 1.111 . . . . 0.0 109.841 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 14.8 m120 -115.38 166.78 11.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.528 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.44 168.53 16.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.859 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.9 tp -63.08 -32.83 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.11 79.61 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.447 0.467 . . . . 0.0 113.083 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 33.9 m-20 -75.05 -35.53 61.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.631 0.772 . . . . 0.0 110.531 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.94 70.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.934 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.34 -33.01 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.324 1.05 . . . . 0.0 110.759 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 t -63.68 -51.85 63.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.765 0.826 . . . . 0.0 110.832 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.81 95.3 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.264 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 40' ' ' ILE . 48.4 t -66.16 -40.11 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.924 0.89 . . . . 0.0 111.725 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -63.62 -43.35 97.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.311 0.645 . . . . 0.0 110.742 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 32.0 ttt180 -65.3 -54.34 30.51 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.969 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 27.4 tpt180 -61.9 -38.13 87.21 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.063 0.852 . . . . 0.0 111.469 -169.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.36 90.39 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.643 0.777 . . . . 0.0 110.619 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.44 -31.61 72.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.685 0.794 . . . . 0.0 110.881 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 4.8 mm-40 -67.04 -33.29 75.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.193 0.597 . . . . 0.0 110.357 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.9 mm-40 -79.74 -12.96 59.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.287 0.635 . . . . 0.0 111.125 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.12 28.05 14.45 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.218 0.324 . . . . 0.0 112.622 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.82 142.16 27.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 0.0 110.705 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.98 -27.72 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.819 0.847 . . . . 0.0 110.253 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 50.4 m -142.88 167.75 21.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.91 0.884 . . . . 0.0 111.137 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 161.8 39.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 109.629 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -155.48 125.11 6.42 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.971 0.508 . . . . 0.0 109.822 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.33 112.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 -41.67 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.456 0.703 . . . . 0.0 110.088 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.0 t70 -131.53 141.0 49.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.728 0.411 . . . . 0.0 110.66 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.0 p -135.41 106.14 6.54 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -121.88 111.09 16.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.904 0.482 . . . . 0.0 109.86 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 10.9 pt-20 -70.66 158.01 36.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.962 0.505 . . . . 0.0 111.414 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -59.34 -41.33 88.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.295 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.69 90.75 0.09 OUTLIER Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.65 -19.82 0.36 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 125.451 1.5 . . . . 0.0 113.028 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.3 p -77.92 156.68 30.14 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.174 0.99 . . . . 0.0 111.13 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.37 -7.82 83.0 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.745 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.79 122.49 32.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.761 0.781 . . . . 0.0 109.462 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.6 p-90 -134.24 136.47 43.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.195 0.998 . . . . 0.0 111.688 -175.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -65.07 136.49 56.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.597 1.159 . . . . 0.0 110.198 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.89 106.65 18.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 59.8 t -96.68 124.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.015 0.926 . . . . 0.0 108.968 174.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.55 125.53 22.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.173 0.589 . . . . 0.0 110.952 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.87 144.28 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.704 0.802 . . . . 0.0 109.518 173.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -115.81 134.39 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.297 0.639 . . . . 0.0 110.196 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 68.5 m-85 -124.17 151.11 44.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.757 0.823 . . . . 0.0 110.54 -166.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.23 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.586 0.755 . . . . 0.0 110.755 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.819 0.848 . . . . 0.0 109.338 175.666 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 138.21 51.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.398 0.279 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.1 m -78.66 138.82 38.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.343 0.657 . . . . 0.0 110.537 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.08 118.12 11.58 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.0 tp -99.18 129.88 45.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.9 p -71.51 154.03 93.49 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.484 0.714 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.27 -18.35 51.83 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.831 2.354 . . . . 0.0 113.498 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.42 -53.63 11.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.211 0.605 . . . . 0.0 109.991 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.19 -33.73 74.96 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.272 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.35 80.8 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.827 0.851 . . . . 0.0 110.772 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.48 -23.29 64.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.244 0.618 . . . . 0.0 111.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.42 3.99 54.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.386 0.674 . . . . 0.0 112.13 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.438 HD12 HD21 ' A' ' 26' ' ' LEU . 93.0 mt -130.2 152.24 49.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.623 0.769 . . . . 0.0 110.245 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -108.18 125.01 32.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 58.1 Cg_endo -68.86 138.99 42.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.234 1.956 . . . . 0.0 111.555 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -79.31 -24.38 42.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.231 0.538 . . . . 0.0 110.459 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -156.24 172.47 18.41 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.592 1.157 . . . . 0.0 108.545 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -143.47 119.87 10.95 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HG13 ' A' ' 56' ' ' VAL . 36.5 pt -94.71 138.15 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 122.777 0.431 . . . . 0.0 110.371 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 85' ' ' VAL . 38.5 t -121.62 131.99 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 pt -123.54 166.13 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.041 0.936 . . . . 0.0 108.948 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -116.5 145.11 43.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 171.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.1 108.78 0.47 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -80.7 79.06 7.41 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.2 t80 44.07 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.478 1.511 . . . . 0.0 113.675 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -122.44 -65.3 1.12 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.08 148.96 5.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 108.824 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.95 -39.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.07 77.47 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.434 0.459 . . . . 0.0 113.148 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.76 -44.51 77.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.828 0.851 . . . . 0.0 109.444 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -67.2 -44.78 78.73 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.042 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.48 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.795 0.838 . . . . 0.0 111.016 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 t -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.94 0.496 . . . . 0.0 110.217 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.88 69.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.952 0.501 . . . . 0.0 110.977 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 40' ' ' ILE . 97.6 t -70.38 -37.49 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.293 0.637 . . . . 0.0 109.926 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.4 t -64.89 -41.86 95.27 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.769 0.827 . . . . 0.0 110.684 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.34 -59.45 4.35 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.159 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 15.6 tpp180 -63.89 -38.33 90.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.67 0.788 . . . . 0.0 111.837 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.35 98.31 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.04 0.448 . . . . 0.0 110.537 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.19 -36.7 85.01 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.774 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.81 -20.6 61.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.256 0.622 . . . . 0.0 111.279 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 34.4 mm-40 -90.97 -4.62 56.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.991 0.516 . . . . 0.0 111.383 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.13 7.93 76.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.067 0.23 . . . . 0.0 113.672 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 137.66 47.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.559 0.743 . . . . 0.0 110.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -71.0 -40.92 71.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.804 0.841 . . . . 0.0 110.525 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 32.7 m -137.32 172.6 12.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.959 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -143.09 165.05 28.45 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.127 0.971 . . . . 0.0 109.365 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.66 112.19 6.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.042 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.34 113.28 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 86' ' ' ALA . 61.7 t -82.67 -48.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -164.6 143.56 7.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.79 -168.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 84' ' ' VAL . 68.8 p -120.84 104.82 10.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 p -129.12 144.88 51.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.329 0.652 . . . . 0.0 111.23 -171.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 27.8 mt-10 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.071 0.948 . . . . 0.0 110.369 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 6.1 p-10 . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 29.6 p-90 -95.83 172.91 7.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.722 172.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' NH1' ' HB ' ' A' ' 85' ' ' VAL . 2.7 ppt_? -142.56 154.76 44.74 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.319 1.048 . . . . 0.0 108.624 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 73' ' ' THR . 57.5 t -119.22 111.76 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 0.0 109.363 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 41' ' ' VAL . 7.3 p -90.34 128.82 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' A' ' 71' ' ' VAL . . . -145.6 131.85 19.5 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.218 0.607 . . . . 0.0 111.167 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 68.7 m-20 -70.12 158.03 36.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 110.6 173.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.9 139.32 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.462 0.705 . . . . 0.0 109.431 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -127.82 136.52 51.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.939 0.896 . . . . 0.0 110.194 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -80.76 167.66 19.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.667 0.787 . . . . 0.0 111.585 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.275 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.83 145.71 42.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.637 0.375 . . . . 0.0 110.328 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.6 m -69.96 140.09 52.94 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.29 0.636 . . . . 0.0 111.107 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.64 126.46 30.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 34' ' ' LEU . 12.7 tp -98.93 126.06 44.52 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 p -74.03 143.61 80.99 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.985 0.514 . . . . 0.0 109.996 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.82 -34.84 6.29 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.551 3.5 . . . . 0.0 115.667 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -69.62 -44.22 71.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.576 0.751 . . . . 0.0 110.695 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -68.9 -39.19 79.87 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.141 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.06 63.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.198 0.999 . . . . 0.0 112.099 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.45 77.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.163 0.585 . . . . 0.0 110.164 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.12 36.83 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.534 HD12 HD21 ' A' ' 26' ' ' LEU . 90.2 mt -89.02 157.4 18.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.333 0.653 . . . . 0.0 111.269 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -110.44 128.6 25.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.25 159.69 48.99 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.201 1.934 . . . . 0.0 111.532 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -96.52 -14.73 22.09 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -158.86 154.84 26.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.979 0.912 . . . . 0.0 109.951 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 86.3 mtm180 -124.49 127.14 47.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.553 1.141 . . . . 0.0 108.764 171.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 56' ' ' VAL . 32.1 pt -103.5 161.7 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.04 0.936 . . . . 0.0 110.63 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.54 129.67 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.984 0.914 . . . . 0.0 109.825 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.66 166.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.407 1.083 . . . . 0.0 108.76 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 29.4 m -149.82 130.47 14.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.38 133.42 6.96 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 23.9 ttm-85 -100.6 123.66 45.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.183 0.593 . . . . 0.0 110.003 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 63.16 11.74 5.51 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.939 1.296 . . . . 0.0 113.049 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 36.1 m-80 -79.79 148.94 31.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.371 0.668 . . . . 0.0 110.287 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.64 168.23 17.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.299 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.1 tp -57.5 -31.9 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.541 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.12 93.59 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.758 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 12.7 m-20 -67.19 -37.51 83.81 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.624 0.77 . . . . 0.0 110.789 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.93 -53.4 47.09 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.913 0.758 . . . . 0.0 110.71 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.46 -36.21 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 0.0 110.853 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 t -64.86 -42.85 94.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.918 0.887 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.44 -37.39 65.86 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.52 0.728 . . . . 0.0 111.451 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 40' ' ' ILE . 76.6 t -65.19 -45.36 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.132 0.573 . . . . 0.0 110.485 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -68.73 -32.28 71.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.821 0.848 . . . . 0.0 110.744 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -65.79 -55.04 19.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.515 0.726 . . . . 0.0 109.8 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -62.28 -44.67 95.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.994 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.47 -49.13 78.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.751 0.82 . . . . 0.0 111.182 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.64 -38.66 91.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.404 0.682 . . . . 0.0 111.088 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -76.16 -21.04 57.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.151 0.581 . . . . 0.0 112.202 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -76.82 -22.59 53.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.992 0.517 . . . . 0.0 110.277 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.02 11.41 60.15 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.902 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.9 129.16 38.82 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.661 0.784 . . . . 0.0 110.141 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.65 84.67 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 123.874 0.734 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 26' ' ' LEU . 13.8 t -141.4 174.99 10.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.019 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.78 163.94 35.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.299 1.04 . . . . 0.0 108.86 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -151.49 118.4 5.83 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -71.24 114.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.28 -23.35 5.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -163.53 129.61 3.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.981 0.419 . . . . 0.0 111.18 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 p -111.33 141.59 44.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 165.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 23.0 t -159.19 139.88 12.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.101 0.56 . . . . 0.0 110.663 -179.174 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 56.6 t30 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -150.22 131.0 14.12 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.368 0.604 . . . . 0.0 111.287 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HD2' ' HB3' ' A' ' 74' ' ' SER . 0.0 OUTLIER -91.66 156.37 17.65 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 110.171 178.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' A' ' 52' ' ' ALA . 61.0 t -139.7 116.58 9.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 124.14 0.976 . . . . 0.0 108.431 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 132.45 40.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.43 138.07 29.06 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.113 0.965 . . . . 0.0 109.048 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.597 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -101.79 141.76 34.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.637 0.775 . . . . 0.0 109.353 176.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.02 142.6 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.038 0.935 . . . . 0.0 110.045 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -124.52 155.94 38.15 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.338 1.055 . . . . 0.0 111.746 -165.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -110.57 145.46 37.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.494 1.118 . . . . 0.0 108.94 169.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.585 0.754 . . . . 0.0 108.983 -178.079 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.71 129.37 39.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -66.17 135.39 54.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.435 0.694 . . . . 0.0 110.663 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.98 115.83 11.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -89.7 134.6 34.08 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.4 p -68.25 142.49 94.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.778 0.674 . . . . 0.0 109.943 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.47 -34.13 7.27 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 124.08 3.187 . . . . 0.0 113.881 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.28 -57.57 9.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 0.0 110.879 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.7 -33.93 77.11 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.82 -24.98 61.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.082 0.953 . . . . 0.0 112.092 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 -18.31 49.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.982 0.513 . . . . 0.0 111.407 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.89 -39.57 8.92 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.346 0.659 . . . . 0.0 111.0 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.33 142.0 28.22 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.985 0.914 . . . . 0.0 109.35 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -103.08 128.78 26.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.75 161.13 30.79 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.887 2.391 . . . . 0.0 112.138 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -98.41 -21.06 16.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.868 0.467 . . . . 0.0 110.502 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -155.83 161.28 40.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.048 0.939 . . . . 0.0 109.558 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.6 mtm180 -123.09 119.03 29.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 56' ' ' VAL . 43.2 pt -90.98 131.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.59 120.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -118.93 179.4 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.158 0.983 . . . . 0.0 109.119 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 23.7 p -119.06 119.47 34.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.648 0.779 . . . . 0.0 109.539 169.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.65 135.06 12.61 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -97.51 171.36 8.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 117.967 0.883 . . . . 0.0 111.122 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.35 3.38 3.77 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 0.0 112.297 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -52.23 -51.56 57.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.399 1.08 . . . . 0.0 111.578 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.48 164.17 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.742 0.817 . . . . 0.0 110.981 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.96 -43.01 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.08 -16.02 70.3 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.671 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.08 -51.99 61.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.965 0.906 . . . . 0.0 109.651 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -68.91 -46.98 66.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.075 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.19 -35.53 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.761 0.825 . . . . 0.0 111.582 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 t -64.23 -44.57 91.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.568 0.747 . . . . 0.0 110.504 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.78 66.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.054 0.542 . . . . 0.0 111.71 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG13 HD11 ' A' ' 40' ' ' ILE . 49.8 t -72.17 -45.94 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.912 0.485 . . . . 0.0 109.717 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -63.35 -45.32 91.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.064 0.946 . . . . 0.0 110.945 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 31.7 mmt180 -72.3 -37.01 69.08 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.994 0.809 . . . . 0.0 111.427 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 tpt180 -66.7 -48.92 67.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.15 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -34.42 76.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.053 0.941 . . . . 0.0 110.905 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.3 -39.13 92.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.79 0.836 . . . . 0.0 110.806 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 51.5 mt-10 -64.74 -34.68 78.9 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.359 0.663 . . . . 0.0 110.925 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.0 mm-40 -78.64 -8.11 58.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.517 0.727 . . . . 0.0 111.374 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.92 17.45 79.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.269 0.356 . . . . 0.0 112.996 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . . . -73.62 128.52 35.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.978 0.911 . . . . 0.0 109.996 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.26 69.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.67 0.788 . . . . 0.0 111.506 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 56.5 m -144.99 171.21 14.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.379 0.672 . . . . 0.0 111.482 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.7 166.62 28.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.447 1.099 . . . . 0.0 108.698 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -155.29 129.12 8.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -77.09 113.16 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.86 0.464 . . . . 0.0 110.094 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.73 -25.93 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.279 0.632 . . . . 0.0 111.539 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 19.7 t70 -148.29 138.44 22.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.012 0.525 . . . . 0.0 110.849 -174.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 84' ' ' VAL . 23.4 p -136.53 106.09 6.14 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.571 1.149 . . . . 0.0 108.033 170.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -121.03 138.44 54.17 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.121 0.968 . . . . 0.0 109.416 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 11.8 pt-20 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.984 0.421 . . . . 0.0 110.985 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.1 p-90 -109.25 108.18 18.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 108.992 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -64.78 149.64 48.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.434 0.694 . . . . 0.0 109.197 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.3 t -126.6 114.39 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.537 . . . . 0.0 109.948 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 34.4 t -88.96 124.32 41.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 165.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.69 121.58 14.51 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.426 0.691 . . . . 0.0 109.338 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 46.8 p-10 -81.28 140.41 34.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.733 0.413 . . . . 0.0 110.133 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.18 137.8 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.144 0.978 . . . . 0.0 110.379 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 35.9 m-85 -118.55 139.28 51.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.568 1.147 . . . . 0.0 110.393 -168.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 65' ' ' ALA . 32.7 mmtp -95.36 159.07 15.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 109.839 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.28 149.14 48.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.58 0.752 . . . . 0.0 111.612 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.7 m -74.02 142.35 45.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.559 0.744 . . . . 0.0 110.545 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.27 118.73 14.43 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.1 tp -85.21 119.25 25.38 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -64.73 141.75 98.38 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.59 -39.4 1.92 Allowed 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 125.044 3.83 . . . . 0.0 116.083 -173.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.93 -40.29 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.281 0.632 . . . . 0.0 110.332 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.94 -38.32 76.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.371 0.669 . . . . 0.0 110.213 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.15 -29.78 70.65 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.335 1.054 . . . . 0.0 111.171 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.91 -29.51 55.74 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.856 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.07 26.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.326 0.651 . . . . 0.0 112.36 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 26' ' ' LEU . 96.9 mt -115.51 143.73 44.89 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.711 0.805 . . . . 0.0 110.171 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -92.7 133.05 29.96 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 0.0 110.137 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.26 153.42 24.4 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 5.7 p90 -99.12 -32.49 11.22 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -143.76 174.73 10.56 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -139.26 125.95 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.477 1.111 . . . . 0.0 108.661 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.58 HD11 HG13 ' A' ' 56' ' ' VAL . 32.7 pt -103.06 152.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.977 0.511 . . . . 0.0 110.427 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.99 133.15 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -116.23 157.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.279 1.032 . . . . 0.0 109.076 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.5 m -134.65 139.46 45.3 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.33 142.96 11.52 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.49 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -68.55 -40.71 80.54 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.225 0.61 . . . . 0.0 110.788 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -166.25 135.84 3.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.34 0.656 . . . . 0.0 109.613 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.6 -116.55 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.0 168.17 19.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 0.0 108.323 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 9.7 tp -63.28 -37.59 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.6 88.3 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.457 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.02 -34.34 77.78 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.743 0.817 . . . . 0.0 111.541 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.21 -46.19 57.18 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.843 0.857 . . . . 0.0 110.259 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.05 -33.68 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.568 0.747 . . . . 0.0 110.598 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -72.66 -35.01 67.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.91 0.884 . . . . 0.0 110.927 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.82 78.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.244 0.617 . . . . 0.0 109.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 40' ' ' ILE . 53.9 t -64.53 -37.05 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.217 1.007 . . . . 0.0 110.852 174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -61.38 -52.73 63.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.888 0.875 . . . . 0.0 110.711 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -69.45 -37.76 77.49 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.79 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 12.5 tpt180 -66.85 -37.35 84.29 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.323 0.649 . . . . 0.0 111.256 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.25 83.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.499 0.72 . . . . 0.0 110.343 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.21 -35.1 73.67 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.481 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 12.6 mm-40 -63.19 -34.49 77.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.741 0.816 . . . . 0.0 110.606 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 37.1 mm-40 -70.63 -29.02 65.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.506 175.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.33 4.28 53.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.071 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 141.77 49.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.693 0.797 . . . . 0.0 110.557 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.21 64.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 110.632 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.1 m -141.14 173.57 11.35 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.719 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.48 173.99 12.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.33 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -160.5 120.24 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 109.944 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.22 113.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.868 0.867 . . . . 0.0 109.67 173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.7 -20.76 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 0.0 111.501 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 22.9 t70 -154.29 145.22 22.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.123 0.569 . . . . 0.0 110.904 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.5 HG22 HG22 ' A' ' 84' ' ' VAL . 26.0 p -137.55 111.49 8.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.915 1.286 . . . . 0.0 107.978 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -118.43 135.19 54.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.227 0.611 . . . . 0.0 109.551 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.114 0.566 . . . . 0.0 110.788 179.4 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.245 0.826 0 CA-C-O 121.251 0.548 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.415 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 1.7 p-90 -157.32 177.45 11.43 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.318 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.73 156.01 44.38 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.333 0.653 . . . . 0.0 109.677 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.603 HG21 ' HB1' ' A' ' 52' ' ' ALA . 98.9 t -130.92 115.83 31.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.009 0.924 . . . . 0.0 109.564 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 56.5 t -92.39 129.89 42.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 108.766 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.57 125.69 13.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.583 0.753 . . . . 0.0 110.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.33 143.02 35.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.01 139.64 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.414 0.686 . . . . 0.0 110.428 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -121.03 139.59 53.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.484 1.113 . . . . 0.0 109.993 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 31.6 mmmt -90.08 165.56 13.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.567 0.747 . . . . 0.0 110.49 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.425 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.38 138.09 33.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.315 1.046 . . . . 0.0 112.48 -169.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -63.37 147.6 50.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.079 0.952 . . . . 0.0 110.817 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.39 122.64 20.71 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -81.92 138.07 35.07 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.7 p -74.47 152.07 87.56 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.303 0.641 . . . . 0.0 109.916 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.96 -23.19 75.57 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.335 2.023 . . . . 0.0 112.683 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.39 -56.24 24.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.074 0.95 . . . . 0.0 110.278 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -76.07 -24.99 55.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.112 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.633 0.773 . . . . 0.0 111.156 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.42 -28.75 26.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.141 0.576 . . . . 0.0 110.187 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.03 3.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.413 0.685 . . . . 0.0 110.849 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.7 148.21 25.54 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.72 0.808 . . . . 0.0 110.193 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.3 143.17 26.24 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.09 144.29 37.49 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.394 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -77.08 -20.56 55.63 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.838 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -159.45 161.97 35.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.524 1.13 . . . . 0.0 108.85 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.0 ttm180 -132.88 120.84 22.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.641 0.777 . . . . 0.0 108.917 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.471 HG21 ' HD2' ' A' ' 59' ' ' ARG . 27.9 pt -91.91 163.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.698 0.799 . . . . 0.0 111.451 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.458 HG23 ' NE ' ' A' ' 83' ' ' ARG . 2.2 p -142.22 130.5 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 110.387 -173.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' A' ' 84' ' ' VAL . 41.4 pt -144.89 174.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.696 1.198 . . . . 0.0 109.109 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 p -136.56 125.01 23.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.369 1.068 . . . . 0.0 108.819 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.16 73.43 1.51 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 62.6 ttt180 -68.5 96.34 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.845 0.458 . . . . 0.0 111.002 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.4 t80 65.33 19.77 11.71 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.13 1.372 . . . . 0.0 111.118 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.44 150.67 21.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.649 0.779 . . . . 0.0 110.069 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.43 161.06 23.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.368 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.4 -46.83 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.549 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.87 -29.08 69.65 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.664 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.09 -48.54 65.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.462 0.705 . . . . 0.0 110.676 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -69.74 -32.49 71.05 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.85 -38.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.846 0.458 . . . . 0.0 110.625 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -65.98 -35.73 81.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.773 0.429 . . . . 0.0 110.479 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.46 64.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.537 0.735 . . . . 0.0 111.485 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.36 -31.63 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.284 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.0 t -69.97 -43.12 72.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.683 0.793 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 ttt180 -61.84 -49.12 77.55 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.466 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.48 -46.07 87.38 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 109.684 -176.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.53 83.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.085 0.866 . . . . 0.0 111.066 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.04 -34.83 79.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.63 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 58.5 mt-10 -70.62 -23.11 62.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.84 0.456 . . . . 0.0 110.916 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -89.72 2.15 55.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.379 0.672 . . . . 0.0 111.58 175.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 24.08 67.32 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.448 -0.342 . . . . 0.0 113.324 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.43 134.13 35.5 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.376 0.671 . . . . 0.0 110.178 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.33 75.96 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.549 0.69 . . . . 0.0 110.174 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 m -148.98 169.66 20.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.792 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -145.13 149.88 35.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.087 0.955 . . . . 0.0 108.521 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -128.5 131.23 48.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -78.28 123.53 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HB ' ' OD1' ' A' ' 87' ' ' ASP . 7.7 p -86.85 -33.5 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.696 0.399 . . . . 0.0 110.139 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -160.72 144.2 13.41 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.795 0.438 . . . . 0.0 110.839 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 21.1 p -133.38 112.98 12.05 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 t -126.74 120.39 29.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.391 0.676 . . . . 0.0 110.523 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 33.9 mt-10 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 123.691 0.796 . . . . 0.0 110.474 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 52.3 t30 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 120.692 0.282 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 3.0 p-90 -142.68 124.74 15.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.054 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.614 ' HE ' ' HB ' ' A' ' 85' ' ' VAL . 12.0 tpt180 -64.44 116.58 6.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.03 1.332 . . . . 0.0 109.747 174.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.51 ' HB ' HG13 ' A' ' 42' ' ' ILE . 26.6 t -106.43 107.99 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.614 ' HB ' ' HE ' ' A' ' 83' ' ' ARG . 5.8 p -118.91 126.84 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.25 142.75 35.75 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.568 0.747 . . . . 0.0 110.214 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.49 143.53 26.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 124.624 1.17 . . . . 0.0 110.38 178.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.29 141.4 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.086 0.954 . . . . 0.0 110.551 -171.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -125.04 167.58 14.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.01 0.924 . . . . 0.0 112.293 -167.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 10.3 mmpt? -101.56 164.46 11.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.796 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.062 173.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.19 115.49 6.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.586 0.354 . . . . 0.0 110.983 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.9 m -67.73 137.33 55.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.7 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -72.83 118.25 15.53 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.9 tp -85.45 144.85 27.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.994 0.918 . . . . 0.0 109.032 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 p -84.92 157.3 60.33 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.042 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.38 -28.42 80.16 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.813 2.342 . . . . 0.0 113.561 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.84 -44.96 75.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.869 0.468 . . . . 0.0 110.586 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.516 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 51.9 mt-30 -72.22 -28.35 63.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.917 0.487 . . . . 0.0 110.98 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 -23.08 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.31 0.644 . . . . 0.0 110.739 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.33 25.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.461 0.704 . . . . 0.0 110.568 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.53 36.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.663 0.785 . . . . 0.0 110.788 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.6 166.2 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.269 1.027 . . . . 0.0 110.236 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -118.86 149.2 46.14 Favored Pre-proline 0 C--O 1.244 0.795 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.48 165.67 22.8 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.603 2.202 . . . . 0.0 111.871 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -96.61 -45.3 6.77 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.23 -173.84 3.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 109.854 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 29.8 mtt180 -123.87 171.55 9.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.304 0.642 . . . . 0.0 109.305 170.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 pt -138.89 138.35 41.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.1 124.73 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 pt -118.45 175.7 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.968 0.907 . . . . 0.0 108.777 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 19.7 p -130.49 113.87 14.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 64.91 3.72 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 53.7 ttt180 -63.77 95.69 0.12 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.93 0.892 . . . . 0.0 111.089 -172.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.8 t80 63.55 16.4 9.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.727 1.211 . . . . 0.0 111.436 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.69 155.94 19.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.813 0.845 . . . . 0.0 109.739 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.91 161.03 30.56 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.261 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 tp -60.16 -37.39 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.338 0.655 . . . . 0.0 110.875 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.66 90.97 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.344 0.402 . . . . 0.0 112.887 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.19 -36.42 77.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.556 0.742 . . . . 0.0 110.767 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.6 82.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.63 0.581 . . . . 0.0 110.15 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.95 -36.64 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.005 0.522 . . . . 0.0 110.295 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.7 t -68.79 -41.42 78.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.964 0.506 . . . . 0.0 110.691 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.54 -35.08 67.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.165 0.586 . . . . 0.0 111.749 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 p -77.0 -31.01 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -72.44 -35.49 68.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.928 0.491 . . . . 0.0 110.407 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -61.06 -56.91 15.43 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.467 1.105 . . . . 0.0 109.797 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -59.44 -45.68 90.89 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.118 0.886 . . . . 0.0 111.403 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.24 94.45 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.611 0.569 . . . . 0.0 111.317 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.03 -37.49 87.61 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.116 0.567 . . . . 0.0 110.665 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.42 -19.31 60.45 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.547 0.739 . . . . 0.0 111.416 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.11 -7.3 59.41 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.914 0.886 . . . . 0.0 111.133 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 13.95 81.28 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.627 -0.26 . . . . 0.0 112.912 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.05 134.9 38.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.702 0.801 . . . . 0.0 110.318 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.76 -38.79 46.08 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.073 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 22.8 m -134.45 169.82 16.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.664 -176.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -149.53 158.41 44.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.641 0.776 . . . . 0.0 109.0 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -143.78 119.05 10.18 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.386 0.674 . . . . 0.0 109.277 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 86' ' ' ALA . 63.8 t -71.47 112.12 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.386 0.675 . . . . 0.0 109.702 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.51 -26.71 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.4 t70 -143.17 133.43 24.57 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.064 0.546 . . . . 0.0 110.281 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.2 p -132.07 112.63 12.51 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -115.88 173.74 6.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.877 0.871 . . . . 0.0 108.98 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.43 0.692 . . . . 0.0 109.993 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 3.6 p-10 . . . . . 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 43.3 p-90 -99.66 127.58 45.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.674 171.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -95.05 153.97 17.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.534 0.733 . . . . 0.0 110.758 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.88 112.78 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.704 1.202 . . . . 0.0 108.863 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 39.9 t -98.08 115.11 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 70' ' ' VAL . . . -126.15 120.57 30.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.497 0.719 . . . . 0.0 109.937 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 1.2 m-20 -70.3 146.12 50.79 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.979 174.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.35 136.86 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.032 0.533 . . . . 0.0 110.186 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 34.5 m-85 -126.04 170.17 12.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.638 1.175 . . . . 0.0 110.744 -168.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.99 178.57 5.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.023 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.733 0.813 . . . . 0.0 108.827 172.676 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.87 136.23 56.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.312 0.645 . . . . 0.0 111.583 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 m -68.24 130.63 43.49 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.048 0.539 . . . . 0.0 110.755 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.1 118.26 12.71 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 27.1 tp -93.16 139.78 30.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.473 1.109 . . . . 0.0 109.717 -172.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -71.38 147.95 93.14 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.545 0.738 . . . . 0.0 110.16 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.48 -33.62 86.76 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.421 2.747 . . . . 0.0 113.991 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.0 -46.8 64.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.999 0.52 . . . . 0.0 111.012 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -73.25 -23.44 60.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.201 0.6 . . . . 0.0 111.463 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.13 -36.06 61.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 0.0 110.352 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.36 61.86 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.25 -48.93 38.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.511 0.725 . . . . 0.0 110.392 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.37 170.5 15.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.441 0.696 . . . . 0.0 111.355 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -121.32 123.33 27.73 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.556 0.742 . . . . 0.0 109.694 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.81 133.26 12.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.936 2.424 . . . . 0.0 112.254 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.68 -34.67 30.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.157 0.583 . . . . 0.0 110.194 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.26 171.86 13.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.471 1.108 . . . . 0.0 108.468 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 5.7 ttp180 -140.71 128.5 21.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.372 1.069 . . . . 0.0 108.116 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.7 pt -103.32 161.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.079 0.552 . . . . 0.0 110.531 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG23 ' HD3' ' A' ' 83' ' ' ARG . 2.0 p -148.76 132.34 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.985 0.914 . . . . 0.0 109.438 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -132.32 166.72 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.608 1.163 . . . . 0.0 109.528 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.7 p -134.08 118.82 18.17 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.382 1.073 . . . . 0.0 109.637 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.86 115.06 5.14 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.653 -0.526 . . . . 0.0 111.811 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -76.11 91.43 3.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.282 0.633 . . . . 0.0 110.165 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 t80 65.79 12.29 8.22 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.309 1.444 . . . . 0.0 112.003 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -72.65 154.78 40.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.9 162.36 29.16 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.592 0.357 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.7 tp -60.31 -31.78 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.053 0.541 . . . . 0.0 110.676 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.88 -42.9 98.24 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.912 -0.382 . . . . 0.0 112.897 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -62.92 -43.18 99.5 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.372 0.669 . . . . 0.0 110.074 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.2 -51.2 67.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.021 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.69 -37.4 79.56 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 123.693 0.797 . . . . 0.0 110.395 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.0 t -69.06 -36.44 77.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.364 0.666 . . . . 0.0 111.198 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.01 -40.25 60.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.39 0.676 . . . . 0.0 111.252 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.03 -27.89 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 123.269 0.628 . . . . 0.0 110.19 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.408 ' OG ' ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -70.26 -42.97 71.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.851 0.861 . . . . 0.0 110.104 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 18.7 ttt180 -57.47 -57.61 11.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.64 175.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.3 tpp85 -61.03 -40.97 95.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.08 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.78 96.31 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.173 0.589 . . . . 0.0 111.283 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.89 -35.6 80.39 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.25 0.62 . . . . 0.0 110.335 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 55.2 mt-10 -71.12 -29.25 65.02 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.97 0.908 . . . . 0.0 110.849 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 23.8 mm-40 -73.82 -14.36 61.08 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.235 0.614 . . . . 0.0 110.754 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.12 2.74 64.04 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.98 138.76 42.47 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.753 0.821 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.45 -32.37 64.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.176 0.99 . . . . 0.0 110.887 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 66.0 m -143.44 171.07 14.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.21 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.36 162.38 38.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.328 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -141.56 117.51 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.26 113.67 3.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.64 -20.81 6.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.22 137.84 4.4 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 123.321 0.388 . . . . 0.0 110.905 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.5 p -122.43 106.42 11.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 t -123.6 126.26 46.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.044 0.538 . . . . 0.0 109.984 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 31.0 mt-10 . . . . . 0 CA--C 1.541 0.632 0 O-C-N 123.552 0.532 . . . . 0.0 110.236 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.9 t30 . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.2 p-90 -109.27 126.78 53.7 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.572 0.749 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.3 tmm_? -83.8 129.19 34.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.782 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.543 HG21 ' HB1' ' A' ' 52' ' ' ALA . 62.6 t -113.3 109.31 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.299 1.04 . . . . 0.0 108.248 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.42 134.81 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.14 129.16 18.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.595 0.758 . . . . 0.0 111.079 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 2.6 m-20 -77.51 141.0 39.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.69 145.69 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.285 0.634 . . . . 0.0 111.095 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -127.74 133.6 49.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.488 1.115 . . . . 0.0 110.432 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -84.46 165.55 18.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.978 0.911 . . . . 0.0 111.247 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . . . . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.39 46.78 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.732 0.645 . . . . 0.0 112.327 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -75.78 145.36 40.79 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.566 0.747 . . . . 0.0 110.311 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.1 118.87 15.51 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HD12 ' A' ' 34' ' ' LEU . 19.7 tp -82.16 138.43 34.72 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -64.3 141.62 98.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.219 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -42.21 -30.1 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.985 3.123 . . . . 0.0 115.162 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.59 -54.52 7.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.248 0.619 . . . . 0.0 111.249 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.58 -31.26 71.86 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.74 0.416 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -31.7 65.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.699 0.8 . . . . 0.0 111.048 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.76 62.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.998 0.519 . . . . 0.0 110.875 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -42.9 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.18 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 HD21 ' A' ' 26' ' ' LEU . 95.7 mt -86.79 167.23 14.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 110.162 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -120.35 125.0 27.43 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.96 146.38 32.73 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.548 2.165 . . . . 0.0 111.923 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -82.58 -22.87 34.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 111.277 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -158.52 168.58 26.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 110.455 -173.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 18.5 mtm180 -126.91 124.01 38.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.928 1.291 . . . . 0.0 108.507 169.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.88 138.7 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.825 0.45 . . . . 0.0 110.317 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.24 123.97 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 pt -109.39 160.44 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.766 0.826 . . . . 0.0 109.826 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.8 p -132.05 131.86 42.85 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.072 0.949 . . . . 0.0 108.664 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.07 154.79 21.15 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtm105 -110.25 118.96 37.74 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.838 0.819 . . . . 0.0 109.969 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 t80 55.94 82.78 0.1 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.994 1.317 . . . . 0.0 110.98 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -132.75 164.77 26.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.702 0.801 . . . . 0.0 110.01 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.2 178.82 4.79 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 53' ' ' VAL . 9.0 tp -65.66 -37.07 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.21 -38.56 96.7 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 123.191 0.307 . . . . 0.0 113.351 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.18 -39.9 78.42 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.412 0.685 . . . . 0.0 110.2 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.1 -40.98 99.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.316 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 49' ' ' ILE . 83.0 t -70.36 -40.2 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.413 0.685 . . . . 0.0 110.467 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -65.89 -34.89 79.17 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 0.0 111.059 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.58 -34.99 58.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.227 0.611 . . . . 0.0 111.222 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.0 p -83.27 -27.01 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.761 0.424 . . . . 0.0 110.685 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -73.32 -36.34 66.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.0 ttt180 -66.36 -45.28 80.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.979 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -64.28 -41.32 96.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.132 0.573 . . . . 0.0 110.883 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.05 -32.54 74.13 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 120.665 0.269 . . . . 0.0 110.889 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 19.8 t70 -67.79 -36.91 81.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.43 0.692 . . . . 0.0 110.872 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.8 mm-40 -63.13 -35.88 81.73 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.378 0.671 . . . . 0.0 110.719 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 29.7 mm-40 -83.79 -11.19 57.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.687 0.795 . . . . 0.0 112.161 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.64 47.8 8.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-O 121.137 0.298 . . . . 0.0 112.554 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.55 131.4 56.68 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 0.0 109.134 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -35.1 74.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.21 0.604 . . . . 0.0 111.507 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -140.92 175.32 9.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.579 0.751 . . . . 0.0 110.613 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 38.5 p90 -149.52 -179.94 7.48 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 173.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -159.11 122.81 3.82 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.7 115.49 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 85' ' ' VAL . 2.5 p -88.56 -31.54 5.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.264 0.626 . . . . 0.0 109.669 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -162.07 142.08 10.03 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.871 0.367 . . . . 0.0 110.982 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.5 p -117.99 147.05 43.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.58 1.152 . . . . 0.0 108.334 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -150.16 169.81 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.69 0.796 . . . . 0.0 110.23 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 171.63 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -66.93 96.82 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.645 1.178 . . . . 0.0 112.556 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.64 111.67 19.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HB1' ' A' ' 52' ' ' ALA . 57.9 t -123.06 121.2 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.93 0.492 . . . . 0.0 109.955 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 p -109.86 134.19 52.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.297 0.639 . . . . 0.0 109.53 173.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.79 124.72 18.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 109.958 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 5.3 p-10 -72.53 130.83 41.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.428 0.691 . . . . 0.0 110.171 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 13.4 m -112.97 151.84 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.103 0.961 . . . . 0.0 111.301 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -130.37 147.42 52.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.782 1.233 . . . . 0.0 110.43 -167.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.3 173.58 9.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.745 0.818 . . . . 0.0 110.268 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.628 174.28 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.37 137.05 58.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.809 0.443 . . . . 0.0 109.951 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 m -62.09 135.44 57.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.44 0.696 . . . . 0.0 110.651 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.01 117.61 13.84 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.7 tp -90.95 142.28 27.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -95.94 153.29 39.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.196 0.599 . . . . 0.0 110.47 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -44.63 -38.62 12.52 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.213 3.276 . . . . 0.0 115.625 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.37 -50.7 72.97 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.358 0.663 . . . . 0.0 111.186 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 44.9 mt-30 -66.31 -46.23 77.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.817 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.67 68.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.889 0.875 . . . . 0.0 112.492 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.22 -24.45 47.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.6 0.76 . . . . 0.0 110.818 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.14 -33.32 14.08 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.759 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -99.45 153.21 19.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.343 0.657 . . . . 0.0 111.191 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -104.76 128.39 26.93 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 109.401 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.34 148.1 23.53 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.677 2.251 . . . . 0.0 111.697 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -80.12 -24.02 40.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.674 0.389 . . . . 0.0 110.47 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -160.74 175.17 12.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.148 0.979 . . . . 0.0 108.923 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.624 HH21 HG11 ' A' ' 71' ' ' VAL . 43.7 mtp180 -132.47 121.15 22.93 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.606 HD11 HG13 ' A' ' 56' ' ' VAL . 44.9 pt -89.55 149.15 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.012 0.369 . . . . 0.0 110.132 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.98 122.57 49.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -109.65 170.56 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.2 p -125.48 106.02 9.48 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.658 0.783 . . . . 0.0 109.136 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.43 88.73 1.59 Allowed Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.51 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 81' ' ' ASN . 10.0 ttm180 -84.06 96.09 8.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 110.221 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.8 t80 60.79 90.65 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.47 1.106 . . . . 0.0 110.033 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.09 162.96 13.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.693 0.797 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.02 161.89 24.04 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 123.547 0.529 . . . . 0.0 110.018 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.498 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.2 tp -64.87 -29.18 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.9 97.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.072 0.232 . . . . 0.0 113.113 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.16 -43.41 82.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.533 0.733 . . . . 0.0 110.459 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -61.81 -50.11 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.086 0.954 . . . . 0.0 111.623 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.6 -35.84 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.064 0.946 . . . . 0.0 111.031 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 t -67.32 -34.93 78.38 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.043 0.537 . . . . 0.0 110.6 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.88 -33.91 64.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.042 0.537 . . . . 0.0 111.009 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.606 HG13 HD11 ' A' ' 40' ' ' ILE . 79.7 t -69.54 -41.71 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.262 0.625 . . . . 0.0 110.96 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.0 p -66.0 -34.18 77.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.938 0.495 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 15.1 tpt180 -65.93 -57.44 7.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.76 0.824 . . . . 0.0 109.67 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -60.46 -40.36 90.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.04 1.336 . . . . 0.0 112.387 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.12 79.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.851 0.86 . . . . 0.0 110.246 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.75 -31.25 72.36 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.66 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 24.5 mm-40 -69.32 -29.44 67.27 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.046 0.538 . . . . 0.0 111.248 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -83.84 -1.93 55.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.989 0.516 . . . . 0.0 111.129 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.26 16.32 71.98 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.345 -0.388 . . . . 0.0 113.304 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -69.81 124.49 24.14 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.687 . . . . 0.0 110.852 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.95 69.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.859 0.724 . . . . 0.0 110.336 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.98 155.64 44.1 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 36.3 p90 -124.41 160.7 27.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -149.69 105.2 3.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.38 107.9 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.624 HG11 HH21 ' A' ' 39' ' ' ARG . 11.4 p -93.49 -36.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.291 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.47 145.28 21.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.875 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.3 p -131.28 134.5 46.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.818 1.247 . . . . 0.0 107.814 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m -139.07 126.57 21.71 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.139 0.576 . . . . 0.0 110.146 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 122.994 0.518 . . . . 0.0 110.83 179.836 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 33.8 p-10 . . . . . 0 C--O 1.24 0.573 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.498 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 7.5 p-90 -146.2 127.21 14.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.853 0.861 . . . . 0.0 109.198 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.93 149.18 50.11 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.979 0.799 . . . . 0.0 108.944 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 52' ' ' ALA . 32.3 t -127.2 105.28 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.69 131.26 41.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.32 112.22 6.56 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.195 -171.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.05 133.89 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 15.6 m -113.99 126.15 71.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.513 0.673 . . . . 0.0 109.859 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -115.11 162.51 16.92 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.868 1.267 . . . . 0.0 110.245 -168.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -107.22 170.2 8.11 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.316 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.848 178.917 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . . . . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.54 140.14 41.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.259 1.024 . . . . 0.0 112.125 -176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.5 m -66.97 134.04 51.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.977 0.911 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -68.71 116.54 9.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -72.99 137.5 45.48 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.9 p -72.03 147.69 91.22 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.443 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.6 -36.44 18.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.963 3.108 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.01 -37.89 69.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.864 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -74.43 -49.47 22.3 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.138 0.494 . . . . 0.0 110.122 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.06 -22.17 66.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.455 1.102 . . . . 0.0 112.348 -175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.14 -53.86 50.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.34 1.056 . . . . 0.0 112.328 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.13 -22.89 17.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.947 0.499 . . . . 0.0 111.852 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.968 0.413 . . . . 0.0 110.339 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -86.91 125.6 66.08 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.7 166.41 23.71 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.973 2.448 . . . . 0.0 111.374 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -93.5 -26.27 17.24 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.465 -0.147 . . . . 0.0 111.232 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -165.21 -170.94 2.03 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.698 0.399 . . . . 0.0 110.251 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -137.94 138.03 38.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.885 1.274 . . . . 0.0 109.983 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -102.77 144.14 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.914 0.886 . . . . 0.0 109.398 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 85' ' ' VAL . 46.1 t -130.83 115.43 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 pt -102.7 156.68 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.1 m -147.1 146.2 29.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 0.0 109.351 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.92 156.57 25.05 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -92.52 132.64 36.66 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.381 1.072 . . . . 0.0 110.003 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 t80 60.46 23.13 12.75 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 124.685 1.194 . . . . 0.0 112.091 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.76 116.93 16.02 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.28 158.98 35.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 tp -57.49 -33.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.284 0.365 . . . . 0.0 111.058 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.28 -45.03 96.82 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.245 0.341 . . . . 0.0 112.936 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.49 -39.67 92.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.711 0.804 . . . . 0.0 110.774 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.36 -47.65 78.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.337 1.055 . . . . 0.0 110.47 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 56' ' ' VAL . 92.8 t -67.35 -37.57 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.795 0.438 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 t -64.04 -41.81 97.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.732 0.413 . . . . 0.0 110.941 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -44.4 66.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.041 0.536 . . . . 0.0 110.882 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.8 p -74.98 -28.86 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.084 0.554 . . . . 0.0 111.145 -174.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.8 p -70.74 -49.94 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.634 0.373 . . . . 0.0 110.211 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 79.2 ttt180 -63.52 -44.18 94.99 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 110.173 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -57.57 -41.85 81.91 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.713 0.805 . . . . 0.0 111.474 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.64 86.11 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.33 -31.09 71.66 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.269 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 74.7 mm-40 -69.53 -31.31 69.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.347 0.659 . . . . 0.0 109.896 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 15.0 mm-40 -82.48 0.48 42.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.85 0.46 . . . . 0.0 111.221 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.85 5.05 71.65 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.167 0.413 . . . . 0.0 113.473 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.1 135.31 38.58 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 110.88 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 -26.64 54.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.367 1.067 . . . . 0.0 110.902 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.3 m -145.81 170.32 16.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 111.422 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -149.6 170.49 18.54 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -153.89 117.79 4.74 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.202 0.601 . . . . 0.0 109.505 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.01 107.93 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.716 0.806 . . . . 0.0 110.369 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.17 -43.55 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.265 0.626 . . . . 0.0 110.246 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.1 t70 -133.97 127.56 32.62 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 110.254 -167.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.3 p -122.56 117.23 25.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.4 t -139.48 162.42 35.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 123.362 0.665 . . . . 0.0 111.015 -170.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 5.9 p-90 -144.51 179.83 7.02 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.375 0.67 . . . . 0.0 110.363 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.21 153.16 41.04 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.198 -171.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' A' ' 52' ' ' ALA . 85.2 t -124.11 110.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 0.0 108.915 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 26.4 t -94.65 123.87 46.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.7 123.56 23.88 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.5 0.72 . . . . 0.0 110.728 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.16 136.21 57.03 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.897 0.879 . . . . 0.0 110.067 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.66 138.65 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.347 0.594 . . . . 0.0 110.373 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -126.24 133.58 51.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.756 1.222 . . . . 0.0 109.735 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.24 176.65 9.57 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.205 0.602 . . . . 0.0 110.818 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.529 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.45 142.78 53.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.111 0.564 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' SER . 59.1 m -68.14 124.77 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.0 0.52 . . . . 0.0 110.12 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.92 128.01 34.72 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 34' ' ' LEU . 17.5 tp -101.75 140.13 36.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.902 0.881 . . . . 0.0 108.999 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 p -79.96 153.26 74.98 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.332 0.653 . . . . 0.0 110.861 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.23 -39.04 52.55 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.132 3.221 . . . . 0.0 114.155 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.54 -52.58 64.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.779 0.832 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.71 -36.42 75.91 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.539 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.69 92.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.993 0.917 . . . . 0.0 111.312 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.3 63.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.996 0.519 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.07 45.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.205 0.602 . . . . 0.0 111.583 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HD21 ' A' ' 26' ' ' LEU . 82.5 mt -89.46 163.33 15.3 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.673 0.789 . . . . 0.0 110.101 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.28 124.7 27.6 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.607 0.763 . . . . 0.0 109.083 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.77 153.13 48.15 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.634 2.223 . . . . 0.0 111.952 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -93.08 -25.31 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.841 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.35 168.15 27.01 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.876 0.87 . . . . 0.0 108.879 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.562 HH21 HG11 ' A' ' 71' ' ' VAL . 34.0 mtp-105 -133.29 126.14 30.79 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.406 ' HB ' HH11 ' A' ' 59' ' ' ARG . 28.6 pt -104.59 159.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.33 0.652 . . . . 0.0 110.365 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.25 139.29 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 pt -125.9 168.65 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.1 0.96 . . . . 0.0 108.985 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -132.79 129.71 38.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.876 . . . . 0.0 109.142 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.18 92.35 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 54.9 ttp180 -60.07 112.24 1.81 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.654 0.782 . . . . 0.0 111.955 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.9 t80 66.75 11.45 8.23 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.389 1.076 . . . . 0.0 111.706 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -77.94 155.8 30.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.067 0.547 . . . . 0.0 110.066 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.99 43.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -61.75 -43.91 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 123.617 0.573 . . . . 0.0 110.688 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.73 88.38 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.053 0.22 . . . . 0.0 112.949 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.05 -42.85 88.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.118 0.967 . . . . 0.0 110.398 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.216 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.501 ' HA ' HG12 ' A' ' 56' ' ' VAL . 69.1 t -67.68 -33.96 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 122.801 0.441 . . . . 0.0 110.448 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -68.68 -39.35 80.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.797 0.439 . . . . 0.0 110.534 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.87 80.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.433 0.693 . . . . 0.0 111.223 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 53' ' ' VAL . 3.7 p -78.44 -27.05 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.103 0.561 . . . . 0.0 110.663 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 t -69.01 -43.74 74.2 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.883 0.873 . . . . 0.0 110.146 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 14.4 tpt180 -63.82 -45.54 89.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.027 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -60.83 -44.94 96.28 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.84 0.713 . . . . 0.0 109.272 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.02 82.62 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.574 0.75 . . . . 0.0 110.592 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.59 -39.08 93.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.31 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 54.5 mm-40 -62.04 -34.92 77.13 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.391 0.676 . . . . 0.0 110.818 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.1 mm-40 -78.81 -11.63 60.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.851 0.46 . . . . 0.0 111.351 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.42 16.31 34.98 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.088 0.242 . . . . 0.0 113.519 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -77.98 135.04 37.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.269 0.628 . . . . 0.0 111.624 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.24 -31.2 49.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.291 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' THR . 51.1 m -143.63 172.01 13.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -162.29 158.86 24.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -130.79 121.0 24.57 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.68 96.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HH21 ' A' ' 39' ' ' ARG . 7.2 p -88.9 -34.51 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.215 -172.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -133.39 129.04 36.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.982 0.513 . . . . 0.0 109.718 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 84' ' ' VAL . 7.1 p -135.35 104.15 5.76 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 166.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -148.74 168.54 22.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.916 1.286 . . . . 0.0 108.528 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.0 pt-20 . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 14.8 t30 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 16.9 p-90 -108.55 150.36 27.59 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.499 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.11 157.12 19.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.44 1.096 . . . . 0.0 110.601 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.9 t -126.98 109.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.567 1.147 . . . . 0.0 108.618 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.1 129.91 42.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.66 117.77 10.64 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 10.6 p-10 -84.86 142.33 29.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 26.8 m -113.18 142.36 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.714 0.805 . . . . 0.0 111.245 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 88.5 m-85 -126.38 167.25 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.107 1.363 . . . . 0.0 111.326 -165.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -108.75 162.97 13.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.83 1.252 . . . . 0.0 109.415 168.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.147 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.64 135.12 29.63 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -66.46 136.18 55.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.789 . . . . 0.0 109.922 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -69.0 125.01 25.31 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 12.8 tp -96.27 105.32 17.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.4 m -56.44 141.86 70.44 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.541 1.136 . . . . 0.0 110.509 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -43.51 -35.09 5.67 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.855 3.037 . . . . 0.0 114.2 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -63.02 -44.62 95.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.979 0.912 . . . . 0.0 111.642 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.85 -41.51 64.73 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.11 -19.52 61.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.382 1.073 . . . . 0.0 111.961 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.66 81.77 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.081 0.552 . . . . 0.0 110.182 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.56 -42.83 11.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.784 0.834 . . . . 0.0 111.352 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.94 134.02 33.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.255 0.622 . . . . 0.0 110.971 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -97.37 134.59 22.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.225 1.01 . . . . 0.0 109.713 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 83.6 Cg_endo -75.32 163.65 34.24 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.98 2.453 . . . . 0.0 113.086 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 25.0 p90 -94.96 -25.66 16.43 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.991 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -155.94 177.4 11.45 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.789 0.835 . . . . 0.0 108.853 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 40.4 ttm180 -134.52 124.24 25.22 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.118 0.967 . . . . 0.0 108.781 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.4 pt -89.52 163.67 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.629 0.772 . . . . 0.0 111.265 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 83' ' ' ARG . 7.6 p -141.65 139.78 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.039 0.936 . . . . 0.0 109.164 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.6 pt -137.39 148.57 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -133.46 133.85 42.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.51 174.84 20.81 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 27.9 ttm180 -149.6 111.72 4.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.4 t80 81.75 -3.71 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.947 1.299 . . . . 0.0 111.165 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -71.24 152.35 43.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.484 1.513 . . . . 0.0 110.861 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.63 172.12 9.52 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.309 0.644 . . . . 0.0 110.923 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.68 -32.64 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.27 -35.52 91.67 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-O 120.899 0.166 . . . . 0.0 112.995 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.07 -35.29 69.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.632 0.773 . . . . 0.0 110.445 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.78 -43.52 88.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.63 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.59 -43.26 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.328 0.651 . . . . 0.0 111.231 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 p -66.34 -40.97 90.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.377 0.271 . . . . 0.0 111.19 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.99 80.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.949 0.499 . . . . 0.0 111.794 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.33 -29.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 122.813 0.445 . . . . 0.0 110.889 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.8 t -74.09 -41.43 61.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.122 0.569 . . . . 0.0 110.152 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -70.17 -41.5 73.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 tpp180 -60.44 -47.16 87.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.296 0.638 . . . . 0.0 110.231 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.55 83.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.759 0.662 . . . . 0.0 111.436 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.24 -40.53 94.37 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.024 0.929 . . . . 0.0 110.936 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.65 -12.09 60.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.395 0.678 . . . . 0.0 112.364 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.7 mm-40 -89.49 -12.64 39.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.457 0.303 . . . . 0.0 110.786 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.23 61.22 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.722 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -75.26 129.34 37.28 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.345 0.658 . . . . 0.0 111.45 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.22 77.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.943 0.897 . . . . 0.0 111.043 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.3 m -137.29 164.56 28.26 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.994 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -144.57 152.49 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.871 0.868 . . . . 0.0 108.927 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -131.54 118.22 19.82 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.86 107.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.57 -28.44 5.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.211 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 129.72 6.05 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.191 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -113.39 115.59 28.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.9 m -129.74 145.57 51.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.943 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.1 143.88 46.86 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.165 0.507 . . . . 0.0 110.916 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.4 tmm_? -107.99 130.87 55.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.738 1.215 . . . . 0.0 109.715 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 73.5 t -112.32 125.78 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.36 140.31 45.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.99 143.53 31.26 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.025 0.53 . . . . 0.0 111.021 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.0 m-20 -77.76 156.12 30.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.905 0.482 . . . . 0.0 109.94 168.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 4.5 m -127.1 141.85 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.279 0.632 . . . . 0.0 110.526 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -131.09 141.84 50.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.352 1.061 . . . . 0.0 109.676 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 3.3 mmmp? -99.92 145.61 27.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 0.0 110.572 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 166.25 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ASP . . . . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.123 0.487 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.35 123.97 17.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 67' ' ' SER . 73.1 m -68.94 124.05 22.67 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.718 0.807 . . . . 0.0 110.028 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.76 116.42 10.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.504 HD21 HD12 ' A' ' 34' ' ' LEU . 14.5 tp -74.43 144.74 44.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.289 . . . . 0.0 109.189 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.9 p -73.48 152.4 89.76 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.963 0.505 . . . . 0.0 110.071 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.64 -32.71 45.85 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.67 2.913 . . . . 0.0 113.54 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -66.65 -52.93 39.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.249 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.16 -32.21 70.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.173 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.38 -29.47 66.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.961 0.904 . . . . 0.0 111.157 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.12 -31.17 65.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.282 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.55 -48.2 9.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.173 0.589 . . . . 0.0 111.068 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.504 HD12 HD21 ' A' ' 26' ' ' LEU . 94.3 mt -81.11 172.97 13.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.751 0.821 . . . . 0.0 110.932 -177.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 36' ' ' PRO . 10.8 tppt? -132.64 131.93 22.4 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.787 0.835 . . . . 0.0 108.944 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HD2' ' HD3' ' A' ' 35' ' ' LYS . 73.5 Cg_endo -68.99 150.98 73.49 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.587 2.191 . . . . 0.0 111.471 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -86.11 -19.69 29.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.923 0.392 . . . . 0.0 110.358 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -162.03 169.2 21.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.476 1.11 . . . . 0.0 109.111 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 88.6 mtm180 -131.79 121.98 25.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.674 1.19 . . . . 0.0 108.754 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.3 pt -96.51 144.08 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.292 0.637 . . . . 0.0 110.177 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.35 133.78 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.641 0.777 . . . . 0.0 109.322 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 pt -126.52 153.86 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.792 0.837 . . . . 0.0 108.942 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' ARG . 39.2 p -121.55 149.93 42.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 0.0 109.074 174.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.06 116.29 0.71 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 40.7 ttp-105 -88.82 120.08 29.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.675 0.79 . . . . 0.0 109.627 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 59.05 81.65 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.733 1.213 . . . . 0.0 111.099 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.91 156.15 36.98 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.595 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.32 154.02 39.08 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 124.025 0.828 . . . . 0.0 110.162 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 53' ' ' VAL . 5.5 tp -59.92 -41.63 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.597 0.359 . . . . 0.0 110.041 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.37 -31.26 80.27 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.317 0.386 . . . . 0.0 113.34 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.07 -36.09 66.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.728 0.811 . . . . 0.0 110.255 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.9 77.82 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.865 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HA ' HG12 ' A' ' 56' ' ' VAL . 87.7 t -66.9 -34.01 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.3 t -65.53 -39.43 91.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.466 0.706 . . . . 0.0 110.694 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.23 76.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.22 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 53' ' ' VAL . 8.3 p -82.4 -27.18 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.232 0.613 . . . . 0.0 111.675 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -69.49 -42.72 74.41 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.2 0.524 . . . . 0.0 109.787 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 7.6 tpt180 -65.78 -42.72 90.47 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.3 tpp180 -62.47 -35.99 81.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.147 0.579 . . . . 0.0 110.404 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.29 66.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 0.0 110.477 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 27.3 t70 -67.79 -34.89 77.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.837 0.455 . . . . 0.0 110.648 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 26.7 mm-40 -60.51 -37.01 79.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.787 0.835 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 50.1 mm-40 -77.72 -15.02 59.43 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.18 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.97 38.5 48.34 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.562 0.539 . . . . 0.0 111.761 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.84 126.66 40.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.236 1.014 . . . . 0.0 110.092 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.65 83.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.561 0.696 . . . . 0.0 110.739 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 37.2 m -139.95 168.99 18.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.659 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 24.8 p90 -148.75 169.95 19.3 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -150.2 127.1 11.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.55 97.55 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -86.33 -16.91 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.751 0.82 . . . . 0.0 110.52 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 21.8 t70 -163.51 150.27 12.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.237 0.615 . . . . 0.0 111.029 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 p -141.61 114.28 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.185 1.394 . . . . 0.0 107.834 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.7 m -137.25 152.35 49.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 108.806 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.9 pt-20 . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 122.497 0.319 . . . . 0.0 110.896 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.0 p-90 -121.75 159.3 26.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.576 0.703 . . . . 0.0 110.571 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HB2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -133.71 132.02 40.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.654 -165.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.98 125.84 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.866 0.866 . . . . 0.0 109.759 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 21.6 t -100.88 120.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 166.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.98 121.92 27.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 13.6 p-10 -85.36 136.04 33.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 16.6 m -112.32 131.64 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.692 0.797 . . . . 0.0 111.349 -166.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.588 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 74.0 m-85 -109.76 163.86 13.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 111.54 -171.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -110.15 165.57 11.64 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 108.709 169.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.698 178.933 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 133.73 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.377 0.671 . . . . 0.0 110.551 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -67.35 134.09 50.86 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.139 0.576 . . . . 0.0 110.557 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.02 116.57 9.63 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.5 tp -84.0 126.65 33.24 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.3 p -66.22 145.23 98.98 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 123.736 0.647 . . . . 0.0 110.208 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -45.65 -31.37 7.3 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.607 2.872 . . . . 0.0 114.25 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.89 -55.66 21.08 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.337 1.055 . . . . 0.0 110.449 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.19 -34.1 75.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.14 69.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.037 0.935 . . . . 0.0 111.423 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.57 -26.05 59.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 0.0 111.174 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.81 19.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.299 0.64 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 26' ' ' LEU . 95.2 mt -101.21 160.89 14.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.731 0.812 . . . . 0.0 111.222 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -111.31 123.88 34.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 108.371 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.31 159.08 36.84 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.081 1.854 . . . . 0.0 111.185 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -100.86 -39.19 7.91 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.771 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.58 -170.61 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 109.469 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HB3' ' HA ' ' A' ' 87' ' ' ASP . 4.5 ptt180 -149.8 168.08 24.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.79 0.836 . . . . 0.0 111.459 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 56' ' ' VAL . 37.7 pt -118.55 151.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.954 0.902 . . . . 0.0 110.33 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG13 ' HD3' ' A' ' 83' ' ' ARG . 85.5 t -121.3 114.17 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.638 1.175 . . . . 0.0 109.545 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 84' ' ' VAL . 43.2 pt -133.9 178.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.483 1.113 . . . . 0.0 108.963 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 3.0 p -126.97 105.11 8.39 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.632 0.773 . . . . 0.0 109.475 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 84' ' ' VAL . . . -89.23 149.48 20.75 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -110.49 151.76 27.16 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.828 0.814 . . . . 0.0 111.166 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -72.07 -4.62 29.91 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.188 0.995 . . . . 0.0 112.817 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.507 0.723 . . . . 0.0 110.657 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.4 143.03 4.07 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.932 0.893 . . . . 0.0 110.216 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 tp -62.67 -37.44 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 167.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.47 -26.77 68.54 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.624 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.62 -49.2 78.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.301 0.64 . . . . 0.0 110.263 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.24 -42.11 93.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.956 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 88.9 t -66.75 -36.18 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.848 0.718 . . . . 0.0 111.338 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.5 m -66.21 -41.77 89.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.782 0.433 . . . . 0.0 110.546 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.17 79.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.69 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 HD11 ' A' ' 40' ' ' ILE . 12.7 p -77.11 -34.15 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.724 0.41 . . . . 0.0 111.469 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -67.84 -39.99 83.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.796 0.438 . . . . 0.0 110.277 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 29.7 ttt180 -65.03 -56.63 11.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.852 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -66.54 -39.31 88.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.102 0.561 . . . . 0.0 112.3 -172.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.35 93.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.33 -35.92 80.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.708 0.803 . . . . 0.0 111.167 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 47.8 mt-10 -66.46 -33.27 75.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.337 0.655 . . . . 0.0 110.736 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 18.9 mm-40 -82.75 -5.17 58.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.717 0.807 . . . . 0.0 111.469 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.01 14.63 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.21 0.319 . . . . 0.0 113.137 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.105 0.962 . . . . 0.0 109.584 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -28.57 62.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.596 0.759 . . . . 0.0 111.067 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.3 m -143.09 169.4 17.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -147.28 168.11 22.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.959 0.903 . . . . 0.0 109.766 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -160.21 122.27 3.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.206 1.002 . . . . 0.0 108.623 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.45 120.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.601 0.563 . . . . 0.0 109.985 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.25 -30.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.257 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -160.2 149.28 17.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.018 0.527 . . . . 0.0 111.243 -172.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 33.7 p -132.89 104.63 6.67 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.612 1.165 . . . . 0.0 108.857 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.3 m -100.97 109.27 21.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.717 0.807 . . . . 0.0 110.33 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 122.674 0.39 . . . . 0.0 111.439 177.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -101.0 124.85 47.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.331 1.052 . . . . 0.0 109.144 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HD3' HG13 ' A' ' 41' ' ' VAL . 2.8 tmm_? -63.88 106.43 1.01 Allowed 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.676 1.19 . . . . 0.0 109.586 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 42' ' ' ILE . 43.7 t -88.68 108.34 18.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.81 129.02 58.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.81 120.75 16.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.962 0.505 . . . . 0.0 110.966 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.722 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 5.0 m-20 -63.86 135.85 56.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.131 0.894 . . . . 0.0 110.846 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.84 142.88 22.88 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.498 0.719 . . . . 0.0 109.419 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 57.3 m-85 -125.1 152.47 44.33 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.177 0.991 . . . . 0.0 109.863 -169.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.68 174.21 7.47 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.289 0.635 . . . . 0.0 109.639 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 C-N-CA 123.307 0.643 . . . . 0.0 110.149 -179.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.97 118.33 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.678 0.672 . . . . 0.0 110.104 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -80.24 149.76 30.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.485 1.114 . . . . 0.0 110.617 -174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.53 134.2 51.9 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.522 0.601 . . . . 0.0 109.438 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.8 tp -94.82 134.92 36.93 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -73.96 144.91 83.07 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.732 0.813 . . . . 0.0 110.362 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.61 -38.19 75.53 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 124.125 3.217 . . . . 0.0 115.687 -165.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -69.83 -41.46 74.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.768 0.427 . . . . 0.0 110.455 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.8 -34.81 76.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.333 0.653 . . . . 0.0 110.63 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.95 -24.12 55.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.051 0.94 . . . . 0.0 111.261 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.03 -35.75 21.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.393 0.677 . . . . 0.0 110.432 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.26 65.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.306 0.643 . . . . 0.0 110.794 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.8 mt -88.17 148.24 24.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -102.54 139.69 20.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 73.9 Cg_endo -72.73 139.29 30.5 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.924 1.749 . . . . 0.0 111.451 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 90' ' ' LYS . 53.4 p90 -78.06 -19.53 54.1 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -166.45 174.3 9.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 108.671 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 87' ' ' ASP . 51.0 mtm180 -135.01 122.76 22.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.084 0.954 . . . . 0.0 108.945 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 pt -87.85 151.88 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.956 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' A' ' 83' ' ' ARG . 78.7 t -135.53 125.31 42.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.926 0.89 . . . . 0.0 109.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.1 152.42 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.066 0.946 . . . . 0.0 109.132 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.67 164.76 12.96 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.552 0.741 . . . . 0.0 109.747 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.41 178.79 41.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.06 139.9 4.33 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.543 0.671 . . . . 0.0 111.085 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 t80 61.47 29.59 18.47 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 124.254 0.971 . . . . 0.0 111.014 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -123.33 168.35 12.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 0.0 110.774 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.38 166.4 13.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.923 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.418 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 6.4 tp -66.08 -31.58 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.953 0.501 . . . . 0.0 110.407 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.97 -33.62 74.9 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.213 0.321 . . . . 0.0 112.914 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.71 -46.73 68.19 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.326 0.65 . . . . 0.0 110.551 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.49 80.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.614 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 56' ' ' VAL . 77.3 t -68.71 -40.36 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 0.0 110.105 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' ARG . 40.2 m -63.14 -36.65 84.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.879 0.471 . . . . 0.0 111.052 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.32 59.69 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.342 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.0 p -74.76 -29.69 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.271 0.628 . . . . 0.0 112.203 -172.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.9 p -69.81 -40.92 75.63 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.746 0.419 . . . . 0.0 110.677 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 54' ' ' SER . 8.6 mpt_? -72.95 -36.93 67.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.321 0.648 . . . . 0.0 110.04 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -64.48 -43.55 93.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.613 0.765 . . . . 0.0 110.887 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.33 73.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 0.0 110.99 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.55 -35.12 79.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.658 0.783 . . . . 0.0 110.483 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -64.12 -38.95 92.9 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.532 0.733 . . . . 0.0 110.666 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -74.8 -2.19 25.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.802 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.53 23.98 75.85 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.754 -0.138 . . . . 0.0 112.754 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.82 128.58 34.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.522 0.729 . . . . 0.0 109.688 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -33.81 76.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.5 m -147.42 158.97 44.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.634 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -122.18 174.11 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.295 1.038 . . . . 0.0 108.852 170.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -159.62 113.96 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.506 0.722 . . . . 0.0 109.134 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.57 118.82 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.28 0.632 . . . . 0.0 110.442 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.46 -36.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.12 141.24 17.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.367 -168.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -119.69 104.09 9.95 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 14.7 m -84.83 177.72 7.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.809 0.844 . . . . 0.0 110.344 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 124.015 0.926 . . . . 0.0 110.542 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.454 0.169 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 p-90 -143.5 173.76 11.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.366 1.067 . . . . 0.0 110.667 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 1.2 tmt_? -152.2 120.2 6.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.826 0.85 . . . . 0.0 109.076 -165.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.48 131.69 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.247 0.619 . . . . 0.0 110.376 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 127.54 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.184 0.994 . . . . 0.0 108.684 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.63 21.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 m-20 -62.42 136.98 58.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.259 1.424 . . . . 0.0 110.06 171.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.49 138.16 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 118.37 0.532 . . . . 0.0 110.996 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.32 135.98 46.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.768 1.227 . . . . 0.0 109.527 -170.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 37' ' ' TYR . 67.5 mttm -98.04 136.47 38.26 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.299 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.76 177.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.496 0.189 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.47 156.8 22.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.586 0.754 . . . . 0.0 109.681 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 m -64.88 135.85 56.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.727 0.811 . . . . 0.0 111.424 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.05 118.07 17.59 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 19.4 tp -93.11 127.22 38.57 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.5 p -72.74 146.85 88.63 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.487 0.715 . . . . 0.0 110.84 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -43.34 -48.21 8.42 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 125.085 3.857 . . . . 0.0 116.517 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -67.94 -41.63 82.21 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.516 0.598 . . . . 0.0 111.263 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.81 -28.17 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.793 0.437 . . . . 0.0 111.16 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.72 70.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.728 0.811 . . . . 0.0 110.644 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.91 -15.14 61.14 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.605 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.01 -40.61 15.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.639 0.776 . . . . 0.0 110.909 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.01 154.59 17.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.072 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -96.23 126.9 42.36 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.554 0.742 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.89 140.22 22.86 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.292 1.995 . . . . 0.0 111.098 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -83.63 -20.13 34.21 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -158.33 175.04 14.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -140.23 121.72 15.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.7 0.8 . . . . 0.0 109.558 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 59' ' ' ARG . 29.2 pt -95.34 165.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.051 0.941 . . . . 0.0 110.64 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.77 133.97 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 123.23 0.612 . . . . 0.0 110.445 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 pt -122.26 157.25 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.166 0.987 . . . . 0.0 108.351 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -149.45 150.5 32.46 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.82 154.0 6.79 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -97.06 3.08 52.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.962 0.505 . . . . 0.0 111.152 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -106.94 76.22 1.09 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.807 0.843 . . . . 0.0 108.746 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -169.81 163.75 9.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.17 0.988 . . . . 0.0 110.173 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' ' HB2' ' A' ' 51' ' ' ASP . . . -119.95 175.25 6.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.266 1.026 . . . . 0.0 108.422 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HA ' ' CH2' ' A' ' 82' ' ' TRP . 7.3 tp -60.07 -44.35 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 118.145 0.429 . . . . 0.0 110.515 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.7 -40.71 65.34 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.107 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 48' ' ' ALA . 45.9 m-20 -75.12 -25.4 58.43 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.606 0.762 . . . . 0.0 112.179 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.73 -43.43 62.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 56' ' ' VAL . 94.8 t -64.38 -33.16 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -67.9 -40.91 83.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.435 0.694 . . . . 0.0 111.279 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.21 -36.69 61.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.122 0.569 . . . . 0.0 111.324 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 53' ' ' VAL . 4.1 p -80.36 -28.65 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.673 0.389 . . . . 0.0 110.307 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.0 p -70.22 -41.16 73.97 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -56.07 -47.87 77.15 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.435 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.3 tpt180 -63.53 -41.1 98.48 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.738 0.649 . . . . 0.0 110.782 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.63 -34.8 76.31 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.188 0.518 . . . . 0.0 111.186 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -70.92 -33.67 70.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.746 0.818 . . . . 0.0 110.574 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -77.55 -18.53 56.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 110.619 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 36.2 mm-40 -80.66 -25.46 38.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.804 170.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.64 3.74 59.47 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.533 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.11 139.92 57.54 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.976 0.91 . . . . 0.0 111.315 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -68.67 -38.81 80.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 110.409 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 42.0 m -143.45 174.3 10.87 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.883 -175.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -151.22 164.17 37.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -146.26 124.37 12.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.141 0.576 . . . . 0.0 109.465 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.87 117.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.781 0.676 . . . . 0.0 109.211 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.1 -31.7 4.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.233 0.613 . . . . 0.0 110.618 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.05 139.47 21.43 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.072 0.463 . . . . 0.0 110.931 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.9 p -131.15 111.09 11.64 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 168.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -144.81 135.91 25.01 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.285 0.634 . . . . 0.0 109.427 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.3 pt-20 . . . . . 0 C--O 1.242 0.67 0 CA-C-O 121.801 0.81 . . . . 0.0 112.096 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.325 0.583 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.5 p-90 -87.62 111.59 21.41 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.002 0.906 . . . . 0.0 111.419 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.56 114.25 6.05 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.848 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 52' ' ' ALA . 34.4 t -102.94 106.76 20.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.49 133.56 55.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.57 136.2 35.77 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.429 0.692 . . . . 0.0 110.81 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.61 144.59 41.69 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.253 0.621 . . . . 0.0 109.64 170.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.62 128.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -109.03 137.5 46.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 109.881 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 91' ' ' ALA . 1.5 tmmm? -89.4 149.58 22.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.048 0.939 . . . . 0.0 108.892 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.384 0.673 . . . . 0.0 110.888 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.316 0.103 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -63.45 130.91 46.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.986 0.514 . . . . 0.0 110.419 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 149.97 25.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.717 0.807 . . . . 0.0 110.963 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.05 122.1 15.24 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 34' ' ' LEU . 17.1 tp -92.56 124.32 36.5 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.7 p -69.83 146.9 95.92 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.598 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.48 -33.27 4.18 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 124.493 3.462 . . . . 0.0 115.088 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.45 -48.28 64.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.621 0.768 . . . . 0.0 111.276 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -71.27 -36.39 71.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.148 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.9 61.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.243 1.017 . . . . 0.0 111.744 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.27 81.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.332 0.653 . . . . 0.0 110.793 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 -39.57 30.93 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.359 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 26' ' ' LEU . 93.4 mt -85.11 169.35 13.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.074 0.549 . . . . 0.0 111.297 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -130.85 134.54 26.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.097 0.959 . . . . 0.0 109.442 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.63 147.48 22.19 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.452 2.101 . . . . 0.0 111.955 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -96.35 -16.8 21.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.231 0.612 . . . . 0.0 110.372 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -158.56 174.47 15.02 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.487 1.115 . . . . 0.0 108.625 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' NH2' HG11 ' A' ' 71' ' ' VAL . 17.1 ttt180 -145.08 121.63 11.07 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 56' ' ' VAL . 23.6 pt -90.22 150.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 175.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 83' ' ' ARG . 5.3 p -145.81 117.78 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.49 0.716 . . . . 0.0 109.647 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.6 pt -127.69 154.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.546 0.738 . . . . 0.0 110.678 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 p -118.67 111.37 18.44 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.774 1.23 . . . . 0.0 108.859 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.33 101.8 2.38 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.16 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -76.52 98.28 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.255 0.622 . . . . 0.0 109.816 177.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 66.13 92.28 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.668 1.187 . . . . 0.0 111.788 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -164.49 164.92 21.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 0.0 110.938 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.71 168.79 12.2 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.801 0.84 . . . . 0.0 110.522 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.8 tp -61.51 -34.14 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.925 0.49 . . . . 0.0 111.079 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.18 -37.04 93.86 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.12 0.263 . . . . 0.0 113.232 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.07 -44.5 65.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.74 0.816 . . . . 0.0 110.504 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -58.72 -53.14 61.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.772 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.14 -32.9 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.661 1.184 . . . . 0.0 111.296 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.1 t -65.16 -42.28 93.9 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.207 0.603 . . . . 0.0 110.583 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 40' ' ' ILE . 76.7 t -68.22 -40.73 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.109 0.964 . . . . 0.0 110.995 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -69.45 -46.88 65.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.403 0.681 . . . . 0.0 110.938 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -61.73 -50.35 72.78 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.152 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 2.7 tpp180 -64.72 -42.83 94.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.806 0.691 . . . . 0.0 111.182 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.35 82.0 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.607 0.567 . . . . 0.0 110.376 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 23' ' ' ALA . 18.7 t70 -64.93 -34.16 77.75 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.782 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.69 -30.46 69.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.257 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 3.3 mm-40 -76.35 -16.97 59.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.928 0.491 . . . . 0.0 110.562 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.08 20.38 14.14 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.53 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.9 151.2 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.572 0.749 . . . . 0.0 111.508 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.414 ' H ' ' HA ' ' A' ' 90' ' ' LYS . . . -89.23 -29.14 19.47 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.606 1.162 . . . . 0.0 110.527 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 73.3 m -147.7 165.76 29.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.931 0.893 . . . . 0.0 110.74 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -127.88 178.05 6.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.2 1.0 . . . . 0.0 109.178 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.57 99.6 1.59 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.08 101.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG11 ' NH2' ' A' ' 39' ' ' ARG . 5.0 p -89.32 -34.17 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.183 -169.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.12 146.38 27.66 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.305 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.7 m -143.02 118.4 10.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.5 m -130.7 124.25 31.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.852 0.861 . . . . 0.0 109.447 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 40.9 tt0 . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 123.426 0.691 . . . . 0.0 111.047 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 37.9 t30 . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.6 p-90 -113.56 123.52 50.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.126 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 41' ' ' VAL . 5.6 tmm_? -86.8 115.91 24.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.555 1.142 . . . . 0.0 109.111 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' HB1' ' A' ' 52' ' ' ALA . 46.9 t -104.18 113.85 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.02 137.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.69 127.82 17.59 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 110.851 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.91 137.0 45.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.147 0.579 . . . . 0.0 109.533 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -114.37 132.71 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.469 0.652 . . . . 0.0 110.722 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.53 120.01 35.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.985 1.314 . . . . 0.0 107.9 -171.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -85.44 169.72 13.38 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.242 0.474 . . . . 0.0 109.798 175.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.489 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 138.9 57.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.863 0.465 . . . . 0.0 110.747 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 m -61.82 124.27 20.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.16 0.984 . . . . 0.0 111.411 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -66.03 116.61 7.33 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 34' ' ' LEU . 15.8 tp -105.67 121.82 44.78 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.9 p -65.81 151.83 94.24 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.58 0.752 . . . . 0.0 110.771 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.47 -31.54 39.41 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.505 2.803 . . . . 0.0 113.099 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.93 -53.27 52.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.986 0.914 . . . . 0.0 110.799 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -75.79 -25.34 56.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.602 0.761 . . . . 0.0 111.421 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.09 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.119 0.968 . . . . 0.0 110.341 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.46 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.6 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.1 -7.27 55.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.526 0.73 . . . . 0.0 112.431 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD12 HD21 ' A' ' 26' ' ' LEU . 96.2 mt -125.03 163.47 22.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.723 0.809 . . . . 0.0 110.477 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 117.07 51.04 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.001 0.921 . . . . 0.0 108.838 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 151.39 46.41 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.539 2.159 . . . . 0.0 111.849 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -96.78 -29.55 13.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.004 0.522 . . . . 0.0 111.471 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -147.76 178.49 8.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.689 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.652 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 66.4 mtt180 -131.36 146.63 52.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 109.204 169.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.03 142.63 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.63 0.772 . . . . 0.0 108.965 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.34 119.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.73 160.04 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 m -148.52 126.23 11.82 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 153.59 24.94 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.709 -0.281 . . . . 0.0 112.88 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 81' ' ' ASN . 3.6 mpt_? -87.28 135.55 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.76 0.824 . . . . 0.0 109.934 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.4 t80 65.01 24.99 12.65 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.8 1.24 . . . . 0.0 111.931 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 13.1 m120 -70.07 136.39 50.22 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.891 -0.506 . . . . 0.0 109.945 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 170.56 15.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 6.5 tp -61.59 -50.45 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.39 69.55 Favored Glycine 0 C--N 1.348 1.223 0 O-C-N 123.272 0.357 . . . . 0.0 113.151 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.9 -36.27 77.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 110.388 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -74.25 -34.76 63.72 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.624 0.77 . . . . 0.0 110.67 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 70.1 t -66.96 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.781 0.433 . . . . 0.0 110.203 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -65.4 -36.6 84.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.28 0.632 . . . . 0.0 110.522 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.83 -48.67 65.56 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.99 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.6 p -77.45 -27.81 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.226 0.61 . . . . 0.0 111.962 -174.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.8 p -69.66 -48.09 61.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.613 0.365 . . . . 0.0 110.188 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 42.6 ttt-85 -63.83 -46.98 82.62 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 176.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.8 tpp180 -54.06 -49.17 69.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.973 0.909 . . . . 0.0 111.066 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.83 -43.99 86.18 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.869 0.731 . . . . 0.0 110.516 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.55 -34.63 78.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.632 0.773 . . . . 0.0 110.723 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 10.0 mm-40 -70.19 -29.98 66.99 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.17 0.588 . . . . 0.0 110.538 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 14.7 mm-40 -77.89 -9.77 59.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.835 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.74 10.5 61.54 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 113.101 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.93 143.25 37.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.786 0.834 . . . . 0.0 110.755 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.22 -36.82 17.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.669 0.788 . . . . 0.0 111.099 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.0 m -140.12 170.92 14.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 110.298 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -154.81 162.66 41.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.241 0.616 . . . . 0.0 109.74 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -147.18 117.89 7.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.595 0.758 . . . . 0.0 109.894 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.84 114.08 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 110.135 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.75 -25.55 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.952 0.501 . . . . 0.0 111.146 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -158.29 145.48 17.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.188 0.518 . . . . 0.0 111.328 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 84' ' ' VAL . 44.1 p -134.96 106.8 7.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.21 1.404 . . . . 0.0 108.362 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 46.9 m -105.02 130.75 53.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 123.204 0.601 . . . . 0.0 111.299 -177.873 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 11.3 t30 . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.572 0.225 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 1.5 p-90 -161.59 158.11 25.75 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.17 0.988 . . . . 0.0 110.136 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -108.65 153.24 23.7 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.01 0.924 . . . . 0.0 110.085 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 83.6 t -136.83 111.98 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.335 1.054 . . . . 0.0 108.258 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.8 134.82 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.78 126.21 18.81 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.211 1.004 . . . . 0.0 109.167 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 2.5 p30 -76.92 144.17 39.05 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.44 142.17 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.909 0.883 . . . . 0.0 110.255 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.602 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 64.3 m-85 -124.86 161.18 27.12 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.438 1.095 . . . . 0.0 110.802 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -92.23 165.06 13.31 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.704 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.491 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 137.4 47.78 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.023 0.529 . . . . 0.0 110.722 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -68.98 139.93 55.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.412 0.685 . . . . 0.0 110.436 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.53 129.38 34.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 34' ' ' LEU . 13.9 tp -90.58 140.16 30.01 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -174.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 p -68.8 147.63 97.91 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.67 -10.6 12.02 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.641 2.228 . . . . 0.0 113.844 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -82.22 -52.95 6.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.308 0.643 . . . . 0.0 110.236 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 53.0 mt-30 -62.36 -46.0 90.61 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.877 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.85 -36.93 84.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 112.083 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.37 64.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.126 0.57 . . . . 0.0 111.633 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.29 -29.3 12.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.625 0.77 . . . . 0.0 112.151 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 26' ' ' LEU . 95.9 mt -98.24 150.74 21.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -96.03 127.83 39.38 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.99 0.916 . . . . 0.0 109.077 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.4 157.46 32.91 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 111.069 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 37.3 p90 -90.35 -32.54 16.43 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.924 0.392 . . . . 0.0 110.567 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.8 -174.95 4.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.03 0.932 . . . . 0.0 110.22 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -149.37 128.9 13.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.11 0.964 . . . . 0.0 108.703 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -109.31 148.28 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 110.972 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.76 121.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.096 0.958 . . . . 0.0 108.446 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 pt -113.95 154.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.053 0.941 . . . . 0.0 109.439 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 83' ' ' ARG . 21.1 p -113.17 153.35 28.43 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.372 0.669 . . . . 0.0 110.167 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.37 97.02 0.15 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-N 116.856 -0.157 . . . . 0.0 112.881 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -96.98 46.39 1.04 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.546 1.165 . . . . 0.0 109.636 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -177.11 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.776 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -56.03 127.03 28.53 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.885 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 -175.78 5.99 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.237 168.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.15 -34.56 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 118.201 0.455 . . . . 0.0 110.49 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.38 -45.87 66.69 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.257 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.26 -31.35 71.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.685 0.794 . . . . 0.0 110.979 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.52 -46.15 64.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.992 0.917 . . . . 0.0 109.686 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 55.0 t -64.35 -32.58 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.745 0.653 . . . . 0.0 110.728 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -69.88 -42.7 73.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.216 0.606 . . . . 0.0 110.723 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.35 75.83 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.213 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 53' ' ' VAL . 11.9 p -80.19 -27.97 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 122.701 0.4 . . . . 0.0 110.844 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -63.32 -47.53 81.85 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 28.3 tpt180 -64.54 -56.29 14.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 13.7 tpp180 -57.56 -46.18 84.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.793 0.837 . . . . 0.0 111.25 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.45 81.32 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.63 0.582 . . . . 0.0 110.962 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.76 -39.06 92.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.319 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.1 mm-40 -70.96 -25.57 62.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.939 0.496 . . . . 0.0 110.901 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 12.6 mm-40 -76.87 -11.47 59.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.299 0.639 . . . . 0.0 111.258 173.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.01 29.04 19.1 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.519 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.28 132.03 42.18 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.784 0.834 . . . . 0.0 110.3 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.49 82.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.637 0.775 . . . . 0.0 109.88 173.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . 10.2 t -139.74 172.38 12.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.277 -173.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -148.71 171.11 16.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -152.24 118.62 5.61 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.67 102.9 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 123.77 0.669 . . . . 0.0 109.415 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.17 -31.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.841 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.8 t70 -153.26 148.34 26.72 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.368 -171.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 84' ' ' VAL . 12.8 p -142.28 112.84 7.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.458 1.503 . . . . 0.0 107.044 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.419 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . 62.0 m -142.85 147.23 35.06 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.569 0.347 . . . . 0.0 111.031 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 4.5 mm-40 . . . . . 0 N--CA 1.47 0.53 0 C-N-CA 124.677 1.191 . . . . 0.0 110.929 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.291 0.567 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.6 p-90 -60.92 133.42 56.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.325 1.05 . . . . 0.0 111.665 -173.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HB3' HG22 ' A' ' 43' ' ' THR . 3.5 ppt_? -105.07 155.24 19.18 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.167 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG21 ' HB1' ' A' ' 52' ' ' ALA . 86.4 t -116.14 123.54 71.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.053 0.941 . . . . 0.0 109.898 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 28.3 t -101.07 124.07 54.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.95 126.47 15.92 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.941 0.496 . . . . 0.0 111.299 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.632 0.773 . . . . 0.0 110.23 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.25 135.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.136 0.493 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 51.9 m-85 -115.39 129.1 56.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.6 1.16 . . . . 0.0 110.306 -170.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HB2' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.62 138.33 32.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.67 1.188 . . . . 0.0 108.878 179.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.34 142.31 48.79 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -81.04 144.12 31.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.709 0.804 . . . . 0.0 110.419 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.11 130.96 44.52 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.2 tp -111.65 122.72 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.5 p -67.89 148.96 98.41 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.706 0.803 . . . . 0.0 111.083 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -41.06 -43.21 4.9 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 124.84 3.694 . . . . 0.0 115.601 -177.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.72 -39.77 66.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.061 0.544 . . . . 0.0 111.221 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.2 -25.02 60.6 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.251 0.62 . . . . 0.0 111.025 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.04 -31.8 56.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.276 1.03 . . . . 0.0 110.631 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.53 -23.32 56.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.919 0.888 . . . . 0.0 110.381 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.24 -47.09 16.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.753 0.821 . . . . 0.0 111.243 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -91.59 145.89 24.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.005 0.522 . . . . 0.0 110.613 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -95.39 118.98 66.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.53 0.732 . . . . 0.0 109.248 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.15 153.22 31.79 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.309 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -94.08 -14.91 25.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.148 0.579 . . . . 0.0 111.701 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -166.83 164.73 16.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.318 0.647 . . . . 0.0 110.164 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 129.21 54.74 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.702 1.201 . . . . 0.0 108.777 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 56' ' ' VAL . 31.7 pt -95.72 156.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.485 0.714 . . . . 0.0 110.664 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.0 t -129.58 121.42 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 109.21 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.6 166.15 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 p -123.91 114.77 20.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.094 0.558 . . . . 0.0 110.982 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.28 1.05 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -92.73 94.66 9.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.177 0.591 . . . . 0.0 110.45 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 59.37 41.6 19.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.479 1.111 . . . . 0.0 109.841 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 14.8 m120 -115.38 166.78 11.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.528 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.44 168.53 16.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.859 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.9 tp -63.08 -32.83 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.11 79.61 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.447 0.467 . . . . 0.0 113.083 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 33.9 m-20 -75.05 -35.53 61.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.631 0.772 . . . . 0.0 110.531 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.94 70.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.934 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.34 -33.01 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.324 1.05 . . . . 0.0 110.759 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 t -63.68 -51.85 63.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.765 0.826 . . . . 0.0 110.832 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.81 95.3 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.264 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 40' ' ' ILE . 48.4 t -66.16 -40.11 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.924 0.89 . . . . 0.0 111.725 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -63.62 -43.35 97.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.311 0.645 . . . . 0.0 110.742 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 32.0 ttt180 -65.3 -54.34 30.51 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.969 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 27.4 tpt180 -61.9 -38.13 87.21 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.063 0.852 . . . . 0.0 111.469 -169.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.36 90.39 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.643 0.777 . . . . 0.0 110.619 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.44 -31.61 72.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.685 0.794 . . . . 0.0 110.881 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 4.8 mm-40 -67.04 -33.29 75.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.193 0.597 . . . . 0.0 110.357 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.9 mm-40 -79.74 -12.96 59.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.287 0.635 . . . . 0.0 111.125 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.12 28.05 14.45 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.218 0.324 . . . . 0.0 112.622 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.82 142.16 27.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 0.0 110.705 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.98 -27.72 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.819 0.847 . . . . 0.0 110.253 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 50.4 m -142.88 167.75 21.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.91 0.884 . . . . 0.0 111.137 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 161.8 39.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 109.629 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -155.48 125.11 6.42 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.971 0.508 . . . . 0.0 109.822 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.33 112.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 -41.67 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.456 0.703 . . . . 0.0 110.088 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.0 t70 -131.53 141.0 49.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.728 0.411 . . . . 0.0 110.66 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.0 p -135.41 106.14 6.54 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -121.88 111.09 16.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.904 0.482 . . . . 0.0 109.86 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 10.9 pt-20 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 122.962 0.505 . . . . 0.0 111.414 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.6 p-90 -134.24 136.47 43.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.195 0.998 . . . . 0.0 111.688 -175.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -65.07 136.49 56.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.597 1.159 . . . . 0.0 110.198 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.89 106.65 18.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 59.8 t -96.68 124.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.015 0.926 . . . . 0.0 108.968 174.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.55 125.53 22.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.173 0.589 . . . . 0.0 110.952 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.87 144.28 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.704 0.802 . . . . 0.0 109.518 173.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -115.81 134.39 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.297 0.639 . . . . 0.0 110.196 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 68.5 m-85 -124.17 151.11 44.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.757 0.823 . . . . 0.0 110.54 -166.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.23 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.586 0.755 . . . . 0.0 110.755 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.819 0.848 . . . . 0.0 109.338 175.666 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.53 142.59 15.58 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.246 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 138.21 51.91 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.398 0.279 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.1 m -78.66 138.82 38.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.343 0.657 . . . . 0.0 110.537 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.08 118.12 11.58 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.0 tp -99.18 129.88 45.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.9 p -71.51 154.03 93.49 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.484 0.714 . . . . 0.0 110.51 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.27 -18.35 51.83 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.831 2.354 . . . . 0.0 113.498 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.42 -53.63 11.66 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.211 0.605 . . . . 0.0 109.991 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -68.19 -33.73 74.96 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.272 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -37.35 80.8 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.827 0.851 . . . . 0.0 110.772 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.48 -23.29 64.56 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.244 0.618 . . . . 0.0 111.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.42 3.99 54.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.386 0.674 . . . . 0.0 112.13 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.438 HD12 HD21 ' A' ' 26' ' ' LEU . 93.0 mt -130.2 152.24 49.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.623 0.769 . . . . 0.0 110.245 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -108.18 125.01 32.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 58.1 Cg_endo -68.86 138.99 42.23 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.234 1.956 . . . . 0.0 111.555 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -79.31 -24.38 42.87 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.231 0.538 . . . . 0.0 110.459 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -156.24 172.47 18.41 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.592 1.157 . . . . 0.0 108.545 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -143.47 119.87 10.95 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.518 HD11 HG13 ' A' ' 56' ' ' VAL . 36.5 pt -94.71 138.15 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 122.777 0.431 . . . . 0.0 110.371 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 85' ' ' VAL . 38.5 t -121.62 131.99 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.2 pt -123.54 166.13 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.041 0.936 . . . . 0.0 108.948 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -116.5 145.11 43.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 171.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.1 108.78 0.47 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.5 OUTLIER -80.7 79.06 7.41 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.2 t80 44.07 79.57 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.478 1.511 . . . . 0.0 113.675 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -122.44 -65.3 1.12 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.08 148.96 5.06 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 108.824 176.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.4 tp -65.95 -39.13 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.07 77.47 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.434 0.459 . . . . 0.0 113.148 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.76 -44.51 77.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.828 0.851 . . . . 0.0 109.444 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -67.2 -44.78 78.73 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.042 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.48 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.795 0.838 . . . . 0.0 111.016 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.7 t -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.94 0.496 . . . . 0.0 110.217 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.88 69.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.952 0.501 . . . . 0.0 110.977 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 40' ' ' ILE . 97.6 t -70.38 -37.49 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.293 0.637 . . . . 0.0 109.926 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.4 t -64.89 -41.86 95.27 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.769 0.827 . . . . 0.0 110.684 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.34 -59.45 4.35 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.159 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 15.6 tpp180 -63.89 -38.33 90.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.67 0.788 . . . . 0.0 111.837 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.35 98.31 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.04 0.448 . . . . 0.0 110.537 175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.19 -36.7 85.01 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.774 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -71.81 -20.6 61.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.256 0.622 . . . . 0.0 111.279 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 34.4 mm-40 -90.97 -4.62 56.32 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.991 0.516 . . . . 0.0 111.383 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.13 7.93 76.21 Favored Glycine 0 C--N 1.347 1.191 0 O-C-N 123.067 0.23 . . . . 0.0 113.672 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 137.66 47.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.559 0.743 . . . . 0.0 110.952 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -71.0 -40.92 71.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.804 0.841 . . . . 0.0 110.525 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 32.7 m -137.32 172.6 12.74 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.959 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -143.09 165.05 28.45 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.127 0.971 . . . . 0.0 109.365 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.66 112.19 6.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.523 0.729 . . . . 0.0 109.042 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.4 t -63.34 113.28 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 173.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 86' ' ' ALA . 61.7 t -82.67 -48.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -164.6 143.56 7.08 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.79 -168.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.542 HG22 HG22 ' A' ' 84' ' ' VAL . 68.8 p -120.84 104.82 10.15 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.8 p -129.12 144.88 51.36 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.329 0.652 . . . . 0.0 111.23 -171.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 27.8 mt-10 -63.77 119.85 10.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.071 0.948 . . . . 0.0 110.369 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.496 ' HB3' HD22 ' A' ' 81' ' ' ASN . 77.2 t80 -71.29 77.27 0.73 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.019 1.328 . . . . 0.0 110.296 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.47 -55.97 4.42 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.885 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -118.96 167.94 11.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 110.156 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 t -77.93 159.38 28.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.52 0.728 . . . . 0.0 110.73 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.97 -55.52 4.62 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 112.046 -0.421 . . . . 0.0 112.046 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.496 HD22 ' HB3' ' A' ' 76' ' ' PHE . 6.1 p-10 -87.43 91.7 8.82 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 29.6 p-90 -95.83 172.91 7.73 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.722 172.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.435 ' NH1' ' HB ' ' A' ' 85' ' ' VAL . 2.7 ppt_? -142.56 154.76 44.74 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.319 1.048 . . . . 0.0 108.624 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.542 HG22 HG22 ' A' ' 73' ' ' THR . 57.5 t -119.22 111.76 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 0.0 109.363 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 41' ' ' VAL . 7.3 p -90.34 128.82 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' A' ' 71' ' ' VAL . . . -145.6 131.85 19.5 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.218 0.607 . . . . 0.0 111.167 -174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 68.7 m-20 -70.12 158.03 36.49 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 110.6 173.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 m -132.9 139.32 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.462 0.705 . . . . 0.0 109.431 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -127.82 136.52 51.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.939 0.896 . . . . 0.0 110.194 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -80.76 167.66 19.71 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.667 0.787 . . . . 0.0 111.585 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.275 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.1 m80 . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 173.71 106.88 0.01 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 124.837 1.255 . . . . 0.0 108.8 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.83 145.71 42.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.637 0.375 . . . . 0.0 110.328 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.6 m -69.96 140.09 52.94 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.29 0.636 . . . . 0.0 111.107 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -79.64 126.46 30.93 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 34' ' ' LEU . 12.7 tp -98.93 126.06 44.52 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 p -74.03 143.61 80.99 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.985 0.514 . . . . 0.0 109.996 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.82 -34.84 6.29 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.551 3.5 . . . . 0.0 115.667 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -69.62 -44.22 71.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.576 0.751 . . . . 0.0 110.695 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -68.9 -39.19 79.87 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.141 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.37 -27.06 63.08 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.198 0.999 . . . . 0.0 112.099 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.15 -36.45 77.44 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.163 0.585 . . . . 0.0 110.164 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.12 36.83 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.467 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.534 HD12 HD21 ' A' ' 26' ' ' LEU . 90.2 mt -89.02 157.4 18.37 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.333 0.653 . . . . 0.0 111.269 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -110.44 128.6 25.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.25 159.69 48.99 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.201 1.934 . . . . 0.0 111.532 174.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -96.52 -14.73 22.09 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.165 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -158.86 154.84 26.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.979 0.912 . . . . 0.0 109.951 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 86.3 mtm180 -124.49 127.14 47.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.553 1.141 . . . . 0.0 108.764 171.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 HG13 ' A' ' 56' ' ' VAL . 32.1 pt -103.5 161.7 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.04 0.936 . . . . 0.0 110.63 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.54 129.67 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.984 0.914 . . . . 0.0 109.825 176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -127.66 166.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.407 1.083 . . . . 0.0 108.76 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 29.4 m -149.82 130.47 14.04 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.38 133.42 6.96 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 23.9 ttm-85 -100.6 123.66 45.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.183 0.593 . . . . 0.0 110.003 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 63.16 11.74 5.51 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.939 1.296 . . . . 0.0 113.049 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 36.1 m-80 -79.79 148.94 31.24 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.371 0.668 . . . . 0.0 110.287 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.64 168.23 17.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.299 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.1 tp -57.5 -31.9 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.541 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.12 93.59 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.758 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 12.7 m-20 -67.19 -37.51 83.81 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.624 0.77 . . . . 0.0 110.789 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.93 -53.4 47.09 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 123.913 0.758 . . . . 0.0 110.71 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.46 -36.21 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.022 0.929 . . . . 0.0 110.853 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.7 t -64.86 -42.85 94.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.918 0.887 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.44 -37.39 65.86 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.52 0.728 . . . . 0.0 111.451 -177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.552 HG13 HD11 ' A' ' 40' ' ' ILE . 76.6 t -65.19 -45.36 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.132 0.573 . . . . 0.0 110.485 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -68.73 -32.28 71.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.821 0.848 . . . . 0.0 110.744 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -65.79 -55.04 19.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.515 0.726 . . . . 0.0 109.8 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -62.28 -44.67 95.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.994 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.47 -49.13 78.97 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.751 0.82 . . . . 0.0 111.182 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.64 -38.66 91.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.404 0.682 . . . . 0.0 111.088 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -76.16 -21.04 57.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.151 0.581 . . . . 0.0 112.202 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -76.82 -22.59 53.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.992 0.517 . . . . 0.0 110.277 170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.02 11.41 60.15 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.902 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.9 129.16 38.82 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.661 0.784 . . . . 0.0 110.141 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.65 84.67 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 123.874 0.734 . . . . 0.0 111.15 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 26' ' ' LEU . 13.8 t -141.4 174.99 10.02 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.019 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.78 163.94 35.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.299 1.04 . . . . 0.0 108.86 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -151.49 118.4 5.83 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -71.24 114.28 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 170.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -94.28 -23.35 5.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -163.53 129.61 3.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.981 0.419 . . . . 0.0 111.18 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.2 p -111.33 141.59 44.67 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 165.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 23.0 t -159.19 139.88 12.49 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 79' ' ' SER . 46.8 mt-10 -77.92 119.72 21.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.101 0.56 . . . . 0.0 110.663 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' H ' ' HA ' ' A' ' 82' ' ' TRP . 69.9 t80 -75.92 132.67 40.41 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.634 1.174 . . . . 0.0 109.92 -174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.48 -76.46 1.51 Allowed Glycine 0 C--N 1.343 0.922 0 O-C-N 124.019 0.825 . . . . 0.0 112.155 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -137.05 -77.63 0.4 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.107 0.963 . . . . 0.0 108.635 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.457 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 74.7 m -154.78 176.59 12.28 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.992 0.917 . . . . 0.0 110.201 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.73 -66.28 3.95 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 56.6 t30 -80.17 135.28 36.25 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.434 ' HA ' ' H ' ' A' ' 76' ' ' PHE . 4.6 p-90 -150.22 131.0 14.12 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.368 0.604 . . . . 0.0 111.287 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HD2' ' HB3' ' A' ' 74' ' ' SER . 0.0 OUTLIER -91.66 156.37 17.65 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 110.171 178.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' A' ' 52' ' ' ALA . 61.0 t -139.7 116.58 9.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 124.14 0.976 . . . . 0.0 108.431 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.28 132.45 40.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.43 138.07 29.06 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.113 0.965 . . . . 0.0 109.048 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.597 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -101.79 141.76 34.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.637 0.775 . . . . 0.0 109.353 176.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.02 142.6 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 124.038 0.935 . . . . 0.0 110.045 -172.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -124.52 155.94 38.15 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.338 1.055 . . . . 0.0 111.746 -165.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -110.57 145.46 37.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.494 1.118 . . . . 0.0 108.94 169.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.585 0.754 . . . . 0.0 108.983 -178.079 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 146.51 31.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.547 1.139 . . . . 0.0 108.805 176.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.71 129.37 39.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -66.17 135.39 54.46 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.435 0.694 . . . . 0.0 110.663 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.98 115.83 11.66 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -89.7 134.6 34.08 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.4 p -68.25 142.49 94.84 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.778 0.674 . . . . 0.0 109.943 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.47 -34.13 7.27 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 124.08 3.187 . . . . 0.0 113.881 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -64.28 -57.57 9.03 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.176 0.99 . . . . 0.0 110.879 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.7 -33.93 77.11 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.82 -24.98 61.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.082 0.953 . . . . 0.0 112.092 -176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.45 -18.31 49.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.982 0.513 . . . . 0.0 111.407 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.89 -39.57 8.92 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.346 0.659 . . . . 0.0 111.0 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.33 142.0 28.22 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.985 0.914 . . . . 0.0 109.35 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -103.08 128.78 26.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.75 161.13 30.79 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.887 2.391 . . . . 0.0 112.138 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -98.41 -21.06 16.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.868 0.467 . . . . 0.0 110.502 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -155.83 161.28 40.65 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.048 0.939 . . . . 0.0 109.558 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.6 mtm180 -123.09 119.03 29.1 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 HG13 ' A' ' 56' ' ' VAL . 43.2 pt -90.98 131.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -107.59 120.71 59.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -118.93 179.4 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.158 0.983 . . . . 0.0 109.119 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 23.7 p -119.06 119.47 34.32 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.648 0.779 . . . . 0.0 109.539 169.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.65 135.06 12.61 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -97.51 171.36 8.42 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 117.967 0.883 . . . . 0.0 111.122 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.35 3.38 3.77 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 0.0 112.297 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -52.23 -51.56 57.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.399 1.08 . . . . 0.0 111.578 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.48 164.17 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.742 0.817 . . . . 0.0 110.981 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.96 -43.01 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 167.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.08 -16.02 70.3 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.671 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.08 -51.99 61.41 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.965 0.906 . . . . 0.0 109.651 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -68.91 -46.98 66.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.075 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.19 -35.53 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.761 0.825 . . . . 0.0 111.582 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 t -64.23 -44.57 91.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.568 0.747 . . . . 0.0 110.504 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.08 -28.78 66.81 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.054 0.542 . . . . 0.0 111.71 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG13 HD11 ' A' ' 40' ' ' ILE . 49.8 t -72.17 -45.94 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 122.912 0.485 . . . . 0.0 109.717 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -63.35 -45.32 91.77 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.064 0.946 . . . . 0.0 110.945 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 31.7 mmt180 -72.3 -37.01 69.08 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.994 0.809 . . . . 0.0 111.427 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 tpt180 -66.7 -48.92 67.75 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.15 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -34.42 76.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.053 0.941 . . . . 0.0 110.905 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.3 -39.13 92.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.79 0.836 . . . . 0.0 110.806 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 51.5 mt-10 -64.74 -34.68 78.9 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.359 0.663 . . . . 0.0 110.925 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.0 mm-40 -78.64 -8.11 58.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.517 0.727 . . . . 0.0 111.374 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.92 17.45 79.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.269 0.356 . . . . 0.0 112.996 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . . . -73.62 128.52 35.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.978 0.911 . . . . 0.0 109.996 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 -30.26 69.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.67 0.788 . . . . 0.0 111.506 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 56.5 m -144.99 171.21 14.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.379 0.672 . . . . 0.0 111.482 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.7 166.62 28.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.447 1.099 . . . . 0.0 108.698 172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -155.29 129.12 8.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -77.09 113.16 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 122.86 0.464 . . . . 0.0 110.094 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -96.73 -25.93 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.279 0.632 . . . . 0.0 111.539 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 19.7 t70 -148.29 138.44 22.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.012 0.525 . . . . 0.0 110.849 -174.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 84' ' ' VAL . 23.4 p -136.53 106.09 6.14 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.571 1.149 . . . . 0.0 108.033 170.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -121.03 138.44 54.17 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.121 0.968 . . . . 0.0 109.416 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 11.8 pt-20 -69.23 160.03 31.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.984 0.421 . . . . 0.0 110.985 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -77.53 -35.72 53.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 142.35 -95.85 0.19 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -86.09 -21.19 27.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.841 0.856 . . . . 0.0 110.859 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.2 m -76.96 151.95 35.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.373 0.669 . . . . 0.0 111.181 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.32 47.7 3.88 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.03 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -130.73 119.4 22.3 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.044 1.338 . . . . 0.0 108.604 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.1 p-90 -109.25 108.18 18.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.112 1.365 . . . . 0.0 108.992 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -64.78 149.64 48.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.434 0.694 . . . . 0.0 109.197 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.3 t -126.6 114.39 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.044 0.537 . . . . 0.0 109.948 -176.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 34.4 t -88.96 124.32 41.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 165.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.69 121.58 14.51 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.426 0.691 . . . . 0.0 109.338 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 46.8 p-10 -81.28 140.41 34.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.733 0.413 . . . . 0.0 110.133 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.18 137.8 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.144 0.978 . . . . 0.0 110.379 -170.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 35.9 m-85 -118.55 139.28 51.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.568 1.147 . . . . 0.0 110.393 -168.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 65' ' ' ALA . 32.7 mmtp -95.36 159.07 15.18 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 109.839 170.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.6 t60 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.86 130.72 4.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.4 1.08 . . . . 0.0 108.652 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.28 149.14 48.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.58 0.752 . . . . 0.0 111.612 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.7 m -74.02 142.35 45.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.559 0.744 . . . . 0.0 110.545 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.27 118.73 14.43 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.1 tp -85.21 119.25 25.38 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -64.73 141.75 98.38 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.265 -176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -39.59 -39.4 1.92 Allowed 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 125.044 3.83 . . . . 0.0 116.083 -173.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -72.93 -40.29 65.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.281 0.632 . . . . 0.0 110.332 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.94 -38.32 76.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.371 0.669 . . . . 0.0 110.213 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.15 -29.78 70.65 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.335 1.054 . . . . 0.0 111.171 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.91 -29.51 55.74 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.856 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.07 26.75 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.326 0.651 . . . . 0.0 112.36 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 26' ' ' LEU . 96.9 mt -115.51 143.73 44.89 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.711 0.805 . . . . 0.0 110.171 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -92.7 133.05 29.96 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 123.466 0.706 . . . . 0.0 110.137 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.26 153.42 24.4 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.467 2.111 . . . . 0.0 111.574 169.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 5.7 p90 -99.12 -32.49 11.22 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.247 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -143.76 174.73 10.56 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -139.26 125.95 20.69 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.477 1.111 . . . . 0.0 108.661 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.58 HD11 HG13 ' A' ' 56' ' ' VAL . 32.7 pt -103.06 152.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.977 0.511 . . . . 0.0 110.427 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.99 133.15 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 pt -116.23 157.43 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.279 1.032 . . . . 0.0 109.076 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.5 m -134.65 139.46 45.3 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.33 142.96 11.52 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.49 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -68.55 -40.71 80.54 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.225 0.61 . . . . 0.0 110.788 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -166.25 135.84 3.21 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.34 0.656 . . . . 0.0 109.613 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -156.6 -116.55 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.0 168.17 19.57 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.595 1.158 . . . . 0.0 108.323 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 9.7 tp -63.28 -37.59 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.6 88.3 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.457 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.02 -34.34 77.78 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.743 0.817 . . . . 0.0 111.541 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.603 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.21 -46.19 57.18 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.843 0.857 . . . . 0.0 110.259 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.05 -33.68 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.568 0.747 . . . . 0.0 110.598 175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -72.66 -35.01 67.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.91 0.884 . . . . 0.0 110.927 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.82 78.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.244 0.617 . . . . 0.0 109.992 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 40' ' ' ILE . 53.9 t -64.53 -37.05 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.217 1.007 . . . . 0.0 110.852 174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -61.38 -52.73 63.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.888 0.875 . . . . 0.0 110.711 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -69.45 -37.76 77.49 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.79 -178.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 12.5 tpt180 -66.85 -37.35 84.29 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.323 0.649 . . . . 0.0 111.256 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.47 -36.25 83.57 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.499 0.72 . . . . 0.0 110.343 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -70.21 -35.1 73.67 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.481 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 12.6 mm-40 -63.19 -34.49 77.75 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.741 0.816 . . . . 0.0 110.606 174.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 37.1 mm-40 -70.63 -29.02 65.28 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.506 175.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.33 4.28 53.31 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.071 -175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.69 141.77 49.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.693 0.797 . . . . 0.0 110.557 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.89 -36.21 64.77 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.642 0.777 . . . . 0.0 110.632 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.1 m -141.14 173.57 11.35 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.719 -173.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -147.48 173.99 12.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.33 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -160.5 120.24 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 109.944 169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.22 113.74 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.868 0.867 . . . . 0.0 109.67 173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.7 -20.76 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 0.0 111.501 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 22.9 t70 -154.29 145.22 22.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.123 0.569 . . . . 0.0 110.904 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.5 HG22 HG22 ' A' ' 84' ' ' VAL . 26.0 p -137.55 111.49 8.32 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.915 1.286 . . . . 0.0 107.978 171.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.2 m -118.43 135.19 54.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.227 0.611 . . . . 0.0 109.551 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -108.39 170.01 8.28 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.114 0.566 . . . . 0.0 110.788 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -71.97 -34.71 69.17 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.011 174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.79 79.88 0.76 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.518 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 67.16 8.85 6.5 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.005 1.322 . . . . 0.0 113.544 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -90.83 4.12 52.6 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.194 0.597 . . . . 0.0 111.234 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.28 -49.3 3.92 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -70.62 141.1 51.75 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-O 121.251 0.548 . . . . 0.0 110.596 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.415 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 1.7 p-90 -157.32 177.45 11.43 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.318 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.73 156.01 44.38 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.333 0.653 . . . . 0.0 109.677 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.603 HG21 ' HB1' ' A' ' 52' ' ' ALA . 98.9 t -130.92 115.83 31.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 124.009 0.924 . . . . 0.0 109.564 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 56.5 t -92.39 129.89 42.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 108.766 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.57 125.69 13.74 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.583 0.753 . . . . 0.0 110.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.33 143.02 35.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.051 0.54 . . . . 0.0 109.749 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.01 139.64 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.414 0.686 . . . . 0.0 110.428 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -121.03 139.59 53.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.484 1.113 . . . . 0.0 109.993 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 31.6 mmmt -90.08 165.56 13.94 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.567 0.747 . . . . 0.0 110.49 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.425 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.71 107.01 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 0.0 109.317 -168.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.38 138.09 33.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.315 1.046 . . . . 0.0 112.48 -169.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -63.37 147.6 50.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.079 0.952 . . . . 0.0 110.817 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.39 122.64 20.71 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -81.92 138.07 35.07 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.7 p -74.47 152.07 87.56 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.303 0.641 . . . . 0.0 109.916 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.96 -23.19 75.57 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.335 2.023 . . . . 0.0 112.683 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.39 -56.24 24.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.074 0.95 . . . . 0.0 110.278 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -76.07 -24.99 55.12 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.112 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.633 0.773 . . . . 0.0 111.156 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.42 -28.75 26.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.141 0.576 . . . . 0.0 110.187 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.03 3.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.413 0.685 . . . . 0.0 110.849 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -86.7 148.21 25.54 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.72 0.808 . . . . 0.0 110.193 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.3 143.17 26.24 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.09 144.29 37.49 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.991 1.794 . . . . 0.0 112.394 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -77.08 -20.56 55.63 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.838 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -159.45 161.97 35.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.524 1.13 . . . . 0.0 108.85 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 38.0 ttm180 -132.88 120.84 22.04 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.641 0.777 . . . . 0.0 108.917 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 HG21 ' HD2' ' A' ' 59' ' ' ARG . 27.9 pt -91.91 163.88 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.698 0.799 . . . . 0.0 111.451 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.458 HG23 ' NE ' ' A' ' 83' ' ' ARG . 2.2 p -142.22 130.5 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.65 1.18 . . . . 0.0 110.387 -173.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' A' ' 84' ' ' VAL . 41.4 pt -144.89 174.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.696 1.198 . . . . 0.0 109.109 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.4 p -136.56 125.01 23.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.369 1.068 . . . . 0.0 108.819 174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.16 73.43 1.51 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 62.6 ttt180 -68.5 96.34 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.845 0.458 . . . . 0.0 111.002 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.4 t80 65.33 19.77 11.71 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.13 1.372 . . . . 0.0 111.118 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.44 150.67 21.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.649 0.779 . . . . 0.0 110.069 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.43 161.06 23.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.368 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.4 -46.83 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.549 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.87 -29.08 69.65 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.664 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.09 -48.54 65.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.462 0.705 . . . . 0.0 110.676 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -69.74 -32.49 71.05 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.85 -38.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.846 0.458 . . . . 0.0 110.625 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.0 t -65.98 -35.73 81.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.773 0.429 . . . . 0.0 110.479 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.53 -48.46 64.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.537 0.735 . . . . 0.0 111.485 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.36 -31.63 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.284 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.0 t -69.97 -43.12 72.16 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.683 0.793 . . . . 0.0 110.277 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 ttt180 -61.84 -49.12 77.55 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.466 175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD2' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -58.48 -46.07 87.38 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 109.684 -176.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.53 83.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.085 0.866 . . . . 0.0 111.066 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -65.04 -34.83 79.37 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.63 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 58.5 mt-10 -70.62 -23.11 62.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.84 0.456 . . . . 0.0 110.916 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -89.72 2.15 55.18 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.379 0.672 . . . . 0.0 111.58 175.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.06 24.08 67.32 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.448 -0.342 . . . . 0.0 113.324 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.43 134.13 35.5 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.376 0.671 . . . . 0.0 110.178 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.33 75.96 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.549 0.69 . . . . 0.0 110.174 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 m -148.98 169.66 20.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.792 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -145.13 149.88 35.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.087 0.955 . . . . 0.0 108.521 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -128.5 131.23 48.32 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 173.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -78.28 123.53 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HB ' ' OD1' ' A' ' 87' ' ' ASP . 7.7 p -86.85 -33.5 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.696 0.399 . . . . 0.0 110.139 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -160.72 144.2 13.41 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.795 0.438 . . . . 0.0 110.839 -173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 21.1 p -133.38 112.98 12.05 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 166.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 t -126.74 120.39 29.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.391 0.676 . . . . 0.0 110.523 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 33.9 mt-10 -66.62 122.24 17.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.691 0.796 . . . . 0.0 110.474 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -59.71 -44.83 93.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.233 1.013 . . . . 0.0 111.297 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.29 -164.25 13.17 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.446 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.54 -11.65 61.07 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.491 0.716 . . . . 0.0 111.626 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 t -72.6 177.27 4.81 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.881 0.872 . . . . 0.0 110.513 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.39 11.42 44.73 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.922 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 52.3 t30 -82.54 129.84 35.0 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.484 0.642 . . . . 0.0 110.356 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 3.0 p-90 -142.68 124.74 15.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.054 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.614 ' HE ' ' HB ' ' A' ' 85' ' ' VAL . 12.0 tpt180 -64.44 116.58 6.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.03 1.332 . . . . 0.0 109.747 174.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.51 ' HB ' HG13 ' A' ' 42' ' ' ILE . 26.6 t -106.43 107.99 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.614 ' HB ' ' HE ' ' A' ' 83' ' ' ARG . 5.8 p -118.91 126.84 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.25 142.75 35.75 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.568 0.747 . . . . 0.0 110.214 -175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.49 143.53 26.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 124.624 1.17 . . . . 0.0 110.38 178.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.29 141.4 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.086 0.954 . . . . 0.0 110.551 -171.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -125.04 167.58 14.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.01 0.924 . . . . 0.0 112.293 -167.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 10.3 mmpt? -101.56 164.46 11.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.796 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.062 173.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 121.341 0.591 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.53 136.81 0.16 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.482 1.513 . . . . 0.0 108.178 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.19 115.49 6.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.586 0.354 . . . . 0.0 110.983 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.9 m -67.73 137.33 55.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.7 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -72.83 118.25 15.53 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.9 tp -85.45 144.85 27.73 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.994 0.918 . . . . 0.0 109.032 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 p -84.92 157.3 60.33 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 119.135 -0.46 . . . . 0.0 110.042 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.38 -28.42 80.16 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.813 2.342 . . . . 0.0 113.561 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.84 -44.96 75.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.869 0.468 . . . . 0.0 110.586 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.516 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 51.9 mt-30 -72.22 -28.35 63.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.917 0.487 . . . . 0.0 110.98 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.97 -23.08 58.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.31 0.644 . . . . 0.0 110.739 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.27 -28.33 25.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.461 0.704 . . . . 0.0 110.568 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.95 -48.53 36.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.663 0.785 . . . . 0.0 110.788 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.4 mt -104.6 166.2 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.269 1.027 . . . . 0.0 110.236 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -118.86 149.2 46.14 Favored Pre-proline 0 C--O 1.244 0.795 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.48 165.67 22.8 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 122.603 2.202 . . . . 0.0 111.871 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -96.61 -45.3 6.77 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -140.23 -173.84 3.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 109.854 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 29.8 mtt180 -123.87 171.55 9.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.304 0.642 . . . . 0.0 109.305 170.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.1 pt -138.89 138.35 41.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.1 124.73 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 pt -118.45 175.7 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.968 0.907 . . . . 0.0 108.777 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 19.7 p -130.49 113.87 14.8 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 64.91 3.72 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 53.7 ttt180 -63.77 95.69 0.12 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.93 0.892 . . . . 0.0 111.089 -172.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.8 t80 63.55 16.4 9.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.727 1.211 . . . . 0.0 111.436 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.69 155.94 19.3 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.813 0.845 . . . . 0.0 109.739 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.91 161.03 30.56 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.261 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.1 tp -60.16 -37.39 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.338 0.655 . . . . 0.0 110.875 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.66 90.97 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.344 0.402 . . . . 0.0 112.887 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.19 -36.42 77.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.556 0.742 . . . . 0.0 110.767 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.6 82.51 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.63 0.581 . . . . 0.0 110.15 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.6 t -64.95 -36.64 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.005 0.522 . . . . 0.0 110.295 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.7 t -68.79 -41.42 78.77 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 122.964 0.506 . . . . 0.0 110.691 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.54 -35.08 67.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.165 0.586 . . . . 0.0 111.749 -177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 p -77.0 -31.01 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 m -72.44 -35.49 68.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.928 0.491 . . . . 0.0 110.407 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -61.06 -56.91 15.43 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 124.467 1.105 . . . . 0.0 109.797 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -59.44 -45.68 90.89 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.118 0.886 . . . . 0.0 111.403 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.24 94.45 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.611 0.569 . . . . 0.0 111.317 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -64.03 -37.49 87.61 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.116 0.567 . . . . 0.0 110.665 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -74.42 -19.31 60.45 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.547 0.739 . . . . 0.0 111.416 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.11 -7.3 59.41 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.914 0.886 . . . . 0.0 111.133 172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.1 13.95 81.28 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.627 -0.26 . . . . 0.0 112.912 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.05 134.9 38.64 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.702 0.801 . . . . 0.0 110.318 176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.76 -38.79 46.08 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.073 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 22.8 m -134.45 169.82 16.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.664 -176.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -149.53 158.41 44.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.641 0.776 . . . . 0.0 109.0 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -143.78 119.05 10.18 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.386 0.674 . . . . 0.0 109.277 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 86' ' ' ALA . 63.8 t -71.47 112.12 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.386 0.675 . . . . 0.0 109.702 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.51 -26.71 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.936 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 13.4 t70 -143.17 133.43 24.57 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.064 0.546 . . . . 0.0 110.281 -171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.2 p -132.07 112.63 12.51 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -115.88 173.74 6.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.877 0.871 . . . . 0.0 108.98 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -142.1 154.21 44.73 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.43 0.692 . . . . 0.0 109.993 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -100.44 82.5 2.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.1 -118.27 12.78 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.351 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -127.66 41.93 3.42 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 122.277 1.037 . . . . 0.0 108.295 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.1 t -88.22 -2.82 58.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.46 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 90.81 -35.43 3.88 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 122.704 0.192 . . . . 0.0 113.363 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 3.6 p-10 -78.31 92.22 4.5 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 0.0 110.926 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 43.3 p-90 -99.66 127.58 45.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.674 171.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -95.05 153.97 17.39 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.534 0.733 . . . . 0.0 110.758 -172.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.1 t -127.88 112.78 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.704 1.202 . . . . 0.0 108.863 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 39.9 t -98.08 115.11 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HB2' HG22 ' A' ' 70' ' ' VAL . . . -126.15 120.57 30.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.497 0.719 . . . . 0.0 109.937 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 1.2 m-20 -70.3 146.12 50.79 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.979 174.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.9 m -114.35 136.86 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.032 0.533 . . . . 0.0 110.186 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 34.5 m-85 -126.04 170.17 12.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.638 1.175 . . . . 0.0 110.744 -168.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.99 178.57 5.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.023 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.733 0.813 . . . . 0.0 108.827 172.676 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.829 0.347 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' OG ' ' A' ' 57' ' ' SER . . . -159.41 130.53 6.04 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.966 0.906 . . . . 0.0 108.967 -175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.87 136.23 56.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.312 0.645 . . . . 0.0 111.583 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.4 m -68.24 130.63 43.49 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.048 0.539 . . . . 0.0 110.755 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.1 118.26 12.71 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 27.1 tp -93.16 139.78 30.23 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.473 1.109 . . . . 0.0 109.717 -172.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.2 p -71.38 147.95 93.14 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.545 0.738 . . . . 0.0 110.16 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.48 -33.62 86.76 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.421 2.747 . . . . 0.0 113.991 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.0 -46.8 64.36 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.999 0.52 . . . . 0.0 111.012 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -73.25 -23.44 60.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.201 0.6 . . . . 0.0 111.463 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.13 -36.06 61.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 0.0 110.352 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.36 61.86 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.577 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.25 -48.93 38.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.511 0.725 . . . . 0.0 110.392 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.37 170.5 15.25 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.441 0.696 . . . . 0.0 111.355 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -121.32 123.33 27.73 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.556 0.742 . . . . 0.0 109.694 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.81 133.26 12.5 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.936 2.424 . . . . 0.0 112.254 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -81.68 -34.67 30.56 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.157 0.583 . . . . 0.0 110.194 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -142.26 171.86 13.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.471 1.108 . . . . 0.0 108.468 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 5.7 ttp180 -140.71 128.5 21.73 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.372 1.069 . . . . 0.0 108.116 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.7 pt -103.32 161.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.079 0.552 . . . . 0.0 110.531 175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG23 ' HD3' ' A' ' 83' ' ' ARG . 2.0 p -148.76 132.34 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.985 0.914 . . . . 0.0 109.438 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 pt -132.32 166.72 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.608 1.163 . . . . 0.0 109.528 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.7 p -134.08 118.82 18.17 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.382 1.073 . . . . 0.0 109.637 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.86 115.06 5.14 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.653 -0.526 . . . . 0.0 111.811 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -76.11 91.43 3.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.282 0.633 . . . . 0.0 110.165 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 t80 65.79 12.29 8.22 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.309 1.444 . . . . 0.0 112.003 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -72.65 154.78 40.57 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.723 0.809 . . . . 0.0 111.185 -174.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.9 162.36 29.16 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 122.592 0.357 . . . . 0.0 110.774 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.7 tp -60.31 -31.78 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.053 0.541 . . . . 0.0 110.676 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.88 -42.9 98.24 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.912 -0.382 . . . . 0.0 112.897 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -62.92 -43.18 99.5 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.372 0.669 . . . . 0.0 110.074 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.543 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.2 -51.2 67.29 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.021 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.69 -37.4 79.56 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 123.693 0.797 . . . . 0.0 110.395 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.0 t -69.06 -36.44 77.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.364 0.666 . . . . 0.0 111.198 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.01 -40.25 60.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.39 0.676 . . . . 0.0 111.252 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.03 -27.89 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 C-N-CA 123.269 0.628 . . . . 0.0 110.19 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.408 ' OG ' ' HB1' ' A' ' 22' ' ' ALA . 39.8 t -70.26 -42.97 71.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.851 0.861 . . . . 0.0 110.104 173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 18.7 ttt180 -57.47 -57.61 11.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.64 175.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.3 tpp85 -61.03 -40.97 95.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.08 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.75 -40.78 96.31 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.173 0.589 . . . . 0.0 111.283 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.89 -35.6 80.39 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.25 0.62 . . . . 0.0 110.335 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 55.2 mt-10 -71.12 -29.25 65.02 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.97 0.908 . . . . 0.0 110.849 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 23.8 mm-40 -73.82 -14.36 61.08 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.235 0.614 . . . . 0.0 110.754 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.12 2.74 64.04 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.98 138.76 42.47 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.753 0.821 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.45 -32.37 64.33 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.176 0.99 . . . . 0.0 110.887 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 66.0 m -143.44 171.07 14.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.21 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.36 162.38 38.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.328 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -141.56 117.51 10.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 171.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.26 113.67 3.44 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.64 -20.81 6.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -165.22 137.84 4.4 Favored 'General case' 0 C--N 1.358 0.954 0 O-C-N 123.321 0.388 . . . . 0.0 110.905 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 35.5 p -122.43 106.42 11.03 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.3 t -123.6 126.26 46.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.044 0.538 . . . . 0.0 109.984 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 31.0 mt-10 -73.22 124.92 26.59 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.552 0.532 . . . . 0.0 110.236 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.401 ' HB3' HD22 ' A' ' 81' ' ' ASN . 81.2 t80 -72.94 128.55 35.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.463 0.705 . . . . 0.0 110.037 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.83 -80.81 1.31 Allowed Glycine 0 C--N 1.346 1.124 0 O-C-N 123.876 0.735 . . . . 0.0 111.884 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -131.45 -72.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.327 1.051 . . . . 0.0 108.899 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 74.6 m -154.51 -173.97 4.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.408 0.683 . . . . 0.0 110.975 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.36 -87.95 1.44 Allowed Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 76' ' ' PHE . 11.9 t30 -71.81 100.16 2.33 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.2 p-90 -109.27 126.78 53.7 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.572 0.749 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.3 tmm_? -83.8 129.19 34.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.782 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.543 HG21 ' HB1' ' A' ' 52' ' ' ALA . 62.6 t -113.3 109.31 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.299 1.04 . . . . 0.0 108.248 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.42 134.81 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.14 129.16 18.56 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.595 0.758 . . . . 0.0 111.079 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 2.6 m-20 -77.51 141.0 39.86 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.69 145.69 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.285 0.634 . . . . 0.0 111.095 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -127.74 133.6 49.52 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.488 1.115 . . . . 0.0 110.432 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -84.46 165.55 18.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.978 0.911 . . . . 0.0 111.247 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.9 m80 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . . . -64.87 134.65 54.49 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 171.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.39 46.78 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.732 0.645 . . . . 0.0 112.327 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -75.78 145.36 40.79 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.566 0.747 . . . . 0.0 110.311 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.1 118.87 15.51 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 HD21 HD12 ' A' ' 34' ' ' LEU . 19.7 tp -82.16 138.43 34.72 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -64.3 141.62 98.18 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.219 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -42.21 -30.1 1.29 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.985 3.123 . . . . 0.0 115.162 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -73.59 -54.52 7.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.248 0.619 . . . . 0.0 111.249 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.58 -31.26 71.86 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.74 0.416 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.27 -31.7 65.99 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.699 0.8 . . . . 0.0 111.048 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.76 62.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.998 0.519 . . . . 0.0 110.875 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.47 -42.9 51.93 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.18 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD12 HD21 ' A' ' 26' ' ' LEU . 95.7 mt -86.79 167.23 14.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.753 0.821 . . . . 0.0 110.162 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -120.35 125.0 27.43 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.96 146.38 32.73 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.548 2.165 . . . . 0.0 111.923 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -82.58 -22.87 34.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 111.277 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -158.52 168.58 26.56 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 110.455 -173.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 18.5 mtm180 -126.91 124.01 38.54 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.928 1.291 . . . . 0.0 108.507 169.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.1 pt -94.88 138.7 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 122.825 0.45 . . . . 0.0 110.317 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 t -117.24 123.97 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 pt -109.39 160.44 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.766 0.826 . . . . 0.0 109.826 170.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.8 p -132.05 131.86 42.85 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.072 0.949 . . . . 0.0 108.664 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.07 154.79 21.15 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtm105 -110.25 118.96 37.74 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.838 0.819 . . . . 0.0 109.969 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 t80 55.94 82.78 0.1 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.994 1.317 . . . . 0.0 110.98 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -132.75 164.77 26.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.702 0.801 . . . . 0.0 110.01 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -99.2 178.82 4.79 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 53' ' ' VAL . 9.0 tp -65.66 -37.07 79.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.21 -38.56 96.7 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 123.191 0.307 . . . . 0.0 113.351 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -69.18 -39.9 78.42 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.412 0.685 . . . . 0.0 110.2 176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -63.1 -40.98 99.23 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.316 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 49' ' ' ILE . 83.0 t -70.36 -40.2 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.413 0.685 . . . . 0.0 110.467 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -65.89 -34.89 79.17 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.062 0.545 . . . . 0.0 111.059 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.58 -34.99 58.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.227 0.611 . . . . 0.0 111.222 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.0 p -83.27 -27.01 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.761 0.424 . . . . 0.0 110.685 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.8 p -73.32 -36.34 66.2 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.436 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.0 ttt180 -66.36 -45.28 80.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.979 175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -64.28 -41.32 96.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.132 0.573 . . . . 0.0 110.883 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.05 -32.54 74.13 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 120.665 0.269 . . . . 0.0 110.889 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 19.8 t70 -67.79 -36.91 81.28 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.43 0.692 . . . . 0.0 110.872 174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.8 mm-40 -63.13 -35.88 81.73 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.378 0.671 . . . . 0.0 110.719 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 29.7 mm-40 -83.79 -11.19 57.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.687 0.795 . . . . 0.0 112.161 -177.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.64 47.8 8.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-O 121.137 0.298 . . . . 0.0 112.554 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.55 131.4 56.68 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 0.0 109.134 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.02 -35.1 74.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.21 0.604 . . . . 0.0 111.507 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.1 m -140.92 175.32 9.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.579 0.751 . . . . 0.0 110.613 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 38.5 p90 -149.52 -179.94 7.48 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 173.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -159.11 122.81 3.82 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.7 115.49 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 85' ' ' VAL . 2.5 p -88.56 -31.54 5.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.264 0.626 . . . . 0.0 109.669 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -162.07 142.08 10.03 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.871 0.367 . . . . 0.0 110.982 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.5 p -117.99 147.05 43.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.58 1.152 . . . . 0.0 108.334 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -150.16 169.81 20.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.69 0.796 . . . . 0.0 110.23 -176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.9 149.02 50.23 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -71.53 98.32 1.84 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.02 -107.87 2.09 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -120.13 1.52 10.85 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.375 0.67 . . . . 0.0 111.113 175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 97.1 p -84.54 154.87 22.4 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.732 0.413 . . . . 0.0 110.197 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.41 25.17 2.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.06 90.65 2.01 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 117.665 0.733 . . . . 0.0 109.44 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -66.93 96.82 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.645 1.178 . . . . 0.0 112.556 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -83.64 111.67 19.34 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.57 HG21 ' HB1' ' A' ' 52' ' ' ALA . 57.9 t -123.06 121.2 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.93 0.492 . . . . 0.0 109.955 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 71' ' ' VAL . 5.1 p -109.86 134.19 52.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.297 0.639 . . . . 0.0 109.53 173.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -139.79 124.72 18.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.818 0.847 . . . . 0.0 109.958 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 5.3 p-10 -72.53 130.83 41.53 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.428 0.691 . . . . 0.0 110.171 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 13.4 m -112.97 151.84 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.103 0.961 . . . . 0.0 111.301 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -130.37 147.42 52.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.782 1.233 . . . . 0.0 110.43 -167.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -86.3 173.58 9.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.745 0.818 . . . . 0.0 110.268 171.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.628 174.28 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.9 m170 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -169.52 132.36 1.22 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.928 1.291 . . . . 0.0 107.873 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.37 137.05 58.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.809 0.443 . . . . 0.0 109.951 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.9 m -62.09 135.44 57.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.44 0.696 . . . . 0.0 110.651 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.01 117.61 13.84 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' ' HB2' ' A' ' 30' ' ' GLN . 11.7 tp -90.95 142.28 27.94 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.9 p -95.94 153.29 39.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.196 0.599 . . . . 0.0 110.47 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -44.63 -38.62 12.52 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 124.213 3.276 . . . . 0.0 115.625 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -59.37 -50.7 72.97 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.358 0.663 . . . . 0.0 111.186 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 44.9 mt-30 -66.31 -46.23 77.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.817 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.67 68.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.889 0.875 . . . . 0.0 112.492 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.22 -24.45 47.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.6 0.76 . . . . 0.0 110.818 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.14 -33.32 14.08 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.759 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -99.45 153.21 19.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.343 0.657 . . . . 0.0 111.191 -169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -104.76 128.39 26.93 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 124.3 1.04 . . . . 0.0 109.401 174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.34 148.1 23.53 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.677 2.251 . . . . 0.0 111.697 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -80.12 -24.02 40.79 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.674 0.389 . . . . 0.0 110.47 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -160.74 175.17 12.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.148 0.979 . . . . 0.0 108.923 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.624 HH21 HG11 ' A' ' 71' ' ' VAL . 43.7 mtp180 -132.47 121.15 22.93 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.606 HD11 HG13 ' A' ' 56' ' ' VAL . 44.9 pt -89.55 149.15 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 118.012 0.369 . . . . 0.0 110.132 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.98 122.57 49.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.4 pt -109.65 170.56 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.2 p -125.48 106.02 9.48 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.658 0.783 . . . . 0.0 109.136 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.43 88.73 1.59 Allowed Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.51 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 81' ' ' ASN . 10.0 ttm180 -84.06 96.09 8.79 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.768 0.427 . . . . 0.0 110.221 -176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.8 t80 60.79 90.65 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 O-C-N 124.47 1.106 . . . . 0.0 110.033 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.09 162.96 13.39 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.693 0.797 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.02 161.89 24.04 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 123.547 0.529 . . . . 0.0 110.018 173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.498 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.2 tp -64.87 -29.18 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.29 0.636 . . . . 0.0 110.479 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.68 -39.9 97.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.072 0.232 . . . . 0.0 113.113 174.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -67.16 -43.41 82.36 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.533 0.733 . . . . 0.0 110.459 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.51 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -61.81 -50.11 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.086 0.954 . . . . 0.0 111.623 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.6 -35.84 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.064 0.946 . . . . 0.0 111.031 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 t -67.32 -34.93 78.38 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.043 0.537 . . . . 0.0 110.6 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.88 -33.91 64.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.042 0.537 . . . . 0.0 111.009 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.606 HG13 HD11 ' A' ' 40' ' ' ILE . 79.7 t -69.54 -41.71 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.262 0.625 . . . . 0.0 110.96 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.403 ' HB3' ' CE1' ' A' ' 68' ' ' PHE . 16.0 p -66.0 -34.18 77.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.938 0.495 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 15.1 tpt180 -65.93 -57.44 7.83 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.76 0.824 . . . . 0.0 109.67 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -60.46 -40.36 90.91 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.04 1.336 . . . . 0.0 112.387 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -44.12 79.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.851 0.86 . . . . 0.0 110.246 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.75 -31.25 72.36 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.66 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 24.5 mm-40 -69.32 -29.44 67.27 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.046 0.538 . . . . 0.0 111.248 174.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -83.84 -1.93 55.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.989 0.516 . . . . 0.0 111.129 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.26 16.32 71.98 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.345 -0.388 . . . . 0.0 113.304 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -69.81 124.49 24.14 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.416 0.687 . . . . 0.0 110.852 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.95 69.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.859 0.724 . . . . 0.0 110.336 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.98 155.64 44.1 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 109.899 177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 57' ' ' SER . 36.3 p90 -124.41 160.7 27.59 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -149.69 105.2 3.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -61.38 107.9 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.624 HG11 HH21 ' A' ' 39' ' ' ARG . 11.4 p -93.49 -36.01 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.291 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.47 145.28 21.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.875 -172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.3 p -131.28 134.5 46.45 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.818 1.247 . . . . 0.0 107.814 172.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.5 m -139.07 126.57 21.71 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.139 0.576 . . . . 0.0 110.146 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.26 128.56 36.02 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.994 0.518 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -86.5 -52.28 5.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.333 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.4 -50.93 0.64 Allowed Glycine 0 C--N 1.349 1.275 0 N-CA-C 114.209 0.444 . . . . 0.0 114.209 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -56.83 107.87 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.029 0.932 . . . . 0.0 112.498 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.6 m 62.62 22.75 13.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.992 0.917 . . . . 0.0 112.148 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.47 38.8 69.49 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.212 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 33.8 p-10 -78.84 146.41 33.69 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.498 ' HH2' ' HA ' ' A' ' 49' ' ' ILE . 7.5 p-90 -146.2 127.21 14.59 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.853 0.861 . . . . 0.0 109.198 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.93 149.18 50.11 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.979 0.799 . . . . 0.0 108.944 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 52' ' ' ALA . 32.3 t -127.2 105.28 13.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.69 131.26 41.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.32 112.22 6.56 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.195 -171.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.05 133.89 51.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 15.6 m -113.99 126.15 71.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.513 0.673 . . . . 0.0 109.859 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -115.11 162.51 16.92 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.868 1.267 . . . . 0.0 110.245 -168.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -107.22 170.2 8.11 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.316 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.848 178.917 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.2 m170 . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . . . 58.71 96.14 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.044 1.337 . . . . 0.0 111.404 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.54 140.14 41.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.259 1.024 . . . . 0.0 112.125 -176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 83.5 m -66.97 134.04 51.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.977 0.911 . . . . 0.0 110.251 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -68.71 116.54 9.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 17.8 tp -72.99 137.5 45.48 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 71.9 p -72.03 147.69 91.22 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.854 -0.593 . . . . 0.0 110.443 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.6 -36.44 18.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.963 3.108 . . . . 0.0 114.021 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.01 -37.89 69.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.864 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -74.43 -49.47 22.3 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.138 0.494 . . . . 0.0 110.122 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.06 -22.17 66.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.455 1.102 . . . . 0.0 112.348 -175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.14 -53.86 50.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.34 1.056 . . . . 0.0 112.328 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.13 -22.89 17.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.947 0.499 . . . . 0.0 111.852 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.968 0.413 . . . . 0.0 110.339 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -86.91 125.6 66.08 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.458 1.103 . . . . 0.0 109.516 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.7 166.41 23.71 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.973 2.448 . . . . 0.0 111.374 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -93.5 -26.27 17.24 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 122.465 -0.147 . . . . 0.0 111.232 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -165.21 -170.94 2.03 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.698 0.399 . . . . 0.0 110.251 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -137.94 138.03 38.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.885 1.274 . . . . 0.0 109.983 174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.0 pt -102.77 144.14 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.914 0.886 . . . . 0.0 109.398 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 85' ' ' VAL . 46.1 t -130.83 115.43 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 pt -102.7 156.68 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.1 m -147.1 146.2 29.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 0.0 109.351 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.92 156.57 25.05 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 114.286 0.475 . . . . 0.0 114.286 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -92.52 132.64 36.66 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.381 1.072 . . . . 0.0 110.003 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 t80 60.46 23.13 12.75 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 124.685 1.194 . . . . 0.0 112.091 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.76 116.93 16.02 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.28 158.98 35.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.5 tp -57.49 -33.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.284 0.365 . . . . 0.0 111.058 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.28 -45.03 96.82 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.245 0.341 . . . . 0.0 112.936 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.49 -39.67 92.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.711 0.804 . . . . 0.0 110.774 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -64.36 -47.65 78.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.337 1.055 . . . . 0.0 110.47 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 56' ' ' VAL . 92.8 t -67.35 -37.57 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 122.795 0.438 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 t -64.04 -41.81 97.28 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.732 0.413 . . . . 0.0 110.941 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.87 -44.4 66.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.041 0.536 . . . . 0.0 110.882 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 53' ' ' VAL . 5.8 p -74.98 -28.86 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.084 0.554 . . . . 0.0 111.145 -174.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.8 p -70.74 -49.94 41.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.634 0.373 . . . . 0.0 110.211 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ALA . 79.2 ttt180 -63.52 -44.18 94.99 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 110.173 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 17.2 tpp180 -57.57 -41.85 81.91 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.713 0.805 . . . . 0.0 111.474 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.64 86.11 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.138 0.494 . . . . 0.0 110.365 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.33 -31.09 71.66 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.269 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 74.7 mm-40 -69.53 -31.31 69.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.347 0.659 . . . . 0.0 109.896 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 15.0 mm-40 -82.48 0.48 42.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.85 0.46 . . . . 0.0 111.221 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.85 5.05 71.65 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.167 0.413 . . . . 0.0 113.473 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.1 135.31 38.58 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.645 0.778 . . . . 0.0 110.88 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.92 -26.64 54.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.367 1.067 . . . . 0.0 110.902 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.3 m -145.81 170.32 16.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.245 1.018 . . . . 0.0 111.422 -176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -149.6 170.49 18.54 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -153.89 117.79 4.74 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.202 0.601 . . . . 0.0 109.505 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.01 107.93 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.719 0 C-N-CA 123.716 0.806 . . . . 0.0 110.369 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.17 -43.55 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.265 0.626 . . . . 0.0 110.246 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 20.1 t70 -133.97 127.56 32.62 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 110.254 -167.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.3 p -122.56 117.23 25.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 44.4 t -139.48 162.42 35.1 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -138.0 174.27 10.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.362 0.665 . . . . 0.0 111.015 -170.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' HB2' HD22 ' A' ' 81' ' ' ASN . 57.1 t80 -77.69 175.04 10.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.69 172.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -57.76 -23.06 49.31 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-O 120.851 0.139 . . . . 0.0 113.056 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -102.65 129.21 49.17 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.66 1.184 . . . . 0.0 109.316 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.8 m -74.45 133.26 42.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.23 0.612 . . . . 0.0 110.343 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.35 -47.5 1.02 Allowed Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.465 HD22 ' HB2' ' A' ' 76' ' ' PHE . 6.6 t30 -90.01 109.95 20.96 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 172.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 5.9 p-90 -144.51 179.83 7.02 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.375 0.67 . . . . 0.0 110.363 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.21 153.16 41.04 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.198 -171.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' A' ' 52' ' ' ALA . 85.2 t -124.11 110.94 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 0.0 108.915 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 26.4 t -94.65 123.87 46.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 169.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.7 123.56 23.88 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.5 0.72 . . . . 0.0 110.728 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -64.16 136.21 57.03 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.897 0.879 . . . . 0.0 110.067 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.66 138.65 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.347 0.594 . . . . 0.0 110.373 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -126.24 133.58 51.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.756 1.222 . . . . 0.0 109.735 -167.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.24 176.65 9.57 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.205 0.602 . . . . 0.0 110.818 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.529 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.63 157.4 42.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.843 0.857 . . . . 0.0 110.137 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.45 142.78 53.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.111 0.564 . . . . 0.0 110.531 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' SER . 59.1 m -68.14 124.77 24.36 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.0 0.52 . . . . 0.0 110.12 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -66.92 128.01 34.72 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 34' ' ' LEU . 17.5 tp -101.75 140.13 36.45 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.902 0.881 . . . . 0.0 108.999 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 p -79.96 153.26 74.98 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.332 0.653 . . . . 0.0 110.861 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.23 -39.04 52.55 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.132 3.221 . . . . 0.0 114.155 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.54 -52.58 64.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.779 0.832 . . . . 0.0 110.559 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.71 -36.42 75.91 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.539 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.69 92.01 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.993 0.917 . . . . 0.0 111.312 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.3 63.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.996 0.519 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.07 45.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.205 0.602 . . . . 0.0 111.583 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD12 HD21 ' A' ' 26' ' ' LEU . 82.5 mt -89.46 163.33 15.3 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.673 0.789 . . . . 0.0 110.101 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -120.28 124.7 27.6 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.607 0.763 . . . . 0.0 109.083 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.77 153.13 48.15 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.634 2.223 . . . . 0.0 111.952 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -93.08 -25.31 17.97 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.841 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -153.35 168.15 27.01 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.876 0.87 . . . . 0.0 108.879 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.562 HH21 HG11 ' A' ' 71' ' ' VAL . 34.0 mtp-105 -133.29 126.14 30.79 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.406 ' HB ' HH11 ' A' ' 59' ' ' ARG . 28.6 pt -104.59 159.03 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.33 0.652 . . . . 0.0 110.365 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.25 139.29 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.71 0.804 . . . . 0.0 109.471 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.6 pt -125.9 168.65 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.1 0.96 . . . . 0.0 108.985 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -132.79 129.71 38.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.876 . . . . 0.0 109.142 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.18 92.35 0.21 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 54.9 ttp180 -60.07 112.24 1.81 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.654 0.782 . . . . 0.0 111.955 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 60.9 t80 66.75 11.45 8.23 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 124.389 1.076 . . . . 0.0 111.706 172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -77.94 155.8 30.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.067 0.547 . . . . 0.0 110.066 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.63 152.99 43.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.886 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -61.75 -43.91 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 123.617 0.573 . . . . 0.0 110.688 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.66 -34.73 88.38 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.053 0.22 . . . . 0.0 112.949 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.05 -42.85 88.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.118 0.967 . . . . 0.0 110.398 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.216 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.501 ' HA ' HG12 ' A' ' 56' ' ' VAL . 69.1 t -67.68 -33.96 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 122.801 0.441 . . . . 0.0 110.448 175.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -68.68 -39.35 80.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.797 0.439 . . . . 0.0 110.534 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.69 -39.87 80.34 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.433 0.693 . . . . 0.0 111.223 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 53' ' ' VAL . 3.7 p -78.44 -27.05 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.103 0.561 . . . . 0.0 110.663 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.8 t -69.01 -43.74 74.2 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.883 0.873 . . . . 0.0 110.146 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 14.4 tpt180 -63.82 -45.54 89.14 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.027 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -60.83 -44.94 96.28 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.84 0.713 . . . . 0.0 109.272 -179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.25 -43.02 82.62 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.574 0.75 . . . . 0.0 110.592 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -64.59 -39.08 93.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.31 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 54.5 mm-40 -62.04 -34.92 77.13 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.391 0.676 . . . . 0.0 110.818 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.1 mm-40 -78.81 -11.63 60.0 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.851 0.46 . . . . 0.0 111.351 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.42 16.31 34.98 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.088 0.242 . . . . 0.0 113.519 176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -77.98 135.04 37.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.269 0.628 . . . . 0.0 111.624 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.24 -31.2 49.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.291 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' THR . 51.1 m -143.63 172.01 13.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -162.29 158.86 24.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -130.79 121.0 24.57 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.68 96.2 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG11 HH21 ' A' ' 39' ' ' ARG . 7.2 p -88.9 -34.51 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.215 -172.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -133.39 129.04 36.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.982 0.513 . . . . 0.0 109.718 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 84' ' ' VAL . 7.1 p -135.35 104.15 5.76 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 166.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 66.7 m -148.74 168.54 22.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.916 1.286 . . . . 0.0 108.528 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.0 pt-20 -68.23 149.45 49.5 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.87 0.367 . . . . 0.0 110.599 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -84.04 48.49 1.48 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 109.346 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.73 45.93 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.42 -0.809 . . . . 0.0 113.508 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -138.29 120.73 16.02 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 123.769 0.828 . . . . 0.0 109.1 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.2 m -65.26 115.25 5.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.883 0.873 . . . . 0.0 110.226 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.72 -55.04 0.6 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 14.8 t30 -86.54 96.76 10.18 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 16.9 p-90 -108.55 150.36 27.59 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.499 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.11 157.12 19.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.44 1.096 . . . . 0.0 110.601 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' A' ' 52' ' ' ALA . 64.9 t -126.98 109.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.567 1.147 . . . . 0.0 108.618 176.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.1 129.91 42.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 170.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.66 117.77 10.64 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 10.6 p-10 -84.86 142.33 29.81 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 26.8 m -113.18 142.36 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.714 0.805 . . . . 0.0 111.245 -164.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 88.5 m-85 -126.38 167.25 15.79 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.107 1.363 . . . . 0.0 111.326 -165.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -108.75 162.97 13.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.83 1.252 . . . . 0.0 109.415 168.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.147 179.585 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 37.3 m80 . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.45 -60.72 3.36 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.64 135.12 29.63 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 170.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.6 m -66.46 136.18 55.34 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.789 . . . . 0.0 109.922 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -69.0 125.01 25.31 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 12.8 tp -96.27 105.32 17.37 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 173.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.4 m -56.44 141.86 70.44 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.541 1.136 . . . . 0.0 110.509 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -43.51 -35.09 5.67 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.855 3.037 . . . . 0.0 114.2 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -63.02 -44.62 95.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.979 0.912 . . . . 0.0 111.642 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.85 -41.51 64.73 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.11 -19.52 61.13 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.382 1.073 . . . . 0.0 111.961 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.66 81.77 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.081 0.552 . . . . 0.0 110.182 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.56 -42.83 11.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.784 0.834 . . . . 0.0 111.352 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.94 134.02 33.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.255 0.622 . . . . 0.0 110.971 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -97.37 134.59 22.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.225 1.01 . . . . 0.0 109.713 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 83.6 Cg_endo -75.32 163.65 34.24 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.98 2.453 . . . . 0.0 113.086 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 25.0 p90 -94.96 -25.66 16.43 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.991 173.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -155.94 177.4 11.45 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.789 0.835 . . . . 0.0 108.853 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 40.4 ttm180 -134.52 124.24 25.22 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.118 0.967 . . . . 0.0 108.781 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.4 pt -89.52 163.67 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.629 0.772 . . . . 0.0 111.265 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 83' ' ' ARG . 7.6 p -141.65 139.78 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.039 0.936 . . . . 0.0 109.164 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.6 pt -137.39 148.57 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.2 m -133.46 133.85 42.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.51 174.84 20.81 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 27.9 ttm180 -149.6 111.72 4.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.4 t80 81.75 -3.71 1.57 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 124.947 1.299 . . . . 0.0 111.165 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -71.24 152.35 43.4 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.484 1.513 . . . . 0.0 110.861 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.63 172.12 9.52 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.309 0.644 . . . . 0.0 110.923 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.68 -32.64 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 C-N-CA 123.608 0.763 . . . . 0.0 110.965 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.27 -35.52 91.67 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-O 120.899 0.166 . . . . 0.0 112.995 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -72.07 -35.29 69.23 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.632 0.773 . . . . 0.0 110.445 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.78 -43.52 88.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.63 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.59 -43.26 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.328 0.651 . . . . 0.0 111.231 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 p -66.34 -40.97 90.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.377 0.271 . . . . 0.0 111.19 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.6 -39.99 80.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.949 0.499 . . . . 0.0 111.794 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.33 -29.26 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 122.813 0.445 . . . . 0.0 110.889 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.8 t -74.09 -41.43 61.69 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.122 0.569 . . . . 0.0 110.152 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -70.17 -41.5 73.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.0 tpp180 -60.44 -47.16 87.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.296 0.638 . . . . 0.0 110.231 175.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.37 -43.55 83.66 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.759 0.662 . . . . 0.0 111.436 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.24 -40.53 94.37 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.024 0.929 . . . . 0.0 110.936 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.65 -12.09 60.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.395 0.678 . . . . 0.0 112.364 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 17.7 mm-40 -89.49 -12.64 39.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.457 0.303 . . . . 0.0 110.786 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.89 5.23 61.22 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.722 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' A' ' 88' ' ' VAL . . . -75.26 129.34 37.28 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.345 0.658 . . . . 0.0 111.45 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.22 77.41 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.943 0.897 . . . . 0.0 111.043 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 52.3 m -137.29 164.56 28.26 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.994 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -144.57 152.49 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.871 0.868 . . . . 0.0 108.927 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -131.54 118.22 19.82 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 171.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.4 t -63.86 107.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.57 -28.44 5.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.211 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -158.97 129.72 6.05 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.191 -175.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -113.39 115.59 28.32 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 165.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.9 m -129.74 145.57 51.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 8.7 pt-20 -69.37 152.18 45.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -92.49 57.68 3.0 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 60.5 27.5 66.01 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-N 115.417 -0.81 . . . . 0.0 113.443 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 81' ' ' ASN . 50.5 t-20 -161.24 137.13 8.03 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -169.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.8 t -68.93 -32.27 71.75 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.001 0.52 . . . . 0.0 111.391 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.36 -43.56 5.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.288 -0.414 . . . . 0.0 112.678 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . 0.2 OUTLIER -83.72 113.4 20.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.1 143.88 46.86 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.165 0.507 . . . . 0.0 110.916 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' A' ' 41' ' ' VAL . 4.4 tmm_? -107.99 130.87 55.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.738 1.215 . . . . 0.0 109.715 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 73.5 t -112.32 125.78 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -121.36 140.31 45.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.99 143.53 31.26 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.025 0.53 . . . . 0.0 111.021 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.0 m-20 -77.76 156.12 30.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.905 0.482 . . . . 0.0 109.94 168.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 65' ' ' ALA . 4.5 m -127.1 141.85 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.279 0.632 . . . . 0.0 110.526 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -131.09 141.84 50.2 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.352 1.061 . . . . 0.0 109.676 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.417 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 3.3 mmmp? -99.92 145.61 27.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 0.0 110.572 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 166.25 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ASP . . . -69.48 -68.12 0.43 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.448 0.699 . . . . 0.0 110.141 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -140.35 123.97 17.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 67' ' ' SER . 73.1 m -68.94 124.05 22.67 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.718 0.807 . . . . 0.0 110.028 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.76 116.42 10.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.504 HD21 HD12 ' A' ' 34' ' ' LEU . 14.5 tp -74.43 144.74 44.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.921 1.289 . . . . 0.0 109.189 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.9 p -73.48 152.4 89.76 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.963 0.505 . . . . 0.0 110.071 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.64 -32.71 45.85 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.67 2.913 . . . . 0.0 113.54 175.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -66.65 -52.93 39.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.249 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -70.16 -32.21 70.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.173 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.38 -29.47 66.13 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.961 0.904 . . . . 0.0 111.157 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.12 -31.17 65.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.282 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.55 -48.2 9.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.173 0.589 . . . . 0.0 111.068 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.504 HD12 HD21 ' A' ' 26' ' ' LEU . 94.3 mt -81.11 172.97 13.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.751 0.821 . . . . 0.0 110.932 -177.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HD3' ' HD2' ' A' ' 36' ' ' PRO . 10.8 tppt? -132.64 131.93 22.4 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.787 0.835 . . . . 0.0 108.944 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.543 ' HD2' ' HD3' ' A' ' 35' ' ' LYS . 73.5 Cg_endo -68.99 150.98 73.49 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.587 2.191 . . . . 0.0 111.471 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -86.11 -19.69 29.82 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.923 0.392 . . . . 0.0 110.358 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -162.03 169.2 21.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.476 1.11 . . . . 0.0 109.111 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 87' ' ' ASP . 88.6 mtm180 -131.79 121.98 25.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.674 1.19 . . . . 0.0 108.754 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.3 pt -96.51 144.08 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.292 0.637 . . . . 0.0 110.177 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -122.35 133.78 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 123.641 0.777 . . . . 0.0 109.322 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 pt -126.52 153.86 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.792 0.837 . . . . 0.0 108.942 175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' ARG . 39.2 p -121.55 149.93 42.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 0.0 109.074 174.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.06 116.29 0.71 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 40.7 ttp-105 -88.82 120.08 29.9 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.675 0.79 . . . . 0.0 109.627 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.1 t80 59.05 81.65 0.16 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.733 1.213 . . . . 0.0 111.099 175.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -153.91 156.15 36.98 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.595 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.32 154.02 39.08 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 124.025 0.828 . . . . 0.0 110.162 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 53' ' ' VAL . 5.5 tp -59.92 -41.63 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.597 0.359 . . . . 0.0 110.041 175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.37 -31.26 80.27 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.317 0.386 . . . . 0.0 113.34 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -73.07 -36.09 66.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.728 0.811 . . . . 0.0 110.255 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.9 77.82 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.865 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' HA ' HG12 ' A' ' 56' ' ' VAL . 87.7 t -66.9 -34.01 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.151 176.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.3 t -65.53 -39.43 91.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.466 0.706 . . . . 0.0 110.694 174.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.81 -43.23 76.04 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.22 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 53' ' ' VAL . 8.3 p -82.4 -27.18 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.232 0.613 . . . . 0.0 111.675 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -69.49 -42.72 74.41 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.2 0.524 . . . . 0.0 109.787 174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 7.6 tpt180 -65.78 -42.72 90.47 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 173.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.3 tpp180 -62.47 -35.99 81.06 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.147 0.579 . . . . 0.0 110.404 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.29 66.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.254 0.622 . . . . 0.0 110.477 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 27.3 t70 -67.79 -34.89 77.65 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.837 0.455 . . . . 0.0 110.648 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 26.7 mm-40 -60.51 -37.01 79.77 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.787 0.835 . . . . 0.0 110.092 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 50.1 mm-40 -77.72 -15.02 59.43 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.18 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.97 38.5 48.34 Favored Glycine 0 C--N 1.346 1.104 0 O-C-N 123.562 0.539 . . . . 0.0 111.761 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.84 126.66 40.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.236 1.014 . . . . 0.0 110.092 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.65 83.59 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.561 0.696 . . . . 0.0 110.739 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 37.2 m -139.95 168.99 18.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.659 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 24.8 p90 -148.75 169.95 19.3 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 169.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -150.2 127.1 11.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.55 97.55 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -86.33 -16.91 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.751 0.82 . . . . 0.0 110.52 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 21.8 t70 -163.51 150.27 12.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.237 0.615 . . . . 0.0 111.029 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 p -141.61 114.28 8.4 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.185 1.394 . . . . 0.0 107.834 168.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.7 m -137.25 152.35 49.73 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 108.806 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.9 pt-20 -64.48 148.9 49.65 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 122.497 0.319 . . . . 0.0 110.896 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -62.31 -34.63 76.98 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.661 0.384 . . . . 0.0 111.081 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.72 -7.11 0.08 OUTLIER Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.88 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -140.07 148.19 41.4 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.3 p -69.94 104.39 2.5 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.985 0.514 . . . . 0.0 109.853 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.79 -39.16 1.43 Allowed Glycine 0 N--CA 1.463 0.474 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -102.55 113.02 26.03 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 10.0 p-90 -121.75 159.3 26.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.576 0.703 . . . . 0.0 110.571 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.443 ' HB2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -133.71 132.02 40.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.654 -165.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.98 125.84 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.866 0.866 . . . . 0.0 109.759 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 21.6 t -100.88 120.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 166.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -129.98 121.92 27.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 13.6 p-10 -85.36 136.04 33.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 68' ' ' PHE . 16.6 m -112.32 131.64 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.692 0.797 . . . . 0.0 111.349 -166.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.588 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 74.0 m-85 -109.76 163.86 13.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 111.54 -171.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -110.15 165.57 11.64 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.449 1.1 . . . . 0.0 108.709 169.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.698 178.933 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.81 108.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.099 1.36 . . . . 0.0 111.879 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 133.73 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.377 0.671 . . . . 0.0 110.551 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -67.35 134.09 50.86 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.139 0.576 . . . . 0.0 110.557 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.02 116.57 9.63 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 173.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 15.5 tp -84.0 126.65 33.24 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.3 p -66.22 145.23 98.98 Favored Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 123.736 0.647 . . . . 0.0 110.208 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -45.65 -31.37 7.3 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.607 2.872 . . . . 0.0 114.25 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -63.89 -55.66 21.08 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.337 1.055 . . . . 0.0 110.449 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -68.19 -34.1 75.67 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.17 -31.14 69.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.037 0.935 . . . . 0.0 111.423 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.57 -26.05 59.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.186 0.594 . . . . 0.0 111.174 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.2 -26.81 19.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.299 0.64 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 26' ' ' LEU . 95.2 mt -101.21 160.89 14.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.731 0.812 . . . . 0.0 111.222 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -111.31 123.88 34.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.295 1.038 . . . . 0.0 108.371 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.31 159.08 36.84 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.081 1.854 . . . . 0.0 111.185 171.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -100.86 -39.19 7.91 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.771 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.58 -170.61 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 109.469 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HB3' ' HA ' ' A' ' 87' ' ' ASP . 4.5 ptt180 -149.8 168.08 24.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.79 0.836 . . . . 0.0 111.459 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.578 HD11 HG23 ' A' ' 56' ' ' VAL . 37.7 pt -118.55 151.95 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.954 0.902 . . . . 0.0 110.33 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG13 ' HD3' ' A' ' 83' ' ' ARG . 85.5 t -121.3 114.17 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.638 1.175 . . . . 0.0 109.545 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.47 HG13 ' HB ' ' A' ' 84' ' ' VAL . 43.2 pt -133.9 178.39 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.483 1.113 . . . . 0.0 108.963 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 83' ' ' ARG . 3.0 p -126.97 105.11 8.39 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.632 0.773 . . . . 0.0 109.475 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 84' ' ' VAL . . . -89.23 149.48 20.75 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -110.49 151.76 27.16 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.828 0.814 . . . . 0.0 111.166 -169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -72.07 -4.62 29.91 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.188 0.995 . . . . 0.0 112.817 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.507 0.723 . . . . 0.0 110.657 176.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.4 143.03 4.07 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.932 0.893 . . . . 0.0 110.216 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.5 tp -62.67 -37.44 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 167.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.47 -26.77 68.54 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 113.624 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.62 -49.2 78.47 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.301 0.64 . . . . 0.0 110.263 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -65.24 -42.11 93.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.956 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 56' ' ' VAL . 88.9 t -66.75 -36.18 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 123.848 0.718 . . . . 0.0 111.338 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.5 m -66.21 -41.77 89.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.782 0.433 . . . . 0.0 110.546 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.17 79.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.69 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.578 HG23 HD11 ' A' ' 40' ' ' ILE . 12.7 p -77.11 -34.15 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 122.724 0.41 . . . . 0.0 111.469 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.5 t -67.84 -39.99 83.77 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.796 0.438 . . . . 0.0 110.277 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 29.7 ttt180 -65.03 -56.63 11.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.852 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.8 OUTLIER -66.54 -39.31 88.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.102 0.561 . . . . 0.0 112.3 -172.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.35 93.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 120.99 0.424 . . . . 0.0 109.949 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.33 -35.92 80.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.708 0.803 . . . . 0.0 111.167 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 47.8 mt-10 -66.46 -33.27 75.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.337 0.655 . . . . 0.0 110.736 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 18.9 mm-40 -82.75 -5.17 58.77 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.717 0.807 . . . . 0.0 111.469 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.01 14.63 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.21 0.319 . . . . 0.0 113.137 176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.105 0.962 . . . . 0.0 109.584 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.42 -28.57 62.06 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.596 0.759 . . . . 0.0 111.067 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.3 m -143.09 169.4 17.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -147.28 168.11 22.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.959 0.903 . . . . 0.0 109.766 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -160.21 122.27 3.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.206 1.002 . . . . 0.0 108.623 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.45 120.49 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 123.601 0.563 . . . . 0.0 109.985 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.25 -30.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.257 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -160.2 149.28 17.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.018 0.527 . . . . 0.0 111.243 -172.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 83' ' ' ARG . 33.7 p -132.89 104.63 6.67 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.612 1.165 . . . . 0.0 108.857 170.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 75.3 m -100.97 109.27 21.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.717 0.807 . . . . 0.0 110.33 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -51.93 127.9 22.57 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.674 0.39 . . . . 0.0 111.439 177.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.53 168.73 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.123 0.969 . . . . 0.0 109.503 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.92 -23.26 67.39 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.162 0.425 . . . . 0.0 114.162 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.405 ' HB2' ' OD1' ' A' ' 81' ' ' ASN . 1.7 m-20 -80.81 162.07 24.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.938 0.495 . . . . 0.0 109.795 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 m -72.9 106.23 4.74 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.29 0.636 . . . . 0.0 112.433 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.0 88.76 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 115.64 1.016 . . . . 0.0 115.64 165.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 27.5 p-10 -95.85 111.29 23.31 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -101.0 124.85 47.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.331 1.052 . . . . 0.0 109.144 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HD3' HG13 ' A' ' 41' ' ' VAL . 2.8 tmm_? -63.88 106.43 1.01 Allowed 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.676 1.19 . . . . 0.0 109.586 -178.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' HG13 ' A' ' 42' ' ' ILE . 43.7 t -88.68 108.34 18.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.81 129.02 58.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 168.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.81 120.75 16.54 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.962 0.505 . . . . 0.0 110.966 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.722 ' HA ' ' HB3' ' A' ' 39' ' ' ARG . 5.0 m-20 -63.86 135.85 56.91 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.131 0.894 . . . . 0.0 110.846 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.84 142.88 22.88 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.498 0.719 . . . . 0.0 109.419 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 57.3 m-85 -125.1 152.47 44.33 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.177 0.991 . . . . 0.0 109.863 -169.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -91.68 174.21 7.47 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.289 0.635 . . . . 0.0 109.639 171.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 C-N-CA 123.307 0.643 . . . . 0.0 110.149 -179.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.478 0.656 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.23 -146.67 0.32 Allowed 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.97 118.33 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.678 0.672 . . . . 0.0 110.104 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.5 m -80.24 149.76 30.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.485 1.114 . . . . 0.0 110.617 -174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.53 134.2 51.9 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.522 0.601 . . . . 0.0 109.438 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.8 tp -94.82 134.92 36.93 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.4 p -73.96 144.91 83.07 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.732 0.813 . . . . 0.0 110.362 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -52.61 -38.19 75.53 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 124.125 3.217 . . . . 0.0 115.687 -165.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -69.83 -41.46 74.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.768 0.427 . . . . 0.0 110.455 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -68.8 -34.81 76.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.333 0.653 . . . . 0.0 110.63 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.95 -24.12 55.43 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.051 0.94 . . . . 0.0 111.261 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.03 -35.75 21.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.393 0.677 . . . . 0.0 110.432 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.76 -41.26 65.28 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.306 0.643 . . . . 0.0 110.794 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.8 mt -88.17 148.24 24.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -102.54 139.69 20.43 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 87' ' ' ASP . 73.9 Cg_endo -72.73 139.29 30.5 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.924 1.749 . . . . 0.0 111.451 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 90' ' ' LYS . 53.4 p90 -78.06 -19.53 54.1 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 174.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -166.45 174.3 9.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.484 1.114 . . . . 0.0 108.671 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 87' ' ' ASP . 51.0 mtm180 -135.01 122.76 22.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.084 0.954 . . . . 0.0 108.945 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.3 pt -87.85 151.88 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.22 0.608 . . . . 0.0 109.956 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' A' ' 83' ' ' ARG . 78.7 t -135.53 125.31 42.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.926 0.89 . . . . 0.0 109.039 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.3 pt -116.1 152.42 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.066 0.946 . . . . 0.0 109.132 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.67 164.76 12.96 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.552 0.741 . . . . 0.0 109.747 170.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.41 178.79 41.8 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.06 139.9 4.33 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.543 0.671 . . . . 0.0 111.085 178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 t80 61.47 29.59 18.47 Favored 'General case' 0 CA--C 1.557 1.222 0 O-C-N 124.254 0.971 . . . . 0.0 111.014 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -123.33 168.35 12.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 0.0 110.774 -174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.38 166.4 13.31 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.923 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 6.4 tp -66.08 -31.58 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.953 0.501 . . . . 0.0 110.407 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.97 -33.62 74.9 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.213 0.321 . . . . 0.0 112.914 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.71 -46.73 68.19 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.326 0.65 . . . . 0.0 110.551 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.49 80.62 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.614 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 56' ' ' VAL . 77.3 t -68.71 -40.36 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 0.0 110.105 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' ARG . 40.2 m -63.14 -36.65 84.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.879 0.471 . . . . 0.0 111.052 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.94 -47.32 59.69 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.342 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.0 p -74.76 -29.69 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.271 0.628 . . . . 0.0 112.203 -172.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.9 p -69.81 -40.92 75.63 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.746 0.419 . . . . 0.0 110.677 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 54' ' ' SER . 8.6 mpt_? -72.95 -36.93 67.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.321 0.648 . . . . 0.0 110.04 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.2 tpt85 -64.48 -43.55 93.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.613 0.765 . . . . 0.0 110.887 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.33 73.33 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.574 0.75 . . . . 0.0 110.99 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.55 -35.12 79.94 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.658 0.783 . . . . 0.0 110.483 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -64.12 -38.95 92.9 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.532 0.733 . . . . 0.0 110.666 174.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -74.8 -2.19 25.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.802 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.53 23.98 75.85 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.754 -0.138 . . . . 0.0 112.754 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.82 128.58 34.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.522 0.729 . . . . 0.0 109.688 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -33.81 76.71 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.478 0.711 . . . . 0.0 110.186 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 69.5 m -147.42 158.97 44.19 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.634 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -122.18 174.11 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.295 1.038 . . . . 0.0 108.852 170.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -159.62 113.96 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.506 0.722 . . . . 0.0 109.134 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.57 118.82 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.28 0.632 . . . . 0.0 110.442 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.46 -36.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.084 0.554 . . . . 0.0 110.601 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -156.12 141.24 17.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.367 -168.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -119.69 104.09 9.95 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 14.7 m -84.83 177.72 7.89 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.809 0.844 . . . . 0.0 110.344 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER -160.54 168.07 25.81 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.015 0.926 . . . . 0.0 110.542 177.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.604 ' HB3' ' HB3' ' A' ' 79' ' ' SER . 44.8 t80 -77.23 -8.01 56.87 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.476 0.71 . . . . 0.0 112.41 -168.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.23 85.68 1.86 Allowed Glycine 0 C--N 1.353 1.472 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.11 35.85 23.35 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.937 1.295 . . . . 0.0 111.582 -174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 76' ' ' PHE . 33.6 t -127.79 164.82 21.34 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.578 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.77 76.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.581 0.551 . . . . 0.0 113.34 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -69.97 137.39 51.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.219 0.608 . . . . 0.0 110.711 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.1 p-90 -143.5 173.76 11.36 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.366 1.067 . . . . 0.0 110.667 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 1.2 tmt_? -152.2 120.2 6.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.826 0.85 . . . . 0.0 109.076 -165.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.2 t -105.48 131.69 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.247 0.619 . . . . 0.0 110.376 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 127.54 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.184 0.994 . . . . 0.0 108.684 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.84 124.63 21.13 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 2.2 m-20 -62.42 136.98 58.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.259 1.424 . . . . 0.0 110.06 171.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.49 138.16 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 118.37 0.532 . . . . 0.0 110.996 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.32 135.98 46.57 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.768 1.227 . . . . 0.0 109.527 -170.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HG3' ' CE1' ' A' ' 37' ' ' TYR . 67.5 mttm -98.04 136.47 38.26 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.299 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.76 177.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 119.903 -0.094 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.12 139.71 15.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.597 0.759 . . . . 0.0 110.949 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.47 156.8 22.7 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.586 0.754 . . . . 0.0 109.681 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.4 m -64.88 135.85 56.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.727 0.811 . . . . 0.0 111.424 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -75.05 118.07 17.59 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 19.4 tp -93.11 127.22 38.57 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.5 p -72.74 146.85 88.63 Favored Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 123.487 0.715 . . . . 0.0 110.84 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -43.34 -48.21 8.42 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 125.085 3.857 . . . . 0.0 116.517 -169.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -67.94 -41.63 82.21 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 118.516 0.598 . . . . 0.0 111.263 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -67.81 -28.17 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.793 0.437 . . . . 0.0 111.16 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.72 70.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.728 0.811 . . . . 0.0 110.644 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.91 -15.14 61.14 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.605 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.01 -40.61 15.62 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.639 0.776 . . . . 0.0 110.909 177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.01 154.59 17.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.072 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -96.23 126.9 42.36 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 123.554 0.742 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.89 140.22 22.86 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.292 1.995 . . . . 0.0 111.098 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -83.63 -20.13 34.21 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.703 0.287 . . . . 0.0 110.849 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -158.33 175.04 14.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -140.23 121.72 15.12 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.7 0.8 . . . . 0.0 109.558 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 59' ' ' ARG . 29.2 pt -95.34 165.57 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.051 0.941 . . . . 0.0 110.64 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.77 133.97 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 123.23 0.612 . . . . 0.0 110.445 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 pt -122.26 157.25 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.166 0.987 . . . . 0.0 108.351 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -149.45 150.5 32.46 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.82 154.0 6.79 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 32.1 ptt-85 -97.06 3.08 52.0 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.962 0.505 . . . . 0.0 111.152 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -106.94 76.22 1.09 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.807 0.843 . . . . 0.0 108.746 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -169.81 163.75 9.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.17 0.988 . . . . 0.0 110.173 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' ' HB2' ' A' ' 51' ' ' ASP . . . -119.95 175.25 6.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.266 1.026 . . . . 0.0 108.422 170.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HA ' ' CH2' ' A' ' 82' ' ' TRP . 7.3 tp -60.07 -44.35 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 118.145 0.429 . . . . 0.0 110.515 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.7 -40.71 65.34 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.038 -0.528 . . . . 0.0 113.107 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 48' ' ' ALA . 45.9 m-20 -75.12 -25.4 58.43 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.606 0.762 . . . . 0.0 112.179 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -72.73 -43.43 62.96 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.491 ' HA ' HG12 ' A' ' 56' ' ' VAL . 94.8 t -64.38 -33.16 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.353 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 t -67.9 -40.91 83.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.435 0.694 . . . . 0.0 111.279 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.21 -36.69 61.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.122 0.569 . . . . 0.0 111.324 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 53' ' ' VAL . 4.1 p -80.36 -28.65 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 122.673 0.389 . . . . 0.0 110.307 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.0 p -70.22 -41.16 73.97 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -56.07 -47.87 77.15 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.435 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.3 tpt180 -63.53 -41.1 98.48 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 123.738 0.649 . . . . 0.0 110.782 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.63 -34.8 76.31 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.188 0.518 . . . . 0.0 111.186 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -70.92 -33.67 70.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.746 0.818 . . . . 0.0 110.574 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -77.55 -18.53 56.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.779 0.832 . . . . 0.0 110.619 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 36.2 mm-40 -80.66 -25.46 38.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.804 170.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.64 3.74 59.47 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.533 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.11 139.92 57.54 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.976 0.91 . . . . 0.0 111.315 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 91' ' ' ALA . . . -68.67 -38.81 80.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 110.409 176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.579 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 42.0 m -143.45 174.3 10.87 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.883 -175.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -151.22 164.17 37.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -146.26 124.37 12.14 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.141 0.576 . . . . 0.0 109.465 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.87 117.12 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 O-C-N 123.781 0.676 . . . . 0.0 109.211 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.1 -31.7 4.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 123.233 0.613 . . . . 0.0 110.618 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.05 139.47 21.43 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.072 0.463 . . . . 0.0 110.931 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.9 p -131.15 111.09 11.64 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 168.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.0 t -144.81 135.91 25.01 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.285 0.634 . . . . 0.0 109.427 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.715 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 12.3 pt-20 -88.14 157.58 18.79 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.801 0.81 . . . . 0.0 112.096 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 81' ' ' ASN . 74.1 m-85 -140.3 -174.51 3.96 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.711 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 59.53 -95.9 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 O-C-N 123.72 0.638 . . . . 0.0 111.806 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -173.22 127.01 0.44 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.232 1.013 . . . . 0.0 109.365 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 m 64.89 85.78 0.14 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.376 1.07 . . . . 0.0 112.953 169.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 83.54 4.77 89.0 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 116.351 1.3 . . . . 0.0 116.351 165.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 52.5 t30 -77.49 63.05 2.57 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.81 1.305 . . . . 0.0 110.245 174.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.5 p-90 -87.62 111.59 21.41 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.002 0.906 . . . . 0.0 111.419 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -67.56 114.25 6.05 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.848 175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 52' ' ' ALA . 34.4 t -102.94 106.76 20.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -110.49 133.56 55.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -138.57 136.2 35.77 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.429 0.692 . . . . 0.0 110.81 -173.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.61 144.59 41.69 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.253 0.621 . . . . 0.0 109.64 170.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.62 128.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -109.03 137.5 46.84 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.322 1.049 . . . . 0.0 109.881 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 91' ' ' ALA . 1.5 tmmm? -89.4 149.58 22.91 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.048 0.939 . . . . 0.0 108.892 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . . . . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.384 0.673 . . . . 0.0 110.888 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.63 -167.79 1.98 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.398 0.679 . . . . 0.0 110.728 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -63.45 130.91 46.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.986 0.514 . . . . 0.0 110.419 176.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 149.97 25.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.717 0.807 . . . . 0.0 110.963 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.05 122.1 15.24 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 34' ' ' LEU . 17.1 tp -92.56 124.32 36.5 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.7 p -69.83 146.9 95.92 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.598 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.48 -33.27 4.18 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 124.493 3.462 . . . . 0.0 115.088 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -68.45 -48.28 64.96 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.621 0.768 . . . . 0.0 111.276 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -71.27 -36.39 71.71 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.148 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.57 -23.9 61.83 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.243 1.017 . . . . 0.0 111.744 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.27 81.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.332 0.653 . . . . 0.0 110.793 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.7 -39.57 30.93 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.359 -178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 26' ' ' LEU . 93.4 mt -85.11 169.35 13.99 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.074 0.549 . . . . 0.0 111.297 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -130.85 134.54 26.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.097 0.959 . . . . 0.0 109.442 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.63 147.48 22.19 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.452 2.101 . . . . 0.0 111.955 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -96.35 -16.8 21.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.231 0.612 . . . . 0.0 110.372 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -158.56 174.47 15.02 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.487 1.115 . . . . 0.0 108.625 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' NH2' HG11 ' A' ' 71' ' ' VAL . 17.1 ttt180 -145.08 121.63 11.07 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 56' ' ' VAL . 23.6 pt -90.22 150.67 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 175.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 83' ' ' ARG . 5.3 p -145.81 117.78 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.49 0.716 . . . . 0.0 109.647 -175.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.6 pt -127.69 154.59 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.546 0.738 . . . . 0.0 110.678 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 p -118.67 111.37 18.44 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.774 1.23 . . . . 0.0 108.859 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.33 101.8 2.38 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.16 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -76.52 98.28 4.59 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.255 0.622 . . . . 0.0 109.816 177.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 66.13 92.28 0.08 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.668 1.187 . . . . 0.0 111.788 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -164.49 164.92 21.74 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.533 0.733 . . . . 0.0 110.938 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.71 168.79 12.2 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.801 0.84 . . . . 0.0 110.522 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HA ' ' HH2' ' A' ' 82' ' ' TRP . 8.8 tp -61.51 -34.14 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 122.925 0.49 . . . . 0.0 111.079 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.18 -37.04 93.86 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.12 0.263 . . . . 0.0 113.232 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.07 -44.5 65.6 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.74 0.816 . . . . 0.0 110.504 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -58.72 -53.14 61.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.772 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.14 -32.9 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.661 1.184 . . . . 0.0 111.296 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.1 t -65.16 -42.28 93.9 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.207 0.603 . . . . 0.0 110.583 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.76 -40.8 75.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.199 0.6 . . . . 0.0 110.903 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG13 HD11 ' A' ' 40' ' ' ILE . 76.7 t -68.22 -40.73 83.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.109 0.964 . . . . 0.0 110.995 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -69.45 -46.88 65.68 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.403 0.681 . . . . 0.0 110.938 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -61.73 -50.35 72.78 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.152 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 2.7 tpp180 -64.72 -42.83 94.95 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.806 0.691 . . . . 0.0 111.182 -175.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.73 -45.35 82.0 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.607 0.567 . . . . 0.0 110.376 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 23' ' ' ALA . 18.7 t70 -64.93 -34.16 77.75 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.782 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.69 -30.46 69.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.712 0.805 . . . . 0.0 111.257 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 3.3 mm-40 -76.35 -16.97 59.63 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.928 0.491 . . . . 0.0 110.562 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.08 20.38 14.14 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.53 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.9 151.2 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.572 0.749 . . . . 0.0 111.508 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.414 ' H ' ' HA ' ' A' ' 90' ' ' LYS . . . -89.23 -29.14 19.47 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.606 1.162 . . . . 0.0 110.527 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 73.3 m -147.7 165.76 29.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.931 0.893 . . . . 0.0 110.74 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -127.88 178.05 6.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.2 1.0 . . . . 0.0 109.178 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.57 99.6 1.59 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.08 101.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG11 ' NH2' ' A' ' 39' ' ' ARG . 5.0 p -89.32 -34.17 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.183 -169.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.12 146.38 27.66 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.305 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.7 m -143.02 118.4 10.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.5 m -130.7 124.25 31.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.852 0.861 . . . . 0.0 109.447 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 40.9 tt0 -95.58 157.24 15.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.426 0.691 . . . . 0.0 111.047 -176.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.62 -29.39 69.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.294 1.037 . . . . 0.0 110.739 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.616 ' H ' ' HG2' ' A' ' 75' ' ' GLU . . . 85.72 -55.2 4.84 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 123.196 0.427 . . . . 0.0 112.167 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -70.4 -13.08 61.99 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.306 1.043 . . . . 0.0 110.734 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 t -146.55 167.94 22.46 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.717 0.807 . . . . 0.0 110.253 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.19 13.23 40.23 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.766 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 37.9 t30 -75.32 102.19 4.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 1.6 p-90 -113.56 123.52 50.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.39 0.676 . . . . 0.0 110.126 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 41' ' ' VAL . 5.6 tmm_? -86.8 115.91 24.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.555 1.142 . . . . 0.0 109.111 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG21 ' HB1' ' A' ' 52' ' ' ALA . 46.9 t -104.18 113.85 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.02 137.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.69 127.82 17.59 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 110.851 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.91 137.0 45.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.147 0.579 . . . . 0.0 109.533 171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -114.37 132.71 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.469 0.652 . . . . 0.0 110.722 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.53 120.01 35.52 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.985 1.314 . . . . 0.0 107.9 -171.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -85.44 169.72 13.38 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.242 0.474 . . . . 0.0 109.798 175.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.489 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.9 m80 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.821 0.343 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 176.57 113.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.667 1.587 . . . . 0.0 107.275 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 138.9 57.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.863 0.465 . . . . 0.0 110.747 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.2 m -61.82 124.27 20.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.16 0.984 . . . . 0.0 111.411 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -66.03 116.61 7.33 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD21 HD12 ' A' ' 34' ' ' LEU . 15.8 tp -105.67 121.82 44.78 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.9 p -65.81 151.83 94.24 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.58 0.752 . . . . 0.0 110.771 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.47 -31.54 39.41 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.505 2.803 . . . . 0.0 113.099 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.93 -53.27 52.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.986 0.914 . . . . 0.0 110.799 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -75.79 -25.34 56.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.602 0.761 . . . . 0.0 111.421 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.77 -37.09 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.119 0.968 . . . . 0.0 110.341 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.46 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.6 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.1 -7.27 55.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.526 0.73 . . . . 0.0 112.431 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.432 HD12 HD21 ' A' ' 26' ' ' LEU . 96.2 mt -125.03 163.47 22.28 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.723 0.809 . . . . 0.0 110.477 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 117.07 51.04 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.001 0.921 . . . . 0.0 108.838 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.7 151.39 46.41 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.539 2.159 . . . . 0.0 111.849 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -96.78 -29.55 13.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.004 0.522 . . . . 0.0 111.471 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -147.76 178.49 8.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.877 0.871 . . . . 0.0 110.689 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.652 ' HG2' ' HB3' ' A' ' 87' ' ' ASP . 66.4 mtt180 -131.36 146.63 52.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 109.204 169.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.1 pt -118.03 142.63 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.63 0.772 . . . . 0.0 108.965 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.34 119.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.73 160.04 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 m -148.52 126.23 11.82 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 153.59 24.94 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.709 -0.281 . . . . 0.0 112.88 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.524 ' HG3' ' HB2' ' A' ' 81' ' ' ASN . 3.6 mpt_? -87.28 135.55 33.27 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.76 0.824 . . . . 0.0 109.934 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.4 t80 65.01 24.99 12.65 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.8 1.24 . . . . 0.0 111.931 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 13.1 m120 -70.07 136.39 50.22 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.891 -0.506 . . . . 0.0 109.945 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 170.56 15.08 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 166.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 6.5 tp -61.59 -50.45 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.72 -29.39 69.55 Favored Glycine 0 C--N 1.348 1.223 0 O-C-N 123.272 0.357 . . . . 0.0 113.151 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.9 -36.27 77.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.98 0.912 . . . . 0.0 110.388 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.488 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -74.25 -34.76 63.72 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.624 0.77 . . . . 0.0 110.67 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ILE . 70.1 t -66.96 -39.22 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 122.781 0.433 . . . . 0.0 110.203 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.4 t -65.4 -36.6 84.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.28 0.632 . . . . 0.0 110.522 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.83 -48.67 65.56 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.99 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 53' ' ' VAL . 10.6 p -77.45 -27.81 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.226 0.61 . . . . 0.0 111.962 -174.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.8 p -69.66 -48.09 61.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.613 0.365 . . . . 0.0 110.188 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 42.6 ttt-85 -63.83 -46.98 82.62 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.724 176.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 14.8 tpp180 -54.06 -49.17 69.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.973 0.909 . . . . 0.0 111.066 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.83 -43.99 86.18 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.869 0.731 . . . . 0.0 110.516 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.55 -34.63 78.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.632 0.773 . . . . 0.0 110.723 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 10.0 mm-40 -70.19 -29.98 66.99 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.17 0.588 . . . . 0.0 110.538 177.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 14.7 mm-40 -77.89 -9.77 59.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.835 175.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.74 10.5 61.54 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 113.101 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.93 143.25 37.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.786 0.834 . . . . 0.0 110.755 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.22 -36.82 17.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.669 0.788 . . . . 0.0 111.099 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 89' ' ' TYR . 50.0 m -140.12 170.92 14.94 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.84 0.856 . . . . 0.0 110.298 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -154.81 162.66 41.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.241 0.616 . . . . 0.0 109.74 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -147.18 117.89 7.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.595 0.758 . . . . 0.0 109.894 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.6 t -68.84 114.08 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 110.135 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.75 -25.55 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 122.952 0.501 . . . . 0.0 111.146 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -158.29 145.48 17.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.188 0.518 . . . . 0.0 111.328 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 84' ' ' VAL . 44.1 p -134.96 106.8 7.0 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.21 1.404 . . . . 0.0 108.362 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.426 ' HB2' ' HD2' ' A' ' 83' ' ' ARG . 46.9 m -105.02 130.75 53.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -89.6 145.87 24.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.204 0.601 . . . . 0.0 111.299 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -103.3 -33.75 9.03 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.438 1.095 . . . . 0.0 109.195 177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.21 -64.8 0.3 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.991 173.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.81 128.54 37.17 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.905 0.882 . . . . 0.0 111.165 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m 65.14 17.16 10.93 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.29 1.036 . . . . 0.0 112.162 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.61 28.61 72.78 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.471 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 11.3 t30 -80.9 140.98 35.02 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.725 0.81 . . . . 0.0 110.394 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' ASN . 1.5 p-90 -161.59 158.11 25.75 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.17 0.988 . . . . 0.0 110.136 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HD2' ' HB2' ' A' ' 74' ' ' SER . 0.0 OUTLIER -108.65 153.24 23.7 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.01 0.924 . . . . 0.0 110.085 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 52' ' ' ALA . 83.6 t -136.83 111.98 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.335 1.054 . . . . 0.0 108.258 -178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.8 134.82 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.78 126.21 18.81 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.211 1.004 . . . . 0.0 109.167 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 39' ' ' ARG . 2.5 p30 -76.92 144.17 39.05 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 174.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.44 142.17 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.909 0.883 . . . . 0.0 110.255 -170.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.602 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 64.3 m-85 -124.86 161.18 27.12 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.438 1.095 . . . . 0.0 110.802 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -92.23 165.06 13.31 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.704 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.491 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 58.5 m80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.611 0.243 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -162.31 117.53 1.89 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.17 0.988 . . . . 0.0 109.109 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.69 137.4 47.78 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.023 0.529 . . . . 0.0 110.722 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -68.98 139.93 55.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.412 0.685 . . . . 0.0 110.436 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.53 129.38 34.77 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 171.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 34' ' ' LEU . 13.9 tp -90.58 140.16 30.01 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -174.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 p -68.8 147.63 97.91 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.67 -10.6 12.02 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.641 2.228 . . . . 0.0 113.844 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -82.22 -52.95 6.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.308 0.643 . . . . 0.0 110.236 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' ' HG ' ' A' ' 26' ' ' LEU . 53.0 mt-30 -62.36 -46.0 90.61 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.877 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.85 -36.93 84.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.962 . . . . 0.0 112.083 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.37 64.35 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.126 0.57 . . . . 0.0 111.633 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.29 -29.3 12.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.625 0.77 . . . . 0.0 112.151 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.497 HD12 HD21 ' A' ' 26' ' ' LEU . 95.9 mt -98.24 150.74 21.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -96.03 127.83 39.38 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.99 0.916 . . . . 0.0 109.077 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.4 157.46 32.91 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 111.069 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CD1' ' HB2' ' A' ' 90' ' ' LYS . 37.3 p90 -90.35 -32.54 16.43 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 120.924 0.392 . . . . 0.0 110.567 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -145.8 -174.95 4.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.03 0.932 . . . . 0.0 110.22 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -149.37 128.9 13.08 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.11 0.964 . . . . 0.0 108.703 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.0 pt -109.31 148.28 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.402 0.681 . . . . 0.0 110.972 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.76 121.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.096 0.958 . . . . 0.0 108.446 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 pt -113.95 154.26 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.053 0.941 . . . . 0.0 109.439 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 83' ' ' ARG . 21.1 p -113.17 153.35 28.43 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.372 0.669 . . . . 0.0 110.167 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.37 97.02 0.15 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-N 116.856 -0.157 . . . . 0.0 112.881 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -96.98 46.39 1.04 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.546 1.165 . . . . 0.0 109.636 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -177.11 -40.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.671 -1.604 . . . . 0.0 107.776 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -56.03 127.03 28.53 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.885 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.27 -175.78 5.99 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.237 168.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 tp -63.15 -34.56 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 118.201 0.455 . . . . 0.0 110.49 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.38 -45.87 66.69 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.257 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.26 -31.35 71.63 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.685 0.794 . . . . 0.0 110.979 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 84' ' ' VAL . . . -70.52 -46.15 64.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.992 0.917 . . . . 0.0 109.686 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 56' ' ' VAL . 55.0 t -64.35 -32.58 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.745 0.653 . . . . 0.0 110.728 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.9 t -69.88 -42.7 73.12 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.216 0.606 . . . . 0.0 110.723 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.04 -38.35 75.83 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.213 -177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 53' ' ' VAL . 11.9 p -80.19 -27.97 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 122.701 0.4 . . . . 0.0 110.844 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.0 t -63.32 -47.53 81.85 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 28.3 tpt180 -64.54 -56.29 14.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.859 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 13.7 tpp180 -57.56 -46.18 84.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.793 0.837 . . . . 0.0 111.25 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.45 81.32 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.63 0.582 . . . . 0.0 110.962 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.76 -39.06 92.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.319 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 6.1 mm-40 -70.96 -25.57 62.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.939 0.496 . . . . 0.0 110.901 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 12.6 mm-40 -76.87 -11.47 59.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.299 0.639 . . . . 0.0 111.258 173.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.01 29.04 19.1 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.519 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.28 132.03 42.18 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.784 0.834 . . . . 0.0 110.3 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.16 -38.49 82.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.637 0.775 . . . . 0.0 109.88 173.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . 10.2 t -139.74 172.38 12.87 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.277 -173.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -148.71 171.11 16.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -152.24 118.62 5.61 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.67 102.9 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 123.77 0.669 . . . . 0.0 109.415 174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.17 -31.44 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.841 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 28.8 t70 -153.26 148.34 26.72 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.368 -171.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 84' ' ' VAL . 12.8 p -142.28 112.84 7.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.458 1.503 . . . . 0.0 107.044 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.419 ' HB2' ' NH1' ' A' ' 83' ' ' ARG . 62.0 m -142.85 147.23 35.06 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.569 0.347 . . . . 0.0 111.031 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 4.5 mm-40 -61.46 136.0 57.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.677 1.191 . . . . 0.0 110.929 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -95.65 27.97 3.22 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.523 0.729 . . . . 0.0 110.362 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.88 3.0 0.7 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.553 -0.582 . . . . 0.0 113.045 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.44 ' H ' ' HB3' ' A' ' 75' ' ' GLU . 26.6 t-20 60.25 82.17 0.16 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.705 1.202 . . . . 0.0 111.37 177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.9 t -168.92 21.01 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.833 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.12 23.04 78.57 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -171.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -105.44 25.9 10.12 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.804 1.242 . . . . 0.0 110.158 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 7.6 p-90 -60.92 133.42 56.08 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.325 1.05 . . . . 0.0 111.665 -173.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HB3' HG22 ' A' ' 43' ' ' THR . 3.5 ppt_? -105.07 155.24 19.18 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.167 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG21 ' HB1' ' A' ' 52' ' ' ALA . 86.4 t -116.14 123.54 71.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 C-N-CA 124.053 0.941 . . . . 0.0 109.898 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 28.3 t -101.07 124.07 54.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.95 126.47 15.92 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.941 0.496 . . . . 0.0 111.299 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.18 142.68 47.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.632 0.773 . . . . 0.0 110.23 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.25 135.57 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.136 0.493 . . . . 0.0 110.837 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 51.9 m-85 -115.39 129.1 56.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.6 1.16 . . . . 0.0 110.306 -170.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HB2' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -94.62 138.33 32.62 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.67 1.188 . . . . 0.0 108.878 179.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.043 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.06 147.77 9.79 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.246 1.018 . . . . 0.0 109.132 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.34 142.31 48.79 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.3 m -81.04 144.12 31.99 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.709 0.804 . . . . 0.0 110.419 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.11 130.96 44.52 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 16.2 tp -111.65 122.72 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.5 p -67.89 148.96 98.41 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.706 0.803 . . . . 0.0 111.083 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -41.06 -43.21 4.9 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 124.84 3.694 . . . . 0.0 115.601 -177.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.72 -39.77 66.68 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.061 0.544 . . . . 0.0 111.221 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -73.2 -25.02 60.6 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.251 0.62 . . . . 0.0 111.025 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.04 -31.8 56.49 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.276 1.03 . . . . 0.0 110.631 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.53 -23.32 56.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.919 0.888 . . . . 0.0 110.381 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.24 -47.09 16.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.753 0.821 . . . . 0.0 111.243 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -91.59 145.89 24.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.005 0.522 . . . . 0.0 110.613 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -95.39 118.98 66.1 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.53 0.732 . . . . 0.0 109.248 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.15 153.22 31.79 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.885 2.39 . . . . 0.0 112.309 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -94.08 -14.91 25.25 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.148 0.579 . . . . 0.0 111.701 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -166.83 164.73 16.42 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.318 0.647 . . . . 0.0 110.164 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 129.21 54.74 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.702 1.201 . . . . 0.0 108.777 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 56' ' ' VAL . 31.7 pt -95.72 156.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.485 0.714 . . . . 0.0 110.664 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.0 t -129.58 121.42 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 109.21 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.6 166.15 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 p -123.91 114.77 20.26 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.094 0.558 . . . . 0.0 110.982 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.64 90.28 1.05 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -92.73 94.66 9.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.177 0.591 . . . . 0.0 110.45 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 59.37 41.6 19.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.479 1.111 . . . . 0.0 109.841 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 14.8 m120 -115.38 166.78 11.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.528 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.44 168.53 16.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.859 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.9 tp -63.08 -32.83 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.269 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.11 79.61 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.447 0.467 . . . . 0.0 113.083 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 33.9 m-20 -75.05 -35.53 61.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.631 0.772 . . . . 0.0 110.531 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.94 70.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.934 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.34 -33.01 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.324 1.05 . . . . 0.0 110.759 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.5 t -63.68 -51.85 63.24 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.765 0.826 . . . . 0.0 110.832 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.81 95.3 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.264 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 40' ' ' ILE . 48.4 t -66.16 -40.11 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.924 0.89 . . . . 0.0 111.725 177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 t -63.62 -43.35 97.09 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.311 0.645 . . . . 0.0 110.742 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 32.0 ttt180 -65.3 -54.34 30.51 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.969 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 27.4 tpt180 -61.9 -38.13 87.21 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 124.063 0.852 . . . . 0.0 111.469 -169.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.36 90.39 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.643 0.777 . . . . 0.0 110.619 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.44 -31.61 72.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.685 0.794 . . . . 0.0 110.881 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 58' ' ' ARG . 4.8 mm-40 -67.04 -33.29 75.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.193 0.597 . . . . 0.0 110.357 176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 13.9 mm-40 -79.74 -12.96 59.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.287 0.635 . . . . 0.0 111.125 177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.12 28.05 14.45 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 123.218 0.324 . . . . 0.0 112.622 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.82 142.16 27.89 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 0.0 110.705 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.98 -27.72 33.04 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.819 0.847 . . . . 0.0 110.253 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 26' ' ' LEU . 50.4 m -142.88 167.75 21.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.91 0.884 . . . . 0.0 111.137 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 161.8 39.97 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.059 0.944 . . . . 0.0 109.629 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -155.48 125.11 6.42 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.971 0.508 . . . . 0.0 109.822 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.33 112.46 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 -41.67 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.456 0.703 . . . . 0.0 110.088 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 27.0 t70 -131.53 141.0 49.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.728 0.411 . . . . 0.0 110.66 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.0 p -135.41 106.14 6.54 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 171.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.1 t -121.88 111.09 16.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.904 0.482 . . . . 0.0 109.86 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 10.9 pt-20 -70.66 158.01 36.98 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.962 0.505 . . . . 0.0 111.414 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -59.34 -41.33 88.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.295 176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.69 90.75 0.09 OUTLIER Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 74.65 -19.82 0.36 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 125.451 1.5 . . . . 0.0 113.028 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.3 p -77.92 156.68 30.14 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.174 0.99 . . . . 0.0 111.13 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.37 -7.82 83.0 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.548 -0.751 . . . . 0.0 114.745 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.79 122.49 32.91 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.761 0.781 . . . . 0.0 109.462 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 4.6 p-90 -134.24 136.47 43.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.195 0.998 . . . . 0.0 111.688 -175.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -65.07 136.49 56.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.597 1.159 . . . . 0.0 110.198 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.6 t -121.89 106.65 18.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 59.8 t -96.68 124.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.015 0.926 . . . . 0.0 108.968 174.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.55 125.53 22.77 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.173 0.589 . . . . 0.0 110.952 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.87 144.28 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.704 0.802 . . . . 0.0 109.518 173.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.3 m -115.81 134.39 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.297 0.639 . . . . 0.0 110.196 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 68.5 m-85 -124.17 151.11 44.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.757 0.823 . . . . 0.0 110.54 -166.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.23 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.586 0.755 . . . . 0.0 110.755 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.819 0.848 . . . . 0.0 109.338 175.666 . . . . . . . . 0 0 . 1 stop_ save_